#SampleID	BarcodeSequence	LinkerPrimerSequence	TARGET_SUBFRAGMENT	SAMP_COLLECT_DEVICE	RUN_CENTER	ASSIGNED_FROM_GEO	EXPERIMENT_CENTER	TITLE	RUN_PREFIX	AGE	INVESTIGATION_TYPE	HOST_COMMON_NAME	DEPTH	SAMPLE_CENTER	HOST_TAXID	SUBMIT_TO_INSDC	COMMON_NAME	INCLUDES_TIMESERIES	PFPH	LONGITUDE	STUDY_ABSTRACT	BODY_SITE	SEQUENCING_METH	PROJECT_NAME	ELEVATION	RUN_DATE	HIV	COLLECTION_DATE	GENDER	ALTITUDE	ENV_BIOME	SRS	SEX	PLATFORM	COUNTRY	STUDY_TITLE	HMPBODYSUPERSITE	HOST_SUBJECT_ID	ANONYMIZED_NAME	TAXON_ID	REGION	SAMP_SIZE	ENV_FEATURE	STUDY_DESCRIPTION	SPECIFIC_BODY_SITE	MISLABELED	AGE_UNIT	MIENS_COMPLIANT	BODY_MASS_INDEX	EXPERIMENT_DESIGN_DESCRIPTION	Description_duplicate	BODY_HABITAT	ABX_PAST_6_MOS	OBESITY	ENV_MATTER	TARGET_GENE	CONTAMINATED	CHRONIC_CONDITION	KEY_SEQ	BODY_PRODUCT	PSN	MYOCARDINFARCT	STUDY_ID	COLLECTDAY	ATHEROSCLEROSIS	SMOKER	STUDY_ALIAS	PCR_PRIMERS	LIBRARY_CONSTRUCTION_PROTOCOL	VISITNO	LATITUDE	HYPERTENSION	HMPBODYSUBSITE	AGE_IN_YEARS	INTPH	STUDY_CENTER	Description
SRS013555.570652	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_251	SRR048269	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013555	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016576_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016548	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	4.7	BCM	HMP_production_phase_1
SRS011642.575855	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_173	SRR045467	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011642	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241795	241795	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033485_from_subject_159470302__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033484	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.1	WUGSC	HMP_production_phase_1
SRS055075.571093	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3898	SRR047156	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055075	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241863	241863	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105007_from_subject_275382046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106982	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	20	0	WUGSC	HMP_production_phase_1
SRS014355.570374	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_355	SRR043956	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023009_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS062455.573083	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4235	SRR046505	22.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257108	257108	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114882_from_subject_682102541__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114860	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	WUGSC	HMP_production_phase_1
SRS052681.576308	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3721	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052681	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102567_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	4.6	JCVI	HMP_production_phase_1
SRS057494.573500	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4110	SRR042911	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057494	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241792	241792	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107005_from_subject_159450072__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102976	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS018282.570729	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1319	SRR042912	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018282	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035689_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700035651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	3.9	BI	HMP_production_phase_1
SRS023559.571506	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2456	SRR043028	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099836_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099810	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS057537.574955	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4113	SRR043285	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101341_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700101306	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS016627.574609	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_935	SRR041250	31.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032380_from_subject_159915365__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032337	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	31	4.3	BI	HMP_production_phase_1
SRS043299.571343	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2859	SRR046410	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043299	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241861	241861	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106723_from_subject_184349034__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700106701	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS057051.574661	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4072	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057051	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108519_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108486	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	32	0	JCVI	HMP_production_phase_1
SRS017023.575878	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1020	SRR041558	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017023	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033536_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033535	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS045177.574326	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3041	SRR045888	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241886	241886	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038618_from_subject_404239096__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038590	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS058077.572170	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4161	SRR047214	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058077	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241860	241860	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105996_from_subject_465578759__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105989	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	31	4.4	WUGSC	HMP_production_phase_1
SRS015921.574456	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_732	SRR044641	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015921	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024576_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024550	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS066144.573251	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048869	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS065676.571725	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4729	SRR046746	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065676	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113519_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700113492	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS018912.574764	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1446	SRR045904	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018912	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241732	241732	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037381_from_subject_765216093__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037353	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS052312.576402	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3691	SRR048691	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052312	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109553_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109520	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	21	0	BCM	HMP_production_phase_1
SRS020298.572912	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1649	SRR041125	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020298	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095551_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	BI	HMP_production_phase_1
SRS019233.574711	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1485	SRR044466	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019233	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241800	241800	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037704_from_subject_765034022__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037683	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.2	WUGSC	HMP_production_phase_1
SRS017701.572771	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1169	SRR040913	30.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017701	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241710	241710	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034794_from_subject_160582958__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034772	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	4.1	BI	HMP_production_phase_1
SRS024108.573683	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2595	SRR041881	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024108	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100573_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100547	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS014426.575548	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_363	SRR043612	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014426	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023080_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023058	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	3.4	WUGSC	HMP_production_phase_1
SRS050761.576528	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3552	SRR046521	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050761	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038574_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038544	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS021625.574686	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1976	SRR048052	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097337_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097303	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	4.9	BCM	HMP_production_phase_1
SRS018441.572372	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1355	SRR041933	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018441	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035875_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035849	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS045908.571765	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3112	SRR045944	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045908	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038428_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038399	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	39	0	WUGSC	HMP_production_phase_1
SRS048194.572491	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3326	SRR049615	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048194	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241887	241887	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106910_from_subject_764811490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106874	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	21	5.3	WUGSC	HMP_production_phase_1
SRS018525.571690	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1380	SRR042815	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241667	241667	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035989_from_subject_160259276__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	4.1	BI	HMP_production_phase_1
SRS023318.574814	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2399	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023318	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099480_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099450	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.3	JCVI	HMP_production_phase_1
SRS014271.575150	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_331	SRR045535	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014271	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021860_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS023879.575298	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2540	SRR048218	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023879	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241755	241755	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100277_from_subject_158883629__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100241	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	4.9	BCM	HMP_production_phase_1
SRS045797.572855	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3101	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045797	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109904_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109874	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	0	JCVI	HMP_production_phase_1
SRS016028.575316	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_765	SRR044267	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016028	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241708	241708	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024683_from_subject_764447348__sex_male_	UBERON:nostril	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	WUGSC	HMP_production_phase_1
SRS014933.575007	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_479	SRR045720	33.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014933	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241808	241808	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023588_from_subject_763860675__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023556	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	WUGSC	HMP_production_phase_1
SRS015464.572001	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_610	SRR044651	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024119_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024092	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS050528.573069	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3536	SRR048654	29.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050528	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241711	241711	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108894_from_subject_160603188__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700108857	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	BCM	HMP_production_phase_1
SRS022609.573783	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2223	SRR041852	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022609	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241820	241820	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098561_from_subject_158499257__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098542	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS065665.572519	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4725	SRR047726	30.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065665	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257118	257118	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	TRUE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114939_from_subject_561079058__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700114911	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	4.1	WUGSC	HMP_production_phase_1
SRS018088.576347	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1267	SRR040597	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018088	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035412_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035379	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS023637.573680	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2480	SRR041407	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023637	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099940_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099902	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	20	4.9	BI	HMP_production_phase_1
SRS015139.571790	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_520	SRR043939	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015139	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023794_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023704	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	4.5	WUGSC	HMP_production_phase_1
SRS011433.572592	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_59	SRR044933	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011433	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016077_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016045	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS023461.572248	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2438	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023461	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099738_from_subject_246515023__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099739	n	969	13	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	38	4.8	JCVI	HMP_production_phase_1
SRS016619.570696	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_931	SRR043013	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032372_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032333	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	4.3	BI	HMP_production_phase_1
SRS024408.572344	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2674	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024408	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101554_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101525	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	5.1	BI	HMP_production_phase_1
SRS011450.576138	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_71	SRR045092	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016101_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016057	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	20	4.2	WUGSC	HMP_production_phase_1
SRS015635.572741	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_656	SRR044239	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015635	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024290_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024252	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.4	WUGSC	HMP_production_phase_1
SRS052249.571509	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3688	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052249	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107234_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107202	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS055924.572484	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3975	SRR046467	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055924	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241869	241869	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106968_from_subject_147406386__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106941	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	0	WUGSC	HMP_production_phase_1
SRS020012.576407	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1592	SRR040658	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020012	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095257_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700095224	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.3	BI	HMP_production_phase_1
SRS022438.574454	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2181	SRR048386	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022438	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098313_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098279	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	5.8	BCM	HMP_production_phase_1
SRS063850.574944	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4452	SRR047058	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063850	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113077_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113058	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	WUGSC	HMP_production_phase_1
SRS016619.576592	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_931	SRR043023	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032372_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032333	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	4.3	BI	HMP_production_phase_1
SRS023504.570883	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2445	SRR048224	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023504	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099781_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099754	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BCM	HMP_production_phase_1
SRS014835.573005	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_452	SRR045701	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014835	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241793	241793	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023489_from_subject_763921366__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023453	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.1	WUGSC	HMP_production_phase_1
SRS044265.573560	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2950	SRR047686	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044265	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241811	241811	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106050_from_subject_764184357__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106015	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	23	3.8	WUGSC	HMP_production_phase_1
SRS011563.573203	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_131	SRR044893	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011563	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033008_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033006	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.7	WUGSC	HMP_production_phase_1
SRS014976.574876	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_491	SRR046584	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014976	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241727	241727	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023631_from_subject_763880905__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023602	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	0	WUGSC	HMP_production_phase_1
SRS021978.573824	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2058	SRR041136	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021978	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097718_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097692	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	4.1	BI	HMP_production_phase_1
SRS015143.571445	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_521	SRR045776	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015143	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023798_from_subject_763901136__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700023706	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	4.5	WUGSC	HMP_production_phase_1
SRS045613.573221	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3088	SRR046419	32.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241879	241879	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106542_from_subject_553359145__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106504	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	32	4.3	WUGSC	HMP_production_phase_1
SRS046108.576547	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3134	SRR046041	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046108	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241864	241864	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038795_from_subject_508703490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700038758	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	5.3	WUGSC	HMP_production_phase_1
SRS011456.574679	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_74	SRR045331	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011456	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016154_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016125	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	WUGSC	HMP_production_phase_1
SRS056153.575428	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3992	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056153	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110389_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110360	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	4.4	JCVI	HMP_production_phase_1
SRS042566.571216	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2798	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042566	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109900_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109872	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	0	JCVI	HMP_production_phase_1
SRS024171.570309	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2613	SRR043008	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100639_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100610	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS017136.574960	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1049	SRR041041	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017136	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033698_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033697	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS014273.575308	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_332	SRR043646	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014273	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021862_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021313	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS045182.570247	TCAGAACCTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3042	SRR041451	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045182	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107087_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107054	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	0	BI	HMP_production_phase_1
SRS043873.573779	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2918	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102464_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102429	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS017136.573269	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1049	SRR041849	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017136	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033698_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700033697	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS015293.573785	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_567	SRR043753	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015293	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023948_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023925	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	37	0	WUGSC	HMP_production_phase_1
SRS023379.574353	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2416	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023379	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099545_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099519	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	0	JCVI	HMP_production_phase_1
SRS020384.570674	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1676	SRR041589	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020384	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095703_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	TRUE	y	TCAG	UBERON:sebum	700095664	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	32	4.2	BI	HMP_production_phase_1
SRS020944.576409	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1806	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020944	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096455_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096427	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	0	JCVI	HMP_production_phase_1
SRS016555.573271	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_914	SRR040687	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016555	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032282_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032241	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4	BI	HMP_production_phase_1
SRS024230.573517	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2628	SRR041771	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024230	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101117_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101087	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS011287.571662	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_24	SRR045119	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015283_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015281	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS017521.573614	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1137	SRR041050	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241691	241691	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034254_from_subject_160502038__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.1	BI	HMP_production_phase_1
SRS018149.573890	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1281	SRR040951	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018149	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035549_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035522	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS017559.573537	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1151	SRR040649	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034292_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034251	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	26	4.1	BI	HMP_production_phase_1
SRS053288.576616	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3765	SRR058084	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053288	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110401_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110366	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	4.4	JCVI	HMP_production_phase_1
SRS045752.572857	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3096	SRR045781	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045752	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038730_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038697	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	3.7	WUGSC	HMP_production_phase_1
SRS022251.576574	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2134	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022251	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098020_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097985	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	4.2	JCVI	HMP_production_phase_1
SRS013228.572778	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_215	SRR040728	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013228	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015935_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015934	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS014456.576022	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_375	SRR046061	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023110_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023073	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	3.4	WUGSC	HMP_production_phase_1
SRS046149.572489	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3141	SRR046531	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046149	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106026_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106003	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	3.8	WUGSC	HMP_production_phase_1
SRS023950.571490	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2559	SRR042961	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241725	241725	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100348_from_subject_159268001__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100311	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS016690.573929	TCAGCCGTTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_952	SRR041585	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016690	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241713	241713	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032474_from_subject_160036745__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032473	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	5	BI	HMP_production_phase_1
SRS024114.573848	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2598	SRR041245	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024114	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100579_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100550	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS015903.574295	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_725	SRR044592	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015903	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024558_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024541	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS014267.570816	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_330	SRR043777	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014267	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021856_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021140	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS044803.572997	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3006	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044803	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107224_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107197	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	JCVI	HMP_production_phase_1
SRS023385.575390	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2419	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023385	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099551_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099522	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	0	JCVI	HMP_production_phase_1
SRS020948.574031	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1808	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096459_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096429	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	0	JCVI	HMP_production_phase_1
SRS064682.570289	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4575	SRR048829	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064682	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268869	268869	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111807_from_subject_872848689__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111765	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.6	BCM	HMP_production_phase_1
SRS062536.576183	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4251	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062536	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110850_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110820	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	4.7	JCVI	HMP_production_phase_1
SRS051219.574878	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3593	SRR058084	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109260_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109234	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	4.8	JCVI	HMP_production_phase_1
SRS020470.572461	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1696	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241733	241733	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095793_from_subject_160825720__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700095774	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS063782.574309	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4439	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063782	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241742	241742	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111554_from_subject_336497421__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700111520	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	JCVI	HMP_production_phase_1
SRS014428.575496	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_364	SRR043588	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014428	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023082_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023059	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	3.4	WUGSC	HMP_production_phase_1
SRS011479.572965	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_86	SRR045426	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011479	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241760	241760	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016178_from_subject_159146620__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016138	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	WUGSC	HMP_production_phase_1
SRS014603.575337	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_400	SRR045672	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014603	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023257_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	4.1	WUGSC	HMP_production_phase_1
SRS015655.571253	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_658	SRR044472	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241845	241845	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024310_from_subject_764487809__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024292	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS024179.570624	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2617	SRR040639	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024179	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100647_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100614	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS049760.572890	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3457	SRR046575	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049760	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038724_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038694	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS045209.575975	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3045	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045209	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102338_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102309	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	JCVI	HMP_production_phase_1
SRS016531.575671	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_902	SRR043257	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016531	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032258_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4	BI	HMP_production_phase_1
SRS066144.575957	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR052699	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS024468.575380	TCAGAACGGTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2689	SRR041825	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101614_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101588	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	38	0	BI	HMP_production_phase_1
SRS064296.574033	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4523	SRR046742	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064296	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113132_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113108	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	0	WUGSC	HMP_production_phase_1
SRS062712.575780	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4281	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062712	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110856_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110823	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	4.7	JCVI	HMP_production_phase_1
SRS050936.572700	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3564	SRR046854	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050936	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105187_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105156	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	4.3	WUGSC	HMP_production_phase_1
SRS047546.570896	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3263	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047546	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110460_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110430	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	0	JCVI	HMP_production_phase_1
SRS063720.570457	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4427	SRR046464	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063720	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257114	257114	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114503_from_subject_739574095__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114482	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.8	WUGSC	HMP_production_phase_1
SRS021131.575798	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1852	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021131	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096678_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096601	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	20	4.9	JCVI	HMP_production_phase_1
SRS017537.571983	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1141	SRR041133	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017537	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034270_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034240	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS057586.575396	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4118	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057586	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102342_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102311	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	JCVI	HMP_production_phase_1
SRS018220.571345	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1303	SRR040708	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018220	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035627_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035590	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS017422.572507	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1114	SRR040643	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017422	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241703	241703	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034128_from_subject_160481808__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034095	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	BI	HMP_production_phase_1
SRS013468.571104	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_236	SRR041846	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016399_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016383	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	BI	HMP_production_phase_1
SRS020783.570733	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1770	SRR058111	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020783	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241780	241780	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096208_from_subject_161412393__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS014353.573297	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_354	SRR043794	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014353	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023007_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700021287	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	0	WUGSC	HMP_production_phase_1
SRS051778.572253	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3640	SRR046778	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051778	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105130_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105099	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	5.6	WUGSC	HMP_production_phase_1
SRS020153.571342	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1616	SRR048378	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020153	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241827	241827	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095406_from_subject_158398106__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095370	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	31	0	BCM	HMP_production_phase_1
SRS021498.570616	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1943	SRR041579	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021498	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097210_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097184	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS016158.574576	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_798	SRR047414	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016158	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024815_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024792	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	3.9	WUGSC	HMP_production_phase_1
SRS016930.575382	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_999	SRR042919	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016930	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033396_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033370	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS022755.575631	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2261	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022755	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098711_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098679	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	4.1	JCVI	HMP_production_phase_1
SRS018102.573993	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1274	SRR041907	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018102	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035426_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035386	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS014653.570943	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_412	SRR047365	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023307_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023287	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	37	0	WUGSC	HMP_production_phase_1
SRS013654.575379	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_266	SRR041522	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013654	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016732_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016700	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	33	0	BI	HMP_production_phase_1
SRS043234.575941	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2853	SRR045982	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043234	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241884	241884	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038406_from_subject_765701615__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038388	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS048224.573800	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3328	SRR049415	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241886	241886	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038622_from_subject_404239096__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS045627.576406	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3090	SRR048520	25.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045627	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241671	241671	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107949_from_subject_160056975__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107930	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BCM	HMP_production_phase_1
SRS018161.575874	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1287	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018161	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035561_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS045403.570225	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3069	SRR048734	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045403	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108947_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108912	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS058170.574805	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4166	SRR047679	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058170	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105741_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105724	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	WUGSC	HMP_production_phase_1
SRS021930.573237	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2051	SRR048076	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021930	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097670_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097641	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	0	BCM	HMP_production_phase_1
SRS063570.574937	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4409	SRR048807	38.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063570	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268878	268878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111276_from_subject_866653606__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700111238	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	38	5	BCM	HMP_production_phase_1
SRS011661.575729	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_182	SRR045109	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011661	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033765_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.4	WUGSC	HMP_production_phase_1
SRS050434.576099	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3528	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050434	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110397_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110364	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	4.4	JCVI	HMP_production_phase_1
SRS024124.573293	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2603	SRR041263	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024124	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100589_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100555	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS015927.571237	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_735	SRR044640	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015927	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024582_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS017551.574763	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1148	SRR040652	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017551	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034284_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700034247	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	4.1	BI	HMP_production_phase_1
SRS020245.571903	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1635	SRR040603	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020245	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095498_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095473	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	0	BI	HMP_production_phase_1
SRS020022.570483	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1597	SRR040747	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020022	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095267_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700095229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4.3	BI	HMP_production_phase_1
SRS044996.573503	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3027	SRR048630	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044996	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108568_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108538	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	30	3.9	BCM	HMP_production_phase_1
SRS018457.575440	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1363	SRR041011	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018457	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035891_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS057726.572080	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4133	SRR048594	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057726	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107798_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107769	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	0	BCM	HMP_production_phase_1
SRS063603.572835	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4410	SRR046763	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063603	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114633_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114605	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	4.3	WUGSC	HMP_production_phase_1
SRS018962.576085	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1451	SRR045895	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018962	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241737	241737	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037431_from_subject_765276783__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037402	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS013506.570645	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_244	SRR041789	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013506	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016486_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016464	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS066144.571333	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048659	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS013583.570664	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_260	SRR048270	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013583	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016604_from_subject_159227541__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016562	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	22	4.7	BCM	HMP_production_phase_1
SRS046874.570323	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3203	SRR048879	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046874	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107922_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107888	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	BCM	HMP_production_phase_1
SRS016432.573247	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_881	SRR042840	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016432	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032119_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032084	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS015468.572711	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_612	SRR044737	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024123_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024094	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS013658.572826	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_268	SRR041577	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013658	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016736_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016702	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	BI	HMP_production_phase_1
SRS055987.576200	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3982	SRR046273	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055987	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105240_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105211	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	4	WUGSC	HMP_production_phase_1
SRS015139.571399	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_520	SRR049362	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015139	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023794_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700023704	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	4.5	WUGSC	HMP_production_phase_1
SRS024301.575112	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2649	SRR041919	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024301	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101279_from_subject_158944319__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700101242	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	3.7	BI	HMP_production_phase_1
SRS019091.574372	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1472	SRR044681	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019091	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037562_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037540	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS057633.575073	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4125	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057633	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109778_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109754	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	JCVI	HMP_production_phase_1
SRS064119.575537	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4502	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111845_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111817	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	36	0	JCVI	HMP_production_phase_1
SRS049648.573969	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3451	SRR049506	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049648	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106916_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106405	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS017886.573743	TCAGTCGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1218	SRR041368	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035184_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035161	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	33	0	BI	HMP_production_phase_1
SRS011541.572042	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_120	SRR044947	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011541	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016640_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016638	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS045145.571497	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3035	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045145	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110317_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110291	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	4.3	JCVI	HMP_production_phase_1
SRS056367.572213	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4012	SRR048546	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108931_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108904	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BCM	HMP_production_phase_1
SRS019087.576091	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1470	SRR044734	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019087	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037558_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037538	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS043704.572569	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2904	SRR048518	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043704	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107599_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700107563	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	0	BCM	HMP_production_phase_1
SRS019087.575655	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1470	SRR044672	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019087	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037558_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700037538	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS017963.574473	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1242	SRR043048	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017963	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241809	241809	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035284_from_subject_158357646__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035251	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS011617.571700	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_160	SRR044924	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033193_from_subject_159733294__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033150	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.3	WUGSC	HMP_production_phase_1
SRS011651.573687	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_177	SRR049313	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011651	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033501_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033499	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.1	WUGSC	HMP_production_phase_1
SRS014550.571626	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_384	SRR045706	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014550	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241730	241730	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023204_from_subject_763638144__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023177	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	3.8	WUGSC	HMP_production_phase_1
SRS024590.570997	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2722	SRR041064	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024590	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101881_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700101851	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS018145.574360	TCAGTTCCGTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1279	SRR040926	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018145	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035545_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035521	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS021820.575351	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2026	SRR058120	40.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021820	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241849	241849	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097533_from_subject_161473083__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097496	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	40	0	JCVI	HMP_production_phase_1
SRS014677.573693	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_423	SRR043592	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023331_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS013674.570599	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_276	SRR042013	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013674	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241672	241672	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016752_from_subject_159288231__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700016710	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS016458.573972	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_886	SRR043010	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032154_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032153	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS020310.575172	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1654	SRR041695	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020310	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095563_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095534	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	BI	HMP_production_phase_1
SRS024470.573418	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2690	SRR041082	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101616_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101589	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	38	0	BI	HMP_production_phase_1
SRS056028.573327	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3984	SRR046624	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056028	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106426_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106403	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS062954.574219	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4316	SRR046816	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062954	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114623_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114600	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	4.3	WUGSC	HMP_production_phase_1
SRS011468.575985	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_80	SRR045130	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016166_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016131	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	WUGSC	HMP_production_phase_1
SRS011499.574718	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_98	SRR045443	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011499	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016339_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016311	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	34	0	WUGSC	HMP_production_phase_1
SRS021175.572518	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1861	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021175	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241842	241842	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096722_from_subject_161007791__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096700	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	5	JCVI	HMP_production_phase_1
SRS023993.574685	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2567	SRR040965	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023993	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100454_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100424	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	0	BI	HMP_production_phase_1
SRS016070.574063	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_777	SRR044416	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016070	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024727_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700024697	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	WUGSC	HMP_production_phase_1
SRS016681.572094	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_949	SRR042824	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016681	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032465_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032464	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	5	BI	HMP_production_phase_1
SRS063918.574122	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4463	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063918	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241742	241742	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111524_from_subject_336497421__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700111505	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	JCVI	HMP_production_phase_1
SRS024343.576600	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2655	SRR041059	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024343	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101378_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101353	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS055888.571398	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3973	SRR049600	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055888	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241854	241854	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106924_from_subject_517810313__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106409	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS055772.573232	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3956	SRR048397	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102940_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102913	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	BCM	HMP_production_phase_1
SRS048599.575620	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3354	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048599	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109782_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109756	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	JCVI	HMP_production_phase_1
SRS018964.571818	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1452	SRR045894	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018964	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241737	241737	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037433_from_subject_765276783__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037403	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS017294.571899	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1083	SRR042873	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017294	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033969_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS011565.574053	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_132	SRR045342	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011565	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033011_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033009	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.7	WUGSC	HMP_production_phase_1
SRS063873.570625	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4456	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111065_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111036	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	JCVI	HMP_production_phase_1
SRS046089.575775	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3133	SRR048768	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046089	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109557_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109522	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	21	0	BCM	HMP_production_phase_1
SRS023571.570925	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2462	SRR041208	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023571	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099848_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099816	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS020366.574302	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1667	SRR041493	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020366	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095685_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095655	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	32	4.2	BI	HMP_production_phase_1
SRS015856.573646	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_712	SRR046573	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015856	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024511_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024493	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS019083.573366	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1469	SRR044727	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019083	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037554_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037536	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS017292.574815	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1082	SRR041229	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017292	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033967_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033935	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS064672.573061	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4574	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064672	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110746_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110714	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	JCVI	HMP_production_phase_1
SRS018015.572340	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1250	SRR040762	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018015	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035339_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035306	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS020502.572375	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1706	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020502	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241733	241733	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095825_from_subject_160825720__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095790	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	JCVI	HMP_production_phase_1
SRS042780.570535	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2819	SRR048906	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042780	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108214_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108178	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	21	0	BCM	HMP_production_phase_1
SRS019757.572573	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1550	SRR044106	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019757	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038233_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038216	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	0	WUGSC	HMP_production_phase_1
SRS051884.574926	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3651	SRR047185	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051884	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241857	241857	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106567_from_subject_208027353__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700106545	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	4.3	WUGSC	HMP_production_phase_1
SRS063018.571904	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4328	SRR046284	38.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063018	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114155_from_subject_763840445__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114120	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	38	4.7	WUGSC	HMP_production_phase_1
SRS011578.572791	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_140	SRR049234	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011578	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033035_from_subject_159247771__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700033033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.7	WUGSC	HMP_production_phase_1
SRS065421.570434	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4677	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065421	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241817	241817	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110834_from_subject_809635352__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110812	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	4.7	JCVI	HMP_production_phase_1
SRS053893.575111	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3815	SRR046404	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053893	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105654_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105624	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	3.8	WUGSC	HMP_production_phase_1
SRS048741.573252	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3369	SRR049397	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048741	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241845	241845	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105396_from_subject_764487809__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105367	n	969	234	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS042246.572414	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2769	SRR048627	26.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042246	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108159_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108116	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	26	3.9	BCM	HMP_production_phase_1
SRS016669.571504	TCAGTCCGGTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_945	SRR041632	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016669	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032453_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032452	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	5	BI	HMP_production_phase_1
SRS023143.571383	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2361	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023143	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241757	241757	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099274_from_subject_441369442__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700099284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	JCVI	HMP_production_phase_1
SRS016865.573324	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_985	SRR041689	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016865	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033226_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033225	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS013674.572760	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_276	SRR042815	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013674	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241672	241672	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016752_from_subject_159288231__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	NA	y	TCAG	UBERON:nasal mucus	700016710	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS050971.572244	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3568	SRR046309	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050971	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105687_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105667	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	31	5	WUGSC	HMP_production_phase_1
SRS042780.570413	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2819	SRR048747	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042780	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108214_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108178	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	21	0	BCM	HMP_production_phase_1
SRS022775.575137	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2271	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022775	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098731_from_subject_370425937__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098689	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	22	0	JCVI	HMP_production_phase_1
SRS021326.575513	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1901	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021326	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096984_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096954	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	0	JCVI	HMP_production_phase_1
SRS065595.572801	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4713	SRR047332	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065595	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257126	257126	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114985_from_subject_103092734__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	WUGSC	HMP_production_phase_1
SRS015829.574605	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_707	SRR044700	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015829	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024484_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024456	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	21	0	WUGSC	HMP_production_phase_1
SRS018392.574182	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1347	SRR041449	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018392	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035826_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035796	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	0	BI	HMP_production_phase_1
SRS019109.570546	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1480	SRR044760	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019109	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037580_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037549	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS056878.574983	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4063	SRR046283	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056878	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241717	241717	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105721_from_subject_763456073__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105684	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	31	5	WUGSC	HMP_production_phase_1
SRS013837.571779	TCAGTCCGGTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_315	SRR041142	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013837	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016997_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016996	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	0	BI	HMP_production_phase_1
SRS016176.571781	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_806	SRR044454	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016176	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241696	241696	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024833_from_subject_764366428__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024801	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	3.9	WUGSC	HMP_production_phase_1
SRS021664.571072	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1984	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021664	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241688	241688	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097376_from_subject_161331472__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097357	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	JCVI	HMP_production_phase_1
SRS021073.574035	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1831	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021073	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096620_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096572	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	4.8	JCVI	HMP_production_phase_1
SRS020306.571286	TCAGAAGTCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1652	SRR041882	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020306	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095559_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	BI	HMP_production_phase_1
SRS051466.575266	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3619	SRR047195	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051466	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103249_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105976	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	31	4.4	WUGSC	HMP_production_phase_1
SRS047411.571202	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3248	SRR048612	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047411	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108133_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108103	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	BCM	HMP_production_phase_1
SRS017300.570855	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1086	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017300	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033975_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033939	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS022113.572306	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2095	SRR041444	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022113	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097879_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097847	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	4.4	BI	HMP_production_phase_1
SRS064462.572000	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4547	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110742_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110712	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	35	0	JCVI	HMP_production_phase_1
SRS055879.573376	TCAGAACCTTATC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_3971	SRR041400	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055879	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107067_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107044	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	0	BI	HMP_production_phase_1
SRS019735.575585	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1549	SRR049431	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019735	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241779	241779	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038211_from_subject_765539774__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	3.8	WUGSC	HMP_production_phase_1
SRS017971.576217	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1244	SRR042954	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017971	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241809	241809	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035292_from_subject_158357646__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035255	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS058590.574970	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4205	SRR048758	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058590	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110145_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700110106	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	4.3	BCM	HMP_production_phase_1
SRS021641.570463	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1982	SRR048056	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021641	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241668	241668	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097353_from_subject_158013734__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097311	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	22	4.9	BCM	HMP_production_phase_1
SRS017298.571000	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1085	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017298	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033973_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033938	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS011452.573598	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_72	SRR044944	28.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011452	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241760	241760	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016142_from_subject_159146620__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016136	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	WUGSC	HMP_production_phase_1
SRS014952.571139	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_481	SRR051577	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014952	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023607_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023590	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	32	0	WUGSC	HMP_production_phase_1
SRS022436.575753	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2180	SRR048197	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022436	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098311_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098278	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	5.8	BCM	HMP_production_phase_1
SRS053293.571487	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3766	SRR048506	31.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053293	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108658_from_subject_159915365__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108616	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	31	4	BCM	HMP_production_phase_1
SRS049990.576615	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3477	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049990	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110203_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110168	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	38	4.5	JCVI	HMP_production_phase_1
SRS020324.575480	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1661	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020324	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095577_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095541	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS020018.571229	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1595	SRR040673	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020018	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095263_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095227	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.3	BI	HMP_production_phase_1
SRS051180.572263	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3587	SRR048746	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051180	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108208_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108175	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	21	0	BCM	HMP_production_phase_1
SRS045771.572907	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3098	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045771	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109155_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109120	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	4.1	JCVI	HMP_production_phase_1
SRS016174.572640	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_805	SRR044512	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016174	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241696	241696	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024831_from_subject_764366428__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024800	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	3.9	WUGSC	HMP_production_phase_1
SRS011405.576483	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_45	SRR049315	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011405	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241834	241834	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015981_from_subject_159247771__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700015979	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.7	WUGSC	HMP_production_phase_1
SRS011655.573884	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_179	SRR045111	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011655	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033757_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033730	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.4	WUGSC	HMP_production_phase_1
SRS053513.574826	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3786	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053513	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109276_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109242	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	4.8	JCVI	HMP_production_phase_1
SRS057163.572051	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4081	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102352_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	JCVI	HMP_production_phase_1
SRS018455.576082	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1362	SRR041040	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035889_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS016874.572702	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_988	SRR042015	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016874	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033235_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS051311.576526	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3604	SRR047691	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051311	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103253_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105978	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	31	4.4	WUGSC	HMP_production_phase_1
SRS052640.574248	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3720	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052640	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110269_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110234	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	40	4.9	JCVI	HMP_production_phase_1
SRS043353.576305	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2866	SRR046306	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043353	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105701_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105674	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	31	5	WUGSC	HMP_production_phase_1
SRS020135.570296	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1607	SRR048129	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020135	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095388_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095361	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	31	0	BCM	HMP_production_phase_1
SRS015452.575634	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_606	SRR044648	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015452	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024107_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700024086	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS023693.571255	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2493	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023693	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100000_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099967	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	4.1	JCVI	HMP_production_phase_1
SRS049313.574491	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3420	SRR047402	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049313	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038510_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038488	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	31	0	WUGSC	HMP_production_phase_1
SRS017855.573099	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1215	SRR042885	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017855	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034960_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034924	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS056730.571712	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4046	SRR045879	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056730	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241853	241853	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038972_from_subject_370027359__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038953	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	30	0	WUGSC	HMP_production_phase_1
SRS017080.574607	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1031	SRR041260	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017080	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033593_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033567	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	BI	HMP_production_phase_1
SRS017041.573626	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1026	SRR043252	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017041	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033554_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS065165.572777	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4640	SRR046736	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065165	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241824	241824	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113535_from_subject_763719065__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700113500	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	25	0	WUGSC	HMP_production_phase_1
SRS065520.572651	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4698	SRR049577	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065520	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113085_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113062	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	WUGSC	HMP_production_phase_1
SRS024042.573263	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2578	SRR042957	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024042	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100504_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100478	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	4.7	BI	HMP_production_phase_1
SRS017100.575290	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1041	SRR041231	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017100	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241705	241705	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033613_from_subject_159611913__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033577	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS018400.575526	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1350	SRR042796	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018400	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035834_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035800	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS023766.570801	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2514	SRR042827	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023766	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100073_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100038	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS064766.572177	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4585	SRR048845	39.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064766	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268877	268877	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111352_from_subject_763721271__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700111313	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	39	4.8	BCM	HMP_production_phase_1
SRS042764.574480	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2818	SRR043036	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042764	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101339_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101305	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS022693.570875	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2246	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022693	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098645_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098611	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	4.6	JCVI	HMP_production_phase_1
SRS024404.576410	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2672	SRR041144	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024404	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101550_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101523	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	5.1	BI	HMP_production_phase_1
SRS016329.572715	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_851	SRR047435	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016329	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024992_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024963	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	20	0	WUGSC	HMP_production_phase_1
SRS015287.575450	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_564	SRR046149	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023942_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023922	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS049958.571096	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3472	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110030_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109999	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS016553.575894	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_913	SRR040582	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016553	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032280_from_subject_159753524__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4	BI	HMP_production_phase_1
SRS015950.571367	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_738	SRR044483	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241769	241769	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024605_from_subject_764325968__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024588	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	WUGSC	HMP_production_phase_1
SRS018280.571930	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1318	SRR042968	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018280	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035687_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035650	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	3.9	BI	HMP_production_phase_1
SRS014972.570302	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_490	SRR046592	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014972	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023627_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023600	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS021994.571163	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2065	SRR041913	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021994	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097734_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700097700	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	4.1	BI	HMP_production_phase_1
SRS048659.570597	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3360	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108316_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108290	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	JCVI	HMP_production_phase_1
SRS064913.576401	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4603	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064913	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110738_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110710	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	0	JCVI	HMP_production_phase_1
SRS042643.570444	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2809	SRR049340	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042643	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038600_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038581	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	WUGSC	HMP_production_phase_1
SRS065578.573250	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4706	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065578	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111620_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111586	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	39	4.8	JCVI	HMP_production_phase_1
SRS016125.573616	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_791	SRR044396	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024782_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024747	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	4.5	WUGSC	HMP_production_phase_1
SRS019663.575358	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1536	SRR045856	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038134_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700038114	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS055631.570786	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3942	SRR047151	22.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055631	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241769	241769	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105284_from_subject_764325968__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105263	n	969	216	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	0	WUGSC	HMP_production_phase_1
SRS049142.571953	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3403	SRR047672	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049142	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105427_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105405	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	34	4.2	WUGSC	HMP_production_phase_1
SRS024568.571681	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2715	SRR040712	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024568	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241833	241833	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101859_from_subject_159591683__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700101840	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS011686.570468	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_194	SRR045291	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011686	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033791_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700033747	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.4	WUGSC	HMP_production_phase_1
SRS016541.574390	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_907	SRR041111	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016541	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032268_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4	BI	HMP_production_phase_1
SRS023145.570507	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2362	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023145	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241757	241757	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099276_from_subject_441369442__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099285	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.3	JCVI	HMP_production_phase_1
SRS043568.570788	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2888	SRR048716	33.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043568	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102901_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700102865	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	33	0	BCM	HMP_production_phase_1
SRS016424.570841	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_877	SRR041383	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016424	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032111_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032080	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS018258.571097	TCAGCCGTTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1308	SRR041200	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035665_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035639	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	3.9	BI	HMP_production_phase_1
SRS015929.574684	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_736	SRR044608	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015929	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024584_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS013252.573761	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_222	SRR040791	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013252	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015959_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015958	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS019310.571761	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1503	SRR045992	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019310	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241848	241848	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037781_from_subject_765377934__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037750	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	35	4.1	WUGSC	HMP_production_phase_1
SRS022195.570556	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2121	SRR058111	27.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022195	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097964_from_subject_638754422__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700097924	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.5	JCVI	HMP_production_phase_1
SRS019990.576063	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1585	SRR041100	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019990	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241847	241847	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095235_from_subject_160643649__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700095213	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.3	BI	HMP_production_phase_1
SRS011621.570901	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_162	SRR044922	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241795	241795	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033438_from_subject_159470302__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033436	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.1	WUGSC	HMP_production_phase_1
SRS011623.572345	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_163	SRR044984	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033450_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033448	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.1	WUGSC	HMP_production_phase_1
SRS024418.573750	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2679	SRR040785	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024418	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101564_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101530	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	5.1	BI	HMP_production_phase_1
SRS024416.573921	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2678	SRR040757	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024416	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101562_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101529	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	5.1	BI	HMP_production_phase_1
SRS022033.571876	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2074	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022033	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241738	241738	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097773_from_subject_161554003__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097754	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	31	0	JCVI	HMP_production_phase_1
SRS047327.576169	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3244	SRR046841	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047327	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105808_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105780	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.6	WUGSC	HMP_production_phase_1
SRS020995.573872	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1817	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020995	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096542_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096517	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	JCVI	HMP_production_phase_1
SRS017420.570810	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1113	SRR041895	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017420	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034126_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034094	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	30	0	BI	HMP_production_phase_1
SRS057589.576012	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4119	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057589	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110023_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109995	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	JCVI	HMP_production_phase_1
SRS024576.576449	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2716	SRR040797	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024576	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101867_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101844	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS046361.574111	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3161	SRR048608	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108192_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108167	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	21	0	BCM	HMP_production_phase_1
SRS043640.574145	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2897	SRR048285	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043640	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241796	241796	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102637_from_subject_159227541__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102600	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.5	BCM	HMP_production_phase_1
SRS011510.574929	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_104	SRR045129	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011510	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016364_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016348	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	20	4.2	WUGSC	HMP_production_phase_1
SRS051970.575576	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3658	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051970	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241867	241867	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101831_from_subject_514014184__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101790	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	21	4.2	JCVI	HMP_production_phase_1
SRS066144.574823	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043076	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS015564.576225	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_632	SRR043995	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015564	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024219_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024194	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	18	0	WUGSC	HMP_production_phase_1
SRS058420.572751	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4192	SRR047615	30.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058420	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241853	241853	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038976_from_subject_370027359__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038955	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	0	WUGSC	HMP_production_phase_1
SRS016984.576174	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1012	SRR045483	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016984	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241795	241795	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033489_from_subject_159470302__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033487	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.1	WUGSC	HMP_production_phase_1
SRS022257.572432	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2136	SRR058111	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022257	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241786	241786	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098026_from_subject_970836795__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097988	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	4.2	JCVI	HMP_production_phase_1
SRS062703.571305	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4279	SRR047331	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062703	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241730	241730	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114293_from_subject_763638144__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114270	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	4.5	WUGSC	HMP_production_phase_1
SRS050457.576087	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3530	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050457	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102159_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102125	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	36	3.9	JCVI	HMP_production_phase_1
SRS014601.571726	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_399	SRR049406	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014601	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023255_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	4.1	WUGSC	HMP_production_phase_1
SRS014562.570872	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_389	SRR045676	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014562	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023216_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	3.8	WUGSC	HMP_production_phase_1
SRS016561.572883	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_917	SRR042843	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032288_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS021750.570367	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2007	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021750	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097463_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097428	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.1	JCVI	HMP_production_phase_1
SRS015261.576292	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_559	SRR043999	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015261	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241729	241729	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023916_from_subject_764143897__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023879	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.4	WUGSC	HMP_production_phase_1
SRS048853.572732	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3379	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257113	257113	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102678_from_subject_840279516__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102659	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS020881.574433	TCAGAACGTTCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1788	SRR041512	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020881	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096392_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096367	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	31	0	BI	HMP_production_phase_1
SRS049396.574725	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3428	SRR047211	18.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049396	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241874	241874	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106091_from_subject_737052003__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106064	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	18	4.5	WUGSC	HMP_production_phase_1
SRS053569.571447	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3792	SRR048454	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053569	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102893_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102861	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	33	0	BCM	HMP_production_phase_1
SRS011472.574267	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_82	SRR047469	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016170_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700016133	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	WUGSC	HMP_production_phase_1
SRS058160.572356	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4165	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058160	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108997_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108964	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	4.3	JCVI	HMP_production_phase_1
SRS020139.571922	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1609	SRR048132	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020139	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095392_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095363	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	31	0	BCM	HMP_production_phase_1
SRS046739.573605	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3191	SRR046697	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046739	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106964_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106939	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	0	WUGSC	HMP_production_phase_1
SRS063429.572254	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4383	SRR047336	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063429	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241876	241876	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113033_from_subject_764750800__sex_male_	UBERON:nostril	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700113012	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	21	0	WUGSC	HMP_production_phase_1
SRS058543.572163	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4202	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110015_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109991	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	JCVI	HMP_production_phase_1
SRS024474.570505	TCAGTTCAACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2692	SRR041708	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101620_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101591	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	38	0	BI	HMP_production_phase_1
SRS017096.574325	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1039	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033609_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033575	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS016678.572737	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_948	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016678	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032462_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032461	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	5	BI	HMP_production_phase_1
SRS021091.574770	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1839	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021091	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096638_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096581	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	4.8	JCVI	HMP_production_phase_1
SRS051551.576269	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3623	SRR043796	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051551	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038504_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038485	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	31	0	WUGSC	HMP_production_phase_1
SRS050838.575500	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3558	SRR046138	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050838	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038888_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038863	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS056749.572418	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4050	SRR048521	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056749	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107965_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107938	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BCM	HMP_production_phase_1
SRS016545.572887	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_909	SRR040624	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032272_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032236	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4	BI	HMP_production_phase_1
SRS018769.575381	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1427	SRR044392	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018769	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241832	241832	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037236_from_subject_765013792__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037141	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	21	4.5	WUGSC	HMP_production_phase_1
SRS019830.572020	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1566	SRR045908	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019830	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241790	241790	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038306_from_subject_765661155__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038276	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	4.3	WUGSC	HMP_production_phase_1
SRS065619.571794	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4718	SRR048795	27.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268876	268876	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111216_from_subject_257905678__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.9	BCM	HMP_production_phase_1
SRS049955.573636	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3471	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049955	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241694	241694	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109376_from_subject_160866180__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109335	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	4.6	JCVI	HMP_production_phase_1
SRS064586.575401	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4559	SRR058092	39.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064586	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268866	268866	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111624_from_subject_937495960__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111588	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	39	0	JCVI	HMP_production_phase_1
SRS013177.574389	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_199	SRR040857	22.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241704	241704	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015876_from_subject_159369152__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700015857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	0	BI	HMP_production_phase_1
SRS047795.571780	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3294	SRR048607	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047795	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108202_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108172	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	21	0	BCM	HMP_production_phase_1
SRS063551.571530	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4406	SRR046995	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063551	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114745_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114715	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	0	WUGSC	HMP_production_phase_1
SRS051098.573036	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3581	SRR047125	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051098	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105648_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105621	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	3.8	WUGSC	HMP_production_phase_1
SRS017038.574203	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1025	SRR042796	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017038	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033551_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033550	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS024363.570333	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2665	SRR042796	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024363	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101398_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101363	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS015194.575809	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_536	SRR046518	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015194	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023849_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023817	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4	WUGSC	HMP_production_phase_1
SRS024704.576019	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2750	SRR058092	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024704	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102084_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102054	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	0	JCVI	HMP_production_phase_1
SRS066144.572817	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058114	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS064603.574200	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4562	SRR047680	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064603	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114078_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114053	n	969	286	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	20	5.6	WUGSC	HMP_production_phase_1
SRS021257.575071	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1881	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021257	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096903_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096873	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	34	5.3	JCVI	HMP_production_phase_1
SRS011273.575418	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_17	SRR045343	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011273	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015260_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015257	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	WUGSC	HMP_production_phase_1
SRS052195.572740	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3681	SRR048412	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052195	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241796	241796	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102635_from_subject_159227541__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102599	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	4.5	BCM	HMP_production_phase_1
SRS019079.573989	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1467	SRR044725	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019079	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037550_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037534	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS024488.572903	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2699	SRR042926	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101634_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101598	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	38	0	BI	HMP_production_phase_1
SRS011363.575184	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_35	SRR045134	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011363	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015647_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015645	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	33	0	WUGSC	HMP_production_phase_1
SRS021015.576604	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1827	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021015	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096562_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096527	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS062964.573468	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4319	SRR050031	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062964	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257117	257117	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114588_from_subject_875002022__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	WUGSC	HMP_production_phase_1
SRS043928.575227	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2925	SRR049402	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043928	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241844	241844	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105222_from_subject_763820215__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105202	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	4	WUGSC	HMP_production_phase_1
SRS022964.571896	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2314	SRR048107	37.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022964	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241781	241781	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098994_from_subject_158236265__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098952	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	37	4.6	BCM	HMP_production_phase_1
SRS052063.573555	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3667	SRR040985	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052063	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102999_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102973	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS015625.570304	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_651	SRR046077	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024280_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024247	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.4	WUGSC	HMP_production_phase_1
SRS055789.576163	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3959	SRR048562	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055789	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109663_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109631	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	19	4.7	BCM	HMP_production_phase_1
SRS047781.573284	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3292	SRR048619	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047781	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108139_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108106	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	BCM	HMP_production_phase_1
SRS046353.572129	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3160	SRR043038	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046353	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102407_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102372	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS015823.572989	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_704	SRR047451	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015823	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024478_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024453	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	21	0	WUGSC	HMP_production_phase_1
SRS011549.575967	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_124	SRR047475	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011549	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016652_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016650	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS015401.572171	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_595	SRR046156	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015401	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024056_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024030	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	3.6	WUGSC	HMP_production_phase_1
SRS011525.570248	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_112	SRR044845	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016504_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016499	n	969	23	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	34	3.6	WUGSC	HMP_production_phase_1
SRS019669.576106	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1539	SRR045916	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038142_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:mucus	700038118	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS017497.576188	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1136	SRR041213	19.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017497	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034230_from_subject_160319967__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034187	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	19	5.1	BI	HMP_production_phase_1
SRS053409.574222	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3775	SRR044092	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053409	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106036_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106008	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	3.8	WUGSC	HMP_production_phase_1
SRS011423.572874	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_54	SRR045321	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011423	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016067_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016040	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS022033.573903	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2074	SRR058114	31.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022033	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241738	241738	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097773_from_subject_161554003__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097754	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	31	0	JCVI	HMP_production_phase_1
SRS066144.572100	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058098	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS015572.573107	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_636	SRR044123	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015572	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024227_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024198	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	18	0	WUGSC	HMP_production_phase_1
SRS021754.575599	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2009	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021754	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241706	241706	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097467_from_subject_161493313__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097430	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.1	JCVI	HMP_production_phase_1
SRS023629.571748	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2476	SRR041003	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099932_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099898	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	20	4.9	BI	HMP_production_phase_1
SRS011531.570600	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_115	SRR045138	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011531	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016622_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016620	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS052982.571415	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3740	SRR048604	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052982	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108188_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108165	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	21	0	BCM	HMP_production_phase_1
SRS050892.570405	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3562	SRR048723	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050892	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108650_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108612	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	31	4	BCM	HMP_production_phase_1
SRS021804.572984	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2018	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021804	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097517_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097488	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	40	0	JCVI	HMP_production_phase_1
SRS045400.572092	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3068	SRR046466	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045400	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241893	241893	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105053_from_subject_178713055__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105032	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.5	WUGSC	HMP_production_phase_1
SRS020320.576046	TCAGCCGACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1659	SRR041052	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020320	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095573_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095539	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS015925.572764	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_734	SRR044625	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024580_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS021504.570544	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1946	SRR041588	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021504	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097216_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097187	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS024484.576521	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2697	SRR041922	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024484	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101630_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101596	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	38	0	BI	HMP_production_phase_1
SRS023147.576003	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2363	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023147	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241757	241757	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099278_from_subject_441369442__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099286	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.3	JCVI	HMP_production_phase_1
SRS046874.572824	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3203	SRR048589	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046874	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107922_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107888	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	BCM	HMP_production_phase_1
SRS021541.571910	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_1954	SRR048083	29.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021541	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241843	241843	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097253_from_subject_158216035__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097234	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	BCM	HMP_production_phase_1
SRS011649.573055	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_176	SRR045320	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011649	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033498_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033496	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.1	WUGSC	HMP_production_phase_1
SRS052844.575712	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3730	SRR046385	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052844	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103674_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103654	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	4.8	WUGSC	HMP_production_phase_1
SRS015186.574269	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_532	SRR043800	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015186	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023841_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023813	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4	WUGSC	HMP_production_phase_1
SRS063608.576098	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4411	SRR058090	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063608	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241816	241816	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110606_from_subject_295137534__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110587	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS020212.575846	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1632	SRR048153	32.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241762	241762	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095465_from_subject_158418336__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095428	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	32	0	BCM	HMP_production_phase_1
SRS054126.575091	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3830	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054126	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241842	241842	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109007_from_subject_161007791__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108969	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	4.3	JCVI	HMP_production_phase_1
SRS016559.574139	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_916	SRR040662	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032286_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4	BI	HMP_production_phase_1
SRS049284.574291	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3417	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049284	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108818_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108790	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	0	JCVI	HMP_production_phase_1
SRS019896.570541	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1577	SRR049223	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019896	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038372_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038347	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS015931.573834	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_737	SRR044613	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015931	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024586_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024555	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS048682.571295	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3363	SRR049403	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048682	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241885	241885	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106194_from_subject_823052294__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS020492.573640	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1702	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020492	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095815_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095785	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	JCVI	HMP_production_phase_1
SRS064291.576211	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4522	SRR046902	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064291	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114323_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114285	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	4.5	WUGSC	HMP_production_phase_1
SRS014927.572641	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_477	SRR049835	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014927	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023582_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS023270.574677	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2392	SRR058092	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023270	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241770	241770	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099428_from_subject_964271349__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099395	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS049748.571337	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3456	SRR047703	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049748	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241685	241685	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106695_from_subject_764224817__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106663	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	WUGSC	HMP_production_phase_1
SRS044395.574642	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2963	SRR048683	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044395	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109539_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109513	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	21	0	BCM	HMP_production_phase_1
SRS017121.573466	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1044	SRR041713	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017121	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033683_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033682	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS017853.572909	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1214	SRR042962	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034958_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS047237.572525	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3237	SRR046090	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047237	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	TRUE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038500_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	TRUE	n	TCAG	UBERON:saliva	700038483	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	31	0	WUGSC	HMP_production_phase_1
SRS018094.573035	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1270	SRR041083	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018094	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035418_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035382	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS020390.572844	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1679	SRR041592	32.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020390	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095709_from_subject_160704339__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095667	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	32	4.2	BI	HMP_production_phase_1
SRS023442.574450	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2433	SRR048161	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023442	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099629_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099600	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	0	BCM	HMP_production_phase_1
SRS018501.572901	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1368	SRR041339	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018501	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035965_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035937	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	4.1	BI	HMP_production_phase_1
SRS015192.572843	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_535	SRR049829	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015192	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023847_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023816	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4	WUGSC	HMP_production_phase_1
SRS048819.571287	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3375	SRR043589	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048819	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241812	241812	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038740_from_subject_763698834__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700038702	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	3.7	WUGSC	HMP_production_phase_1
SRS054121.573331	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3829	SRR048647	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054121	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108872_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108846	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	BCM	HMP_production_phase_1
SRS050733.571338	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3550	SRR049499	28.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241859	241859	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105496_from_subject_643185023__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105468	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	5	WUGSC	HMP_production_phase_1
SRS021861.570435	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2032	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021861	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097597_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097574	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	JCVI	HMP_production_phase_1
SRS011181.570583	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_14	SRR045370	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011181	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241686	241686	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015006_from_subject_158822939__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015004	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	38	0	WUGSC	HMP_production_phase_1
SRS021123.571750	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1848	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096670_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700096597	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	4.9	JCVI	HMP_production_phase_1
SRS013205.571865	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_209	SRR040962	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013205	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015904_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015871	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS017369.571493	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1101	SRR041274	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017369	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241674	241674	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034075_from_subject_160340197__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034040	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS019627.571695	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1534	SRR047574	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241807	241807	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038098_from_subject_765620695__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038066	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	4	WUGSC	HMP_production_phase_1
SRS019081.571164	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1468	SRR047459	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019081	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037552_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037535	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS065429.575288	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4679	SRR048857	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065429	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112024_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111995	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Palatine_Tonsils	26	0	BCM	HMP_production_phase_1
SRS043437.571933	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2877	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043437	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110197_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110165	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	38	4.5	JCVI	HMP_production_phase_1
SRS044032.572786	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2933	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044032	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108507_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108480	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	32	0	JCVI	HMP_production_phase_1
SRS018206.575669	TCAGAACCTTCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1296	SRR040776	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035613_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035584	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	0	BI	HMP_production_phase_1
SRS062399.571976	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4227	SRR049580	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062399	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114369_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114338	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS044206.571828	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2945	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109492_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109461	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	31	0	JCVI	HMP_production_phase_1
SRS045493.572124	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3081	SRR048558	19.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045493	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241721	241721	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109643_from_subject_160319967__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109621	n	969	250	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	19	0	BCM	HMP_production_phase_1
SRS020777.574163	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1767	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020777	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096202_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	JCVI	HMP_production_phase_1
SRS053570.570783	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3793	SRR046790	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053570	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105508_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105474	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	5	WUGSC	HMP_production_phase_1
SRS051089.575133	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3579	SRR046468	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051089	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241883	241883	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103503_from_subject_132902142__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700103481	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	31	5.6	WUGSC	HMP_production_phase_1
SRS022123.572032	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2100	SRR042815	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097889_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097852	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.4	BI	HMP_production_phase_1
SRS057537.572547	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4113	SRR042846	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101341_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101306	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS020318.573593	TCAGTTCCGAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1658	SRR041093	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020318	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095571_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095538	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS020437.572627	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1689	SRR040992	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020437	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095760_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095729	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	0	BI	HMP_production_phase_1
SRS020032.573522	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1602	SRR040610	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020032	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095277_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.3	BI	HMP_production_phase_1
SRS063416.572482	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4380	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063416	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111365_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108288	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	JCVI	HMP_production_phase_1
SRS023623.571692	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2473	SRR041091	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099926_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099895	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	20	4.9	BI	HMP_production_phase_1
SRS017671.570368	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1165	SRR040608	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241775	241775	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034686_from_subject_160461578__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034637	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	0	BI	HMP_production_phase_1
SRS016654.576196	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_940	SRR041564	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016654	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032438_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032437	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	5	BI	HMP_production_phase_1
SRS024690.573229	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2744	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024690	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102070_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700102047	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	30	0	JCVI	HMP_production_phase_1
SRS013741.570703	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_296	SRR041539	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013741	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241725	241725	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016819_from_subject_159268001__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016818	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS049453.570822	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3434	SRR046622	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049453	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106962_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700106938	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	20	0	WUGSC	HMP_production_phase_1
SRS023393.571276	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2423	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023393	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099559_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099526	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	38	0	JCVI	HMP_production_phase_1
SRS023807.571184	TCAGTATAGCGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2521	SRR058086	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023807	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100201_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	JCVI	HMP_production_phase_1
SRS014542.575872	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_380	SRR046160	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014542	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241730	241730	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023196_from_subject_763638144__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	3.8	WUGSC	HMP_production_phase_1
SRS052485.574378	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3708	SRR043943	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052485	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241823	241823	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038524_from_subject_763476303__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038495	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	31	0	WUGSC	HMP_production_phase_1
SRS016488.570750	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_896	SRR042963	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032184_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS024351.572392	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2659	SRR041997	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101386_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101357	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS023579.572391	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2466	SRR041308	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023579	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099856_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099820	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS046500.572964	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3172	SRR046479	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241874	241874	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106077_from_subject_737052003__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106057	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	18	4.5	WUGSC	HMP_production_phase_1
SRS019844.573340	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1568	SRR045858	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019844	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241790	241790	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038320_from_subject_765661155__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700038283	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	4.3	WUGSC	HMP_production_phase_1
SRS017947.574659	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1234	SRR041615	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017947	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035268_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035243	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS043848.575539	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2917	SRR046453	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043848	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241892	241892	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106318_from_subject_550534656__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106287	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.2	WUGSC	HMP_production_phase_1
SRS053783.574215	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3810	SRR048762	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053783	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108254_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108225	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	32	4.6	BCM	HMP_production_phase_1
SRS016271.576598	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_833	SRR044017	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016271	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024934_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024910	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	WUGSC	HMP_production_phase_1
SRS043728.573405	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2908	SRR047173	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043728	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241878	241878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105171_from_subject_612472597__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105148	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	38	4.3	WUGSC	HMP_production_phase_1
SRS055853.575560	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3967	SRR046298	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105874_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105843	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS051206.570644	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3592	SRR048652	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108880_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108850	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	0	BCM	HMP_production_phase_1
SRS023942.573951	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2556	SRR042820	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023942	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100340_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100307	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS057867.570438	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4146	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057867	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108509_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108481	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	32	0	JCVI	HMP_production_phase_1
SRS052921.572232	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3735	SRR046835	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052921	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105134_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105101	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	20	5.6	WUGSC	HMP_production_phase_1
SRS014877.574602	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_464	SRR049872	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023531_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023504	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS022006.571394	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2070	SRR040577	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022006	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097746_from_subject_158256496__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097706	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	4.1	BI	HMP_production_phase_1
SRS020889.574328	TCAGTCGGTTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1792	SRR041618	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020889	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096400_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096371	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	31	0	BI	HMP_production_phase_1
SRS065086.574397	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4628	SRR046987	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065086	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113081_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113060	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	WUGSC	HMP_production_phase_1
SRS018400.571088	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1350	SRR042997	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018400	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035834_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035800	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS016164.570371	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_801	SRR044280	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016164	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024821_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024795	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	3.9	WUGSC	HMP_production_phase_1
SRS017072.570532	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1028	SRR041306	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017072	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033585_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033563	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	BI	HMP_production_phase_1
SRS015021.575294	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_500	SRR049849	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015021	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023676_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023645	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	4.8	WUGSC	HMP_production_phase_1
SRS024527.573801	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2705	SRR048159	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024527	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101673_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101646	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BCM	HMP_production_phase_1
SRS048570.573904	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3350	SRR046791	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048570	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241890	241890	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105794_from_subject_375450439__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105773	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.6	WUGSC	HMP_production_phase_1
SRS011545.574166	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_122	SRR049316	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011545	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016646_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016644	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS016537.574468	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_905	SRR041137	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016537	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032264_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4	BI	HMP_production_phase_1
SRS019675.575098	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1542	SRR043918	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038148_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038121	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS023502.575773	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2444	SRR048225	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023502	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099779_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099753	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BCM	HMP_production_phase_1
SRS019241.576270	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1488	SRR044402	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019241	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241800	241800	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037712_from_subject_765034022__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037687	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.2	WUGSC	HMP_production_phase_1
SRS011677.571279	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_190	SRR044855	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011677	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033781_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700033742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.4	WUGSC	HMP_production_phase_1
SRS052631.574183	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3719	SRR048615	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108137_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108105	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	BCM	HMP_production_phase_1
SRS064539.572456	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4554	SRR048782	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064539	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111198_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111166	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.9	BCM	HMP_production_phase_1
SRS013456.574881	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_231	SRR041861	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013456	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016387_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016377	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	BI	HMP_production_phase_1
SRS042205.570479	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2766	SRR058092	29.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042205	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257120	257120	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102354_from_subject_604812005__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102317	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	JCVI	HMP_production_phase_1
SRS011675.576253	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_189	SRR045131	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011675	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033779_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700033741	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.4	WUGSC	HMP_production_phase_1
SRS049002.574644	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3391	SRR047728	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049002	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241861	241861	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106715_from_subject_184349034__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106697	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS011442.572490	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_66	SRR045402	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016091_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016052	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS021241.571478	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1877	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021241	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241669	241669	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096887_from_subject_161230322__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096865	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	34	5.3	JCVI	HMP_production_phase_1
SRS017521.570962	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1137	SRR041700	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241691	241691	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034254_from_subject_160502038__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700034232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.1	BI	HMP_production_phase_1
SRS015960.575325	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_742	SRR044119	22.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015960	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241769	241769	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024615_from_subject_764325968__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024593	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	0	WUGSC	HMP_production_phase_1
SRS044477.575453	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2971	SRR046457	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044477	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241869	241869	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106970_from_subject_147406386__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106942	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	0	WUGSC	HMP_production_phase_1
SRS016156.575473	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_797	SRR044211	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016156	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024813_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024791	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	3.9	WUGSC	HMP_production_phase_1
SRS020308.575864	TCAGAATTCCTAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1653	SRR041833	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020308	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095561_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095533	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	BI	HMP_production_phase_1
SRS056044.571703	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3985	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056044	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241780	241780	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110040_from_subject_161412393__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110004	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS043058.571455	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2838	SRR046478	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043058	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103643_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103616	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS023869.570764	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2535	SRR048210	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023869	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100267_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100236	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	4.9	BCM	HMP_production_phase_1
SRS044993.575132	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3026	SRR046462	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044993	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241879	241879	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106506_from_subject_553359145__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106486	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	32	4.3	WUGSC	HMP_production_phase_1
SRS022832.573021	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2283	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022832	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241816	241816	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098788_from_subject_295137534__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098752	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	JCVI	HMP_production_phase_1
SRS046974.570989	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3212	SRR048561	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046974	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109661_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109630	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	19	4.7	BCM	HMP_production_phase_1
SRS043351.571752	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2865	SRR047223	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106368_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106342	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	WUGSC	HMP_production_phase_1
SRS050910.574156	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3563	SRR047685	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050910	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103682_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103658	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	4.8	WUGSC	HMP_production_phase_1
SRS055886.570978	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3972	SRR058113	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055886	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	TRUE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109354_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700109324	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	4.6	JCVI	HMP_production_phase_1
SRS011289.576319	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_25	SRR044982	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011289	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015286_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS021742.576205	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2003	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021742	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097455_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097424	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.1	JCVI	HMP_production_phase_1
SRS022810.573727	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2275	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022810	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098766_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098741	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	JCVI	HMP_production_phase_1
SRS014448.574221	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_372	SRR045508	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014448	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023102_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023069	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	25	3.4	WUGSC	HMP_production_phase_1
SRS021135.576300	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1854	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021135	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096682_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096603	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	20	4.9	JCVI	HMP_production_phase_1
SRS065051.575065	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4620	SRR058090	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065051	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110622_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110595	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	JCVI	HMP_production_phase_1
SRS018797.573706	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1432	SRR046217	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018797	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037264_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	WUGSC	HMP_production_phase_1
SRS062800.575564	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4298	SRR046810	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062800	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113509_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700113487	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	WUGSC	HMP_production_phase_1
SRS015665.573239	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_663	SRR044262	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024320_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024297	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	WUGSC	HMP_production_phase_1
SRS015196.574270	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_537	SRR043892	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015196	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023851_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023818	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4	WUGSC	HMP_production_phase_1
SRS020449.576240	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1695	SRR040885	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020449	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241680	241680	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095772_from_subject_160684109__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095735	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	BI	HMP_production_phase_1
SRS055137.575999	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3905	SRR048532	24.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055137	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241797	241797	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109582_from_subject_160178356__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109563	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	0	BCM	HMP_production_phase_1
SRS016414.575356	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_872	SRR041477	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016414	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032101_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032075	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS057146.571622	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4080	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057146	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102149_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102120	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	36	3.9	JCVI	HMP_production_phase_1
SRS020382.575264	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1675	SRR042931	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020382	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095701_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	4.2	BI	HMP_production_phase_1
SRS045170.574496	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3039	SRR046792	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045170	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241883	241883	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103515_from_subject_132902142__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103487	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	31	5.6	WUGSC	HMP_production_phase_1
SRS019105.574933	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1478	SRR044745	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019105	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037576_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037547	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS016119.575336	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_788	SRR044418	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024776_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	4.5	WUGSC	HMP_production_phase_1
SRS065336.576602	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4666	SRR046567	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065336	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114478_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114441	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	3.9	WUGSC	HMP_production_phase_1
SRS021764.573379	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2013	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021764	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241706	241706	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097477_from_subject_161493313__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097435	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.1	JCVI	HMP_production_phase_1
SRS014970.570362	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_489	SRR043933	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014970	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023625_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023599	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS064782.574232	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4587	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064782	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241742	241742	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111558_from_subject_336497421__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700111522	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	JCVI	HMP_production_phase_1
SRS013386.571770	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_229	SRR041817	29.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013386	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241666	241666	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016214_from_subject_159328691__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016210	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	BI	HMP_production_phase_1
SRS016880.576536	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_990	SRR041802	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016880	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033241_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS062468.571788	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4241	SRR049558	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113091_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113065	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS020188.572152	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1620	SRR048152	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020188	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095441_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095416	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	32	0	BCM	HMP_production_phase_1
SRS016533.576206	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_903	SRR041055	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016533	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032260_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4	BI	HMP_production_phase_1
SRS011510.573590	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_104	SRR044897	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011510	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016364_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016348	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	20	4.2	WUGSC	HMP_production_phase_1
SRS023204.575179	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2375	SRR041970	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023204	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099335_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099302	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS017242.574308	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1071	SRR042943	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017242	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033848_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033847	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS052468.570727	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3705	SRR048463	23.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052468	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108401_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108360	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	23	4.4	BCM	HMP_production_phase_1
SRS011271.570242	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_16	SRR044974	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011271	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241748	241748	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015250_from_subject_158802708__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700015245	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	WUGSC	HMP_production_phase_1
SRS056159.573832	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3993	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102340_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102310	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	JCVI	HMP_production_phase_1
SRS043159.575865	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2844	SRR048599	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107808_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107774	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	0	BCM	HMP_production_phase_1
SRS054246.570953	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3834	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054246	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108080_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700108049	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	JCVI	HMP_production_phase_1
SRS017416.576429	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1111	SRR040782	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017416	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034122_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034092	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	0	BI	HMP_production_phase_1
SRS011434.572452	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_60	SRR044888	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016079_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016046	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS063984.574811	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4478	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063984	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110675_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110650	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	30	0	JCVI	HMP_production_phase_1
SRS011363.576083	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_35	SRR044902	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011363	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015647_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015645	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	33	0	WUGSC	HMP_production_phase_1
SRS052428.572963	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3701	SRR046850	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052428	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106956_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106935	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	20	0	WUGSC	HMP_production_phase_1
SRS015358.570670	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_586	SRR044100	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015358	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024013_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023980	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	3.7	WUGSC	HMP_production_phase_1
SRS011604.571410	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_153	SRR044976	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011604	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033179_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033143	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.3	WUGSC	HMP_production_phase_1
SRS024592.570730	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2723	SRR041031	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024592	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101883_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101852	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS022012.575639	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2073	SRR040667	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022012	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097752_from_subject_158256496__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097709	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	4.1	BI	HMP_production_phase_1
SRS018987.574238	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1455	SRR044609	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018987	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037456_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037439	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS011498.575170	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_97	SRR045126	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011498	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016337_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016310	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS022115.572474	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2096	SRR041611	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022115	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097881_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097848	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	4.4	BI	HMP_production_phase_1
SRS023401.573849	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2427	SRR058092	38.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023401	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099567_from_subject_246515023__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700099530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	38	0	JCVI	HMP_production_phase_1
SRS022709.575008	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2253	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022709	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241689	241689	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098661_from_subject_432193348__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098619	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.6	JCVI	HMP_production_phase_1
SRS015462.571404	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_609	SRR044682	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024117_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024091	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS019572.575854	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1527	SRR045532	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019572	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038043_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038016	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	37	0	WUGSC	HMP_production_phase_1
SRS015425.571374	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_602	SRR047559	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015425	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241682	241682	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024080_from_subject_764042746__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	3.6	WUGSC	HMP_production_phase_1
SRS021762.574895	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2012	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021762	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241706	241706	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097475_from_subject_161493313__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097434	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.1	JCVI	HMP_production_phase_1
SRS023625.571226	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2474	SRR041855	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099928_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099896	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	20	4.9	BI	HMP_production_phase_1
SRS018406.571749	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1351	SRR042796	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241797	241797	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035840_from_subject_160178356__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035803	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	BI	HMP_production_phase_1
SRS023679.570267	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2487	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023679	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099986_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099960	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	4.1	JCVI	HMP_production_phase_1
SRS021107.576111	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1844	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021107	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241694	241694	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096654_from_subject_160866180__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096589	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	25	4.8	JCVI	HMP_production_phase_1
SRS064323.572736	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4528	SRR048827	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064323	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268869	268869	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111801_from_subject_872848689__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700111762	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.6	BCM	HMP_production_phase_1
SRS023073.572936	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2340	SRR048116	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023073	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099107_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099072	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	4.1	BCM	HMP_production_phase_1
SRS016716.573817	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_957	SRR042940	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016716	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032661_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032644	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.3	BI	HMP_production_phase_1
SRS045908.573844	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3112	SRR047656	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045908	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038428_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038399	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	39	0	WUGSC	HMP_production_phase_1
SRS018161.570533	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1287	SRR042988	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018161	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035561_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS024345.575899	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2656	SRR041749	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024345	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101380_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101354	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS013561.571660	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_254	SRR048263	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013561	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016582_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016551	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	4.7	BCM	HMP_production_phase_1
SRS024466.570577	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2688	SRR041781	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101612_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101587	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	38	0	BI	HMP_production_phase_1
SRS063132.576391	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4342	SRR046739	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063132	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241876	241876	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113029_from_subject_764750800__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113010	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS011165.572829	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_5	SRR045303	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011165	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014979_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014977	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	0	WUGSC	HMP_production_phase_1
SRS046080.571937	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3131	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046080	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110215_from_subject_246515023__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700110174	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	38	4.5	JCVI	HMP_production_phase_1
SRS015970.571242	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_746	SRR043992	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015970	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024625_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024598	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	0	WUGSC	HMP_production_phase_1
SRS057900.571743	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4150	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057900	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110413_from_subject_650853796__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110372	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	22	4.4	JCVI	HMP_production_phase_1
SRS065582.575903	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4707	SRR049907	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065582	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113087_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700113063	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS065125.570982	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4632	SRR046301	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114143_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114114	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	38	4.7	WUGSC	HMP_production_phase_1
SRS063123.574370	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4340	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111610_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111581	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	39	4.8	JCVI	HMP_production_phase_1
SRS023752.571075	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2508	SRR041000	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023752	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100059_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100031	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS057069.574886	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4075	SRR049342	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057069	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038614_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038588	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS014128.573467	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_316	SRR045692	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014128	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021687_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021683	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	3.9	WUGSC	HMP_production_phase_1
SRS022938.572207	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2303	SRR048097	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022938	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098968_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098939	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	37	4.6	BCM	HMP_production_phase_1
SRS014458.575346	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_376	SRR045792	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014458	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023112_from_subject_763698834__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700023074	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	3.4	WUGSC	HMP_production_phase_1
SRS018386.575460	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1344	SRR041439	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018386	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035820_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035793	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	0	BI	HMP_production_phase_1
SRS058643.570916	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4210	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058643	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109918_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109881	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	0	JCVI	HMP_production_phase_1
SRS015464.572728	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_610	SRR044715	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024119_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024092	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS021089.574085	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1838	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021089	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096636_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096580	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	4.8	JCVI	HMP_production_phase_1
SRS024470.576077	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2690	SRR042003	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101616_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101589	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	38	0	BI	HMP_production_phase_1
SRS063494.572889	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4394	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063494	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111469_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111443	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.8	JCVI	HMP_production_phase_1
SRS020484.570285	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1698	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020484	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095807_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095780	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	JCVI	HMP_production_phase_1
SRS018801.574444	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1434	SRR047570	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018801	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037268_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700037244	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS021017.570892	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1828	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021017	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096564_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS056677.570657	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4041	SRR048903	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107812_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107776	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS047005.571819	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3218	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047005	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108318_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108291	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	JCVI	HMP_production_phase_1
SRS048045.572654	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3316	SRR048398	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048045	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102936_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102911	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	BCM	HMP_production_phase_1
SRS014365.575658	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_358	SRR043791	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014365	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023019_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021293	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS015356.572913	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_585	SRR049875	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015356	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024011_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023979	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	3.7	WUGSC	HMP_production_phase_1
SRS065179.575811	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4643	SRR046832	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065179	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241682	241682	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114452_from_subject_764042746__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114428	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	3.9	WUGSC	HMP_production_phase_1
SRS014999.573319	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_493	SRR044015	20.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014999	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241718	241718	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023654_from_subject_764062976__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023634	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	20	4.8	WUGSC	HMP_production_phase_1
SRS023948.575600	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2558	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100346_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100310	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS013472.575723	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_238	SRR041757	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016403_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016385	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	BI	HMP_production_phase_1
SRS046341.570935	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3158	SRR043792	31.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046341	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241823	241823	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038520_from_subject_763476303__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038493	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	31	0	WUGSC	HMP_production_phase_1
SRS017902.574551	TCAGTCGGTTCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1225	SRR041432	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017902	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035200_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035169	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	33	0	BI	HMP_production_phase_1
SRS046376.571499	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3162	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046376	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108082_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108050	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS021376.571403	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1910	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021376	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097034_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097006	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	4.6	JCVI	HMP_production_phase_1
SRS024056.571141	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2585	SRR043027	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024056	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100518_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100485	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	4.7	BI	HMP_production_phase_1
SRS013207.572153	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_210	SRR043043	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013207	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015906_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015872	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS047180.574885	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3233	SRR049498	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047180	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106599_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106561	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	4.3	WUGSC	HMP_production_phase_1
SRS045129.570602	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3032	SRR041462	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045129	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107093_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107057	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS021439.575188	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1927	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021439	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097147_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097122	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	32	0	JCVI	HMP_production_phase_1
SRS020551.575598	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1715	SRR041750	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020551	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095874_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095843	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	BI	HMP_production_phase_1
SRS049430.573968	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3431	SRR047174	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049430	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241854	241854	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106926_from_subject_517810313__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106410	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS018757.570690	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1422	SRR044475	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018757	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241832	241832	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037224_from_subject_765013792__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037135	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	4.5	WUGSC	HMP_production_phase_1
SRS024299.573067	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2648	SRR041792	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024299	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101277_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101241	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	3.7	BI	HMP_production_phase_1
SRS023500.574751	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2443	SRR048232	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023500	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099777_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099752	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BCM	HMP_production_phase_1
SRS018463.572668	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1365	SRR041065	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018463	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241826	241826	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035897_from_subject_160218816__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035860	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS017800.575202	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1201	SRR042815	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017800	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241782	241782	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034893_from_subject_160542498__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700034856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS023613.571389	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2469	SRR042016	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099916_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099890	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	20	4.9	BI	HMP_production_phase_1
SRS020198.574365	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1625	SRR048151	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020198	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095451_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095421	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	0	BCM	HMP_production_phase_1
SRS015518.572205	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_623	SRR044243	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015518	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241707	241707	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024173_from_subject_764245047__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024141	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.1	WUGSC	HMP_production_phase_1
SRS018793.575061	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1430	SRR045917	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018793	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037260_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	WUGSC	HMP_production_phase_1
SRS015358.570878	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_586	SRR049435	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015358	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024013_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023980	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	3.7	WUGSC	HMP_production_phase_1
SRS063287.575666	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4364	SRR046822	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113626_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113604	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS020008.570807	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1590	SRR041048	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020008	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095253_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.3	BI	HMP_production_phase_1
SRS019789.574113	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1565	SRR045924	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019789	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038265_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700038117	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS050199.573205	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3494	SRR049401	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050199	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241692	241692	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105536_from_subject_765155402__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700105518	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	18	0	WUGSC	HMP_production_phase_1
SRS050599.575868	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3538	SRR048273	22.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241796	241796	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102607_from_subject_159227541__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102585	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	4.5	BCM	HMP_production_phase_1
SRS018527.573918	TCAGCCGACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1381	SRR040715	21.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018527	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241667	241667	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035991_from_subject_160259276__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700035950	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	21	4.1	BI	HMP_production_phase_1
SRS018997.572061	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1460	SRR044614	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018997	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037466_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037444	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS050329.574510	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3515	SRR048462	23.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050329	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108405_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108362	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	23	4.4	BCM	HMP_production_phase_1
SRS017778.571875	TCAGTCGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1190	SRR040765	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017778	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034871_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034845	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	0	BI	HMP_production_phase_1
SRS017148.572893	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1053	SRR041176	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017148	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033710_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033709	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS022683.574332	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2241	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022683	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098635_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098606	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	4.6	JCVI	HMP_production_phase_1
SRS063515.573548	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4400	SRR046990	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063515	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113045_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113018	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	21	0	WUGSC	HMP_production_phase_1
SRS023631.575419	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2477	SRR041718	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099934_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099899	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	20	4.9	BI	HMP_production_phase_1
SRS011477.574168	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_85	SRR047526	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011477	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016176_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016137	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS046302.575495	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3154	SRR048259	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046302	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102291_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102257	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	BCM	HMP_production_phase_1
SRS056514.572488	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4029	SRR048508	31.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056514	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108656_from_subject_159915365__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108615	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	31	4	BCM	HMP_production_phase_1
SRS021463.574029	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1939	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021463	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241754	241754	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097171_from_subject_160967330__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700097134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	0	JCVI	HMP_production_phase_1
SRS045463.575000	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3075	SRR046483	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045463	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103696_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103665	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	4.8	WUGSC	HMP_production_phase_1
SRS022743.574759	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2256	SRR058114	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022743	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098699_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098673	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	4.1	JCVI	HMP_production_phase_1
SRS018553.575965	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1388	SRR044496	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018553	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241851	241851	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037020_from_subject_764710340__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037005	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4	WUGSC	HMP_production_phase_1
SRS011369.576412	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_38	SRR045110	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011369	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015656_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700015654	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	33	0	WUGSC	HMP_production_phase_1
SRS017910.571200	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1229	SRR041411	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241799	241799	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035208_from_subject_160441347__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS015135.570262	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_518	SRR043936	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015135	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023790_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700023702	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	4.5	WUGSC	HMP_production_phase_1
SRS015255.575414	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_556	SRR045743	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241729	241729	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023910_from_subject_764143897__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023876	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	4.4	WUGSC	HMP_production_phase_1
SRS011529.572499	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_114	SRR045294	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011529	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241837	241837	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016610_from_subject_159166850__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016608	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS013270.571420	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_228	SRR042807	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013270	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241833	241833	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015977_from_subject_159591683__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700015976	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS055377.570303	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3926	SRR051584	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055377	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038880_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038859	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	WUGSC	HMP_production_phase_1
SRS024400.571393	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2670	SRR040693	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024400	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101546_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101521	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	5.1	BI	HMP_production_phase_1
SRS057292.574151	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4092	SRR046288	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057292	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241761	241761	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105451_from_subject_763557224__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105417	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	34	4.2	WUGSC	HMP_production_phase_1
SRS016543.576556	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_908	SRR041150	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016543	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032270_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032235	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4	BI	HMP_production_phase_1
SRS013209.574977	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_211	SRR041473	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013209	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015908_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015873	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS023217.574320	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2379	SRR048071	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023217	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241700	241700	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099348_from_subject_158114885__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099345	n	969	319	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	29	4.2	BCM	HMP_production_phase_1
SRS015423.571406	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_601	SRR045677	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015423	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241682	241682	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024078_from_subject_764042746__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	3.6	WUGSC	HMP_production_phase_1
SRS014956.575209	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_483	SRR045846	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014956	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023611_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	32	0	WUGSC	HMP_production_phase_1
SRS065203.574959	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4648	SRR048804	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065203	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111266_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700111233	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	5	BCM	HMP_production_phase_1
SRS015303.570218	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_571	SRR050307	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015303	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023958_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023930	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	37	0	WUGSC	HMP_production_phase_1
SRS020421.574973	TCAGACCGGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1682	SRR040922	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020421	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095744_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095721	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	0	BI	HMP_production_phase_1
SRS020002.572093	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1587	SRR040600	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020002	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095247_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095219	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.3	BI	HMP_production_phase_1
SRS024404.573642	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2672	SRR041746	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024404	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101550_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101523	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	5.1	BI	HMP_production_phase_1
SRS023643.572216	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2483	SRR040792	20.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023643	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099946_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099905	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	20	4.9	BI	HMP_production_phase_1
SRS058326.573295	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4181	SRR047147	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058326	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105604_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105576	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	20	0	WUGSC	HMP_production_phase_1
SRS022388.572037	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2171	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022388	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241768	241768	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098254_from_subject_492786515__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098218	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	35	0	JCVI	HMP_production_phase_1
SRS063985.573558	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4479	SRR046830	28.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063985	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241850	241850	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114653_from_subject_763901136__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114615	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	4.3	WUGSC	HMP_production_phase_1
SRS015466.570631	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_611	SRR044728	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024121_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024093	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS011500.572744	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_99	SRR044889	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016341_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	34	0	WUGSC	HMP_production_phase_1
SRS045435.574527	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3073	SRR049634	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045435	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241761	241761	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105439_from_subject_763557224__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700105411	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	34	4.2	WUGSC	HMP_production_phase_1
SRS044548.575505	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2975	SRR046800	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044548	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106595_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700106559	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	4.3	WUGSC	HMP_production_phase_1
SRS065316.575593	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4664	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065316	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111612_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111582	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	39	4.8	JCVI	HMP_production_phase_1
SRS063898.575103	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4460	SRR046831	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063898	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241730	241730	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114287_from_subject_763638144__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114267	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	4.5	WUGSC	HMP_production_phase_1
SRS053439.571859	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3778	SRR048702	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053439	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109204_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109179	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	31	0	BCM	HMP_production_phase_1
SRS011576.571518	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_138	SRR047534	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011576	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033029_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700033027	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.7	WUGSC	HMP_production_phase_1
SRS017218.575017	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1063	SRR041454	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017218	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033824_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033823	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	BI	HMP_production_phase_1
SRS065209.573936	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4649	SRR058108	35.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065209	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241768	241768	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110752_from_subject_492786515__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110717	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	0	JCVI	HMP_production_phase_1
SRS015470.575238	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_613	SRR044759	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024125_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024095	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS051829.573493	TCAGTTCAACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3644	SRR041458	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051829	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107073_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107047	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	BI	HMP_production_phase_1
SRS011454.573338	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_73	SRR044853	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016150_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016123	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	WUGSC	HMP_production_phase_1
SRS018041.574191	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1262	SRR042821	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018041	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035365_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035319	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.3	BI	HMP_production_phase_1
SRS020026.571898	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1599	SRR040684	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020026	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095271_from_subject_160643649__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700095231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	4.3	BI	HMP_production_phase_1
SRS054431.573274	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3848	SRR046481	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054431	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106637_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106610	n	969	184	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS023629.570250	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2476	SRR041921	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099932_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099898	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	20	4.9	BI	HMP_production_phase_1
SRS055003.570393	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3893	SRR046681	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055003	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106414_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106397	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS024216.570728	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2622	SRR041927	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101103_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101080	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS043591.570353	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2892	SRR049614	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043591	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106366_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106341	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	WUGSC	HMP_production_phase_1
SRS046524.575675	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3177	SRR049612	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046524	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103597_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103569	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	WUGSC	HMP_production_phase_1
SRS017209.573818	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1060	SRR041447	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017209	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033815_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033814	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	BI	HMP_production_phase_1
SRS023274.570536	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2394	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023274	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241770	241770	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099432_from_subject_964271349__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099397	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS063727.574914	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4428	SRR048420	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063727	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110784_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110762	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	4.6	BCM	HMP_production_phase_1
SRS042648.573212	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2810	SRR047164	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042648	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241857	241857	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106569_from_subject_208027353__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106546	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	4.3	WUGSC	HMP_production_phase_1
SRS022456.573048	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2188	SRR048205	27.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241719	241719	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098331_from_subject_158742018__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098288	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	5.8	BCM	HMP_production_phase_1
SRS024040.572784	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2577	SRR040863	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024040	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100502_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100477	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	4.7	BI	HMP_production_phase_1
SRS020257.573938	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1641	SRR042010	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020257	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095510_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095479	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	0	BI	HMP_production_phase_1
SRS021609.571842	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_1969	SRR048050	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021609	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097321_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097295	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	4.9	BCM	HMP_production_phase_1
SRS017430.572600	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1118	SRR040721	30.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017430	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241703	241703	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034136_from_subject_160481808__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034099	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	0	BI	HMP_production_phase_1
SRS023332.574822	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2406	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023332	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241835	241835	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099494_from_subject_206906765__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099457	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	JCVI	HMP_production_phase_1
SRS055875.575404	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3970	SRR048494	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055875	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108632_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108603	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	31	0	BCM	HMP_production_phase_1
SRS015442.570933	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_603	SRR044755	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015442	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024097_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS063444.574875	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4386	SRR048812	38.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268878	268878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111286_from_subject_866653606__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	38	5	BCM	HMP_production_phase_1
SRS065604.572509	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4715	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065604	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110876_from_subject_809635352__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110833	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	26	4.7	JCVI	HMP_production_phase_1
SRS058459.572272	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4193	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058459	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101811_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101780	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	JCVI	HMP_production_phase_1
SRS063990.572342	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4481	SRR047099	22.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063990	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241865	241865	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114727_from_subject_764831721__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114706	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	0	WUGSC	HMP_production_phase_1
SRS018459.573104	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1364	SRR043293	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018459	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035893_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS013813.575942	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_309	SRR041057	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013813	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016973_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016972	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	38	0	BI	HMP_production_phase_1
SRS018511.575932	TCAGAATTCCTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1373	SRR040720	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018511	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035975_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035942	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	4.1	BI	HMP_production_phase_1
SRS022924.571645	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2300	SRR048095	37.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022924	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241781	241781	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098954_from_subject_158236265__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098932	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	37	4.6	BCM	HMP_production_phase_1
SRS024431.572065	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2684	SRR040688	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024431	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101577_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700101573	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	5.1	BI	HMP_production_phase_1
SRS019683.574800	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1546	SRR045940	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019683	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241791	241791	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038156_from_subject_763678604__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	NA	y	TCAG	UBERON:nasal mucus	700038125	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS015389.573465	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_591	SRR045688	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015389	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241682	241682	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024044_from_subject_764042746__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024024	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	3.6	WUGSC	HMP_production_phase_1
SRS063361.575860	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4375	SRR058108	35.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241768	241768	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110750_from_subject_492786515__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110716	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	JCVI	HMP_production_phase_1
SRS020358.575254	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1664	SRR041651	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020358	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095677_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	32	4.2	BI	HMP_production_phase_1
SRS048462.575497	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3343	SRR046053	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048462	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038775_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038748	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	5.3	WUGSC	HMP_production_phase_1
SRS020249.572146	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1637	SRR041019	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020249	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095502_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095475	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	0	BI	HMP_production_phase_1
SRS011631.571015	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_167	SRR045091	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033465_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033463	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.1	WUGSC	HMP_production_phase_1
SRS019101.573186	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1476	SRR044714	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019101	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037572_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037545	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS024187.574179	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2620	SRR040631	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024187	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241676	241676	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100655_from_subject_159207311__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100618	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS011531.572733	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_115	SRR044905	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011531	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016622_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016620	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS020433.576594	TCAGTCGGTTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1687	SRR040875	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020433	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095756_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095727	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	0	BI	HMP_production_phase_1
SRS052199.572144	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3683	SRR048635	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052199	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108578_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108543	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	30	3.9	BCM	HMP_production_phase_1
SRS053877.573643	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3814	SRR048680	32.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053877	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108278_from_subject_160704339__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700108237	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	32	4.6	BCM	HMP_production_phase_1
SRS063964.573301	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4475	SRR046754	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063964	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257130	257130	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114240_from_subject_663835652__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114215	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	4.5	WUGSC	HMP_production_phase_1
SRS024167.572795	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2611	SRR041067	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100635_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100608	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS058328.575302	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4182	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058328	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241780	241780	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110036_from_subject_161412393__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110002	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS011578.574181	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_140	SRR045401	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011578	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033035_from_subject_159247771__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.7	WUGSC	HMP_production_phase_1
SRS023889.576549	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2543	SRR048222	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023889	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241755	241755	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100287_from_subject_158883629__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100246	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	29	4.9	BCM	HMP_production_phase_1
SRS058381.571366	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4185	SRR046484	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058381	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241729	241729	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106821_from_subject_764143897__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106801	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	4.4	WUGSC	HMP_production_phase_1
SRS021970.574298	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2057	SRR041390	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021970	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241747	241747	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097710_from_subject_158256496__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097688	n	969	225	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS011497.573485	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_96	SRR044901	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011497	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016335_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016309	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS023134.570976	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2358	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023134	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241757	241757	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099265_from_subject_441369442__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099139	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS024265.573046	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2635	SRR042014	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024265	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241712	241712	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101243_from_subject_158944319__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101224	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	3.7	BI	HMP_production_phase_1
SRS019685.570945	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1547	SRR045945	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019685	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241791	241791	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038158_from_subject_763678604__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	NA	y	TCAG	UBERON:feces	700038126	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS011470.570260	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_81	SRR044918	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016168_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	WUGSC	HMP_production_phase_1
SRS064781.570890	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4586	SRR046568	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064781	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113640_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700113611	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS023326.570900	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2403	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023326	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099488_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099454	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.3	JCVI	HMP_production_phase_1
SRS011499.572441	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_98	SRR045123	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011499	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016339_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016311	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	34	0	WUGSC	HMP_production_phase_1
SRS020427.572536	TCAGTCGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1684	SRR040968	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095750_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095724	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	0	BI	HMP_production_phase_1
SRS011682.574630	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_192	SRR044908	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011682	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033787_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700033745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.4	WUGSC	HMP_production_phase_1
SRS051170.576198	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3586	SRR049385	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051170	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241891	241891	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105324_from_subject_516889361__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105307	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS016414.571784	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_872	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016414	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032101_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032075	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS019894.576304	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1576	SRR044391	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019894	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038370_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038346	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS020541.571177	TCAGTCGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1710	SRR041099	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020541	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095864_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095838	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	BI	HMP_production_phase_1
SRS016473.571188	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_891	SRR041248	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016473	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032169_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032168	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS065592.570995	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4710	SRR046891	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065592	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241784	241784	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113578_from_subject_764346198__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700113550	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	23	4.1	WUGSC	HMP_production_phase_1
SRS016239.574748	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_825	SRR044440	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016239	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024902_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024864	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS017133.574750	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1048	SRR041090	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017133	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033695_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033694	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS022107.571400	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2092	SRR042956	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022107	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097873_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097844	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	4.4	BI	HMP_production_phase_1
SRS043336.575627	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2862	SRR046582	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043336	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106587_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106555	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	4.3	WUGSC	HMP_production_phase_1
SRS017394.570518	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1104	SRR041932	30.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017394	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241703	241703	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034100_from_subject_160481808__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700034081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	BI	HMP_production_phase_1
SRS022635.576081	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2232	SRR041670	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022635	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098587_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098555	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS011627.572133	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_165	SRR045079	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033459_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033457	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.1	WUGSC	HMP_production_phase_1
SRS011180.570744	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_13	SRR045372	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011180	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241686	241686	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015003_from_subject_158822939__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700015001	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	38	0	WUGSC	HMP_production_phase_1
SRS063872.576397	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4455	SRR046817	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063872	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113517_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700113491	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS020153.576451	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1616	SRR048309	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020153	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241827	241827	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095406_from_subject_158398106__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095370	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	31	0	BCM	HMP_production_phase_1
SRS048462.573762	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3343	SRR045922	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048462	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038775_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038748	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	5.3	WUGSC	HMP_production_phase_1
SRS011484.573684	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_88	SRR044872	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011484	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016319_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016301	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	34	0	WUGSC	HMP_production_phase_1
SRS022894.574275	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2296	SRR058111	22.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022894	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098924_from_subject_650853796__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098884	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	4.6	JCVI	HMP_production_phase_1
SRS011561.575154	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_130	SRR044861	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011561	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033005_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033003	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.7	WUGSC	HMP_production_phase_1
SRS043873.570576	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2918	SRR042828	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102464_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102429	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS022798.573725	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2273	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022798	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241816	241816	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098754_from_subject_295137534__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098735	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS014772.571994	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_433	SRR046164	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014772	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241824	241824	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023426_from_subject_763719065__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023393	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	4.2	WUGSC	HMP_production_phase_1
SRS052335.575186	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3694	SRR048584	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052335	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107916_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107885	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	0	BCM	HMP_production_phase_1
SRS065630.571373	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4721	SRR049573	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065630	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113055_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113023	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS053617.576048	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3797	SRR042855	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101323_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101297	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS020302.574375	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1650	SRR041918	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020302	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095555_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	BI	HMP_production_phase_1
SRS022769.570833	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2268	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022769	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098725_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098686	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	JCVI	HMP_production_phase_1
SRS023922.574146	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2547	SRR041645	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023922	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100320_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100297	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS019669.572521	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1539	SRR046206	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038142_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700038118	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS024651.574439	TCAGTACGGATTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2737	SRR041252	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024651	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101942_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101910	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	0	BI	HMP_production_phase_1
SRS024064.575689	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2588	SRR040877	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024064	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100526_from_subject_159247771__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100489	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	4.7	BI	HMP_production_phase_1
SRS063236.574900	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4356	SRR046289	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063236	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114141_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114113	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	38	4.7	WUGSC	HMP_production_phase_1
SRS014261.573356	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_329	SRR046134	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014261	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021850_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700021820	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS043552.571254	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2886	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043552	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109274_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700109241	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	4.8	JCVI	HMP_production_phase_1
SRS024108.576130	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2595	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024108	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100573_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100547	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS016708.571920	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_954	SRR040957	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016708	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032653_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.3	BI	HMP_production_phase_1
SRS020131.576469	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1605	SRR048137	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020131	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095384_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095359	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	31	0	BCM	HMP_production_phase_1
SRS014247.574495	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_325	SRR046593	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014247	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241791	241791	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021836_from_subject_763678604__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700021812	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS013255.573658	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_223	SRR040743	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013255	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015962_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015961	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS024588.571755	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2721	SRR040750	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024588	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101879_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101850	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS018960.573136	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1450	SRR046527	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018960	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241737	241737	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037429_from_subject_765276783__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037401	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS023272.575681	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2393	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023272	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241770	241770	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099430_from_subject_964271349__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099396	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS049644.575196	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_3449	SRR041937	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049644	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101317_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101294	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS046006.573171	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3126	SRR048579	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046006	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107912_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107883	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	0	BCM	HMP_production_phase_1
SRS021435.573365	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1926	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097143_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097120	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	32	0	JCVI	HMP_production_phase_1
SRS063087.571805	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4337	SRR049470	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063087	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241863	241863	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114539_from_subject_275382046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106988	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	0	WUGSC	HMP_production_phase_1
SRS050795.573349	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3555	SRR045890	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050795	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241886	241886	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038620_from_subject_404239096__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038591	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS048242.576414	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3333	SRR048755	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048242	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110129_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110098	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	4.3	BCM	HMP_production_phase_1
SRS021334.574240	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1905	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021334	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096992_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096958	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS054258.572995	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3835	SRR048616	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108125_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108099	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	BCM	HMP_production_phase_1
SRS023713.574561	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2502	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023713	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100020_from_subject_892969023__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099977	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	28	4.1	JCVI	HMP_production_phase_1
SRS017203.571597	TCAGCCGTTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1059	SRR041430	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017203	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033809_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033808	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	BI	HMP_production_phase_1
SRS022896.572639	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2297	SRR058086	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022896	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098926_from_subject_650853796__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098885	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	22	4.6	JCVI	HMP_production_phase_1
SRS021390.574570	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1917	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021390	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097048_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097013	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	4.6	JCVI	HMP_production_phase_1
SRS020791.574974	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1773	SRR058111	27.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020791	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241780	241780	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096216_from_subject_161412393__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096179	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	JCVI	HMP_production_phase_1
SRS043594.570227	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2893	SRR048450	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043594	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102881_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102855	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	33	0	BCM	HMP_production_phase_1
SRS015605.573911	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_643	SRR044484	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015605	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241784	241784	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024260_from_subject_764346198__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.4	WUGSC	HMP_production_phase_1
SRS020895.570284	TCAGAAGGAACCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1795	SRR041649	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020895	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096406_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096374	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	31	0	BI	HMP_production_phase_1
SRS044011.570800	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2929	SRR048557	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044011	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108945_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108911	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS015615.576241	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_648	SRR044213	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241784	241784	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024270_from_subject_764346198__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.4	WUGSC	HMP_production_phase_1
SRS048760.571247	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3371	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048760	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108505_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108479	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	32	0	JCVI	HMP_production_phase_1
SRS013668.574557	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_273	SRR041543	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013668	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016746_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700016707	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS053814.573460	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3811	SRR046843	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053814	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106918_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106406	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS055669.574866	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3947	SRR046384	37.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241787	241787	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106645_from_subject_763982056__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700106614	n	969	184	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	37	0	WUGSC	HMP_production_phase_1
SRS016722.570769	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_960	SRR040952	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016722	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032667_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700032647	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4.3	BI	HMP_production_phase_1
SRS020557.574919	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1718	SRR041158	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095880_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS011294.571578	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_29	SRR045398	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011294	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015298_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS011442.571113	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_66	SRR045425	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016091_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016052	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS015023.574401	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_501	SRR044094	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015023	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023678_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023646	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	4.8	WUGSC	HMP_production_phase_1
SRS057422.573208	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4100	SRR048411	22.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102643_from_subject_159227541__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102603	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.5	BCM	HMP_production_phase_1
SRS017890.571149	TCAGAAGGAACCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1219	SRR041468	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017890	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035188_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035163	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	33	0	BI	HMP_production_phase_1
SRS020386.572562	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1677	SRR041620	32.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020386	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095705_from_subject_160704339__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700095665	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	4.2	BI	HMP_production_phase_1
SRS019842.573676	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1567	SRR046523	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019842	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241790	241790	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038318_from_subject_765661155__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700038282	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.3	WUGSC	HMP_production_phase_1
SRS018286.574356	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1321	SRR042866	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018286	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241785	241785	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035693_from_subject_160137896__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035653	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	3.9	BI	HMP_production_phase_1
SRS019558.575175	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1521	SRR043890	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019558	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038029_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038009	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS020823.571171	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1776	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020823	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096297_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096273	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	JCVI	HMP_production_phase_1
SRS016331.571080	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_852	SRR044384	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016331	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024994_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	0	WUGSC	HMP_production_phase_1
SRS023851.574796	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2530	SRR048207	29.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023851	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241755	241755	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100249_from_subject_158883629__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700100227	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	4.9	BCM	HMP_production_phase_1
SRS015764.576586	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_687	SRR044256	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015764	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024419_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024399	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	WUGSC	HMP_production_phase_1
SRS020983.570993	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1815	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020983	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241806	241806	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096530_from_subject_161311242__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096511	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS022002.576295	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2069	SRR041401	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022002	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241747	241747	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097742_from_subject_158256496__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097704	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	4.1	BI	HMP_production_phase_1
SRS024050.570243	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2582	SRR040845	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024050	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100512_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100482	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	4.7	BI	HMP_production_phase_1
SRS011472.572346	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_82	SRR047491	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016170_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700016133	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	WUGSC	HMP_production_phase_1
SRS042091.576167	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2760	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042091	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102702_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102671	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS048090.573760	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3319	SRR045545	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048090	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038714_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038689	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	3.7	WUGSC	HMP_production_phase_1
SRS016660.575938	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_942	SRR041599	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016660	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032444_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032443	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	5	BI	HMP_production_phase_1
SRS051800.574724	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3641	SRR049393	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051800	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103645_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103617	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS045215.572920	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3049	SRR046393	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045215	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105610_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105579	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	20	0	WUGSC	HMP_production_phase_1
SRS014970.576121	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_489	SRR043884	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014970	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023625_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023599	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS045255.572604	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3051	SRR058108	28.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110345_from_subject_892969023__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700110305	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	4.3	JCVI	HMP_production_phase_1
SRS022380.572858	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2168	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022380	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098246_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098214	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	35	0	JCVI	HMP_production_phase_1
SRS047078.571220	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3222	SRR046486	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047078	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241844	241844	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105228_from_subject_763820215__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105205	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	4	WUGSC	HMP_production_phase_1
SRS018345.576330	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1337	SRR043232	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018345	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035779_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS015627.573052	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_652	SRR044281	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024282_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024248	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.4	WUGSC	HMP_production_phase_1
SRS065310.573919	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4662	SRR046814	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065310	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114476_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114440	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	3.9	WUGSC	HMP_production_phase_1
SRS016765.571498	TCAGAATTCCTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_968	SRR041377	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016765	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032956_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032931	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	BI	HMP_production_phase_1
SRS062600.571198	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4260	SRR048424	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062600	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110776_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110758	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	35	4.6	BCM	HMP_production_phase_1
SRS015520.574094	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_624	SRR044283	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015520	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024175_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024142	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.1	WUGSC	HMP_production_phase_1
SRS017673.571441	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1166	SRR041484	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017673	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241775	241775	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034688_from_subject_160461578__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034638	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	19	0	BI	HMP_production_phase_1
SRS021643.573670	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1983	SRR048057	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021643	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241668	241668	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097355_from_subject_158013734__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097312	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	22	4.9	BCM	HMP_production_phase_1
SRS043472.570412	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2879	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043472	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241867	241867	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101825_from_subject_514014184__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101787	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	4.2	JCVI	HMP_production_phase_1
SRS013504.573007	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_243	SRR041680	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013504	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016484_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016463	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS015354.571119	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_584	SRR044005	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015354	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024009_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023978	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	3.7	WUGSC	HMP_production_phase_1
SRS018787.573781	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1428	SRR046135	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037254_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	WUGSC	HMP_production_phase_1
SRS019011.574161	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1465	SRR044624	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019011	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037480_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037451	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS042680.573977	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2813	SRR048514	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042680	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107591_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107559	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	0	BCM	HMP_production_phase_1
SRS066144.572149	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043085	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS066188.575389	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048772	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS044355.574207	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2960	SRR046676	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038928_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038907	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	WUGSC	HMP_production_phase_1
SRS011357.574704	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_32	SRR045289	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015633_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015631	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	33	0	WUGSC	HMP_production_phase_1
SRS011578.574530	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_140	SRR045478	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011578	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033035_from_subject_159247771__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700033033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.7	WUGSC	HMP_production_phase_1
SRS015927.576375	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_735	SRR044610	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015927	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024582_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS024580.574762	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2717	SRR040781	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024580	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101871_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101846	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS017855.571636	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1215	SRR043049	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017855	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034960_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034924	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS016868.574746	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_986	SRR041747	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016868	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033229_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS018100.575514	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1273	SRR041178	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018100	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035424_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035385	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS048843.576492	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3378	SRR049411	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048843	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038572_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038543	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS014659.575591	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_415	SRR043602	37.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241720	241720	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023313_from_subject_763597684__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700023290	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	37	0	WUGSC	HMP_production_phase_1
SRS023645.571701	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2484	SRR040647	20.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023645	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099948_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099906	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	20	4.9	BI	HMP_production_phase_1
SRS066188.575651	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058111	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS013516.575410	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_248	SRR041063	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013516	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016496_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016469	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS066188.575654	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR057609	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS047465.572445	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3257	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047465	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241694	241694	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109372_from_subject_160866180__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109333	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	4.6	JCVI	HMP_production_phase_1
SRS019572.571474	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1527	SRR043630	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019572	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038043_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038016	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	37	0	WUGSC	HMP_production_phase_1
SRS015149.573372	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_524	SRR045671	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015149	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023804_from_subject_763901136__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023709	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	28	4.5	WUGSC	HMP_production_phase_1
SRS022625.574705	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2227	SRR041904	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022625	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098577_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098550	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS011161.575030	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3	SRR045328	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011161	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014973_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014971	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	0	WUGSC	HMP_production_phase_1
SRS015913.572208	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_729	SRR044600	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015913	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024568_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024546	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS014976.571077	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_491	SRR046242	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014976	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241727	241727	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023631_from_subject_763880905__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700023602	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	0	WUGSC	HMP_production_phase_1
SRS013462.571371	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_233	SRR041940	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016393_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016380	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	BI	HMP_production_phase_1
SRS016231.572292	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_821	SRR044425	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016231	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024894_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024860	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.1	WUGSC	HMP_production_phase_1
SRS022617.572476	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2224	SRR041926	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098569_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098546	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS014568.575260	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_392	SRR047558	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014568	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023222_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023186	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	3.8	WUGSC	HMP_production_phase_1
SRS017215.573737	TCAGTTGTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1062	SRR041443	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017215	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033821_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033820	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	BI	HMP_production_phase_1
SRS020413.572892	TCAGAACCGGATAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1681	SRR040994	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020413	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241680	241680	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095736_from_subject_160684109__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700095717	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	0	BI	HMP_production_phase_1
SRS055377.570366	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3926	SRR046199	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055377	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038880_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038859	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	WUGSC	HMP_production_phase_1
SRS023995.573098	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2568	SRR040907	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023995	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100456_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100425	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	0	BI	HMP_production_phase_1
SRS018382.571321	TCAGAACCGACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1342	SRR041405	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018382	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035816_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035791	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	0	BI	HMP_production_phase_1
SRS018755.572731	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1421	SRR044494	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018755	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241832	241832	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037222_from_subject_765013792__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	4.5	WUGSC	HMP_production_phase_1
SRS021193.571117	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1866	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021193	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096740_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096709	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	5	JCVI	HMP_production_phase_1
SRS056384.574809	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4013	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056384	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257133	257133	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102581_from_subject_937415040__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102539	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	38	4.6	JCVI	HMP_production_phase_1
SRS050839.575055	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3559	SRR046387	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050839	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241887	241887	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106878_from_subject_764811490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106858	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	21	5.3	WUGSC	HMP_production_phase_1
SRS050114.574411	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3487	SRR046862	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050114	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105828_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105790	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.6	WUGSC	HMP_production_phase_1
SRS048044.574157	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3315	SRR048550	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048044	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108923_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108900	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BCM	HMP_production_phase_1
SRS015504.570297	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_618	SRR044245	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015504	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241707	241707	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024159_from_subject_764245047__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.1	WUGSC	HMP_production_phase_1
SRS015909.573279	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_727	SRR044601	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015909	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241778	241778	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024564_from_subject_764305738__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024544	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	WUGSC	HMP_production_phase_1
SRS063480.575295	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4391	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063480	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111851_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111820	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	36	0	JCVI	HMP_production_phase_1
SRS013249.576538	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_221	SRR040774	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013249	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015956_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700015955	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS020903.571379	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1799	SRR043296	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020903	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096414_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096378	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	0	BI	HMP_production_phase_1
SRS023545.572820	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2453	SRR041247	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023545	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241748	241748	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099822_from_subject_158802708__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099803	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS015198.571793	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_538	SRR043886	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015198	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023853_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023819	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4	WUGSC	HMP_production_phase_1
SRS051984.570887	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3661	SRR048570	19.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051984	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109671_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109635	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	19	4.7	BCM	HMP_production_phase_1
SRS044378.573757	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2962	SRR048548	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044378	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108933_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108905	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BCM	HMP_production_phase_1
SRS023444.576403	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2434	SRR048165	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023444	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099631_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099601	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	0	BCM	HMP_production_phase_1
SRS024716.575275	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2756	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024716	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102096_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102060	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	0	JCVI	HMP_production_phase_1
SRS014452.571179	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_374	SRR046092	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014452	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023106_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023071	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS014281.576380	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_336	SRR043601	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014281	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021870_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700021358	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS015874.575388	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_718	SRR043761	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015874	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024529_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024502	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	39	0	WUGSC	HMP_production_phase_1
SRS023075.576356	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2341	SRR048122	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023075	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241789	241789	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099109_from_subject_158276726__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099073	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	4.1	BCM	HMP_production_phase_1
SRS063214.574091	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4353	SRR047081	32.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063214	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241858	241858	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114419_from_subject_764953101__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114387	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	32	0	WUGSC	HMP_production_phase_1
SRS057603.575084	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4121	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057603	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101801_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101775	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	JCVI	HMP_production_phase_1
SRS023605.575155	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2468	SRR041010	20.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023605	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241702	241702	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099908_from_subject_159005010__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099886	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	20	4.9	BI	HMP_production_phase_1
SRS014552.575992	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_385	SRR045673	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014552	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023206_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023178	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	3.8	WUGSC	HMP_production_phase_1
SRS024054.573197	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2584	SRR040882	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024054	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100516_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100484	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	4.7	BI	HMP_production_phase_1
SRS022623.576033	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2226	SRR041837	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022623	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098575_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098549	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS022572.571476	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2214	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022572	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098477_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098442	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	5	JCVI	HMP_production_phase_1
SRS014675.572296	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_422	SRR043605	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023329_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023298	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS064312.570587	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4525	SRR048866	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064312	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112038_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700112002	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Right_Antecubital_fossa	26	0	BCM	HMP_production_phase_1
SRS016871.571376	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_987	SRR041709	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033232_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS017471.576529	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1123	SRR041257	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017471	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034204_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	19	5.1	BI	HMP_production_phase_1
SRS023200.574546	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2373	SRR041723	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023200	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099331_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099300	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	33	0	BI	HMP_production_phase_1
SRS011594.571637	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_148	SRR045323	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011594	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033169_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033138	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.3	WUGSC	HMP_production_phase_1
SRS023007.574930	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2322	SRR048060	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023007	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099041_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099012	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	BCM	HMP_production_phase_1
SRS016259.573521	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_827	SRR044509	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016259	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024922_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024904	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	29	0	WUGSC	HMP_production_phase_1
SRS014925.576242	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_476	SRR043908	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023580_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS018515.573181	TCAGAAGTCGGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1375	SRR040725	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018515	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035979_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035944	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	4.1	BI	HMP_production_phase_1
SRS044435.570999	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2966	SRR046194	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038434_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038402	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS055621.571423	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3939	SRR048600	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055621	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108196_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108169	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	21	0	BCM	HMP_production_phase_1
SRS023514.570317	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2450	SRR048229	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023514	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099791_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099759	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BCM	HMP_production_phase_1
SRS016010.573049	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_757	SRR044284	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016010	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024665_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024642	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	WUGSC	HMP_production_phase_1
SRS017914.576144	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1231	SRR041374	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017914	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241799	241799	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035212_from_subject_160441347__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS023577.572151	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2465	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023577	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099854_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099819	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS045931.572840	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3118	SRR047250	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045931	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105378_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700105358	n	969	234	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	WUGSC	HMP_production_phase_1
SRS052430.571140	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3702	SRR046839	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052430	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241883	241883	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103531_from_subject_132902142__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700103495	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	31	5.6	WUGSC	HMP_production_phase_1
SRS064244.575558	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4516	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064244	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111053_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111030	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	JCVI	HMP_production_phase_1
SRS017298.573827	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1085	SRR042948	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017298	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033973_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033938	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS042888.576135	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2827	SRR048674	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042888	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108252_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108224	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	32	4.6	BCM	HMP_production_phase_1
SRS055124.571183	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3903	SRR045913	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055124	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038990_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038962	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	30	0	WUGSC	HMP_production_phase_1
SRS021516.572935	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1952	SRR042815	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021516	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241722	241722	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097228_from_subject_158479027__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097193	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS057938.572483	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4155	SRR049389	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057938	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241887	241887	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106900_from_subject_764811490__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106869	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	21	5.3	WUGSC	HMP_production_phase_1
SRS051166.572047	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3585	SRR047144	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051166	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105455_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105419	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	34	4.2	WUGSC	HMP_production_phase_1
SRS042698.573231	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2814	SRR046191	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042698	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038876_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	WUGSC	HMP_production_phase_1
SRS046108.571154	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3134	SRR045873	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046108	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241864	241864	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038795_from_subject_508703490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700038758	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	5.3	WUGSC	HMP_production_phase_1
SRS044586.571118	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2979	SRR058108	40.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044586	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241849	241849	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110271_from_subject_161473083__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110235	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	40	4.9	JCVI	HMP_production_phase_1
SRS015568.574928	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_634	SRR043986	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015568	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024223_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024196	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	18	0	WUGSC	HMP_production_phase_1
SRS011415.570853	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_50	SRR044930	34.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011415	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241673	241673	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016029_from_subject_159085930__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016008	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	34	0	WUGSC	HMP_production_phase_1
SRS021443.573607	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1929	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021443	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097151_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097124	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	32	0	JCVI	HMP_production_phase_1
SRS063268.571310	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4361	SRR049644	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063268	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241756	241756	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113152_from_subject_764467579__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700113118	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	0	WUGSC	HMP_production_phase_1
SRS049248.575106	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3413	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049248	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107844_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107820	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	JCVI	HMP_production_phase_1
SRS011588.576369	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_145	SRR044926	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011588	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033161_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.3	WUGSC	HMP_production_phase_1
SRS052196.570693	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3682	SRR046417	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052196	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241890	241890	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105822_from_subject_375450439__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105787	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.6	WUGSC	HMP_production_phase_1
SRS045846.576462	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3103	SRR042970	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045846	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102466_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102430	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS014321.573533	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_344	SRR045674	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014321	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021910_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021890	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	3.9	WUGSC	HMP_production_phase_1
SRS015613.571108	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_647	SRR044204	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241784	241784	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024268_from_subject_764346198__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024241	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.4	WUGSC	HMP_production_phase_1
SRS049599.574559	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3442	SRR043877	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038726_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038695	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS043422.575529	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2875	SRR041456	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043422	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107075_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107048	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	0	BI	HMP_production_phase_1
SRS064240.574623	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4515	SRR047687	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064240	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114074_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114051	n	969	286	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	20	5.6	WUGSC	HMP_production_phase_1
SRS043226.575272	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2852	SRR043623	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043226	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038710_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038687	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	3.7	WUGSC	HMP_production_phase_1
SRS013784.575083	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_304	SRR048139	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013784	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016944_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700016913	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BCM	HMP_production_phase_1
SRS011527.573153	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_113	SRR044869	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011527	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016506_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016500	n	969	23	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	34	3.6	WUGSC	HMP_production_phase_1
SRS042533.574284	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2794	SRR047232	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042533	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105652_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105623	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	3.8	WUGSC	HMP_production_phase_1
SRS022747.574744	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2257	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022747	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098703_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098675	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	4.1	JCVI	HMP_production_phase_1
SRS024718.570307	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2757	SRR058092	30.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024718	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241753	241753	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102098_from_subject_368533040__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102061	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	0	JCVI	HMP_production_phase_1
SRS045980.571975	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3123	SRR051588	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045980	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038992_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038963	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	30	0	WUGSC	HMP_production_phase_1
SRS057320.571159	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4095	SRR043747	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057320	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038514_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038490	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	31	0	WUGSC	HMP_production_phase_1
SRS017788.573983	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1195	SRR040701	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017788	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034881_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034850	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	0	BI	HMP_production_phase_1
SRS056424.572204	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4017	SRR047157	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056424	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241880	241880	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105964_from_subject_658594300__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700105936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	WUGSC	HMP_production_phase_1
SRS063907.574138	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4461	SRR048815	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063907	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111783_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111753	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.6	BCM	HMP_production_phase_1
SRS014867.571352	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_459	SRR047404	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014867	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023521_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023499	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	39	0	WUGSC	HMP_production_phase_1
SRS016726.570487	TCAGTCCGGTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_962	SRR040989	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016726	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032671_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032649	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.3	BI	HMP_production_phase_1
SRS054730.570966	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3874	SRR048719	23.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054730	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107433_from_subject_159753524__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107393	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	23	4.7	BCM	HMP_production_phase_1
SRS023334.574228	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2407	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023334	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241835	241835	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099496_from_subject_206906765__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099458	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	JCVI	HMP_production_phase_1
SRS013672.573498	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_275	SRR043270	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013672	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016750_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700016709	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS044297.573579	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2954	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044297	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107862_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107829	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS014770.572970	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_432	SRR043947	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014770	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241824	241824	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023424_from_subject_763719065__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023392	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	4.2	WUGSC	HMP_production_phase_1
SRS013738.570784	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_295	SRR042799	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013738	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016816_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016815	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS054094.572324	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3826	SRR046463	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054094	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241866	241866	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106788_from_subject_857980665__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106756	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	4.2	WUGSC	HMP_production_phase_1
SRS047859.572185	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3297	SRR046514	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047859	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038773_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038747	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	5.3	WUGSC	HMP_production_phase_1
SRS023805.571672	TCAGACTCTGTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2520	SRR058086	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023805	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100199_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700100172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	JCVI	HMP_production_phase_1
SRS021940.572116	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2056	SRR048082	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021940	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241739	241739	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097680_from_subject_158155345__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097646	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	0	BCM	HMP_production_phase_1
SRS062457.574777	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4236	SRR048821	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062457	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111791_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111757	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.6	BCM	HMP_production_phase_1
SRS021698.575031	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1997	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021698	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241688	241688	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097410_from_subject_161331472__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097374	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	JCVI	HMP_production_phase_1
SRS023865.570986	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2533	SRR048209	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023865	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100263_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100234	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	4.9	BCM	HMP_production_phase_1
SRS017402.574558	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1105	SRR041179	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017402	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034108_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	30	0	BI	HMP_production_phase_1
SRS023137.572351	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2359	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023137	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241757	241757	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099268_from_subject_441369442__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099281	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS014247.574396	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_325	SRR045844	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014247	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241791	241791	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021836_from_subject_763678604__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	NA	y	TCAG	UBERON:nasal mucus	700021812	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS046266.572644	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3150	SRR041565	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046266	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102395_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102366	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS045414.575582	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3072	SRR049611	18.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045414	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241874	241874	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106093_from_subject_737052003__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106065	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	18	4.5	WUGSC	HMP_production_phase_1
SRS021818.571924	TCAGAGTAGCGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2025	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021818	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241849	241849	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097531_from_subject_161473083__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097495	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	40	0	JCVI	HMP_production_phase_1
SRS014966.571545	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_488	SRR045864	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014966	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023621_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023597	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS016781.573234	TCAGACCTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_976	SRR041419	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016781	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032972_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032939	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS021457.570754	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1936	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021457	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097165_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700097131	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	0	JCVI	HMP_production_phase_1
SRS062597.572661	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4259	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062597	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111059_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111033	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	JCVI	HMP_production_phase_1
SRS017821.573378	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1202	SRR041310	29.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017821	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241711	241711	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034926_from_subject_160603188__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034907	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	BI	HMP_production_phase_1
SRS047619.573200	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3271	SRR048399	28.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047619	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241760	241760	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102960_from_subject_159146620__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102923	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BCM	HMP_production_phase_1
SRS044355.575895	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2960	SRR046196	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038928_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038907	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	WUGSC	HMP_production_phase_1
SRS066144.570571	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043081	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS066144.570570	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043082	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS066144.570579	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058090	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS054830.574426	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3882	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054830	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241698	241698	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110409_from_subject_650853796__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110370	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	4.4	JCVI	HMP_production_phase_1
SRS014960.570738	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_485	SRR045805	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014960	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023615_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023594	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	32	0	WUGSC	HMP_production_phase_1
SRS053731.571419	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3805	SRR048560	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053731	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109657_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109628	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	19	4.7	BCM	HMP_production_phase_1
SRS018276.575519	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1316	SRR041357	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018276	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035683_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035648	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	3.9	BI	HMP_production_phase_1
SRS016430.573541	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_880	SRR041489	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016430	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032117_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032083	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS014446.573809	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_371	SRR043628	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014446	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023100_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023068	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	25	3.4	WUGSC	HMP_production_phase_1
SRS015468.574374	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_612	SRR047455	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024123_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024094	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS020726.572284	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1757	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020726	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096151_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096118	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	JCVI	HMP_production_phase_1
SRS020388.575278	TCAGCCGACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1678	SRR041613	32.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095707_from_subject_160704339__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095666	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	32	4.2	BI	HMP_production_phase_1
SRS018035.571575	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1259	SRR043262	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018035	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035359_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.3	BI	HMP_production_phase_1
SRS016056.575793	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_771	SRR044252	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016056	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241741	241741	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024711_from_subject_764508039__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024689	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	WUGSC	HMP_production_phase_1
SRS063007.573669	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4327	SRR047666	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063007	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114035_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114009	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	36	0	WUGSC	HMP_production_phase_1
SRS021332.574713	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1904	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021332	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096990_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096957	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS023518.570717	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2451	SRR048315	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023518	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099795_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099761	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS017841.573975	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1208	SRR041315	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017841	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034946_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034917	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	BI	HMP_production_phase_1
SRS015876.575225	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_719	SRR043739	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015876	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024531_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024503	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	39	0	WUGSC	HMP_production_phase_1
SRS015917.575485	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_730	SRR044637	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015917	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024572_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024548	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS049738.573949	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3455	SRR051579	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049738	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038930_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038908	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	WUGSC	HMP_production_phase_1
SRS051976.574883	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3659	SRR044007	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051976	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106028_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106004	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	3.8	WUGSC	HMP_production_phase_1
SRS013738.573529	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_295	SRR042949	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013738	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016816_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016815	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS014869.574060	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_460	SRR043797	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014869	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023523_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023500	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	39	0	WUGSC	HMP_production_phase_1
SRS021567.572237	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1963	SRR048089	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021567	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097279_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097247	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	BCM	HMP_production_phase_1
SRS019005.570386	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1464	SRR044596	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019005	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037474_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037448	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS063808.573029	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4445	SRR046277	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063808	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114139_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114112	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	38	4.7	WUGSC	HMP_production_phase_1
SRS017371.573914	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1102	SRR041215	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017371	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241674	241674	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034077_from_subject_160340197__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS024073.572268	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2591	SRR040889	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024073	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100538_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100533	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	4.7	BI	HMP_production_phase_1
SRS011680.574047	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_191	SRR045124	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011680	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033785_from_subject_159713063__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700033744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.4	WUGSC	HMP_production_phase_1
SRS054039.571561	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3822	SRR049471	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054039	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105138_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105103	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	5.6	WUGSC	HMP_production_phase_1
SRS016052.570292	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_769	SRR046147	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016052	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241741	241741	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024707_from_subject_764508039__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024687	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS021191.573875	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1865	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021191	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096738_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096708	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	5	JCVI	HMP_production_phase_1
SRS017782.571769	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1192	SRR040749	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017782	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034875_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034847	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	0	BI	HMP_production_phase_1
SRS048284.570897	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3335	SRR045551	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048284	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038458_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038438	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS018321.576000	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1326	SRR041545	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018321	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035755_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035732	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	BI	HMP_production_phase_1
SRS023219.573588	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2380	SRR048069	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241700	241700	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099350_from_subject_158114885__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099346	n	969	319	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	29	4.2	BCM	HMP_production_phase_1
SRS064784.575814	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4588	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064784	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257123	257123	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111871_from_subject_414519462__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111830	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	36	4.7	JCVI	HMP_production_phase_1
SRS016277.575594	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_836	SRR044108	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016277	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024940_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024913	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	WUGSC	HMP_production_phase_1
SRS020557.571414	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1718	SRR043251	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095880_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS055961.570942	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3980	SRR048591	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055961	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107794_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107767	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	0	BCM	HMP_production_phase_1
SRS020602.574133	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1727	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020602	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095993_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	JCVI	HMP_production_phase_1
SRS018995.573741	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1459	SRR044593	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018995	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037464_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037443	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS021380.576086	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1912	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021380	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097038_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097008	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	4.6	JCVI	HMP_production_phase_1
SRS017971.576045	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1244	SRR042837	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017971	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241809	241809	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035292_from_subject_158357646__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035255	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS016871.575119	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_987	SRR041769	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033232_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS048722.571397	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3368	SRR046409	28.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048722	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241857	241857	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106579_from_subject_208027353__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106551	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	4.3	WUGSC	HMP_production_phase_1
SRS062829.574419	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4301	SRR046380	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062829	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114084_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114056	n	969	286	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	20	5.6	WUGSC	HMP_production_phase_1
SRS046353.575596	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3160	SRR042892	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046353	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102407_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102372	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS064707.573364	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4576	SRR048802	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064707	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111270_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111235	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	5	BCM	HMP_production_phase_1
SRS024283.572992	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2640	SRR042008	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024283	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101261_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101233	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	3.7	BI	HMP_production_phase_1
SRS014619.573717	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_405	SRR046168	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241693	241693	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023273_from_subject_763840445__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	38	4.1	WUGSC	HMP_production_phase_1
SRS014295.571550	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_339	SRR046139	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014295	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021884_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021681	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS015784.570668	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_694	SRR044282	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015784	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024439_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024409	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	WUGSC	HMP_production_phase_1
SRS013201.576199	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_207	SRR040954	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013201	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015900_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015869	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	0	BI	HMP_production_phase_1
SRS014599.573244	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_398	SRR045681	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023253_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	4.1	WUGSC	HMP_production_phase_1
SRS014452.573441	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_374	SRR045780	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014452	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023106_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023071	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS016097.572579	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_781	SRR044480	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016097	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241701	241701	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024754_from_subject_764588959__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024733	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	4.5	WUGSC	HMP_production_phase_1
SRS023340.575303	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2410	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023340	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241835	241835	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099502_from_subject_206906765__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099461	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4.3	JCVI	HMP_production_phase_1
SRS016541.576313	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_907	SRR041800	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016541	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032268_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4	BI	HMP_production_phase_1
SRS064038.572308	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4493	SRR046979	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064038	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114248_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114219	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	4.5	WUGSC	HMP_production_phase_1
SRS064413.570390	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4543	SRR046976	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064413	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114743_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114714	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	0	WUGSC	HMP_production_phase_1
SRS056779.573398	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4054	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056779	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109143_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109114	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	4.1	JCVI	HMP_production_phase_1
SRS018958.573549	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1449	SRR047589	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241737	241737	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037427_from_subject_765276783__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037400	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS054275.572962	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3836	SRR046469	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054275	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241859	241859	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	TRUE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105482_from_subject_643185023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700105461	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	5	WUGSC	HMP_production_phase_1
SRS018435.571010	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1353	SRR041812	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035869_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS020147.573763	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1613	SRR048140	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020147	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241827	241827	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095400_from_subject_158398106__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095367	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	0	BCM	HMP_production_phase_1
SRS011275.573242	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_18	SRR044913	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011275	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015265_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015263	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	WUGSC	HMP_production_phase_1
SRS015285.574572	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_563	SRR046171	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023940_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023921	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS022588.571833	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2222	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022588	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098493_from_subject_809635352__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098450	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	5	JCVI	HMP_production_phase_1
SRS020557.572729	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1718	SRR043276	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095880_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS016600.574934	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_922	SRR041343	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016600	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032353_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032324	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	31	4.3	BI	HMP_production_phase_1
SRS021990.571852	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2063	SRR041976	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021990	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097730_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700097698	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	4.1	BI	HMP_production_phase_1
SRS043014.573957	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2833	SRR048554	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043014	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108927_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108902	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BCM	HMP_production_phase_1
SRS021199.570601	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1869	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021199	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096746_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096712	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	5	JCVI	HMP_production_phase_1
SRS024036.576486	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2576	SRR041573	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024036	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100498_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100475	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	4.7	BI	HMP_production_phase_1
SRS014253.576094	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_326	SRR046212	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014253	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021842_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700021816	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS018161.575436	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1287	SRR040919	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018161	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035561_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS021938.571606	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2055	SRR048081	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021938	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241739	241739	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097678_from_subject_158155345__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097645	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	0	BCM	HMP_production_phase_1
SRS055348.574039	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3924	SRR047229	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055348	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106374_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106345	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	WUGSC	HMP_production_phase_1
SRS020883.573804	TCAGTCGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1789	SRR041628	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020883	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096394_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096368	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	31	0	BI	HMP_production_phase_1
SRS011553.573867	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_126	SRR047476	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011553	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016658_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016656	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS021615.570477	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1971	SRR048047	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097327_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097298	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	4.9	BCM	HMP_production_phase_1
SRS017035.572280	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1024	SRR041538	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017035	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033548_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033547	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS015472.574441	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_614	SRR044644	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024127_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024096	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS016420.575163	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_875	SRR041410	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016420	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032107_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032078	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS064008.570251	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4485	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064008	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257123	257123	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111833_from_subject_414519462__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111811	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	36	4.7	JCVI	HMP_production_phase_1
SRS016364.575956	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_863	SRR040931	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016364	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032028_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032027	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS057537.573933	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4113	SRR042850	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101341_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101306	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS022428.571147	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2176	SRR048385	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022428	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098303_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098274	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	5.8	BCM	HMP_production_phase_1
SRS018799.572112	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1433	SRR045797	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018799	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037266_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	WUGSC	HMP_production_phase_1
SRS020541.574975	TCAGTCGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1710	SRR041841	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020541	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095864_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095838	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	BI	HMP_production_phase_1
SRS014617.571396	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_404	SRR046597	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241693	241693	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023271_from_subject_763840445__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	4.1	WUGSC	HMP_production_phase_1
SRS064034.570648	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4491	SRR049521	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064034	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114649_from_subject_763901136__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114613	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	28	4.3	WUGSC	HMP_production_phase_1
SRS054619.571076	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3868	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101817_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101783	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	JCVI	HMP_production_phase_1
SRS022319.570266	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2151	SRR058111	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022319	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241841	241841	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098159_from_subject_533247696__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098123	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	4.5	JCVI	HMP_production_phase_1
SRS055231.571584	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3914	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055231	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241733	241733	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108332_from_subject_160825720__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108298	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	JCVI	HMP_production_phase_1
SRS062893.576074	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4309	SRR046813	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062893	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241682	241682	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114448_from_subject_764042746__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114426	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	3.9	WUGSC	HMP_production_phase_1
SRS018999.574114	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1461	SRR044617	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037468_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037445	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS016777.576593	TCAGAAGTCGGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_974	SRR041376	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016777	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032968_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032937	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	BI	HMP_production_phase_1
SRS011537.571308	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_118	SRR045107	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016634_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016632	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS016233.572882	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_822	SRR044382	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016233	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024896_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024861	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.1	WUGSC	HMP_production_phase_1
SRS016485.573661	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_895	SRR041278	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016485	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032181_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS016785.570673	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_978	SRR041370	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016785	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032976_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032941	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS048471.571572	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3345	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048471	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109151_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109118	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	4.1	JCVI	HMP_production_phase_1
SRS045891.570220	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3111	SRR048513	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045891	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107585_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107556	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	0	BCM	HMP_production_phase_1
SRS014450.572695	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_373	SRR043906	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023104_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023070	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS048383.571236	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3339	SRR049377	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048383	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103603_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103572	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS055697.576062	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3951	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055697	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257120	257120	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110438_from_subject_604812005__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110419	n	969	85	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	JCVI	HMP_production_phase_1
SRS015281.574499	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_561	SRR047403	37.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015281	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241787	241787	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023936_from_subject_763982056__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700023919	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	37	0	WUGSC	HMP_production_phase_1
SRS015780.576389	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_692	SRR044207	26.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015780	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241685	241685	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024435_from_subject_764224817__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024407	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	WUGSC	HMP_production_phase_1
SRS022012.574112	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2073	SRR040619	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022012	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097752_from_subject_158256496__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097709	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	4.1	BI	HMP_production_phase_1
SRS013581.572241	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_259	SRR048272	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013581	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016602_from_subject_159227541__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016561	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	22	4.7	BCM	HMP_production_phase_1
SRS019568.570590	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1525	SRR045550	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019568	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038039_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038014	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	37	0	WUGSC	HMP_production_phase_1
SRS063324.572433	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4373	SRR047727	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063324	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257114	257114	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	TRUE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114517_from_subject_739574095__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700114489	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.8	WUGSC	HMP_production_phase_1
SRS058500.571443	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4198	SRR058113	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058500	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109851_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109819	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS018449.574980	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1359	SRR041080	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018449	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035883_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035853	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS024181.571907	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2618	SRR040635	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024181	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100649_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100615	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS022751.574859	TCAGACTCTGTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2259	SRR058120	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022751	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098707_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098677	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	4.1	JCVI	HMP_production_phase_1
SRS022522.574863	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2204	SRR048187	30.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022522	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241810	241810	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098423_from_subject_158458797__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098380	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	30	4.5	BCM	HMP_production_phase_1
SRS062662.576165	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4273	SRR046900	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062662	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113128_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113106	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	0	WUGSC	HMP_production_phase_1
SRS063481.573859	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4392	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063481	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110632_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110600	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS023200.573087	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2373	SRR041839	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023200	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099331_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099300	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	33	0	BI	HMP_production_phase_1
SRS019673.571115	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1541	SRR046204	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019673	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038146_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038120	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS066144.570493	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043075	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS019097.575343	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1474	SRR044750	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019097	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037568_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037543	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS017935.572108	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1232	SRR041737	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017935	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241809	241809	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035256_from_subject_158357646__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035237	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS064626.572086	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4566	SRR049486	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064626	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113594_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700113558	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	4.1	WUGSC	HMP_production_phase_1
SRS017669.572914	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1164	SRR040692	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241775	241775	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034684_from_subject_160461578__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034636	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	0	BI	HMP_production_phase_1
SRS023768.576431	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2515	SRR042924	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023768	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100075_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100039	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS019249.570891	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1492	SRR044417	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019249	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037720_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037691	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.2	WUGSC	HMP_production_phase_1
SRS011157.572834	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1	SRR045333	38.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241686	241686	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014956_from_subject_158822939__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700014954	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	0	WUGSC	HMP_production_phase_1
SRS018167.572017	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1290	SRR042905	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035567_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035531	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS055304.572196	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3918	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107854_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107825	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	JCVI	HMP_production_phase_1
SRS020376.574690	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1672	SRR041595	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020376	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095695_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095660	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	32	4.2	BI	HMP_production_phase_1
SRS019308.570920	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1502	SRR047575	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019308	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241848	241848	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037779_from_subject_765377934__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037749	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	35	4.1	WUGSC	HMP_production_phase_1
SRS018793.575801	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1430	SRR046208	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018793	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037260_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	WUGSC	HMP_production_phase_1
SRS046855.571214	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3200	SRR045541	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046855	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038716_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038690	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	3.7	WUGSC	HMP_production_phase_1
SRS048964.572722	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3385	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048964	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102151_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102121	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	36	3.9	JCVI	HMP_production_phase_1
SRS024412.576518	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2676	SRR041848	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024412	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101558_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101527	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	5.1	BI	HMP_production_phase_1
SRS011606.571998	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_154	SRR045067	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011606	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033181_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033144	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.3	WUGSC	HMP_production_phase_1
SRS020014.574061	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1593	SRR042868	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020014	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095259_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095225	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.3	BI	HMP_production_phase_1
SRS022374.576284	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2165	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022374	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098240_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098211	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	35	0	JCVI	HMP_production_phase_1
SRS020903.575670	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1799	SRR043282	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020903	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096414_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096378	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	0	BI	HMP_production_phase_1
SRS011423.575259	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_54	SRR044939	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011423	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016067_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016040	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS062549.572742	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4255	SRR048840	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062549	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111340_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700111307	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	39	4.8	BCM	HMP_production_phase_1
SRS045061.574408	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3029	SRR046268	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045061	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105866_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105839	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	30	0	WUGSC	HMP_production_phase_1
SRS055988.570721	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3983	SRR046487	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055988	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241874	241874	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106079_from_subject_737052003__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106058	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	18	4.5	WUGSC	HMP_production_phase_1
SRS017098.570687	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1040	SRR042942	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017098	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033611_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033576	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS023069.570428	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2338	SRR048376	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023069	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099103_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099070	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	4.1	BCM	HMP_production_phase_1
SRS017737.575831	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1183	SRR041309	30.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017737	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034830_from_subject_160582958__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034790	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	4.1	BI	HMP_production_phase_1
SRS023184.571451	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2366	SRR041739	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023184	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099315_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099292	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	33	0	BI	HMP_production_phase_1
SRS011442.570411	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_66	SRR045490	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016091_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016052	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS017351.572631	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1092	SRR041277	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034057_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034031	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	BI	HMP_production_phase_1
SRS016485.575968	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_895	SRR042815	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016485	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032181_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS045371.571035	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3064	SRR048533	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045371	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109598_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109571	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	0	BCM	HMP_production_phase_1
SRS011485.574379	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_89	SRR045486	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011485	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016321_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016302	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	34	0	WUGSC	HMP_production_phase_1
SRS064921.571676	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4605	SRR048825	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064921	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268869	268869	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111799_from_subject_872848689__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700111761	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4.6	BCM	HMP_production_phase_1
SRS024476.571249	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2693	SRR041104	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024476	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101622_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101592	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	38	0	BI	HMP_production_phase_1
SRS019101.576049	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1476	SRR044679	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019101	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037572_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037545	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS055574.570370	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3936	SRR045943	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055574	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038924_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038905	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	WUGSC	HMP_production_phase_1
SRS057737.575177	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4135	SRR048752	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057737	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108892_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108856	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	BCM	HMP_production_phase_1
SRS015858.570662	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_713	SRR043941	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015858	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024513_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024494	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS055318.571489	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3921	SRR043801	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055318	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241727	241727	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038576_from_subject_763880905__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038545	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	32	0	WUGSC	HMP_production_phase_1
SRS052830.574821	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3728	SRR048528	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052830	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107971_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107941	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BCM	HMP_production_phase_1
SRS019908.576337	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1583	SRR044380	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019908	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038384_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038353	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS014964.574617	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_487	SRR046203	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014964	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023619_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023596	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS024279.574190	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2638	SRR041894	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024279	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101257_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101231	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	3.7	BI	HMP_production_phase_1
SRS016535.573905	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_904	SRR043248	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016535	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032262_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4	BI	HMP_production_phase_1
SRS016327.573581	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_850	SRR044448	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016327	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024990_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024962	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	0	WUGSC	HMP_production_phase_1
SRS044660.573093	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2988	SRR048522	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044660	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107963_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107937	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BCM	HMP_production_phase_1
SRS011448.573363	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_70	SRR045338	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011448	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016099_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016056	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	20	4.2	WUGSC	HMP_production_phase_1
SRS020245.571429	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1635	SRR040779	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020245	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095498_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095473	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	0	BI	HMP_production_phase_1
SRS022818.572496	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2279	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022818	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098774_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	JCVI	HMP_production_phase_1
SRS015237.574861	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_547	SRR049838	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015237	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023892_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023867	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	4.4	WUGSC	HMP_production_phase_1
SRS055314.575776	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3919	SRR048280	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055314	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102631_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102597	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	4.5	BCM	HMP_production_phase_1
SRS050119.574536	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3488	SRR048661	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110119_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110093	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	4.3	BCM	HMP_production_phase_1
SRS019781.575187	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1562	SRR046141	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019781	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241681	241681	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038257_from_subject_764669880__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038228	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS052230.573714	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3686	SRR049837	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052230	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106038_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106009	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	3.8	WUGSC	HMP_production_phase_1
SRS052737.575756	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3725	SRR058108	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052737	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241786	241786	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109161_from_subject_970836795__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109123	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	4.1	JCVI	HMP_production_phase_1
SRS024535.572221	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2709	SRR048183	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024535	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101681_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101650	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BCM	HMP_production_phase_1
SRS024639.576504	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2731	SRR041233	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024639	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101930_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101904	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	0	BI	HMP_production_phase_1
SRS049521.575189	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3436	SRR047203	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049521	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106380_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106348	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS019371.574993	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1508	SRR045903	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019371	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241771	241771	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037842_from_subject_765337473__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037809	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.5	WUGSC	HMP_production_phase_1
SRS063383.571134	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4377	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063383	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110689_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110657	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	30	0	JCVI	HMP_production_phase_1
SRS022010.573589	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2072	SRR040669	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022010	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097750_from_subject_158256496__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097708	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	4.1	BI	HMP_production_phase_1
SRS011485.573216	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_89	SRR045435	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011485	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016321_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016302	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	34	0	WUGSC	HMP_production_phase_1
SRS015192.570930	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_535	SRR043945	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015192	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023847_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023816	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4	WUGSC	HMP_production_phase_1
SRS013699.572981	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_283	SRR041612	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013699	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016777_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016776	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS023316.572225	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2398	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023316	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099478_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099449	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.3	JCVI	HMP_production_phase_1
SRS014273.574619	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_332	SRR045517	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014273	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021862_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021313	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS018286.572258	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1321	SRR042869	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018286	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241785	241785	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035693_from_subject_160137896__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035653	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	3.9	BI	HMP_production_phase_1
SRS044110.574242	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2939	SRR058112	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044110	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108834_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108798	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	0	JCVI	HMP_production_phase_1
SRS020958.572059	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1813	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241752	241752	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096469_from_subject_161068481__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096434	n	969	10	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	JCVI	HMP_production_phase_1
SRS045129.576511	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3032	SRR042860	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045129	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107093_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107057	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS011537.574097	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_118	SRR044877	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016634_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016632	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS044339.575858	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2958	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044339	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109494_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109462	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	31	0	JCVI	HMP_production_phase_1
SRS022886.574696	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2295	SRR058111	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022886	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241698	241698	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098916_from_subject_650853796__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098880	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	4.6	JCVI	HMP_production_phase_1
SRS011508.576195	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_103	SRR049233	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011508	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016362_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016347	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	4.2	WUGSC	HMP_production_phase_1
SRS024159.572606	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2608	SRR041138	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100627_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100604	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS018169.575321	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1291	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035569_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS018545.573632	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1385	SRR047432	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241851	241851	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037012_from_subject_764710340__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037001	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4	WUGSC	HMP_production_phase_1
SRS021461.571536	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1938	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021461	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097169_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097133	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	32	0	JCVI	HMP_production_phase_1
SRS044879.573265	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3014	SRR049491	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044879	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105498_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105469	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	5	WUGSC	HMP_production_phase_1
SRS055541.573449	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3935	SRR049370	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055541	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105431_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105407	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	34	4.2	WUGSC	HMP_production_phase_1
SRS021553.574364	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1956	SRR048092	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021553	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097265_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097240	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	0	BCM	HMP_production_phase_1
SRS023065.574487	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2336	SRR048113	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023065	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099099_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099068	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	4.1	BCM	HMP_production_phase_1
SRS011494.576024	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_94	SRR044940	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011494	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016331_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016307	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	34	0	WUGSC	HMP_production_phase_1
SRS021121.576388	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1847	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021121	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096668_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096596	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	4.9	JCVI	HMP_production_phase_1
SRS051437.573070	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3613	SRR043998	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051437	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106030_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106005	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	3.8	WUGSC	HMP_production_phase_1
SRS050075.570720	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3484	SRR048586	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050075	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107904_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107879	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	BCM	HMP_production_phase_1
SRS021982.570440	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2059	SRR040627	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021982	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097722_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097694	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	4.1	BI	HMP_production_phase_1
SRS057499.574508	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4111	SRR046458	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057499	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241890	241890	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105800_from_subject_375450439__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105776	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.6	WUGSC	HMP_production_phase_1
SRS021826.571225	TCAGTATAGCGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2027	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021826	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097539_from_subject_161473083__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700097499	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	40	0	JCVI	HMP_production_phase_1
SRS044450.573836	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2968	SRR048632	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108570_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108539	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	30	3.9	BCM	HMP_production_phase_1
SRS022127.576267	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2102	SRR042796	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022127	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097893_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097854	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	4.4	BI	HMP_production_phase_1
SRS016724.572543	TCAGCGGAACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_961	SRR040948	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016724	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032669_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032648	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.3	BI	HMP_production_phase_1
SRS020314.574434	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1656	SRR041195	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020314	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095567_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095536	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	BI	HMP_production_phase_1
SRS054376.572658	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3843	SRR046696	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054376	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241863	241863	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105023_from_subject_275382046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106990	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	0	WUGSC	HMP_production_phase_1
SRS062708.571890	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4280	SRR048837	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062708	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111326_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111300	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	39	4.8	BCM	HMP_production_phase_1
SRS017959.572360	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1240	SRR041534	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017959	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035280_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035249	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS014871.571089	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_461	SRR043763	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023525_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023501	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	39	0	WUGSC	HMP_production_phase_1
SRS056493.570588	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4024	SRR046772	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056493	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105201_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105163	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	4.3	WUGSC	HMP_production_phase_1
SRS062997.570715	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4325	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062997	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110624_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110596	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	JCVI	HMP_production_phase_1
SRS064713.570404	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4579	SRR046744	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064713	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113598_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113560	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS053216.576268	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3757	SRR045920	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038998_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038966	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS020024.576238	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1598	SRR042834	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020024	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095269_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.3	BI	HMP_production_phase_1
SRS020714.571762	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1751	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020714	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096139_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096112	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	0	JCVI	HMP_production_phase_1
SRS020322.572523	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1660	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020322	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095575_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095540	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS016022.574555	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_763	SRR044500	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016022	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241708	241708	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024677_from_subject_764447348__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024648	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS023701.575104	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2497	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023701	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100008_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099971	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	4.1	JCVI	HMP_production_phase_1
SRS024056.570341	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2585	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024056	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100518_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100485	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	4.7	BI	HMP_production_phase_1
SRS022687.573267	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2243	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022687	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098639_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098608	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	4.6	JCVI	HMP_production_phase_1
SRS018210.570399	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1298	SRR040694	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018210	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035617_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035585	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	0	BI	HMP_production_phase_1
SRS046956.573497	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3210	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046956	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102704_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102672	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS014665.573932	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_418	SRR045777	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023319_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700023293	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS023756.575211	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2509	SRR040917	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023756	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100063_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100033	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS011427.571282	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_56	SRR044871	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016071_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS055113.570929	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3900	SRR049617	29.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055113	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257127	257127	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105644_from_subject_953045535__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105619	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	29	3.8	WUGSC	HMP_production_phase_1
SRS045387.571466	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3066	SRR043789	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045387	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038518_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038492	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	31	0	WUGSC	HMP_production_phase_1
SRS014970.574640	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_489	SRR046528	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014970	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023625_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023599	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS066144.573011	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058092	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS020324.571539	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1661	SRR042972	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020324	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095577_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095541	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS053059.576458	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3744	SRR048595	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053059	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107804_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107772	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	0	BCM	HMP_production_phase_1
SRS020732.570979	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1759	SRR058111	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020732	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096157_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096121	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	JCVI	HMP_production_phase_1
SRS046164.571699	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3145	SRR048609	21.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046164	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241715	241715	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108216_from_subject_160421117__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700108179	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	21	0	BCM	HMP_production_phase_1
SRS043620.575792	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2896	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043620	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102692_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102666	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	JCVI	HMP_production_phase_1
SRS015470.576552	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_613	SRR047457	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024125_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024095	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS049203.575506	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3409	SRR048253	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049203	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102285_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102254	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	0	BCM	HMP_production_phase_1
SRS013705.571069	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_284	SRR041510	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013705	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016783_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016782	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS017296.573408	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1084	SRR041236	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017296	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033971_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033937	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS023683.570766	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2488	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023683	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099990_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099962	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	4.1	JCVI	HMP_production_phase_1
SRS011479.576271	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_86	SRR044884	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011479	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241760	241760	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016178_from_subject_159146620__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700016138	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	WUGSC	HMP_production_phase_1
SRS064652.574610	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4572	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064652	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110679_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110652	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	30	0	JCVI	HMP_production_phase_1
SRS011357.572409	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_32	SRR047477	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015633_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015631	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	33	0	WUGSC	HMP_production_phase_1
SRS019705.573580	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1548	SRR045909	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019705	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241779	241779	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038179_from_subject_765539774__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038159	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	3.8	WUGSC	HMP_production_phase_1
SRS044643.576112	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2987	SRR047190	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044643	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105433_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105408	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	34	4.2	WUGSC	HMP_production_phase_1
SRS020722.572856	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1755	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020722	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096147_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096116	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	0	JCVI	HMP_production_phase_1
SRS022882.570869	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2293	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022882	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098912_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098878	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	4.6	JCVI	HMP_production_phase_1
SRS018157.576362	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1285	SRR040918	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035557_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035527	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS051631.571492	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3626	SRR048624	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108151_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700108112	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	3.9	BCM	HMP_production_phase_1
SRS024339.573198	TCAGTTGTTGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2654	SRR041170	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024339	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101374_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101351	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS046051.576095	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3130	SRR058084	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046051	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110383_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110357	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	4.4	JCVI	HMP_production_phase_1
SRS046477.575373	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3169	SRR041124	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046477	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101337_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101304	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS044146.570376	TCAGACTCTGTGAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2941	SRR052699	38.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044146	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257133	257133	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102541_from_subject_937415040__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102519	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	4.6	JCVI	HMP_production_phase_1
SRS050125.573587	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3489	SRR045883	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050125	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241884	241884	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038410_from_subject_765701615__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038390	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	39	0	WUGSC	HMP_production_phase_1
SRS055643.576379	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3944	SRR046576	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055643	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106420_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106400	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS055808.573040	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3961	SRR046692	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055808	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106581_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	4.3	WUGSC	HMP_production_phase_1
SRS018147.575622	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1280	SRR040970	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018147	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035547_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035520	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS058420.572865	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4192	SRR045915	30.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058420	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241853	241853	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038976_from_subject_370027359__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700038955	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	0	WUGSC	HMP_production_phase_1
SRS011182.571587	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_15	SRR045359	38.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011182	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241686	241686	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015009_from_subject_158822939__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700015007	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	38	0	WUGSC	HMP_production_phase_1
SRS017949.572505	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1235	SRR041568	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017949	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035270_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035244	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS062414.573771	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4230	SRR049517	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062414	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113515_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700113490	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS054219.570472	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3831	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054219	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109786_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109758	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	0	JCVI	HMP_production_phase_1
SRS015342.571923	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_580	SRR045772	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015342	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241811	241811	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023997_from_subject_764184357__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023972	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	3.7	WUGSC	HMP_production_phase_1
SRS013490.574260	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_240	SRR041145	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013490	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241676	241676	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016470_from_subject_159207311__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016456	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS022370.572087	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2163	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022370	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098236_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098209	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	35	0	JCVI	HMP_production_phase_1
SRS024094.573524	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2592	SRR041232	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024094	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241724	241724	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100559_from_subject_159510762__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700100540	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS016946.573964	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1007	SRR043033	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016946	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033412_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033378	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS011502.574834	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_100	SRR044875	34.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011502	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016343_from_subject_159085930__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016313	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	34	0	WUGSC	HMP_production_phase_1
SRS022442.570517	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2183	SRR048201	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241719	241719	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098317_from_subject_158742018__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098281	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	5.8	BCM	HMP_production_phase_1
SRS020661.571918	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1741	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096086_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096057	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	JCVI	HMP_production_phase_1
SRS063628.574358	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4416	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063628	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111487_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111452	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.8	JCVI	HMP_production_phase_1
SRS021277.571169	TCAGAGTAGCGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1890	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021277	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241669	241669	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096923_from_subject_161230322__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096883	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	34	5.3	JCVI	HMP_production_phase_1
SRS020950.574171	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1809	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096461_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096430	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS016376.570447	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_867	SRR042991	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016376	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032040_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS017041.573726	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1026	SRR042839	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017041	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033554_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS016942.575808	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1005	SRR040963	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016942	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033408_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033376	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS017659.573752	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1159	SRR042796	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034659_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034631	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	0	BI	HMP_production_phase_1
SRS011492.570315	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_93	SRR045085	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011492	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016329_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016306	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	34	0	WUGSC	HMP_production_phase_1
SRS024406.576102	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2673	SRR042849	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024406	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101552_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101524	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	5.1	BI	HMP_production_phase_1
SRS043675.572127	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2900	SRR048318	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043675	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241796	241796	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102639_from_subject_159227541__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102601	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	4.5	BCM	HMP_production_phase_1
SRS063780.573798	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4438	SRR049490	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063780	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113592_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113557	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	4.1	WUGSC	HMP_production_phase_1
SRS017296.575248	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1084	SRR042955	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017296	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033971_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033937	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS024345.573280	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2656	SRR041149	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024345	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101380_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101354	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS017410.574589	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1108	SRR042002	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017410	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034116_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034089	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	30	0	BI	HMP_production_phase_1
SRS011413.574891	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_49	SRR047508	20.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011413	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241702	241702	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016021_from_subject_159005010__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016004	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	20	4.2	WUGSC	HMP_production_phase_1
SRS011289.573414	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_25	SRR045353	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011289	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015286_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS048083.570337	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3318	SRR048234	28.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048083	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241760	241760	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102924_from_subject_159146620__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102905	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	BCM	HMP_production_phase_1
SRS021744.575257	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2004	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021744	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097457_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097425	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.1	JCVI	HMP_production_phase_1
SRS019111.574286	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1481	SRR044756	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019111	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037582_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024089	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS021087.576493	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1837	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021087	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096634_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096579	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	4.8	JCVI	HMP_production_phase_1
SRS017853.573126	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1214	SRR042825	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034958_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS018607.574882	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1406	SRR045872	19.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018607	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241758	241758	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037074_from_subject_765094712__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700037042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	19	0	WUGSC	HMP_production_phase_1
SRS022763.575606	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2265	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022763	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098719_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098683	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	JCVI	HMP_production_phase_1
SRS052501.572374	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3709	SRR051580	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052501	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038994_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700038964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	0	WUGSC	HMP_production_phase_1
SRS011163.576601	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4	SRR045452	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014976_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700014974	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	0	WUGSC	HMP_production_phase_1
SRS023742.570747	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2504	SRR042985	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023742	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100049_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100026	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS018378.574402	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1341	SRR041414	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018378	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035812_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	0	BI	HMP_production_phase_1
SRS045391.574055	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3067	SRR048466	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045391	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107522_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107496	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BCM	HMP_production_phase_1
SRS020012.573871	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1592	SRR040786	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020012	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095257_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700095224	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.3	BI	HMP_production_phase_1
SRS018805.575908	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1436	SRR046136	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018805	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037272_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037246	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS020877.574780	TCAGACCGGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1787	SRR041607	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096388_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096365	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	31	0	BI	HMP_production_phase_1
SRS017078.572767	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1030	SRR041264	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017078	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033591_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033566	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	BI	HMP_production_phase_1
SRS047225.575825	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3236	SRR041404	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047225	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241838	241838	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107095_from_subject_159814214__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107058	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS016672.574249	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_946	SRR041499	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016672	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032456_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032455	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	5	BI	HMP_production_phase_1
SRS024429.575911	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2683	SRR040618	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024429	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101575_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700101572	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	5.1	BI	HMP_production_phase_1
SRS064897.572978	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4600	SRR058092	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064897	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257122	257122	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111077_from_subject_686765762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111042	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	JCVI	HMP_production_phase_1
SRS023687.576230	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2490	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023687	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099994_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	4.1	JCVI	HMP_production_phase_1
SRS017361.573508	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1097	SRR041346	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034067_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	BI	HMP_production_phase_1
SRS019677.574620	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1543	SRR043916	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038150_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038122	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS014279.570849	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_335	SRR045549	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014279	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021868_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS011535.574831	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_117	SRR045071	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011535	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016631_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016629	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS014319.574022	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_343	SRR045760	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014319	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021908_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700021889	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	3.9	WUGSC	HMP_production_phase_1
SRS042733.570347	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2817	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241867	241867	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101833_from_subject_514014184__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101791	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	21	4.2	JCVI	HMP_production_phase_1
SRS023948.572477	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2558	SRR042967	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100346_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100310	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS017545.572420	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1145	SRR041744	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034278_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034244	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS053138.575152	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3753	SRR048656	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053138	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108888_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108854	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	0	BCM	HMP_production_phase_1
SRS018587.575974	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1397	SRR044447	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018587	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037054_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037032	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	19	0	WUGSC	HMP_production_phase_1
SRS046929.573808	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3207	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046929	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109796_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109763	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	0	JCVI	HMP_production_phase_1
SRS024226.573735	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2626	SRR041668	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024226	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101113_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101085	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS063235.576457	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4355	SRR047026	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063235	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114365_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114336	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	21	0	WUGSC	HMP_production_phase_1
SRS021211.573788	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1873	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021211	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096758_from_subject_161007791__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700096718	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	5	JCVI	HMP_production_phase_1
SRS024416.572758	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2678	SRR040681	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024416	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101562_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101529	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	5.1	BI	HMP_production_phase_1
SRS049090.574498	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3397	SRR048916	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049090	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108274_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700108235	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	4.6	BCM	HMP_production_phase_1
SRS016877.574244	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_989	SRR041883	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033238_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS046784.570551	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3195	SRR058108	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046784	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110209_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700110171	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	38	4.5	JCVI	HMP_production_phase_1
SRS016213.576322	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_813	SRR044403	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016213	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241687	241687	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024876_from_subject_764649650__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024851	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4.1	WUGSC	HMP_production_phase_1
SRS013258.573427	TCAGTCCTGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_224	SRR040697	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013258	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241833	241833	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015965_from_subject_159591683__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS011367.572195	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_37	SRR045083	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015653_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	WUGSC	HMP_production_phase_1
SRS011516.570996	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_107	SRR044868	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011516	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016370_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016351	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	20	4.2	WUGSC	HMP_production_phase_1
SRS018033.573886	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1258	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018033	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241734	241734	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035357_from_subject_160239046__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS013240.571927	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_218	SRR041033	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013240	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015947_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015946	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS043758.572077	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2910	SRR046773	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043758	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105189_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105157	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	4.3	WUGSC	HMP_production_phase_1
SRS023979.574422	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2561	SRR040906	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023979	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100440_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100417	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	0	BI	HMP_production_phase_1
SRS062908.575245	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4312	SRR047345	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062908	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114321_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114284	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	4.5	WUGSC	HMP_production_phase_1
SRS022321.575733	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2152	SRR058114	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022321	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241841	241841	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098161_from_subject_533247696__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098124	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	4.5	JCVI	HMP_production_phase_1
SRS024228.574051	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2627	SRR041938	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024228	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101115_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101086	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS014839.576589	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_454	SRR049332	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014839	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241793	241793	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023493_from_subject_763921366__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023455	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.1	WUGSC	HMP_production_phase_1
SRS065263.574513	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4656	SRR046316	36.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065263	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241815	241815	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114017_from_subject_763395383__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114000	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	36	0	WUGSC	HMP_production_phase_1
SRS018043.571925	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1263	SRR040846	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018043	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241836	241836	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035367_from_subject_160016515__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700035320	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4.3	BI	HMP_production_phase_1
SRS023023.574015	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2330	SRR048066	29.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023023	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241700	241700	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099057_from_subject_158114885__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700099020	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	BCM	HMP_production_phase_1
SRS015245.571086	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_551	SRR049850	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015245	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023900_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023871	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	4.4	WUGSC	HMP_production_phase_1
SRS020486.573415	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1699	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020486	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095809_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095782	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	JCVI	HMP_production_phase_1
SRS043508.573241	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2882	SRR048893	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043508	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241671	241671	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107977_from_subject_160056975__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107944	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS065489.571071	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4690	SRR047053	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065489	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114197_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114171	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	WUGSC	HMP_production_phase_1
SRS011645.575719	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_174	SRR045357	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011645	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033492_from_subject_159470302__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033490	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4.1	WUGSC	HMP_production_phase_1
SRS049834.574204	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3461	SRR047577	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049834	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241886	241886	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038624_from_subject_404239096__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700038593	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS044092.575656	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2938	SRR046282	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044092	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105691_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105669	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	31	5	WUGSC	HMP_production_phase_1
SRS062517.574209	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4248	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062517	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111550_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111518	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS047772.572769	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3291	SRR043926	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241823	241823	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038522_from_subject_763476303__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038494	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	0	WUGSC	HMP_production_phase_1
SRS048103.570889	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3321	SRR058084	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110462_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110431	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	JCVI	HMP_production_phase_1
SRS013211.573751	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_212	SRR043279	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013211	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015910_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015874	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS063623.575328	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4414	SRR048788	27.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:268876	268876	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111214_from_subject_257905678__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700111174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.9	BCM	HMP_production_phase_1
SRS043921.574239	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2922	SRR048461	23.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043921	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108403_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:mucus	700108361	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	23	4.4	BCM	HMP_production_phase_1
SRS049372.572390	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3424	SRR049492	32.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049372	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241879	241879	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106520_from_subject_553359145__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106493	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	32	4.3	WUGSC	HMP_production_phase_1
SRS024173.575255	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2614	SRR040654	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024173	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100641_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100611	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS018011.572132	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1248	SRR040704	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018011	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035335_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035304	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS024230.572555	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2628	SRR041910	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024230	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101117_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101087	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS017495.574915	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1135	SRR041326	19.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017495	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034228_from_subject_160319967__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034186	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	19	5.1	BI	HMP_production_phase_1
SRS048463.571194	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3344	SRR046719	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048463	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241893	241893	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105077_from_subject_178713055__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105044	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.5	WUGSC	HMP_production_phase_1
SRS042716.571375	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2816	SRR043954	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042716	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038568_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038541	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS050374.572987	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3518	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050374	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241786	241786	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109129_from_subject_970836795__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109107	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	4.1	JCVI	HMP_production_phase_1
SRS011549.575204	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_124	SRR045136	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011549	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016652_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016650	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS063776.572898	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4437	SRR046981	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063776	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114733_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114709	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	0	WUGSC	HMP_production_phase_1
SRS042331.571157	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2781	SRR046205	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042331	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038424_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038397	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	39	0	WUGSC	HMP_production_phase_1
SRS063715.570530	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4426	SRR058092	39.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063715	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268866	268866	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111630_from_subject_937495960__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111591	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	39	0	JCVI	HMP_production_phase_1
SRS048589.571475	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3352	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048589	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102565_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102531	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	4.6	JCVI	HMP_production_phase_1
SRS016728.574011	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_963	SRR040876	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016728	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241836	241836	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032673_from_subject_160016515__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700032650	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4.3	BI	HMP_production_phase_1
SRS011458.576054	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_75	SRR045104	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016156_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016126	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	WUGSC	HMP_production_phase_1
SRS020290.576064	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1648	SRR041935	21.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020290	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241829	241829	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095543_from_subject_160663879__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700095524	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	BI	HMP_production_phase_1
SRS016373.576255	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_866	SRR043234	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016373	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032037_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS020014.571679	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1593	SRR041775	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020014	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095259_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095225	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.3	BI	HMP_production_phase_1
SRS043408.573613	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2873	SRR047623	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024999_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023544	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	33	0	WUGSC	HMP_production_phase_1
SRS042543.576376	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2795	SRR046218	39.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241884	241884	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038412_from_subject_765701615__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038391	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	39	0	WUGSC	HMP_production_phase_1
SRS057813.572932	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4143	SRR045519	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057813	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038462_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038440	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS042298.572300	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2778	SRR046585	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042298	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105816_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105784	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.6	WUGSC	HMP_production_phase_1
SRS024406.573850	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2673	SRR041972	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024406	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101552_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101524	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	5.1	BI	HMP_production_phase_1
SRS020847.571204	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1785	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020847	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241677	241677	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096321_from_subject_160886410__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700096284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	JCVI	HMP_production_phase_1
SRS014595.571849	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_396	SRR045710	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014595	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023249_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	4.1	WUGSC	HMP_production_phase_1
SRS017892.573619	TCAGCCGACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1220	SRR041488	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017892	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035190_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035164	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	33	0	BI	HMP_production_phase_1
SRS021011.573491	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1825	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021011	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096558_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096525	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS063437.573272	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4384	SRR048799	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063437	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111262_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	5	BCM	HMP_production_phase_1
SRS016948.573970	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1008	SRR043059	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033414_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033379	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS056981.574306	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4068	SRR046786	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056981	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241893	241893	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105063_from_subject_178713055__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105037	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.5	WUGSC	HMP_production_phase_1
SRS052762.573051	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3726	SRR041112	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052762	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101325_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101298	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS017485.573511	TCAGACGGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1130	SRR041334	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017485	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034218_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034181	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	5.1	BI	HMP_production_phase_1
SRS011436.571759	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_62	SRR047522	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011436	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016083_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016048	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS015198.574251	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_538	SRR049873	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015198	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023853_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023819	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4	WUGSC	HMP_production_phase_1
SRS058805.575795	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4224	SRR049454	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058805	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105916_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105888	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	WUGSC	HMP_production_phase_1
SRS011629.574109	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_166	SRR045064	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033462_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.1	WUGSC	HMP_production_phase_1
SRS015884.576336	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_723	SRR043748	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015884	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024539_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024507	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS054571.571753	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3862	SRR046207	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054571	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038926_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038906	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	WUGSC	HMP_production_phase_1
SRS047732.575235	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3287	SRR047682	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047732	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105749_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105728	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	WUGSC	HMP_production_phase_1
SRS024396.572648	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2669	SRR041914	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024396	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101542_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101519	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	5.1	BI	HMP_production_phase_1
SRS018025.576434	TCAGTCCGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1255	SRR040760	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018025	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241734	241734	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035349_from_subject_160239046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035311	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS048595.571331	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3353	SRR048896	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048595	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109616_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109580	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS063383.573793	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4377	SRR058084	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063383	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110689_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110657	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	30	0	JCVI	HMP_production_phase_1
SRS014978.570429	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_492	SRR047637	32.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014978	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241727	241727	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023633_from_subject_763880905__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023603	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	32	0	WUGSC	HMP_production_phase_1
SRS011520.575892	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_109	SRR044927	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011520	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016374_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016353	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	20	4.2	WUGSC	HMP_production_phase_1
SRS048684.575828	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3364	SRR048908	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048684	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108586_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108547	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	30	3.9	BCM	HMP_production_phase_1
SRS017349.570486	TCAGCCGACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1091	SRR041341	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034055_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034030	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	BI	HMP_production_phase_1
SRS016343.572924	TCAGAACCTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_856	SRR040855	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016343	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032007_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032006	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS016877.571309	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_989	SRR041896	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033238_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS044748.572996	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3001	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044748	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101815_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101782	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	JCVI	HMP_production_phase_1
SRS017641.576524	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1154	SRR041832	19.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017641	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241775	241775	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034641_from_subject_160461578__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700034622	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	19	0	BI	HMP_production_phase_1
SRS023645.573100	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2484	SRR040614	20.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023645	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099948_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099906	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	20	4.9	BI	HMP_production_phase_1
SRS021932.576160	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2052	SRR048079	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021932	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097672_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097642	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	0	BCM	HMP_production_phase_1
SRS024365.572247	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2666	SRR043014	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024365	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101400_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101364	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS055647.575734	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3945	SRR048639	30.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055647	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108588_from_subject_160582958__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700108548	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	30	3.9	BCM	HMP_production_phase_1
SRS052010.573843	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3663	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052010	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108070_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107999	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	JCVI	HMP_production_phase_1
SRS020962.575996	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1814	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020962	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241752	241752	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096473_from_subject_161068481__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096436	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	JCVI	HMP_production_phase_1
SRS047449.576433	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3254	SRR058112	27.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047449	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241806	241806	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107872_from_subject_161311242__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107834	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	JCVI	HMP_production_phase_1
SRS022063.574792	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2085	SRR058111	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022063	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097803_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097769	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	31	0	JCVI	HMP_production_phase_1
SRS016285.575603	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_840	SRR043984	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024948_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024917	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	WUGSC	HMP_production_phase_1
SRS046510.576286	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3174	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046510	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109001_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108966	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	4.3	JCVI	HMP_production_phase_1
SRS052382.576596	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3697	SRR046383	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052382	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105755_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105731	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS015170.574021	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_525	SRR043737	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015170	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023825_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023805	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4	WUGSC	HMP_production_phase_1
SRS051696.575392	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3631	SRR058112	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051696	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241776	241776	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109857_from_subject_160947100__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109822	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	JCVI	HMP_production_phase_1
SRS042121.571107	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2764	SRR045927	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042121	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241873	241873	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038948_from_subject_355657046__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700038917	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS021696.574839	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1996	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021696	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241688	241688	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097408_from_subject_161331472__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097373	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	JCVI	HMP_production_phase_1
SRS043219.572503	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2851	SRR049511	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241893	241893	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105075_from_subject_178713055__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105043	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.5	WUGSC	HMP_production_phase_1
SRS019679.574412	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1544	SRR047642	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019679	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038152_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038123	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS020368.570756	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1668	SRR041580	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020368	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095687_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095656	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	32	4.2	BI	HMP_production_phase_1
SRS019003.570649	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1463	SRR044598	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019003	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037472_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037447	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS024347.575169	TCAGTCCTGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2657	SRR041835	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024347	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101382_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101355	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS042093.570415	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2761	SRR046046	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042093	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038779_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038750	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	5.3	WUGSC	HMP_production_phase_1
SRS063078.575744	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4335	SRR047051	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063078	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114264_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114227	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	4.5	WUGSC	HMP_production_phase_1
SRS019558.574092	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1521	SRR046069	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019558	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038029_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038009	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS023106.570451	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2348	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023106	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241757	241757	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099237_from_subject_441369442__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099125	n	969	8	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	0	JCVI	HMP_production_phase_1
SRS011300.570651	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_31	SRR045304	33.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011300	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241767	241767	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015407_from_subject_158924089__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700015390	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	33	0	WUGSC	HMP_production_phase_1
SRS065480.573123	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4688	SRR058108	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065480	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241816	241816	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110636_from_subject_295137534__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110602	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	JCVI	HMP_production_phase_1
SRS045226.574273	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3050	SRR046295	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045226	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105868_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105840	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	30	0	WUGSC	HMP_production_phase_1
SRS045318.576472	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3059	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045318	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109421_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109391	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	4.8	JCVI	HMP_production_phase_1
SRS023703.572502	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2498	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023703	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100010_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099972	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	4.1	JCVI	HMP_production_phase_1
SRS015880.572211	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_721	SRR047409	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015880	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024535_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024505	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	39	0	WUGSC	HMP_production_phase_1
SRS017963.570513	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1242	SRR041517	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017963	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241809	241809	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035284_from_subject_158357646__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035251	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS014556.576310	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_387	SRR045697	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014556	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023210_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	3.8	WUGSC	HMP_production_phase_1
SRS043190.575477	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2847	SRR041703	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043190	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241749	241749	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101345_from_subject_159672603__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700101308	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS043924.572262	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2924	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043924	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102344_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102312	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	JCVI	HMP_production_phase_1
SRS024003.574503	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2572	SRR042804	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024003	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100464_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100429	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS065545.570293	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4701	SRR048781	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111196_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111165	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.9	BCM	HMP_production_phase_1
SRS024291.573603	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2644	SRR041853	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024291	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101269_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101237	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	3.7	BI	HMP_production_phase_1
SRS052423.575301	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3700	SRR047216	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052423	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103259_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105981	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	31	4.4	WUGSC	HMP_production_phase_1
SRS046087.572586	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3132	SRR048875	33.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046087	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241672	241672	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102903_from_subject_159288231__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700102866	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	33	0	BCM	HMP_production_phase_1
SRS019237.573360	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1486	SRR044502	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019237	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241800	241800	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037708_from_subject_765034022__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037685	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.2	WUGSC	HMP_production_phase_1
SRS058051.573080	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4160	SRR058108	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058051	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109496_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109463	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	0	JCVI	HMP_production_phase_1
SRS062465.574791	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4240	SRR046825	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062465	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113513_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700113489	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS021740.572632	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2002	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021740	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097453_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097423	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.1	JCVI	HMP_production_phase_1
SRS023190.570259	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2368	SRR041736	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023190	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099321_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099295	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	33	0	BI	HMP_production_phase_1
SRS013638.573699	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_262	SRR041606	33.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013638	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241672	241672	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016716_from_subject_159288231__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700016692	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	33	0	BI	HMP_production_phase_1
SRS020265.571908	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1645	SRR040706	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020265	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095518_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095483	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS017665.574059	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1162	SRR041015	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034680_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034634	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	19	0	BI	HMP_production_phase_1
SRS058650.574668	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4211	SRR046768	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058650	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241893	241893	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105065_from_subject_178713055__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105038	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.5	WUGSC	HMP_production_phase_1
SRS042961.575559	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2830	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042961	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110347_from_subject_892969023__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110306	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	28	4.3	JCVI	HMP_production_phase_1
SRS020382.572098	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1675	SRR043025	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020382	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095701_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	TRUE	y	TCAG	UBERON:sebum	700095663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	4.2	BI	HMP_production_phase_1
SRS058681.573819	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4214	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058681	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109147_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109116	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	4.1	JCVI	HMP_production_phase_1
SRS049609.572264	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3443	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049609	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110456_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110428	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	JCVI	HMP_production_phase_1
SRS046871.572946	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3202	SRR048402	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102293_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102258	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BCM	HMP_production_phase_1
SRS044088.570276	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2937	SRR058096	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044088	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241780	241780	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110007_from_subject_161412393__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109987	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS050422.573287	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3526	SRR045544	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050422	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241825	241825	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038472_from_subject_763536994__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038445	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS018547.575648	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1386	SRR044420	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018547	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241851	241851	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037014_from_subject_764710340__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037002	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4	WUGSC	HMP_production_phase_1
SRS063110.573423	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4339	SRR058092	23.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063110	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:268865	268865	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111497_from_subject_451588811__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700111457	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4.8	JCVI	HMP_production_phase_1
SRS014442.576591	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_369	SRR043620	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241812	241812	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023096_from_subject_763698834__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700023066	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	3.4	WUGSC	HMP_production_phase_1
SRS017103.576059	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1042	SRR041032	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241814	241814	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033665_from_subject_159551223__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033664	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS022518.574969	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2202	SRR048188	30.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022518	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241810	241810	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098419_from_subject_158458797__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098378	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	30	4.5	BCM	HMP_production_phase_1
SRS021996.573758	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2066	SRR041186	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021996	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097736_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097701	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	4.1	BI	HMP_production_phase_1
SRS011629.573718	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_166	SRR047467	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033462_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.1	WUGSC	HMP_production_phase_1
SRS049168.570677	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3406	SRR049616	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049168	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241887	241887	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106894_from_subject_764811490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106866	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	21	5.3	WUGSC	HMP_production_phase_1
SRS014432.572326	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_366	SRR043632	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014432	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023086_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023061	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	3.4	WUGSC	HMP_production_phase_1
SRS057746.573159	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4136	SRR048713	34.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057746	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109975_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700109937	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	34	4.6	BCM	HMP_production_phase_1
SRS058256.573258	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4177	SRR048553	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058256	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108937_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108907	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BCM	HMP_production_phase_1
SRS018292.574526	TCAGCGGAACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1324	SRR041262	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018292	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241785	241785	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035699_from_subject_160137896__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700035656	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	3.9	BI	HMP_production_phase_1
SRS022321.574616	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2152	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022321	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241841	241841	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098161_from_subject_533247696__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098124	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	4.5	JCVI	HMP_production_phase_1
SRS053096.575708	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_3749	SRR041192	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101327_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101299	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS018141.572200	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1278	SRR040910	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018141	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035541_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035518	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS011684.571257	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_193	SRR045317	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011684	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033789_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700033746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.4	WUGSC	HMP_production_phase_1
SRS018262.572302	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1309	SRR041207	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018262	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035669_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035641	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	3.9	BI	HMP_production_phase_1
SRS055211.573910	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3913	SRR058114	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055211	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101819_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101784	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	JCVI	HMP_production_phase_1
SRS013156.572097	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_198	SRR041191	38.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013156	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241794	241794	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015785_from_subject_159571453__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700015784	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	38	0	BI	HMP_production_phase_1
SRS021561.572693	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1960	SRR048087	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097273_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097244	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	BCM	HMP_production_phase_1
SRS016412.570898	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_871	SRR041387	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016412	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032099_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032074	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS054616.573412	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3867	SRR040969	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054616	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102989_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102968	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS018966.573306	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1453	SRR047562	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018966	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241737	241737	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037435_from_subject_765276783__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037404	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	0	WUGSC	HMP_production_phase_1
SRS057792.576119	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4141	SRR048502	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057792	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108630_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108602	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	31	0	BCM	HMP_production_phase_1
SRS047873.573526	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3299	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108320_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108292	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	JCVI	HMP_production_phase_1
SRS018605.572150	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1405	SRR045936	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018605	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037072_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	19	0	WUGSC	HMP_production_phase_1
SRS053285.573995	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3764	SRR046328	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053285	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241844	241844	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105234_from_subject_763820215__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105208	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	25	4	WUGSC	HMP_production_phase_1
SRS014885.571435	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_467	SRR049220	39.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014885	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241830	241830	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023539_from_subject_764002286__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023509	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	39	0	WUGSC	HMP_production_phase_1
SRS018704.572406	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1411	SRR045889	40.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018704	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241723	241723	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037171_from_subject_765195863__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037194	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	40	4.6	WUGSC	HMP_production_phase_1
SRS019097.570528	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1474	SRR044661	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019097	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037568_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037543	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS044589.575330	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2980	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044589	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109482_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109456	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	31	0	JCVI	HMP_production_phase_1
SRS058482.574733	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4195	SRR048257	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058482	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102289_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102256	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	0	BCM	HMP_production_phase_1
SRS054762.571872	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3876	SRR058113	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054762	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110325_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110295	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	4.3	JCVI	HMP_production_phase_1
SRS019667.575691	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1538	SRR045849	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038138_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700038116	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS024659.573479	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2741	SRR042987	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101950_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101914	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS065076.571556	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4626	SRR058108	30.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065076	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241753	241753	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110699_from_subject_368533040__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700110662	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	30	0	JCVI	HMP_production_phase_1
SRS065365.571906	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4673	SRR048848	39.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065365	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268877	268877	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111360_from_subject_763721271__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700111317	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	39	4.8	BCM	HMP_production_phase_1
SRS015450.574024	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_605	SRR044669	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015450	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024105_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700024085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS024625.570280	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2728	SRR041243	23.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024625	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241705	241705	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101916_from_subject_159611913__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101897	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	0	BI	HMP_production_phase_1
SRS062847.575019	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4305	SRR047097	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062847	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241875	241875	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114179_from_subject_289996019__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700114162	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	WUGSC	HMP_production_phase_1
SRS054588.573403	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3864	SRR040942	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054588	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102448_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102421	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS011569.573686	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_134	SRR044986	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011569	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033017_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033015	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.7	WUGSC	HMP_production_phase_1
SRS021619.575699	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_1973	SRR048048	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097331_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097300	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	4.9	BCM	HMP_production_phase_1
SRS045846.575595	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3103	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045846	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102466_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102430	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS023944.572421	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2557	SRR041638	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023944	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100342_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100308	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS021263.570496	TCAGTATAGCGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1884	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021263	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096909_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096876	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	34	5.3	JCVI	HMP_production_phase_1
SRS011559.572514	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_129	SRR045375	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033002_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.7	WUGSC	HMP_production_phase_1
SRS016853.571185	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_982	SRR041784	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033214_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033213	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS047034.576534	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3219	SRR049372	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047034	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105423_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105403	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	34	4.2	WUGSC	HMP_production_phase_1
SRS024128.575331	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2605	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024128	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100593_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100557	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS042572.572619	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2800	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042572	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241842	241842	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108977_from_subject_161007791__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108954	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	4.3	JCVI	HMP_production_phase_1
SRS013209.575455	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_211	SRR042796	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013209	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015908_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015873	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS049196.571384	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3408	SRR048409	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049196	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102633_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102598	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	4.5	BCM	HMP_production_phase_1
SRS011435.571713	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_61	SRR045440	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016081_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016047	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS017792.574287	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1197	SRR041007	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017792	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241782	241782	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034885_from_subject_160542498__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034852	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS020905.575022	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1800	SRR041581	31.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020905	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241679	241679	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096416_from_subject_160765029__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096379	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	31	0	BI	HMP_production_phase_1
SRS017739.573206	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1184	SRR041241	30.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017739	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034832_from_subject_160582958__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034791	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	30	4.1	BI	HMP_production_phase_1
SRS055253.576254	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3915	SRR046315	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055253	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105870_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105841	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	30	0	WUGSC	HMP_production_phase_1
SRS063784.572938	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4441	SRR047100	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063784	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114359_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114333	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	21	0	WUGSC	HMP_production_phase_1
SRS013211.575123	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_212	SRR042982	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013211	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015910_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015874	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS023758.576043	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2510	SRR040879	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023758	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100065_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100034	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS016617.571306	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_930	SRR042835	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032370_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032332	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	31	4.3	BI	HMP_production_phase_1
SRS046941.572343	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3209	SRR049386	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046941	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241854	241854	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106922_from_subject_517810313__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106408	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS046196.571867	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3146	SRR046619	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046196	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106422_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106401	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS016273.570879	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_834	SRR044097	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016273	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024936_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024911	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	WUGSC	HMP_production_phase_1
SRS014667.575416	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_419	SRR043920	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023321_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023294	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS022578.575794	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2217	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022578	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098483_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098445	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	5	JCVI	HMP_production_phase_1
SRS019498.574102	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1515	SRR046517	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019498	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241818	241818	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037969_from_subject_765317243__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	3.8	WUGSC	HMP_production_phase_1
SRS024604.572182	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2727	SRR043284	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024604	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241833	241833	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101895_from_subject_159591683__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	NA	y	TCAG	UBERON:nasal mucus	700101858	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS016227.573863	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_819	SRR044434	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016227	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024890_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.1	WUGSC	HMP_production_phase_1
SRS043499.576176	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2880	SRR048510	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043499	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107581_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107554	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	0	BCM	HMP_production_phase_1
SRS051994.570773	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3662	SRR046806	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051994	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105952_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700105930	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	WUGSC	HMP_production_phase_1
SRS062601.574741	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4261	SRR047048	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062601	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113047_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113019	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	21	0	WUGSC	HMP_production_phase_1
SRS022430.571126	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2177	SRR048190	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022430	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098305_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098275	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	5.8	BCM	HMP_production_phase_1
SRS023827.572828	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2529	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023827	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241742	241742	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100221_from_subject_336497421__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	NA	y	TCAG	UBERON:nasal mucus	700100183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	JCVI	HMP_production_phase_1
SRS020326.574073	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1662	SRR041415	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020326	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241829	241829	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095579_from_subject_160663879__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095542	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS021003.572842	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1821	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021003	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096550_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096521	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	JCVI	HMP_production_phase_1
SRS064233.571548	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4514	SRR049986	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064233	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241784	241784	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113562_from_subject_764346198__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700113542	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	4.1	WUGSC	HMP_production_phase_1
SRS019097.572038	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1474	SRR044724	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019097	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037568_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037543	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS065258.570519	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4655	SRR058108	35.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065258	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241768	241768	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110754_from_subject_492786515__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110718	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	35	0	JCVI	HMP_production_phase_1
SRS013801.571266	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_308	SRR040705	38.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013801	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241794	241794	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016961_from_subject_159571453__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016960	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	0	BI	HMP_production_phase_1
SRS021019.576142	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1829	SRR058111	27.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021019	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241806	241806	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096566_from_subject_161311242__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096529	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	JCVI	HMP_production_phase_1
SRS015566.575820	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_633	SRR044000	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015566	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024221_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024195	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	18	0	WUGSC	HMP_production_phase_1
SRS013462.576151	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_233	SRR042021	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016393_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016380	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	BI	HMP_production_phase_1
SRS043253.571125	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2855	SRR046472	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043253	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241692	241692	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105538_from_subject_765155402__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105519	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	18	0	WUGSC	HMP_production_phase_1
SRS046796.572257	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3196	SRR046374	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046796	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105747_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105727	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	WUGSC	HMP_production_phase_1
SRS055785.575105	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3957	SRR046785	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055785	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241878	241878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105179_from_subject_612472597__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105152	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	38	4.3	WUGSC	HMP_production_phase_1
SRS063101.572506	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4338	SRR049424	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063101	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241682	241682	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114450_from_subject_764042746__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114427	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	3.9	WUGSC	HMP_production_phase_1
SRS047906.573266	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3302	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047906	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109898_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109871	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	0	JCVI	HMP_production_phase_1
SRS046537.571377	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3179	SRR048767	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109547_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109517	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	21	0	BCM	HMP_production_phase_1
SRS018325.573321	TCAGTTCGGACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1327	SRR041525	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018325	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035759_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	BI	HMP_production_phase_1
SRS046845.572823	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3199	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046845	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108814_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108788	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	0	JCVI	HMP_production_phase_1
SRS024490.573772	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2700	SRR041782	38.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024490	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241794	241794	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101636_from_subject_159571453__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700101599	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	38	0	BI	HMP_production_phase_1
SRS016046.570712	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_766	SRR044498	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016046	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241741	241741	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024701_from_subject_764508039__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024684	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS066144.576050	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043086	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS058537.570272	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4201	SRR047218	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058537	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103255_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105979	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	31	4.4	WUGSC	HMP_production_phase_1
SRS022129.570851	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2103	SRR041603	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022129	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241803	241803	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097895_from_subject_158337416__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097855	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.4	BI	HMP_production_phase_1
SRS017914.573994	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1231	SRR042796	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017914	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241799	241799	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035212_from_subject_160441347__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS018601.573765	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1403	SRR044386	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018601	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037068_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	19	0	WUGSC	HMP_production_phase_1
SRS022327.573625	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2155	SRR058111	25.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022327	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241841	241841	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098167_from_subject_533247696__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098127	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	4.5	JCVI	HMP_production_phase_1
SRS015332.574075	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_576	SRR044104	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015332	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241811	241811	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023987_from_subject_764184357__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023967	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	3.7	WUGSC	HMP_production_phase_1
SRS049082.573028	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3396	SRR048474	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049082	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107536_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107503	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BCM	HMP_production_phase_1
SRS019079.574206	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1467	SRR044689	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019079	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037550_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037534	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS021013.573224	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1826	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021013	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096560_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096526	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS053492.573228	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3785	SRR047162	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053492	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241883	241883	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103507_from_subject_132902142__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700103483	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	5.6	WUGSC	HMP_production_phase_1
SRS014564.570497	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_390	SRR045708	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014564	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023218_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023184	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	3.8	WUGSC	HMP_production_phase_1
SRS020020.572789	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1596	SRR040626	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020020	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095265_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.3	BI	HMP_production_phase_1
SRS042331.570938	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2781	SRR045912	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042331	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038424_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038397	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	39	0	WUGSC	HMP_production_phase_1
SRS023635.571795	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2479	SRR040641	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023635	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099938_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099901	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	20	4.9	BI	HMP_production_phase_1
SRS047760.574947	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3289	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047760	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109853_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109820	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS044351.573012	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2959	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044351	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110399_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110365	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	4.4	JCVI	HMP_production_phase_1
SRS021760.576158	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2011	SRR058114	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021760	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241706	241706	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097473_from_subject_161493313__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097433	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	4.1	JCVI	HMP_production_phase_1
SRS045467.575114	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3077	SRR046725	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045467	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106597_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106560	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	4.3	WUGSC	HMP_production_phase_1
SRS018991.572090	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1457	SRR044632	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018991	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037460_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037441	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS013822.574319	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_311	SRR041119	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013822	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016982_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016981	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	0	BI	HMP_production_phase_1
SRS016533.571138	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_903	SRR041712	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016533	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032260_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4	BI	HMP_production_phase_1
SRS018284.575185	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1320	SRR043239	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018284	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035691_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035652	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	3.9	BI	HMP_production_phase_1
SRS017455.572226	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1119	SRR041254	19.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017455	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241721	241721	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034188_from_subject_160319967__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034166	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	19	5.1	BI	HMP_production_phase_1
SRS064224.573088	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4512	SRR048854	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112020_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111993	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Buccal_mucosa	26	0	BCM	HMP_production_phase_1
SRS022125.574451	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2101	SRR042927	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097891_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097853	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	4.4	BI	HMP_production_phase_1
SRS015815.570980	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_701	SRR044705	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015815	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241763	241763	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024470_from_subject_763435843__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024449	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	21	0	WUGSC	HMP_production_phase_1
SRS023059.574799	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2333	SRR048119	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023059	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099093_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099065	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	4.1	BCM	HMP_production_phase_1
SRS045880.572359	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3110	SRR046075	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045880	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106046_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106013	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	3.8	WUGSC	HMP_production_phase_1
SRS015472.574486	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_614	SRR044736	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024127_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024096	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS021506.573117	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1947	SRR041528	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021506	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097218_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097188	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS016485.571843	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_895	SRR042864	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016485	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032181_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS042643.572446	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2809	SRR046038	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042643	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038600_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038581	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	WUGSC	HMP_production_phase_1
SRS019554.570899	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1519	SRR043913	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019554	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038025_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038007	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS014452.576422	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_374	SRR043924	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014452	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023106_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023071	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS018910.573653	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1445	SRR045902	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241732	241732	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037379_from_subject_765216093__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037352	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS063829.573289	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4450	SRR047079	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063829	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114407_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114381	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS017798.572755	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1200	SRR042805	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017798	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241782	241782	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034891_from_subject_160542498__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS011475.570847	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_84	SRR047524	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011475	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016174_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016135	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS011454.573907	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_73	SRR045078	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016150_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016123	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	WUGSC	HMP_production_phase_1
SRS058791.574322	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4223	SRR046292	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058791	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105258_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105220	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	4	WUGSC	HMP_production_phase_1
SRS052157.572218	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3677	SRR048653	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108870_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108845	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	0	BCM	HMP_production_phase_1
SRS023208.574225	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2377	SRR042796	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099339_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700099304	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS017224.571962	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1065	SRR041394	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033830_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033829	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	BI	HMP_production_phase_1
SRS016687.573094	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_951	SRR041604	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016687	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241713	241713	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032471_from_subject_160036745__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032470	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	5	BI	HMP_production_phase_1
SRS065451.571431	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4682	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065451	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110740_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110711	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	0	JCVI	HMP_production_phase_1
SRS024400.574058	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2670	SRR040585	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024400	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101546_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101521	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	5.1	BI	HMP_production_phase_1
SRS052195.574730	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3681	SRR048284	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052195	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241796	241796	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102635_from_subject_159227541__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102599	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	4.5	BCM	HMP_production_phase_1
SRS020901.572145	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1798	SRR043253	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096412_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096377	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	31	0	BI	HMP_production_phase_1
SRS017776.575976	TCAGAACGTTCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1189	SRR040784	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017776	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034869_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034844	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	0	BI	HMP_production_phase_1
SRS021388.574688	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1916	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097046_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097012	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	4.6	JCVI	HMP_production_phase_1
SRS020539.571785	TCAGAACGTTCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1709	SRR041947	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020539	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095862_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095837	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	BI	HMP_production_phase_1
SRS043400.571599	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2872	SRR058108	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043400	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241786	241786	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109159_from_subject_970836795__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109122	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	4.1	JCVI	HMP_production_phase_1
SRS051827.574049	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3643	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051827	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109270_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109239	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	4.8	JCVI	HMP_production_phase_1
SRS011680.571972	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_191	SRR044892	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011680	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033785_from_subject_159713063__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700033744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.4	WUGSC	HMP_production_phase_1
SRS013672.571395	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_275	SRR043250	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013672	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016750_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700016709	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS011600.572819	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_151	SRR045065	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011600	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033175_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033141	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.3	WUGSC	HMP_production_phase_1
SRS022376.574922	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2166	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022376	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098242_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098212	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	0	JCVI	HMP_production_phase_1
SRS019623.574637	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1533	SRR045887	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241807	241807	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038094_from_subject_765620695__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038064	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	4	WUGSC	HMP_production_phase_1
SRS016932.571984	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1000	SRR040934	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016932	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033398_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033371	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS018457.571336	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1363	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018457	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035891_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS019771.573073	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1557	SRR044112	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019771	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038247_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038223	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS020143.571114	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1611	SRR048135	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020143	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095396_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095365	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	31	0	BCM	HMP_production_phase_1
SRS022061.572595	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2084	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022061	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097801_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097768	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	31	0	JCVI	HMP_production_phase_1
SRS014138.572637	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_319	SRR045741	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014138	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021697_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021282	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	0	WUGSC	HMP_production_phase_1
SRS017365.573102	TCAGTCGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1099	SRR041270	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017365	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241674	241674	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034071_from_subject_160340197__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034038	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS023081.573902	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2343	SRR048307	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023081	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241789	241789	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099115_from_subject_158276726__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099076	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	4.1	BCM	HMP_production_phase_1
SRS053113.572462	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3750	SRR048899	19.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053113	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109677_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109638	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	19	4.7	BCM	HMP_production_phase_1
SRS017088.576058	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1035	SRR041225	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017088	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033601_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033571	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	BI	HMP_production_phase_1
SRS050826.570301	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3557	SRR040905	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050826	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102446_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102420	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS011475.572910	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_84	SRR045137	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011475	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016174_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016135	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS011479.575754	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_86	SRR045115	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011479	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241760	241760	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016178_from_subject_159146620__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700016138	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	WUGSC	HMP_production_phase_1
SRS022325.571101	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2154	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022325	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241841	241841	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098165_from_subject_533247696__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098126	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	4.5	JCVI	HMP_production_phase_1
SRS058379.572570	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4184	SRR048542	24.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058379	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241797	241797	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109618_from_subject_160178356__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109581	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	0	BCM	HMP_production_phase_1
SRS047088.575443	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3224	SRR048617	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047088	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108143_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108108	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	BCM	HMP_production_phase_1
SRS057362.571006	TCAGTACGGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4097	SRR041551	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057362	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102387_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102362	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS020306.576381	TCAGAAGTCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1652	SRR041181	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020306	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095559_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	BI	HMP_production_phase_1
SRS063168.571244	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4348	SRR048826	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063168	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268869	268869	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111795_from_subject_872848689__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111759	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.6	BCM	HMP_production_phase_1
SRS020775.573566	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1766	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020775	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096200_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096171	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	JCVI	HMP_production_phase_1
SRS064754.575834	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4584	SRR046743	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064754	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241805	241805	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114347_from_subject_765560005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114327	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS011492.575589	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_93	SRR044859	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011492	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016329_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016306	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	34	0	WUGSC	HMP_production_phase_1
SRS049323.572724	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3421	SRR048662	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049323	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110137_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110102	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	4.3	BCM	HMP_production_phase_1
SRS018035.572319	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1259	SRR042929	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018035	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035359_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.3	BI	HMP_production_phase_1
SRS017124.570439	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1045	SRR041982	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017124	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033686_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033685	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS020435.576148	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1688	SRR040929	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095758_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095728	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	0	BI	HMP_production_phase_1
SRS017729.572551	TCAGAACGTTCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1179	SRR041285	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017729	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034822_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034786	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	4.1	BI	HMP_production_phase_1
SRS022669.575393	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2238	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022669	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241689	241689	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098621_from_subject_432193348__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098599	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	JCVI	HMP_production_phase_1
SRS066144.575082	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058085	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS018761.570521	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1423	SRR044471	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018761	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241832	241832	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037228_from_subject_765013792__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037137	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	4.5	WUGSC	HMP_production_phase_1
SRS066144.574174	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048500	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS023619.575038	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2471	SRR041820	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099922_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099893	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	20	4.9	BI	HMP_production_phase_1
SRS015174.572189	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_526	SRR043773	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015174	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023829_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023807	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4	WUGSC	HMP_production_phase_1
SRS051445.574913	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3615	SRR048651	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108882_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108851	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	BCM	HMP_production_phase_1
SRS011606.575482	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_154	SRR044842	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011606	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033181_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033144	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.3	WUGSC	HMP_production_phase_1
SRS014655.570437	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_413	SRR046643	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023309_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	37	0	WUGSC	HMP_production_phase_1
SRS020151.570568	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1615	SRR048308	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020151	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241827	241827	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095404_from_subject_158398106__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095369	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	31	0	BCM	HMP_production_phase_1
SRS023579.573928	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2466	SRR041985	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023579	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099856_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099820	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS051407.575881	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3611	SRR047667	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051407	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241844	241844	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105232_from_subject_763820215__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105207	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	25	4	WUGSC	HMP_production_phase_1
SRS065172.575261	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4642	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065172	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110860_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110825	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	4.7	JCVI	HMP_production_phase_1
SRS023176.573947	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2365	SRR041890	33.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023176	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241767	241767	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099307_from_subject_158924089__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700099288	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	33	0	BI	HMP_production_phase_1
SRS047414.572957	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3249	SRR046220	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047414	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038426_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038398	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	39	0	WUGSC	HMP_production_phase_1
SRS053393.570685	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3773	SRR047175	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053393	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257131	257131	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103579_from_subject_863126187__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103560	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS016237.573728	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_824	SRR044414	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016237	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024900_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024863	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS024277.572697	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2637	SRR041730	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024277	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101255_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101230	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	3.7	BI	HMP_production_phase_1
SRS022354.575121	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2159	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022354	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241768	241768	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098220_from_subject_492786515__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098201	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	35	0	JCVI	HMP_production_phase_1
SRS047554.574942	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3264	SRR058096	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047554	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109910_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109877	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS064015.574989	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4486	SRR046828	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064015	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241682	241682	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114454_from_subject_764042746__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114429	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	3.9	WUGSC	HMP_production_phase_1
SRS052697.573305	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3724	SRR049639	36.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052697	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241862	241862	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106170_from_subject_706846339__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	36	4.5	WUGSC	HMP_production_phase_1
SRS058494.573256	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4196	SRR048401	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058494	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102269_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102246	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	BCM	HMP_production_phase_1
SRS046639.576096	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3187	SRR046281	34.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046639	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241761	241761	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105459_from_subject_763557224__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105421	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	34	4.2	WUGSC	HMP_production_phase_1
SRS023120.573195	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2351	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023120	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099251_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099132	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.3	JCVI	HMP_production_phase_1
SRS052471.570830	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3707	SRR045938	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052471	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241852	241852	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038902_from_subject_861967750__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038870	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	WUGSC	HMP_production_phase_1
SRS042843.573330	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2824	SRR048509	22.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042843	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241765	241765	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107565_from_subject_160097436__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700107546	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	0	BCM	HMP_production_phase_1
SRS018341.572235	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1335	SRR042938	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018341	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035775_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS047411.570795	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3248	SRR048882	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047411	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108133_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108103	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	BCM	HMP_production_phase_1
SRS015570.570678	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_635	SRR043994	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015570	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024225_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024197	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	18	0	WUGSC	HMP_production_phase_1
SRS018165.571050	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1289	SRR042971	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018165	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035565_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS015403.576018	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_596	SRR045691	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015403	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024058_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024031	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	3.6	WUGSC	HMP_production_phase_1
SRS015135.572270	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_518	SRR046151	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015135	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023790_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023702	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	4.5	WUGSC	HMP_production_phase_1
SRS019103.571013	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1477	SRR044654	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037574_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037546	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS019888.573065	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1574	SRR044433	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019888	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241772	241772	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038364_from_subject_764892411__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038343	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	23	0	WUGSC	HMP_production_phase_1
SRS011293.571970	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_28	SRR049319	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011293	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015295_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700015293	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS043241.576031	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2854	SRR048704	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043241	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109220_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109187	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	0	BCM	HMP_production_phase_1
SRS065607.571964	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4716	SRR046829	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065607	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113590_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113556	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	4.1	WUGSC	HMP_production_phase_1
SRS063184.574924	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4350	SRR046372	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063184	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114072_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114050	n	969	286	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	20	5.6	WUGSC	HMP_production_phase_1
SRS043704.571767	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2904	SRR048877	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043704	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107599_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700107563	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	0	BCM	HMP_production_phase_1
SRS018039.573032	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1261	SRR043237	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018039	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035363_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035318	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.3	BI	HMP_production_phase_1
SRS019904.575058	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1581	SRR044450	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019904	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038380_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038351	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS022422.574501	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2174	SRR048194	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098297_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098271	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	5.8	BCM	HMP_production_phase_1
SRS024708.571657	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2752	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024708	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102088_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102056	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	30	0	JCVI	HMP_production_phase_1
SRS023021.572692	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2329	SRR048302	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023021	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241700	241700	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099055_from_subject_158114885__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	y	TCAG	UBERON:sebum	700099019	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	BCM	HMP_production_phase_1
SRS014978.574493	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_492	SRR045796	32.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014978	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241727	241727	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023633_from_subject_763880905__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700023603	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	32	0	WUGSC	HMP_production_phase_1
SRS050388.576507	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3521	SRR048634	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108560_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108534	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	30	3.9	BCM	HMP_production_phase_1
SRS043574.573665	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2890	SRR046391	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043574	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103591_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103566	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	WUGSC	HMP_production_phase_1
SRS024181.574723	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2618	SRR040674	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024181	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100649_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100615	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS054108.570542	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3827	SRR048317	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054108	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102275_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102249	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	0	BCM	HMP_production_phase_1
SRS018449.575950	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1359	SRR041875	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018449	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035883_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700035853	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS053617.572128	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3797	SRR042817	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101323_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101297	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS013727.573923	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_291	SRR043046	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013727	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016805_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016806	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS017800.572948	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1201	SRR041868	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017800	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241782	241782	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034893_from_subject_160542498__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS065725.572916	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4735	SRR046537	22.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065725	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257108	257108	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114872_from_subject_682102541__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700114855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	0	WUGSC	HMP_production_phase_1
SRS014237.575541	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_322	SRR046173	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014237	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021826_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700021808	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS013474.572674	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_239	SRR041884	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016405_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016386	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	BI	HMP_production_phase_1
SRS015657.572215	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_659	SRR044504	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241845	241845	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024312_from_subject_764487809__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024293	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	WUGSC	HMP_production_phase_1
SRS016787.571299	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_979	SRR041445	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032978_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032942	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS015919.571238	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_731	SRR044604	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015919	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024574_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024549	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS011464.570460	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_78	SRR044883	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016162_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016129	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	WUGSC	HMP_production_phase_1
SRS063820.574394	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4448	SRR049584	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063820	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114741_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114713	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	0	WUGSC	HMP_production_phase_1
SRS052946.575464	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3738	SRR048447	34.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052946	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109981_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109940	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	34	4.6	BCM	HMP_production_phase_1
SRS057907.573944	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4152	SRR046455	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057907	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241882	241882	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106449_from_subject_338793263__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106429	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	4.9	WUGSC	HMP_production_phase_1
SRS049090.573895	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3397	SRR048766	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049090	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108274_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108235	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	4.6	BCM	HMP_production_phase_1
SRS020290.575215	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1648	SRR041047	21.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020290	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241829	241829	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095543_from_subject_160663879__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700095524	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	BI	HMP_production_phase_1
SRS063931.570252	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4467	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063931	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110866_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110828	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	4.7	JCVI	HMP_production_phase_1
SRS050984.575532	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3570	SRR049613	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050984	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105664_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700105629	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	3.8	WUGSC	HMP_production_phase_1
SRS063154.572623	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4346	SRR048774	39.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063154	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268866	268866	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111626_from_subject_937495960__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111589	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	39	0	BCM	HMP_production_phase_1
SRS054571.573769	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3862	SRR049341	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054571	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038926_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038906	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	WUGSC	HMP_production_phase_1
SRS043565.574363	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2887	SRR049605	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043565	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103257_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105980	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	31	4.4	WUGSC	HMP_production_phase_1
SRS016257.574135	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_826	SRR044506	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016257	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024920_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024903	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	29	0	WUGSC	HMP_production_phase_1
SRS018517.570426	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1376	SRR041366	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018517	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035981_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035945	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	4.1	BI	HMP_production_phase_1
SRS048690.576296	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3365	SRR048679	32.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048690	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108282_from_subject_160704339__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700108239	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	32	4.6	BCM	HMP_production_phase_1
SRS053222.571892	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3758	SRR046367	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053222	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105753_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105730	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	WUGSC	HMP_production_phase_1
SRS011488.575610	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_91	SRR044876	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011488	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016325_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016304	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	34	0	WUGSC	HMP_production_phase_1
SRS044375.572091	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2961	SRR048443	34.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044375	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109971_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109935	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	34	4.6	BCM	HMP_production_phase_1
SRS024177.571285	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2616	SRR041097	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100645_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100613	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS014257.572289	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_328	SRR047572	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014257	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021846_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700021818	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS065424.576226	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4678	SRR047348	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065424	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114191_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114168	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	0	WUGSC	HMP_production_phase_1
SRS021736.574188	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2001	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021736	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097449_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097421	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.1	JCVI	HMP_production_phase_1
SRS011645.571889	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_174	SRR044987	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011645	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033492_from_subject_159470302__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033490	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4.1	WUGSC	HMP_production_phase_1
SRS045846.571969	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3103	SRR043002	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045846	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102466_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102430	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS016309.574647	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_843	SRR044470	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016309	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241813	241813	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024972_from_subject_765074482__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024953	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	20	0	WUGSC	HMP_production_phase_1
SRS055956.571912	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3979	SRR044010	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055956	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241811	241811	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106054_from_subject_764184357__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106017	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	23	3.8	WUGSC	HMP_production_phase_1
SRS021625.575852	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1976	SRR048362	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097337_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097303	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	4.9	BCM	HMP_production_phase_1
SRS024645.575817	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2734	SRR041198	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024645	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101936_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101907	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	0	BI	HMP_production_phase_1
SRS020535.575438	TCAGACCGGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1708	SRR041088	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020535	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095858_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095835	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	BI	HMP_production_phase_1
SRS048022.572305	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3313	SRR048901	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048022	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107926_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107890	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	0	BCM	HMP_production_phase_1
SRS024486.570351	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2698	SRR043244	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024486	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101632_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700101597	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	38	0	BI	HMP_production_phase_1
SRS044893.570578	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3015	SRR048601	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044893	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108194_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108168	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	21	0	BCM	HMP_production_phase_1
SRS058660.574034	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4212	SRR048888	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058660	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107431_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107392	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	4.7	BCM	HMP_production_phase_1
SRS020677.571110	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1746	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241776	241776	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096102_from_subject_160947100__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700096065	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	JCVI	HMP_production_phase_1
SRS022111.570471	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2094	SRR041648	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022111	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097877_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097846	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	4.4	BI	HMP_production_phase_1
SRS045710.572486	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3093	SRR041066	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045710	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101321_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101296	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS016370.573876	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_865	SRR040899	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016370	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032034_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS023442.575516	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2433	SRR048380	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023442	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099629_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099600	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	0	BCM	HMP_production_phase_1
SRS018517.570632	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1376	SRR042871	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018517	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035981_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035945	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	4.1	BI	HMP_production_phase_1
SRS018858.575357	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1442	SRR045987	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018858	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241716	241716	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037325_from_subject_765256553__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037295	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	18	3.8	WUGSC	HMP_production_phase_1
SRS015468.572045	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_612	SRR044645	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024123_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700024094	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS015133.575616	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_517	SRR045722	28.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015133	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241850	241850	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023788_from_subject_763901136__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023701	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	4.5	WUGSC	HMP_production_phase_1
SRS013670.574917	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_274	SRR042992	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013670	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016748_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700016708	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS024169.575483	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2612	SRR043055	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100637_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100609	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS051483.575239	TCAGTTCAAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_3621	SRR041492	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051483	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102393_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102365	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS023063.575562	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2335	SRR048111	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023063	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099097_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099067	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	4.1	BCM	HMP_production_phase_1
SRS023212.574888	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2378	SRR041906	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241767	241767	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099343_from_subject_158924089__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700099306	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS023563.574036	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2458	SRR041360	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023563	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099840_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099812	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS055748.575075	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3955	SRR047168	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055748	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241855	241855	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103291_from_subject_682449369__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103271	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	4.7	WUGSC	HMP_production_phase_1
SRS066188.571680	TCAGAGTAGCGTGT	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058093	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS015470.573946	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_613	SRR044696	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024125_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024095	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS044585.575907	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2978	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044585	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241842	241842	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109005_from_subject_161007791__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108968	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	4.3	JCVI	HMP_production_phase_1
SRS046889.574739	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3204	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046889	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108826_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108794	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	0	JCVI	HMP_production_phase_1
SRS017096.575096	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1039	SRR042969	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033609_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033575	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS013798.570432	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_307	SRR048320	25.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013798	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241819	241819	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016958_from_subject_159389382__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700016920	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BCM	HMP_production_phase_1
SRS020372.570217	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1670	SRR041540	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020372	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095691_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700095658	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	32	4.2	BI	HMP_production_phase_1
SRS024454.572753	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2686	SRR041673	38.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241794	241794	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101600_from_subject_159571453__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700101581	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	38	0	BI	HMP_production_phase_1
SRS022333.575569	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2158	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022333	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241841	241841	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098173_from_subject_533247696__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	25	4.5	JCVI	HMP_production_phase_1
SRS049119.574254	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3401	SRR048633	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108572_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108540	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	30	3.9	BCM	HMP_production_phase_1
SRS064616.575366	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4563	SRR046274	36.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064616	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241815	241815	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114047_from_subject_763395383__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114015	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	36	0	WUGSC	HMP_production_phase_1
SRS049325.572961	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3422	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049325	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109145_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109115	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	4.1	JCVI	HMP_production_phase_1
SRS022233.574488	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2126	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022233	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098002_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097976	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	4.2	JCVI	HMP_production_phase_1
SRS050152.570461	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3491	SRR048711	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050152	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109961_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109930	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	34	4.6	BCM	HMP_production_phase_1
SRS019263.572911	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1499	SRR046169	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019263	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037734_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037698	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.2	WUGSC	HMP_production_phase_1
SRS023130.576209	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2356	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023130	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099261_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099137	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.3	JCVI	HMP_production_phase_1
SRS022305.575586	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2144	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022305	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098145_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098116	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	4.5	JCVI	HMP_production_phase_1
SRS043683.570339	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2901	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043683	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109272_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109240	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	4.8	JCVI	HMP_production_phase_1
SRS022131.575391	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2104	SRR041569	22.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022131	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241803	241803	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097897_from_subject_158337416__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097856	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	22	4.4	BI	HMP_production_phase_1
SRS024281.575762	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2639	SRR041698	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024281	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101259_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101232	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	3.7	BI	HMP_production_phase_1
SRS056403.575848	TCAGACATAGTAGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4015	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056403	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110025_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109996	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	JCVI	HMP_production_phase_1
SRS057046.575268	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4071	SRR049495	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057046	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106966_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106940	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	20	0	WUGSC	HMP_production_phase_1
SRS023221.573545	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2381	SRR048368	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023221	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241700	241700	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099352_from_subject_158114885__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099347	n	969	319	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	29	4.2	BCM	HMP_production_phase_1
SRS066144.576441	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058095	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS023510.573606	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2448	SRR048396	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023510	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099787_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099757	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BCM	HMP_production_phase_1
SRS049828.574569	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3460	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049828	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107860_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107828	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS047712.570226	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3283	SRR048578	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047712	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107910_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107882	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	0	BCM	HMP_production_phase_1
SRS023055.575674	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2332	SRR048115	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023055	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099089_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099063	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	4.1	BCM	HMP_production_phase_1
SRS023922.570381	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2547	SRR043057	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023922	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100320_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100297	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS015722.570410	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_680	SRR044208	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015722	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024377_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024348	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	3.6	WUGSC	HMP_production_phase_1
SRS016281.573855	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_838	SRR043991	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016281	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024944_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024915	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS017029.575283	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1022	SRR041515	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017029	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033542_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033541	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS016666.573942	TCAGCGGAACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_944	SRR041647	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016666	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032450_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032449	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	5	BI	HMP_production_phase_1
SRS011559.571434	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_129	SRR045396	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033002_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.7	WUGSC	HMP_production_phase_1
SRS018033.574318	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1258	SRR042897	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018033	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241734	241734	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035357_from_subject_160239046__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS014627.575563	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_409	SRR045689	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023281_from_subject_763840445__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023244	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	38	4.1	WUGSC	HMP_production_phase_1
SRS056286.574469	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4005	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056286	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109017_from_subject_161007791__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108974	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	24	4.3	JCVI	HMP_production_phase_1
SRS011281.575408	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_21	SRR044860	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011281	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015274_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015272	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	WUGSC	HMP_production_phase_1
SRS018268.572422	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1312	SRR041202	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018268	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035675_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035644	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	3.9	BI	HMP_production_phase_1
SRS011624.572147	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_164	SRR044968	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011624	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033455_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033454	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.1	WUGSC	HMP_production_phase_1
SRS024224.571807	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2625	SRR041867	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101111_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101084	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS054065.574892	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3824	SRR046807	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054065	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106585_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	4.3	WUGSC	HMP_production_phase_1
SRS018803.574381	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1435	SRR045939	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018803	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037270_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037245	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS056458.573114	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4020	SRR048748	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056458	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108584_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108546	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	30	3.9	BCM	HMP_production_phase_1
SRS049575.576288	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3439	SRR046378	26.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049575	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241685	241685	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106693_from_subject_764224817__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700106662	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	WUGSC	HMP_production_phase_1
SRS065435.574940	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4680	SRR047090	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114209_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114177	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS013543.571468	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_249	SRR048260	22.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013543	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241796	241796	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016564_from_subject_159227541__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016542	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	4.7	BCM	HMP_production_phase_1
SRS017115.576279	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1043	SRR041978	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017115	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033677_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033676	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS017304.573438	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1088	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033986_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016468	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS020893.572891	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1794	SRR041614	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020893	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096404_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096373	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	31	0	BI	HMP_production_phase_1
SRS014861.575659	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_456	SRR043772	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014861	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023515_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023496	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	39	0	WUGSC	HMP_production_phase_1
SRS019261.575994	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1498	SRR044409	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019261	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037732_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037697	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.2	WUGSC	HMP_production_phase_1
SRS023557.573831	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2455	SRR041276	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099834_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099809	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS055114.575697	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3901	SRR058092	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055114	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102563_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	4.6	JCVI	HMP_production_phase_1
SRS058273.575676	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4178	SRR048610	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058273	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108210_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108176	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	21	0	BCM	HMP_production_phase_1
SRS015235.571385	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_546	SRR043979	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015235	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023890_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023866	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	4.4	WUGSC	HMP_production_phase_1
SRS051204.571078	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3591	SRR043275	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051204	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107091_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107056	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS058383.574143	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4186	SRR048559	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058383	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109659_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109629	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	19	4.7	BCM	HMP_production_phase_1
SRS011641.576166	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_172	SRR049322	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011641	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241795	241795	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033483_from_subject_159470302__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033481	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.1	WUGSC	HMP_production_phase_1
SRS016551.571547	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_912	SRR041413	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016551	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032278_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4	BI	HMP_production_phase_1
SRS063888.576608	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4458	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063888	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111847_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111818	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	36	0	JCVI	HMP_production_phase_1
SRS021790.576317	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2015	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021790	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241849	241849	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097503_from_subject_161473083__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097481	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	40	0	JCVI	HMP_production_phase_1
SRS055740.571411	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3953	SRR048498	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055740	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108642_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108608	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	31	0	BCM	HMP_production_phase_1
SRS011466.575547	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_79	SRR045097	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016164_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	WUGSC	HMP_production_phase_1
SRS014825.575590	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_448	SRR046180	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014825	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241793	241793	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023479_from_subject_763921366__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023448	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.1	WUGSC	HMP_production_phase_1
SRS011601.573326	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_152	SRR045335	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011601	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033176_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033142	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.3	WUGSC	HMP_production_phase_1
SRS018583.576186	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1395	SRR044510	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018583	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037050_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037030	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	19	0	WUGSC	HMP_production_phase_1
SRS016648.570441	TCAGAACGGTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_938	SRR041513	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016648	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032432_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032431	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	5	BI	HMP_production_phase_1
SRS063998.570876	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4483	SRR049390	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063998	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241693	241693	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114149_from_subject_763840445__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114117	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	38	4.7	WUGSC	HMP_production_phase_1
SRS052074.573513	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3668	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052074	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108324_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108294	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	JCVI	HMP_production_phase_1
SRS020897.571425	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1796	SRR041605	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020897	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096408_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096375	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	31	0	BI	HMP_production_phase_1
SRS064987.573782	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4614	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064987	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257123	257123	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111873_from_subject_414519462__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111831	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	36	4.7	JCVI	HMP_production_phase_1
SRS063400.574765	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4379	SRR046819	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063400	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113521_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700113493	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS021748.572096	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2006	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021748	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097461_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097427	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.1	JCVI	HMP_production_phase_1
SRS015466.572522	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_611	SRR044754	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024121_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024093	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS021516.571340	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1952	SRR043051	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021516	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241722	241722	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097228_from_subject_158479027__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097193	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS023942.573573	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2556	SRR042815	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023942	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100340_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100307	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS024584.575640	TCAGTTGTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2719	SRR040754	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024584	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101875_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101848	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS021081.573953	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1834	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021081	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096628_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096576	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	4.8	JCVI	HMP_production_phase_1
SRS022253.572267	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2135	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022253	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241786	241786	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098022_from_subject_970836795__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097986	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	29	4.2	JCVI	HMP_production_phase_1
SRS014925.573283	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_476	SRR043953	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023580_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS049644.575494	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_3449	SRR041069	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049644	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101317_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101294	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS022502.575012	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2196	SRR048382	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022502	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098403_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098370	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	30	4.5	BCM	HMP_production_phase_1
SRS022183.573006	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2115	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022183	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097952_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097918	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.5	JCVI	HMP_production_phase_1
SRS015679.571261	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_669	SRR044254	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015679	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024334_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024304	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	WUGSC	HMP_production_phase_1
SRS016944.571176	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1006	SRR042838	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016944	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033410_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033377	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS016525.576215	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_900	SRR041102	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032252_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032226	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4	BI	HMP_production_phase_1
SRS043873.570937	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2918	SRR042886	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102464_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102429	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS011649.570254	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_176	SRR044938	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011649	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033498_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033496	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.1	WUGSC	HMP_production_phase_1
SRS021077.576052	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1832	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021077	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096624_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096574	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	4.8	JCVI	HMP_production_phase_1
SRS018997.570621	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1460	SRR044584	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018997	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037466_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037444	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS019675.576490	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1542	SRR046633	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038148_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038121	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS051250.573847	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3599	SRR040943	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051250	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102397_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102367	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS019552.574614	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1518	SRR043946	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019552	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038023_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038006	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS052055.572743	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3665	SRR048727	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052055	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107597_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700107562	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	0	BCM	HMP_production_phase_1
SRS024700.573791	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2748	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024700	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102080_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102052	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	30	0	JCVI	HMP_production_phase_1
SRS022185.573873	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2116	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022185	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097954_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097919	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.5	JCVI	HMP_production_phase_1
SRS063986.572738	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4480	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063986	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110681_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110653	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	30	0	JCVI	HMP_production_phase_1
SRS019083.571473	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1469	SRR044691	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019083	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037554_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037536	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS064340.570473	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4532	SRR048839	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064340	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111342_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111308	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	39	4.8	BCM	HMP_production_phase_1
SRS021271.574277	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1888	SRR058095	34.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021271	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241669	241669	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096917_from_subject_161230322__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096880	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	34	5.3	JCVI	HMP_production_phase_1
SRS022378.575067	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2167	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022378	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098244_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098213	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	35	0	JCVI	HMP_production_phase_1
SRS043395.572943	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2871	SRR049305	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043395	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038736_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700038700	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	25	3.7	WUGSC	HMP_production_phase_1
SRS017764.574643	TCAGAACCGGATAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1187	SRR040696	22.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017764	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241782	241782	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034857_from_subject_160542498__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034838	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	0	BI	HMP_production_phase_1
SRS065718.570491	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4733	SRR058092	39.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065718	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:268866	268866	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111632_from_subject_937495960__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700111592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	39	0	JCVI	HMP_production_phase_1
SRS022498.573146	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2194	SRR048174	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022498	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098399_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098368	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	30	4.5	BCM	HMP_production_phase_1
SRS015464.572413	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_610	SRR044680	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024119_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024092	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS058746.570279	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_4218	SRR040932	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058746	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102995_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102971	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS023689.572425	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2491	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023689	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099996_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	4.1	JCVI	HMP_production_phase_1
SRS018747.573109	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1417	SRR046625	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018747	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037214_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	4.5	WUGSC	HMP_production_phase_1
SRS024653.575696	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2738	SRR041287	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101944_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101911	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS011377.572998	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_42	SRR045362	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011377	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015668_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015666	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS011486.576178	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_90	SRR045117	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011486	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016323_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016303	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	34	0	WUGSC	HMP_production_phase_1
SRS011640.573144	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_171	SRR045364	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011640	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241795	241795	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033480_from_subject_159470302__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033478	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.1	WUGSC	HMP_production_phase_1
SRS022191.575714	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2119	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022191	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097960_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097922	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.5	JCVI	HMP_production_phase_1
SRS057447.570806	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4102	SRR046411	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241872	241872	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105904_from_subject_668248235__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105882	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	WUGSC	HMP_production_phase_1
SRS046505.575635	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3173	SRR046451	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046505	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241863	241863	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105005_from_subject_275382046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106981	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	0	WUGSC	HMP_production_phase_1
SRS051204.576155	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3591	SRR042833	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051204	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107091_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107056	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS017796.576244	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1199	SRR042902	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017796	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241782	241782	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034889_from_subject_160542498__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034854	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS019089.573755	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1471	SRR044757	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019089	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037560_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037539	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS057613.574126	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4124	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101807_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101778	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	JCVI	HMP_production_phase_1
SRS054928.573085	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3886	SRR046294	30.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054928	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241736	241736	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105856_from_subject_763516763__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105834	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	30	0	WUGSC	HMP_production_phase_1
SRS021577.571142	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1967	SRR048093	29.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021577	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241843	241843	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097289_from_subject_158216035__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097252	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	BCM	HMP_production_phase_1
SRS045108.570772	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3030	SRR046729	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045108	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105944_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700105926	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	0	WUGSC	HMP_production_phase_1
SRS014657.573387	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_414	SRR045526	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023311_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023289	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	37	0	WUGSC	HMP_production_phase_1
SRS011292.571421	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_27	SRR045374	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011292	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015292_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015290	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS016493.572283	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_898	SRR041717	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016493	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032189_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016987	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	0	BI	HMP_production_phase_1
SRS050737.575039	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3551	SRR045745	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050737	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038512_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038489	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	31	0	WUGSC	HMP_production_phase_1
SRS023314.573452	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2397	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023314	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099476_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099448	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.3	JCVI	HMP_production_phase_1
SRS020241.570436	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1634	SRR041094	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020241	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095494_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095471	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	0	BI	HMP_production_phase_1
SRS063819.575971	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4447	SRR048803	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063819	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111268_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	5	BCM	HMP_production_phase_1
SRS064133.575662	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4505	SRR048858	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064133	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112012_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111989	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Saliva	26	0	BCM	HMP_production_phase_1
SRS015001.570430	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_494	SRR047563	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015001	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241718	241718	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023656_from_subject_764062976__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700023635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	4.8	WUGSC	HMP_production_phase_1
SRS011486.574235	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_90	SRR045447	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011486	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016323_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016303	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	34	0	WUGSC	HMP_production_phase_1
SRS011490.572808	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_92	SRR044865	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011490	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016327_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016305	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	34	0	WUGSC	HMP_production_phase_1
SRS065311.573795	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4663	SRR046533	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065311	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257115	257115	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114679_from_subject_938202701__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114658	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS063963.573139	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4474	SRR046324	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063963	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114135_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114110	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	38	4.7	WUGSC	HMP_production_phase_1
SRS016267.574460	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_831	SRR044091	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016267	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241681	241681	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024930_from_subject_764669880__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024908	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	WUGSC	HMP_production_phase_1
SRS051734.572203	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3635	SRR048737	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051734	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107924_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107889	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BCM	HMP_production_phase_1
SRS042436.570527	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2788	SRR048545	25.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042436	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241826	241826	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108915_from_subject_160218816__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108896	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BCM	HMP_production_phase_1
SRS018797.576418	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1432	SRR045934	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018797	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037264_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	WUGSC	HMP_production_phase_1
SRS046759.572739	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3194	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046759	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109845_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109816	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	0	JCVI	HMP_production_phase_1
SRS016349.575027	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_858	SRR040949	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032013_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032012	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS011373.573322	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_40	SRR045350	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011373	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015662_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015660	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS063861.573777	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4454	SRR046747	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063861	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114639_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114608	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	4.3	WUGSC	HMP_production_phase_1
SRS022759.570501	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2263	SRR058114	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022759	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098715_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098681	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	4.1	JCVI	HMP_production_phase_1
SRS023685.571160	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2489	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023685	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099992_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099963	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	4.1	JCVI	HMP_production_phase_1
SRS018204.570329	TCAGTTCAACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1295	SRR040700	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018204	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035611_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035582	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	0	BI	HMP_production_phase_1
SRS057258.572180	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4085	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241694	241694	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109340_from_subject_160866180__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109317	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS020559.571269	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1719	SRR041042	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095882_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700095847	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS015856.571346	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_712	SRR043922	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015856	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024511_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024493	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS019005.575682	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1464	SRR044626	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019005	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037474_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037448	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS014317.573552	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_342	SRR047560	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014317	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021906_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021888	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	3.9	WUGSC	HMP_production_phase_1
SRS064629.574180	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4568	SRR046560	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241784	241784	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113570_from_subject_764346198__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113546	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	4.1	WUGSC	HMP_production_phase_1
SRS055461.570552	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3929	SRR043765	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055461	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038566_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038540	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS013670.570755	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_274	SRR042796	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013670	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016748_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700016708	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS053264.576466	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3760	SRR047186	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053264	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103243_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105973	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	31	4.4	WUGSC	HMP_production_phase_1
SRS048671.576496	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3362	SRR046044	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038604_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038583	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS043338.573860	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2863	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043338	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241786	241786	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109171_from_subject_970836795__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109128	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	29	4.1	JCVI	HMP_production_phase_1
SRS011283.572230	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_22	SRR044951	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011283	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015277_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015275	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	WUGSC	HMP_production_phase_1
SRS011551.574606	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_125	SRR045080	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011551	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016655_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016653	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS043826.571181	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2916	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043826	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108072_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108045	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	JCVI	HMP_production_phase_1
SRS011516.573546	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_107	SRR045098	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011516	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016370_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016351	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	20	4.2	WUGSC	HMP_production_phase_1
SRS063248.572617	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4358	SRR047132	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063248	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114023_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114003	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	36	0	WUGSC	HMP_production_phase_1
SRS045963.576168	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3121	SRR046715	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045963	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241893	241893	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105079_from_subject_178713055__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105045	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.5	WUGSC	HMP_production_phase_1
SRS016263.570834	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_829	SRR044461	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016263	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024926_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024906	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	WUGSC	HMP_production_phase_1
SRS014446.576373	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_371	SRR045529	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014446	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023100_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023068	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	25	3.4	WUGSC	HMP_production_phase_1
SRS023639.570776	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2481	SRR041446	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023639	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099942_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099903	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	20	4.9	BI	HMP_production_phase_1
SRS044901.570419	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3017	SRR047669	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103466_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103440	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS017900.571439	TCAGACCGGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1224	SRR041361	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017900	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035198_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035168	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	33	0	BI	HMP_production_phase_1
SRS011277.576438	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_19	SRR045360	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011277	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015268_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015266	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	WUGSC	HMP_production_phase_1
SRS021637.576250	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1980	SRR048055	22.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021637	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241668	241668	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097349_from_subject_158013734__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700097309	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.9	BCM	HMP_production_phase_1
SRS018027.571778	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1256	SRR040717	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018027	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241734	241734	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035351_from_subject_160239046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035313	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS013585.572048	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_261	SRR048271	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013585	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016606_from_subject_159227541__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016563	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	22	4.7	BCM	HMP_production_phase_1
SRS017533.574147	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1139	SRR040650	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017533	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034266_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034238	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS011292.571116	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_27	SRR047532	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011292	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015292_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015290	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS049959.574584	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3473	SRR045933	39.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049959	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241884	241884	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038414_from_subject_765701615__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038392	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	39	0	WUGSC	HMP_production_phase_1
SRS022621.574683	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2225	SRR041734	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022621	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098573_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098548	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS023859.575269	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2531	SRR048212	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023859	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100257_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100231	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	4.9	BCM	HMP_production_phase_1
SRS043160.574789	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2845	SRR058108	40.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043160	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241849	241849	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110275_from_subject_161473083__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110237	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	40	4.9	JCVI	HMP_production_phase_1
SRS016859.575045	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_983	SRR041693	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016859	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033220_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033219	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS024353.573866	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2660	SRR041089	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024353	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101388_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101358	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS024222.570832	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2624	SRR041808	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024222	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101109_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101083	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS017426.573023	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1116	SRR041384	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017426	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241703	241703	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034132_from_subject_160481808__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034097	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	30	0	BI	HMP_production_phase_1
SRS047653.570340	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3278	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047653	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110327_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110296	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	4.3	JCVI	HMP_production_phase_1
SRS021453.575803	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1934	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021453	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097161_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097129	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	32	0	JCVI	HMP_production_phase_1
SRS042206.575930	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2767	SRR048250	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102281_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102252	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	0	BCM	HMP_production_phase_1
SRS014279.573072	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_335	SRR043598	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014279	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021868_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS018329.573227	TCAGTTCAACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1329	SRR041520	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018329	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035763_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035736	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	BI	HMP_production_phase_1
SRS064637.571052	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4569	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064637	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110854_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110822	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	4.7	JCVI	HMP_production_phase_1
SRS017914.576533	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1231	SRR042806	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017914	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241799	241799	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035212_from_subject_160441347__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS016160.570958	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_799	SRR044259	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016160	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024817_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024793	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	3.9	WUGSC	HMP_production_phase_1
SRS049599.572772	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3442	SRR043603	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038726_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038695	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS015336.575784	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_578	SRR044503	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015336	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023991_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023969	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	3.7	WUGSC	HMP_production_phase_1
SRS017898.571248	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1223	SRR042973	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017898	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035196_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035167	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	BI	HMP_production_phase_1
SRS052615.571655	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3716	SRR058096	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109278_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109243	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	4.8	JCVI	HMP_production_phase_1
SRS064375.571109	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4536	SRR047037	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064375	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241805	241805	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114349_from_subject_765560005__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114328	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	21	0	WUGSC	HMP_production_phase_1
SRS016018.576061	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_761	SRR044251	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016018	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241708	241708	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024673_from_subject_764447348__sex_male_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024646	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	WUGSC	HMP_production_phase_1
SRS016675.570465	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_947	SRR041652	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016675	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032459_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032458	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	5	BI	HMP_production_phase_1
SRS055673.570617	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3948	SRR048676	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055673	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108268_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108232	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	32	4.6	BCM	HMP_production_phase_1
SRS048515.572362	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3347	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048515	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108991_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108961	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	4.3	JCVI	HMP_production_phase_1
SRS021151.572084	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1860	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021151	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241801	241801	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096698_from_subject_160744799__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096611	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	20	4.9	JCVI	HMP_production_phase_1
SRS022063.570394	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2085	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022063	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097803_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097769	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	31	0	JCVI	HMP_production_phase_1
SRS022711.574662	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2254	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022711	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241689	241689	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098663_from_subject_432193348__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098620	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	4.6	JCVI	HMP_production_phase_1
SRS045858.574429	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3106	SRR046275	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045858	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105862_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105837	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	30	0	WUGSC	HMP_production_phase_1
SRS017422.574862	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1114	SRR040789	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017422	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241703	241703	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034128_from_subject_160481808__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034095	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	BI	HMP_production_phase_1
SRS017653.574835	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1156	SRR040587	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034653_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034628	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	19	0	BI	HMP_production_phase_1
SRS024696.573166	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2746	SRR058092	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024696	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102076_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700102050	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	30	0	JCVI	HMP_production_phase_1
SRS021520.575760	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1953	SRR041544	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021520	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241722	241722	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097232_from_subject_158479027__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097195	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS048602.570240	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3355	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048602	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109423_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109392	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	4.8	JCVI	HMP_production_phase_1
SRS019089.575777	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1471	SRR044694	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019089	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037560_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700037539	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS058741.575501	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4217	SRR047200	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058741	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105660_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105627	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	3.8	WUGSC	HMP_production_phase_1
SRS019451.574354	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1513	SRR045993	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019451	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241728	241728	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037922_from_subject_765519544__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037903	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	WUGSC	HMP_production_phase_1
SRS020322.570275	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1660	SRR041385	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020322	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095575_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095540	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS021686.575749	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1991	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021686	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097398_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097368	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	JCVI	HMP_production_phase_1
SRS011653.571620	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_178	SRR045296	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011653	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241764	241764	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033749_from_subject_159713063__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700033726	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.4	WUGSC	HMP_production_phase_1
SRS020720.571070	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1754	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020720	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096145_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096115	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	JCVI	HMP_production_phase_1
SRS013784.570314	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_304	SRR048414	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013784	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016944_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700016913	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BCM	HMP_production_phase_1
SRS023631.573066	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2477	SRR041085	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099934_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099899	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	20	4.9	BI	HMP_production_phase_1
SRS065559.572295	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4703	SRR046824	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113134_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700113109	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	0	WUGSC	HMP_production_phase_1
SRS020445.574880	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1693	SRR042894	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095768_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095733	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS015291.572079	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_566	SRR043802	37.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015291	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241787	241787	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023946_from_subject_763982056__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700023924	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	37	0	WUGSC	HMP_production_phase_1
SRS064327.570384	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4529	SRR050388	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064327	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114466_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114435	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	3.9	WUGSC	HMP_production_phase_1
SRS016060.573600	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_772	SRR044291	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016060	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024717_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024692	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	WUGSC	HMP_production_phase_1
SRS045460.575845	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3074	SRR047219	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045460	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103261_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105982	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	31	4.4	WUGSC	HMP_production_phase_1
SRS066188.574633	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058112	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS017282.576530	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1077	SRR041330	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017282	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033957_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033930	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS042427.572607	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2787	SRR046035	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038984_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038959	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	0	WUGSC	HMP_production_phase_1
SRS017236.576404	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1069	SRR041416	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017236	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033842_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033841	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	29	0	BI	HMP_production_phase_1
SRS042607.575832	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2805	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042607	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109137_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109111	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	4.1	JCVI	HMP_production_phase_1
SRS016708.574648	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_954	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016708	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032653_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700032640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.3	BI	HMP_production_phase_1
SRS017032.575228	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1023	SRR041523	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017032	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033545_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033544	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS018088.572325	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1267	SRR040634	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018088	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035412_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035379	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS023190.571370	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2368	SRR041957	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023190	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099321_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099295	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	33	0	BI	HMP_production_phase_1
SRS056498.576617	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4025	SRR046185	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056498	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038890_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038864	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS050571.574804	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3537	SRR048750	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050571	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108876_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700108848	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	BCM	HMP_production_phase_1
SRS048631.570475	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3357	SRR046723	19.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241855	241855	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103301_from_subject_682449369__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103276	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	19	4.7	WUGSC	HMP_production_phase_1
SRS053457.571483	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3780	SRR048544	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053457	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109612_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109578	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	0	BCM	HMP_production_phase_1
SRS024694.574596	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2745	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024694	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102074_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102049	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	0	JCVI	HMP_production_phase_1
SRS045406.571635	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3070	SRR043881	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038476_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038447	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS016265.573300	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_830	SRR044110	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016265	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241681	241681	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024928_from_subject_764669880__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024907	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS045289.571763	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3057	SRR040847	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045289	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102399_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102368	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS015239.574564	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_548	SRR044118	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015239	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023894_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023868	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	4.4	WUGSC	HMP_production_phase_1
SRS020718.573058	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1753	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020718	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096143_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096114	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	0	JCVI	HMP_production_phase_1
SRS011283.572007	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_22	SRR045329	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011283	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015277_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015275	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	WUGSC	HMP_production_phase_1
SRS021867.571329	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2034	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021867	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097603_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097577	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	JCVI	HMP_production_phase_1
SRS024046.574952	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2580	SRR040938	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024046	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100508_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100480	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	4.7	BI	HMP_production_phase_1
SRS064850.574641	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4595	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064850	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110626_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110597	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	JCVI	HMP_production_phase_1
SRS063956.573671	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4471	SRR058092	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063956	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257122	257122	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111075_from_subject_686765762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111041	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS023302.575573	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2395	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023302	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241835	241835	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099464_from_subject_206906765__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099442	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	JCVI	HMP_production_phase_1
SRS013708.575368	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_285	SRR041636	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013708	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016786_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016785	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS015139.572066	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_520	SRR043887	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015139	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023794_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023704	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	4.5	WUGSC	HMP_production_phase_1
SRS057208.571630	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4082	SRR048715	33.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102899_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	TRUE	y	TCAG	UBERON:sebum	700102864	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	33	0	BCM	HMP_production_phase_1
SRS057550.575745	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4115	SRR048534	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057550	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109596_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109570	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	0	BCM	HMP_production_phase_1
SRS052132.572504	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3675	SRR047692	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052132	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241875	241875	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106360_from_subject_289996019__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700106338	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS062913.573655	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4313	SRR048798	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062913	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111258_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	5	BCM	HMP_production_phase_1
SRS016535.570531	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_904	SRR043259	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016535	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032262_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4	BI	HMP_production_phase_1
SRS013470.571694	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_237	SRR041887	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016401_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016384	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	BI	HMP_production_phase_1
SRS018333.573380	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1331	SRR041548	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018333	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035767_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035738	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	BI	HMP_production_phase_1
SRS019109.576113	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1480	SRR044697	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019109	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037580_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037549	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS052851.572229	TCAGTCCGGTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3732	SRR041463	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052851	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107071_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107046	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	0	BI	HMP_production_phase_1
SRS045406.575731	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3070	SRR043627	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038476_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038447	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS057898.572899	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4149	SRR048644	30.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057898	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108590_from_subject_160582958__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108549	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	30	3.9	BCM	HMP_production_phase_1
SRS022105.574004	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2091	SRR041503	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022105	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097871_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097843	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	4.4	BI	HMP_production_phase_1
SRS024486.575049	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2698	SRR043291	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024486	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101632_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101597	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	38	0	BI	HMP_production_phase_1
SRS054970.574717	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3890	SRR046735	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054970	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105140_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105104	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	20	5.6	WUGSC	HMP_production_phase_1
SRS045710.571638	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3093	SRR041758	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045710	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101321_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101296	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS024431.571196	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2684	SRR040713	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024431	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101577_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700101573	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	5.1	BI	HMP_production_phase_1
SRS016449.570923	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_884	SRR040979	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016449	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032145_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032144	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS024171.575982	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2613	SRR043290	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100639_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100610	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS045850.573421	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3105	SRR047212	29.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045850	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257127	257127	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105646_from_subject_953045535__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105620	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	29	3.8	WUGSC	HMP_production_phase_1
SRS014865.575320	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_458	SRR043786	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014865	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023519_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023498	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	39	0	WUGSC	HMP_production_phase_1
SRS011533.573177	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_116	SRR044934	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011533	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016628_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016626	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS023985.576498	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2563	SRR040843	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023985	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100446_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100420	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	0	BI	HMP_production_phase_1
SRS011557.573851	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_128	SRR044952	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241837	241837	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016664_from_subject_159166850__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016662	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	WUGSC	HMP_production_phase_1
SRS015921.575078	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_732	SRR044611	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015921	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024576_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024550	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS045992.570936	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3124	SRR048735	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045992	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108949_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108913	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS011547.572005	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_123	SRR044932	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011547	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016649_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016647	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS050846.571350	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3560	SRR047569	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050846	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038934_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700038910	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	WUGSC	HMP_production_phase_1
SRS044264.571552	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2949	SRR058096	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044264	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109839_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109813	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	JCVI	HMP_production_phase_1
SRS017677.570361	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1168	SRR040644	19.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241775	241775	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034692_from_subject_160461578__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	19	0	BI	HMP_production_phase_1
SRS046871.575737	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3202	SRR048256	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102293_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102258	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BCM	HMP_production_phase_1
SRS056274.573027	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4004	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056274	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109288_from_subject_638754422__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700109248	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	4.8	JCVI	HMP_production_phase_1
SRS015901.574464	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_724	SRR044629	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024556_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024540	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS013674.572178	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_276	SRR043018	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013674	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241672	241672	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016752_from_subject_159288231__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700016710	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS015198.573927	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_538	SRR046525	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015198	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023853_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700023819	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4	WUGSC	HMP_production_phase_1
SRS020811.575527	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1774	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020811	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241677	241677	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096285_from_subject_160886410__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096267	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	JCVI	HMP_production_phase_1
SRS014456.575940	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_375	SRR046166	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023110_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023073	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	3.4	WUGSC	HMP_production_phase_1
SRS015605.573386	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_643	SRR049448	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015605	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241784	241784	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024260_from_subject_764346198__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.4	WUGSC	HMP_production_phase_1
SRS018163.576331	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1288	SRR042998	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035563_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035529	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS024064.576580	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2588	SRR042935	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024064	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100526_from_subject_159247771__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100489	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	4.7	BI	HMP_production_phase_1
SRS017481.575912	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1128	SRR041305	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017481	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034214_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034179	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	19	5.1	BI	HMP_production_phase_1
SRS050292.575126	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3509	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050292	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102700_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102670	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	JCVI	HMP_production_phase_1
SRS017230.573092	TCAGCGGAACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1067	SRR041367	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017230	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033836_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033835	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	BI	HMP_production_phase_1
SRS017245.576248	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1072	SRR042796	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017245	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241838	241838	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033851_from_subject_159814214__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700033850	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS056105.571880	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3989	SRR046241	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056105	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038932_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038909	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	WUGSC	HMP_production_phase_1
SRS017406.573641	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1106	SRR040583	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034112_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034087	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	0	BI	HMP_production_phase_1
SRS063417.576103	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4381	SRR046276	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063417	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114161_from_subject_763840445__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114123	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	38	4.7	WUGSC	HMP_production_phase_1
SRS018092.576232	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1269	SRR041203	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018092	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035416_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035381	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS014954.572933	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_482	SRR045937	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014954	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023609_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023591	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	32	0	WUGSC	HMP_production_phase_1
SRS018270.571036	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1313	SRR041204	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018270	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035677_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035645	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	3.9	BI	HMP_production_phase_1
SRS047486.574443	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3259	SRR058108	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047486	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110337_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110301	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	4.3	JCVI	HMP_production_phase_1
SRS020488.572568	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1700	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095811_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095783	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	JCVI	HMP_production_phase_1
SRS064182.571913	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4508	SRR048855	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064182	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112018_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111992	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Hard_palate	26	0	BCM	HMP_production_phase_1
SRS020190.575525	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1621	SRR048145	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020190	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095443_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095417	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	32	0	BCM	HMP_production_phase_1
SRS022450.573090	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2185	SRR048199	27.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241719	241719	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098325_from_subject_158742018__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098285	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	5.8	BCM	HMP_production_phase_1
SRS056460.571883	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4021	SRR058084	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056460	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110199_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700110166	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	38	4.5	JCVI	HMP_production_phase_1
SRS045999.574601	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3125	SRR043289	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102997_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102972	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS065181.574458	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4644	SRR049487	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065181	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241876	241876	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113025_from_subject_764750800__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113008	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS016974.574090	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1011	SRR045128	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016974	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033468_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033466	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.1	WUGSC	HMP_production_phase_1
SRS020767.575668	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1762	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020767	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096192_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096167	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	JCVI	HMP_production_phase_1
SRS053216.574154	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3757	SRR046049	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038998_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038966	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS018815.570369	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1440	SRR045931	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018815	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241731	241731	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037282_from_subject_765135172__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700037251	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	WUGSC	HMP_production_phase_1
SRS064648.576162	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4571	SRR047105	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064648	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241890	241890	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114830_from_subject_375450439__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114804	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	24	4.1	WUGSC	HMP_production_phase_1
SRS064183.574935	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4509	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064183	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111536_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111511	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	JCVI	HMP_production_phase_1
SRS024281.575955	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2639	SRR041859	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024281	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101259_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101232	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	3.7	BI	HMP_production_phase_1
SRS015864.571929	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_715	SRR045763	39.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015864	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241830	241830	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024519_from_subject_764002286__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024497	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	39	0	WUGSC	HMP_production_phase_1
SRS063793.573214	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4442	SRR046546	30.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063793	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257118	257118	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114937_from_subject_561079058__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:mucus	700114910	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	30	4.1	WUGSC	HMP_production_phase_1
SRS044666.573930	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2989	SRR049455	19.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044666	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241855	241855	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103299_from_subject_682449369__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700103275	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	19	4.7	WUGSC	HMP_production_phase_1
SRS021139.572527	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1856	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021139	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241801	241801	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096686_from_subject_160744799__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096605	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	4.9	JCVI	HMP_production_phase_1
SRS023114.573068	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2349	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023114	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099245_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099129	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.3	JCVI	HMP_production_phase_1
SRS011631.571600	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_167	SRR044863	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033465_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033463	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.1	WUGSC	HMP_production_phase_1
SRS015952.573913	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_739	SRR047441	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015952	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241769	241769	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024607_from_subject_764325968__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024589	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	WUGSC	HMP_production_phase_1
SRS063728.572952	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4429	SRR047334	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063728	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114468_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114436	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	3.9	WUGSC	HMP_production_phase_1
SRS016101.572806	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_783	SRR046150	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016101	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241701	241701	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024758_from_subject_764588959__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024735	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	4.5	WUGSC	HMP_production_phase_1
SRS017363.570258	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1098	SRR041316	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017363	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034069_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034037	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	BI	HMP_production_phase_1
SRS043291.573852	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2858	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043291	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241780	241780	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110034_from_subject_161412393__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110001	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS047642.574920	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3276	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047642	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257122	257122	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107208_from_subject_686765762__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107189	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	JCVI	HMP_production_phase_1
SRS063197.572895	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4351	SRR047032	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063197	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114846_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114812	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	4.1	WUGSC	HMP_production_phase_1
SRS046126.572633	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3136	SRR048678	32.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046126	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108280_from_subject_160704339__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700108238	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	32	4.6	BCM	HMP_production_phase_1
SRS023938.573037	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2554	SRR041514	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023938	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100336_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100305	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS023881.575517	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2541	SRR048219	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023881	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241755	241755	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100279_from_subject_158883629__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100242	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	4.9	BCM	HMP_production_phase_1
SRS014827.573950	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_449	SRR043944	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014827	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241793	241793	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023481_from_subject_763921366__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023449	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.1	WUGSC	HMP_production_phase_1
SRS055141.572024	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3906	SRR046036	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055141	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038763_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	5.3	WUGSC	HMP_production_phase_1
SRS019665.571928	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1537	SRR047635	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038136_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038115	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS046752.570947	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3192	SRR046691	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046752	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105954_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105931	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	0	WUGSC	HMP_production_phase_1
SRS017661.574086	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1160	SRR041051	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034661_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034632	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	19	0	BI	HMP_production_phase_1
SRS046109.576131	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3135	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046109	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110351_from_subject_892969023__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110308	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	28	4.3	JCVI	HMP_production_phase_1
SRS011635.575138	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_169	SRR045345	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011635	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033473_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033472	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS018966.572311	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1453	SRR047619	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018966	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241737	241737	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037435_from_subject_765276783__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037404	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	0	WUGSC	HMP_production_phase_1
SRS017479.570524	TCAGTTCCGTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1127	SRR041268	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017479	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034212_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034178	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	19	5.1	BI	HMP_production_phase_1
SRS046412.574062	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3168	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046412	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109280_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700109244	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	4.8	JCVI	HMP_production_phase_1
SRS018033.570921	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1258	SRR042900	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018033	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241734	241734	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035357_from_subject_160239046__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS017239.571063	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1070	SRR043258	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017239	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033845_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033844	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS055482.574421	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3932	SRR049504	38.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055482	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241878	241878	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105181_from_subject_612472597__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105153	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	4.3	WUGSC	HMP_production_phase_1
SRS011429.574227	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_57	SRR044862	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011429	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016073_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016043	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS056795.576464	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4055	SRR049593	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056795	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106665_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106648	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	WUGSC	HMP_production_phase_1
SRS014345.572672	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_350	SRR046148	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014345	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241844	241844	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021934_from_subject_763820215__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700021902	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	3.9	WUGSC	HMP_production_phase_1
SRS016319.574268	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_846	SRR044435	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016319	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024982_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024958	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	0	WUGSC	HMP_production_phase_1
SRS048544.573192	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3348	SRR047205	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048544	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106376_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700106346	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	WUGSC	HMP_production_phase_1
SRS011407.573150	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_46	SRR044929	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011407	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015993_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015991	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.7	WUGSC	HMP_production_phase_1
SRS015623.575571	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_650	SRR044221	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024278_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024246	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.4	WUGSC	HMP_production_phase_1
SRS055034.575574	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3896	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055034	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257122	257122	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107242_from_subject_686765762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107206	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	JCVI	HMP_production_phase_1
SRS051769.576311	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3639	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051769	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110261_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110230	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	40	4.9	JCVI	HMP_production_phase_1
SRS042117.570939	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2763	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042117	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109435_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109398	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.8	JCVI	HMP_production_phase_1
SRS024120.571741	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2601	SRR041199	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024120	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100585_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100553	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS050170.573448	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3493	SRR048641	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050170	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108582_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108545	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	30	3.9	BCM	HMP_production_phase_1
SRS021613.575927	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1970	SRR048054	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097325_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700097297	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	4.9	BCM	HMP_production_phase_1
SRS023336.575322	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2408	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023336	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241835	241835	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099498_from_subject_206906765__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099459	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	JCVI	HMP_production_phase_1
SRS015774.570905	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_691	SRR044457	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015774	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241685	241685	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024429_from_subject_764224817__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024404	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS047715.575297	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3284	SRR047165	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047715	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257127	257127	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105638_from_subject_953045535__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700105616	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	3.8	WUGSC	HMP_production_phase_1
SRS018167.574009	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1290	SRR043231	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035567_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035531	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS015574.575989	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_637	SRR044120	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015574	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024229_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024199	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	18	0	WUGSC	HMP_production_phase_1
SRS046349.572107	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3159	SRR046051	30.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241853	241853	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038978_from_subject_370027359__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038956	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	WUGSC	HMP_production_phase_1
SRS018076.571839	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1265	SRR041340	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018076	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241671	241671	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035400_from_subject_160056975__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035373	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS050640.572251	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3544	SRR049482	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050640	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241883	241883	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103517_from_subject_132902142__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103488	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	31	5.6	WUGSC	HMP_production_phase_1
SRS045314.571554	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3058	SRR045859	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045314	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038980_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038957	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	30	0	WUGSC	HMP_production_phase_1
SRS017008.570236	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1015	SRR041563	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017008	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033521_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033520	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS020425.570360	TCAGAACGTTCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1683	SRR040996	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020425	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095748_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095723	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	0	BI	HMP_production_phase_1
SRS051535.574691	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3622	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051535	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241694	241694	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109370_from_subject_160866180__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109332	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	4.6	JCVI	HMP_production_phase_1
SRS062660.571861	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4272	SRR047045	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062660	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114361_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114334	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	21	0	WUGSC	HMP_production_phase_1
SRS022516.573952	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2201	SRR048383	30.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022516	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241810	241810	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098417_from_subject_158458797__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098377	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	30	4.5	BCM	HMP_production_phase_1
SRS024533.570669	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2708	SRR048184	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024533	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101679_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700101649	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BCM	HMP_production_phase_1
SRS046216.575963	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3147	SRR058096	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241806	241806	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107836_from_subject_161311242__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107816	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS058776.574560	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4221	SRR043742	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058776	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038506_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038486	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	31	0	WUGSC	HMP_production_phase_1
SRS015127.573384	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_514	SRR047618	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015127	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023782_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023698	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	4.5	WUGSC	HMP_production_phase_1
SRS021001.576365	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1820	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021001	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096548_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096520	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	JCVI	HMP_production_phase_1
SRS011444.571702	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_68	SRR045076	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016095_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016054	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	4.2	WUGSC	HMP_production_phase_1
SRS020827.572556	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1777	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020827	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096301_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096275	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	JCVI	HMP_production_phase_1
SRS018284.572871	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1320	SRR043238	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018284	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035691_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035652	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	3.9	BI	HMP_production_phase_1
SRS023399.572770	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2426	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023399	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099565_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700099529	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	38	0	JCVI	HMP_production_phase_1
SRS020002.571992	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1587	SRR040599	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020002	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095247_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095219	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.3	BI	HMP_production_phase_1
SRS011441.571567	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_65	SRR045132	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011441	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016089_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016051	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS055347.571791	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3923	SRR049635	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055347	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241685	241685	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106685_from_subject_764224817__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106658	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS024637.572979	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2730	SRR041244	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024637	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101928_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101903	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	BI	HMP_production_phase_1
SRS056751.572613	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4051	SRR046034	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056751	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038606_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038584	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS022987.574475	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2316	SRR048059	29.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022987	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241700	241700	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099021_from_subject_158114885__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700099002	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	BCM	HMP_production_phase_1
SRS050321.575998	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3513	SRR049376	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050321	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105386_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700105362	n	969	234	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	WUGSC	HMP_production_phase_1
SRS020494.571272	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1703	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020494	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095817_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095786	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS051645.573926	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3627	SRR048883	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051645	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108131_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108102	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BCM	HMP_production_phase_1
SRS021281.574127	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1892	SRR058095	34.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021281	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241669	241669	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096927_from_subject_161230322__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096885	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	34	5.3	JCVI	HMP_production_phase_1
SRS015962.570257	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_743	SRR047626	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015962	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024617_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024594	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	0	WUGSC	HMP_production_phase_1
SRS048650.575415	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3358	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048650	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109490_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109460	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	31	0	JCVI	HMP_production_phase_1
SRS022432.573586	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2178	SRR048192	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022432	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098307_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098276	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	5.8	BCM	HMP_production_phase_1
SRS015249.573685	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_553	SRR044488	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015249	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241729	241729	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023904_from_subject_764143897__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023873	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	4.4	WUGSC	HMP_production_phase_1
SRS048226.575819	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3329	SRR058112	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048226	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241688	241688	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109802_from_subject_161331472__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109766	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	JCVI	HMP_production_phase_1
SRS066188.573531	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058108	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS024071.571629	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2590	SRR042903	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024071	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100536_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100532	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	4.7	BI	HMP_production_phase_1
SRS063070.570538	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4334	SRR047127	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063070	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114068_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114048	n	969	286	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	20	5.6	WUGSC	HMP_production_phase_1
SRS063298.574430	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4367	SRR046756	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063298	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241824	241824	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113537_from_subject_763719065__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700113501	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	25	0	WUGSC	HMP_production_phase_1
SRS023488.574897	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2441	SRR048392	25.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241709	241709	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099765_from_subject_158964549__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099746	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BCM	HMP_production_phase_1
SRS012191.575409	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_195	SRR048044	22.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS012191	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241668	241668	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700013596_from_subject_158013734__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700013549	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	3.4	BCM	HMP_production_phase_1
SRS022639.575602	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2234	SRR042018	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022639	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098591_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098557	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS011175.573375	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_10	SRR044910	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011175	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014994_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014992	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	0	WUGSC	HMP_production_phase_1
SRS023381.573544	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2417	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023381	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099547_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099520	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	0	JCVI	HMP_production_phase_1
SRS011434.575842	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_60	SRR045120	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016079_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016046	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS022119.570348	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2098	SRR041549	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097885_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097850	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	4.4	BI	HMP_production_phase_1
SRS014966.572749	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_488	SRR047650	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014966	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023621_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023597	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS011573.573853	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_136	SRR045300	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011573	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033023_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033021	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.7	WUGSC	HMP_production_phase_1
SRS021253.576343	TCAGACTCTGTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1879	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021253	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096899_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096871	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	34	5.3	JCVI	HMP_production_phase_1
SRS022944.574292	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2306	SRR048099	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022944	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098974_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098942	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	37	4.6	BCM	HMP_production_phase_1
SRS023522.570862	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2452	SRR048314	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023522	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099799_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099763	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS014758.574336	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_428	SRR047408	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014758	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023412_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023386	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	4.2	WUGSC	HMP_production_phase_1
SRS024647.570794	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2735	SRR041420	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024647	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101938_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101908	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	0	BI	HMP_production_phase_1
SRS051204.570584	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3591	SRR043224	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051204	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107091_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107056	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS015835.573896	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_710	SRR044704	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015835	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024490_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024459	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS011673.575062	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_188	SRR044886	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011673	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033777_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700033740	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.4	WUGSC	HMP_production_phase_1
SRS021520.571671	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1953	SRR042984	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021520	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241722	241722	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097232_from_subject_158479027__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097195	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS024183.576442	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2619	SRR041482	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024183	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100651_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100616	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS011567.570946	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_133	SRR044954	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011567	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033014_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033012	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.7	WUGSC	HMP_production_phase_1
SRS018339.573081	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1334	SRR041644	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018339	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035773_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035741	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	BI	HMP_production_phase_1
SRS013207.571206	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_210	SRR042990	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013207	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015906_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015872	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS046893.575277	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3205	SRR058113	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046893	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108501_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108477	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	32	0	JCVI	HMP_production_phase_1
SRS022386.571165	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2170	SRR058111	35.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022386	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241768	241768	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098252_from_subject_492786515__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098217	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	35	0	JCVI	HMP_production_phase_1
SRS021406.576273	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1924	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021406	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241774	241774	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097064_from_subject_161028021__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097021	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	25	4.6	JCVI	HMP_production_phase_1
SRS011677.573226	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_190	SRR045445	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011677	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033781_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700033742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.4	WUGSC	HMP_production_phase_1
SRS017843.574692	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1209	SRR041325	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017843	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034948_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034918	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	BI	HMP_production_phase_1
SRS049982.576069	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3476	SRR048657	24.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049982	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241847	241847	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110111_from_subject_160643649__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700110089	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	4.3	BCM	HMP_production_phase_1
SRS056832.575423	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4058	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056832	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241744	241744	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108058_from_subject_161270782__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700107993	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	JCVI	HMP_production_phase_1
SRS018094.576502	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1270	SRR041864	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018094	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035418_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035382	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS017653.573355	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1156	SRR040719	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034653_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034628	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	19	0	BI	HMP_production_phase_1
SRS022488.571938	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2190	SRR048176	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022488	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098389_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098363	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	30	4.5	BCM	HMP_production_phase_1
SRS024331.575951	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2653	SRR041801	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024331	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241814	241814	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101366_from_subject_159551223__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700101347	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS043730.575013	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_2909	SRR046866	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043730	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106424_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106402	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS011520.572939	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_109	SRR045309	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011520	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016374_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016353	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	20	4.2	WUGSC	HMP_production_phase_1
SRS011504.573495	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_101	SRR044961	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011504	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016356_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016344	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	20	4.2	WUGSC	HMP_production_phase_1
SRS051734.574013	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3635	SRR048900	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051734	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107924_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107889	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BCM	HMP_production_phase_1
SRS048669.572041	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3361	SRR049618	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048669	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106109_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700106073	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	18	4.5	WUGSC	HMP_production_phase_1
SRS011167.573019	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_6	SRR045346	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014982_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014980	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	0	WUGSC	HMP_production_phase_1
SRS023387.571042	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2420	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023387	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099553_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700099523	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	0	JCVI	HMP_production_phase_1
SRS024365.570940	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2666	SRR041139	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024365	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101400_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101364	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS021322.576579	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1899	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021322	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096980_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096952	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	0	JCVI	HMP_production_phase_1
SRS044317.574068	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2957	SRR048703	31.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044317	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241679	241679	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109228_from_subject_160765029__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109191	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	31	0	BCM	HMP_production_phase_1
SRS020267.573668	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1646	SRR040666	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020267	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095520_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095484	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS015464.571292	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_610	SRR044743	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024119_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024092	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS048299.576214	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3336	SRR048575	23.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048299	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241695	241695	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107892_from_subject_160380657__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107873	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	0	BCM	HMP_production_phase_1
SRS015029.570327	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_504	SRR044102	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015029	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023684_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023649	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	4.8	WUGSC	HMP_production_phase_1
SRS064510.576479	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4553	SRR048873	35.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064510	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241804	241804	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110802_from_subject_158984779__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110771	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	35	4.6	BCM	HMP_production_phase_1
SRS053253.574198	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3759	SRR046734	19.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053253	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241855	241855	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103303_from_subject_682449369__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103277	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	19	4.7	WUGSC	HMP_production_phase_1
SRS018098.572885	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1272	SRR041292	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018098	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035422_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035384	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS054043.574853	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3823	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054043	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102336_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102308	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	JCVI	HMP_production_phase_1
SRS020956.574776	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1812	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020956	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241752	241752	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096467_from_subject_161068481__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096433	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS018282.573015	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1319	SRR042934	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018282	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035689_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	3.9	BI	HMP_production_phase_1
SRS047859.576065	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3297	SRR045910	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047859	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038773_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038747	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	5.3	WUGSC	HMP_production_phase_1
SRS011440.575835	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_64	SRR044882	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011440	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241709	241709	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016087_from_subject_158964549__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016050	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS063651.570977	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4418	SRR047103	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063651	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113041_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113016	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	21	0	WUGSC	HMP_production_phase_1
SRS015409.571129	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_599	SRR045683	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015409	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024064_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024034	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	3.6	WUGSC	HMP_production_phase_1
SRS019083.574554	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1469	SRR044753	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019083	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037554_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037536	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS016681.571956	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_949	SRR042986	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016681	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032465_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700032464	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	5	BI	HMP_production_phase_1
SRS016434.574463	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_882	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241749	241749	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032123_from_subject_159672603__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700032086	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS024310.571669	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2652	SRR041952	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024310	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101288_from_subject_158944319__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101283	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	24	3.7	BI	HMP_production_phase_1
SRS018278.576474	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1317	SRR041317	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018278	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035685_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035649	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	3.9	BI	HMP_production_phase_1
SRS021996.570971	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2066	SRR041678	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021996	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097736_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700097701	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	4.1	BI	HMP_production_phase_1
SRS020958.574903	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1813	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241752	241752	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096469_from_subject_161068481__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096434	n	969	10	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	JCVI	HMP_production_phase_1
SRS020445.575004	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1693	SRR042815	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095768_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095733	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS021832.572333	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2030	SRR058120	40.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021832	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097545_from_subject_161473083__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097502	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	40	5.1	JCVI	HMP_production_phase_1
SRS014833.575607	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_451	SRR045700	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014833	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241793	241793	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023487_from_subject_763921366__sex_female_	UBERON:nostril	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023452	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.1	WUGSC	HMP_production_phase_1
SRS058159.571252	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4164	SRR045929	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241852	241852	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038900_from_subject_861967750__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700038869	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	WUGSC	HMP_production_phase_1
SRS055814.574359	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3962	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055814	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109268_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109238	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	4.8	JCVI	HMP_production_phase_1
SRS049858.575893	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3462	SRR047135	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049858	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105858_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105835	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	30	0	WUGSC	HMP_production_phase_1
SRS023328.570957	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2404	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023328	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099490_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099455	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.3	JCVI	HMP_production_phase_1
SRS049823.574392	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3459	SRR046414	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049823	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257127	257127	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105632_from_subject_953045535__sex_female_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105613	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	3.8	WUGSC	HMP_production_phase_1
SRS015460.575867	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_608	SRR044676	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024115_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024090	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS023567.573527	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2460	SRR043005	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023567	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099844_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099814	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS017227.576007	TCAGAACGGTGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1066	SRR041433	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017227	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033833_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033832	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	BI	HMP_production_phase_1
SRS019107.574757	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1479	SRR047447	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019107	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037578_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037548	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS017561.576417	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1152	SRR040637	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017561	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034294_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034252	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.1	BI	HMP_production_phase_1
SRS022201.576020	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2124	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022201	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097970_from_subject_638754422__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700097927	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.5	JCVI	HMP_production_phase_1
SRS015340.573979	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_579	SRR045767	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015340	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023995_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700023971	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	3.7	WUGSC	HMP_production_phase_1
SRS052128.571659	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3674	SRR048486	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052128	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107409_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107381	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	4.7	BCM	HMP_production_phase_1
SRS011647.573407	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_175	SRR045307	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011647	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033495_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033493	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4.1	WUGSC	HMP_production_phase_1
SRS021682.570914	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1989	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021682	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097394_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097366	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	JCVI	HMP_production_phase_1
SRS024710.572470	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2753	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024710	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102090_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102057	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	JCVI	HMP_production_phase_1
SRS014750.572577	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_425	SRR043758	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014750	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023404_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023382	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	4.2	WUGSC	HMP_production_phase_1
SRS045350.575299	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3060	SRR048744	21.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045350	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241715	241715	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108180_from_subject_160421117__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108161	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	21	0	BCM	HMP_production_phase_1
SRS044715.572723	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2998	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044715	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241786	241786	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109167_from_subject_970836795__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109126	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	29	4.1	JCVI	HMP_production_phase_1
SRS045314.571947	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3058	SRR046031	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045314	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038980_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038957	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	30	0	WUGSC	HMP_production_phase_1
SRS017727.572667	TCAGACCGGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1178	SRR041319	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017727	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034820_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034785	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	30	4.1	BI	HMP_production_phase_1
SRS020837.571716	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1782	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020837	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096311_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096280	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	JCVI	HMP_production_phase_1
SRS052599.572440	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3714	SRR048569	19.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109675_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109637	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	19	4.7	BCM	HMP_production_phase_1
SRS044943.571215	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3021	SRR045893	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044943	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241853	241853	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038968_from_subject_370027359__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038951	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS018037.573672	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1260	SRR043056	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018037	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035361_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035317	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.3	BI	HMP_production_phase_1
SRS046408.572239	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3167	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046408	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110335_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110300	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	4.3	JCVI	HMP_production_phase_1
SRS019779.573196	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1561	SRR044474	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019779	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038255_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700038227	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	WUGSC	HMP_production_phase_1
SRS023512.570464	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2449	SRR048395	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023512	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099789_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099758	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BCM	HMP_production_phase_1
SRS021928.573869	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2050	SRR048075	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021928	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097668_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097640	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	0	BCM	HMP_production_phase_1
SRS014546.576234	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_382	SRR045714	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014546	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241730	241730	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023200_from_subject_763638144__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	3.8	WUGSC	HMP_production_phase_1
SRS014831.570627	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_450	SRR046158	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014831	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241793	241793	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023485_from_subject_763921366__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023451	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.1	WUGSC	HMP_production_phase_1
SRS018585.575869	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1396	SRR044449	19.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018585	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241758	241758	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037052_from_subject_765094712__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037031	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	19	0	WUGSC	HMP_production_phase_1
SRS016225.576071	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_818	SRR044381	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016225	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024888_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.1	WUGSC	HMP_production_phase_1
SRS018084.570512	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1266	SRR041821	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018084	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035408_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035377	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS016936.576008	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1002	SRR040856	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016936	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033402_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033373	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS020547.571864	TCAGTCGGTTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1713	SRR041053	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020547	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095870_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095841	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	BI	HMP_production_phase_1
SRS053348.570566	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3770	SRR048621	26.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053348	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108153_from_subject_160502038__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700108113	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	3.9	BCM	HMP_production_phase_1
SRS017667.571840	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1163	SRR041725	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034682_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	19	0	BI	HMP_production_phase_1
SRS023338.570954	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2409	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023338	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241835	241835	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099500_from_subject_206906765__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	JCVI	HMP_production_phase_1
SRS021502.570683	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1945	SRR041506	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021502	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097214_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097186	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS065164.570622	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4639	SRR049515	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065164	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113584_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113553	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	4.1	WUGSC	HMP_production_phase_1
SRS016205.573075	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_809	SRR044479	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016205	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241687	241687	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024868_from_subject_764649650__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024847	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.1	WUGSC	HMP_production_phase_1
SRS043769.570931	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2911	SRR058096	22.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043769	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241759	241759	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108802_from_subject_160987560__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108782	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	0	JCVI	HMP_production_phase_1
SRS024187.571103	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2620	SRR040664	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024187	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241676	241676	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100655_from_subject_159207311__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100618	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS015998.570239	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_752	SRR047418	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015998	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024653_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024636	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	WUGSC	HMP_production_phase_1
SRS054770.572854	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3877	SRR049379	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054770	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105662_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105628	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	3.8	WUGSC	HMP_production_phase_1
SRS020155.574766	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1617	SRR048138	31.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020155	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241827	241827	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095408_from_subject_158398106__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700095371	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	31	0	BCM	HMP_production_phase_1
SRS058599.574612	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4206	SRR048480	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107415_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107384	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	4.7	BCM	HMP_production_phase_1
SRS057978.573802	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4159	SRR046397	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057978	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105608_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105578	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	20	0	WUGSC	HMP_production_phase_1
SRS048709.572539	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3367	SRR046304	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048709	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105244_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105213	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	4	WUGSC	HMP_production_phase_1
SRS047983.574373	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3310	SRR049512	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047983	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103323_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103287	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	19	4.7	WUGSC	HMP_production_phase_1
SRS047816.576585	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3295	SRR041425	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047816	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107081_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107051	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	0	BI	HMP_production_phase_1
SRS017898.575289	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1223	SRR041469	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017898	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035196_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035167	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	BI	HMP_production_phase_1
SRS018993.574442	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1458	SRR044590	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018993	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037462_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037442	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS016934.575711	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1001	SRR040982	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016934	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033400_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033372	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS022127.574436	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2102	SRR043037	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022127	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097893_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097854	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	4.4	BI	HMP_production_phase_1
SRS011584.573592	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_143	SRR049312	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011584	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033044_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.7	WUGSC	HMP_production_phase_1
SRS045466.572805	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3076	SRR047698	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045466	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103247_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105975	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	31	4.4	WUGSC	HMP_production_phase_1
SRS046889.574347	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3204	SRR058096	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046889	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108826_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108794	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	0	JCVI	HMP_production_phase_1
SRS021816.573480	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2024	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021816	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097529_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097494	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	40	0	JCVI	HMP_production_phase_1
SRS015736.574850	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_682	SRR044271	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015736	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241756	241756	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024391_from_subject_764467579__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024355	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	3.6	WUGSC	HMP_production_phase_1
SRS021766.571656	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2014	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021766	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241706	241706	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097479_from_subject_161493313__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097436	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.1	JCVI	HMP_production_phase_1
SRS054475.570490	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3854	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054475	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107226_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107198	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	JCVI	HMP_production_phase_1
SRS015202.573091	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_540	SRR043787	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015202	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023857_from_subject_763759525__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023821	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4	WUGSC	HMP_production_phase_1
SRS042197.570820	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2765	SRR048255	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042197	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102273_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102248	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	BCM	HMP_production_phase_1
SRS016775.574193	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_973	SRR042818	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016775	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032966_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	BI	HMP_production_phase_1
SRS022816.572894	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2278	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022816	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098772_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	JCVI	HMP_production_phase_1
SRS021990.571405	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2063	SRR041123	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021990	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097730_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097698	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	4.1	BI	HMP_production_phase_1
SRS022834.574020	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2284	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022834	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241816	241816	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098790_from_subject_295137534__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700098753	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	JCVI	HMP_production_phase_1
SRS022685.571058	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2242	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022685	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098637_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098607	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	4.6	JCVI	HMP_production_phase_1
SRS055144.571028	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3907	SRR049412	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055144	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038562_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038538	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	0	WUGSC	HMP_production_phase_1
SRS045136.576350	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3033	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045136	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109792_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109761	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	0	JCVI	HMP_production_phase_1
SRS053564.576575	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3791	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053564	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109849_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109818	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	JCVI	HMP_production_phase_1
SRS015360.573010	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_587	SRR044093	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015360	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024015_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023981	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	3.7	WUGSC	HMP_production_phase_1
SRS056362.573439	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4010	SRR048580	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056362	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107900_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107877	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	BCM	HMP_production_phase_1
SRS022010.571789	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2072	SRR040707	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022010	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097750_from_subject_158256496__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097708	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	4.1	BI	HMP_production_phase_1
SRS051645.573799	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3627	SRR048613	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051645	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108131_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108102	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BCM	HMP_production_phase_1
SRS058818.574909	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4225	SRR058112	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058818	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108523_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108488	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	32	0	JCVI	HMP_production_phase_1
SRS047422.574304	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3252	SRR049383	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241856	241856	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105110_from_subject_256789458__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105089	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	5.6	WUGSC	HMP_production_phase_1
SRS019089.571081	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1471	SRR044731	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019089	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037560_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037539	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS018805.575518	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1436	SRR045800	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018805	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037272_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037246	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS021879.572689	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2040	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021879	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097615_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097583	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS065193.576513	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4646	SRR046297	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065193	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114131_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114108	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	38	4.7	WUGSC	HMP_production_phase_1
SRS053478.573381	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3783	SRR043636	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053478	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038738_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700038701	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	25	3.7	WUGSC	HMP_production_phase_1
SRS011490.573352	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_92	SRR045432	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011490	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016327_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016305	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	34	0	WUGSC	HMP_production_phase_1
SRS019558.575948	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1521	SRR049834	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019558	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038029_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038009	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS011448.576484	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_70	SRR044965	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011448	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016099_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016056	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	20	4.2	WUGSC	HMP_production_phase_1
SRS053052.575673	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3743	SRR046398	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053052	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103595_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103568	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	WUGSC	HMP_production_phase_1
SRS016376.574208	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_867	SRR040866	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016376	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032040_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS017847.570423	TCAGAACCGACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1211	SRR041578	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017847	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034952_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034920	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	BI	HMP_production_phase_1
SRS046038.574645	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3129	SRR058112	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046038	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108521_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108487	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	32	0	JCVI	HMP_production_phase_1
SRS045920.573841	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3116	SRR046591	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045920	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241857	241857	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106573_from_subject_208027353__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106548	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	28	4.3	WUGSC	HMP_production_phase_1
SRS021372.573382	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1909	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021372	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097030_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097004	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	4.6	JCVI	HMP_production_phase_1
SRS048074.570529	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3317	SRR058084	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048074	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110458_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110429	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	JCVI	HMP_production_phase_1
SRS063753.574538	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4431	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063753	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110870_from_subject_809635352__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700110830	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	4.7	JCVI	HMP_production_phase_1
SRS020014.571153	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1593	SRR041086	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020014	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095259_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095225	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.3	BI	HMP_production_phase_1
SRS049386.573935	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3425	SRR058112	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049386	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108527_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108490	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	0	JCVI	HMP_production_phase_1
SRS055697.575212	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3951	SRR058084	29.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055697	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257120	257120	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110438_from_subject_604812005__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110419	n	969	85	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	JCVI	HMP_production_phase_1
SRS064558.571471	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4557	SRR046983	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064558	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114252_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114221	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	4.5	WUGSC	HMP_production_phase_1
SRS017418.570288	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1112	SRR041004	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017418	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034124_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034093	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	30	0	BI	HMP_production_phase_1
SRS016068.572818	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_776	SRR044441	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016068	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024725_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024696	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	WUGSC	HMP_production_phase_1
SRS011409.576237	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_47	SRR047515	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011409	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015999_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015997	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.7	WUGSC	HMP_production_phase_1
SRS016681.576543	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_949	SRR042796	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016681	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032465_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032464	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	5	BI	HMP_production_phase_1
SRS056664.571686	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4040	SRR049462	20.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056664	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241869	241869	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106976_from_subject_147406386__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700106945	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	20	0	WUGSC	HMP_production_phase_1
SRS019574.575474	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1528	SRR043595	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019574	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038045_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038017	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	37	0	WUGSC	HMP_production_phase_1
SRS050217.573828	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3497	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050217	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109433_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109397	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	4.8	JCVI	HMP_production_phase_1
SRS018212.572677	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1299	SRR040742	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035619_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700035586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	BI	HMP_production_phase_1
SRS047772.575021	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3291	SRR043969	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241823	241823	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038522_from_subject_763476303__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038494	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	0	WUGSC	HMP_production_phase_1
SRS018787.572028	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1428	SRR045799	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037254_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	WUGSC	HMP_production_phase_1
SRS015348.574307	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_582	SRR043978	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015348	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241811	241811	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024003_from_subject_764184357__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023975	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	3.7	WUGSC	HMP_production_phase_1
SRS065347.572242	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4670	SRR046833	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065347	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114651_from_subject_763901136__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114614	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	28	4.3	WUGSC	HMP_production_phase_1
SRS066144.576607	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058108	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS021883.571256	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2041	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021883	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097619_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097585	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS022942.574342	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2305	SRR048373	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022942	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098972_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098941	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	37	4.6	BCM	HMP_production_phase_1
SRS049548.572317	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3437	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049548	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241867	241867	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101827_from_subject_514014184__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101788	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	4.2	JCVI	HMP_production_phase_1
SRS053598.570824	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3795	SRR046325	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053598	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241844	241844	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105236_from_subject_763820215__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105209	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	25	4	WUGSC	HMP_production_phase_1
SRS020265.571409	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1645	SRR040596	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020265	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095518_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095483	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS066188.574867	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048118	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS017896.571760	TCAGAACCGGATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1222	SRR041471	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017896	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035194_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035166	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	33	0	BI	HMP_production_phase_1
SRS016470.575465	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_890	SRR041293	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032166_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032165	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS020527.575553	TCAGAACCGGATAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1707	SRR041930	21.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020527	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241821	241821	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095850_from_subject_160845950__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700095831	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	BI	HMP_production_phase_1
SRS021129.572565	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1851	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021129	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096676_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096600	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	4.9	JCVI	HMP_production_phase_1
SRS048891.575540	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3382	SRR048763	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048891	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108266_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108231	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	32	4.6	BCM	HMP_production_phase_1
SRS047484.571407	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3258	SRR048655	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047484	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108886_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108853	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	0	BCM	HMP_production_phase_1
SRS022510.570964	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2200	SRR048185	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022510	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241810	241810	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098411_from_subject_158458797__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098374	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	30	4.5	BCM	HMP_production_phase_1
SRS022880.575880	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2292	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022880	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098910_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098877	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	4.6	JCVI	HMP_production_phase_1
SRS022645.573550	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2237	SRR042011	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022645	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241820	241820	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098597_from_subject_158499257__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098560	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS023373.573428	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2414	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023373	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099539_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099516	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	38	0	JCVI	HMP_production_phase_1
SRS023194.570926	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2370	SRR041986	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023194	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099325_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099297	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	33	0	BI	HMP_production_phase_1
SRS014357.573738	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_356	SRR043928	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023011_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021289	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS049882.573530	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3463	SRR046708	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049882	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105191_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105158	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	4.3	WUGSC	HMP_production_phase_1
SRS016732.571001	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_965	SRR042933	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016732	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241836	241836	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032677_from_subject_160016515__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700032652	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.3	BI	HMP_production_phase_1
SRS016123.574773	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_790	SRR044421	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024780_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	4.5	WUGSC	HMP_production_phase_1
SRS055144.576346	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3907	SRR049352	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055144	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038562_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038538	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	0	WUGSC	HMP_production_phase_1
SRS018163.576487	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1288	SRR041002	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035563_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035529	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS015858.575219	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_713	SRR043893	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015858	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024513_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024494	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS056561.572138	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4034	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056561	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241694	241694	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109378_from_subject_160866180__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109336	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	25	4.6	JCVI	HMP_production_phase_1
SRS050772.570614	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3553	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108328_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108296	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS022051.573455	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2079	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022051	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097791_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097763	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	31	0	JCVI	HMP_production_phase_1
SRS014677.575520	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_423	SRR045548	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023331_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS043360.574483	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2867	SRR047171	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043360	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241861	241861	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106719_from_subject_184349034__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106699	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS011434.575446	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_60	SRR045405	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016079_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700016046	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS011619.573243	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_161	SRR044931	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033195_from_subject_159733294__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033151	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.3	WUGSC	HMP_production_phase_1
SRS057272.570643	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4089	SRR058112	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057272	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108830_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108796	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	0	JCVI	HMP_production_phase_1
SRS047127.576489	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3228	SRR047180	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047127	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241869	241869	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106974_from_subject_147406386__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106944	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	0	WUGSC	HMP_production_phase_1
SRS015421.570838	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_600	SRR045737	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015421	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241682	241682	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024076_from_subject_764042746__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024040	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	3.6	WUGSC	HMP_production_phase_1
SRS013213.570508	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_213	SRR040904	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013213	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241704	241704	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015912_from_subject_159369152__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700015875	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS020200.571775	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1626	SRR048150	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020200	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095453_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095422	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	32	0	BCM	HMP_production_phase_1
SRS017733.575120	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1181	SRR043263	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034826_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700034788	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	30	4.1	BI	HMP_production_phase_1
SRS046636.574261	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3186	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046636	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107232_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107201	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS021998.571826	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2067	SRR041362	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021998	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241747	241747	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097738_from_subject_158256496__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097702	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	4.1	BI	HMP_production_phase_1
SRS019886.574743	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1573	SRR044511	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241772	241772	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038362_from_subject_764892411__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700038342	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS023122.571265	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2352	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023122	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099253_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099133	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.3	JCVI	HMP_production_phase_1
SRS014962.571588	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_486	SRR049359	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014962	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023617_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023595	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	32	0	WUGSC	HMP_production_phase_1
SRS021364.571294	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1908	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021364	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241774	241774	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097022_from_subject_161028021__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	4.6	JCVI	HMP_production_phase_1
SRS049259.576564	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3414	SRR048593	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049259	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107796_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107768	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	0	BCM	HMP_production_phase_1
SRS045672.572140	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3092	SRR047179	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045672	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257131	257131	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103583_from_subject_863126187__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103562	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	WUGSC	HMP_production_phase_1
SRS023821.573962	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2528	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023821	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241742	241742	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100215_from_subject_336497421__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700100180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	JCVI	HMP_production_phase_1
SRS024306.574305	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2650	SRR041759	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024306	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101284_from_subject_158944319__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101281	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	24	3.7	BI	HMP_production_phase_1
SRS047917.574754	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3303	SRR048631	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047917	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108566_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108537	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	30	3.9	BCM	HMP_production_phase_1
SRS019783.574553	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1563	SRR044095	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019783	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038259_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038229	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	0	WUGSC	HMP_production_phase_1
SRS024388.570331	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2668	SRR043286	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241764	241764	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101534_from_subject_159713063__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700101515	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	5.1	BI	HMP_production_phase_1
SRS046924.574905	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3206	SRR048236	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046924	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102938_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102912	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	BCM	HMP_production_phase_1
SRS044700.571582	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2995	SRR046266	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044700	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105437_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105410	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	34	4.2	WUGSC	HMP_production_phase_1
SRS018817.575802	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1441	SRR045867	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018817	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241731	241731	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037284_from_subject_765135172__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700037252	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	WUGSC	HMP_production_phase_1
SRS021724.575151	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1999	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021724	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241706	241706	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097437_from_subject_161493313__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097415	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.1	JCVI	HMP_production_phase_1
SRS055315.571283	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3920	SRR046730	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055315	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241857	241857	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106571_from_subject_208027353__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700106547	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	4.3	WUGSC	HMP_production_phase_1
SRS056751.576359	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4051	SRR045865	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056751	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038606_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038584	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS023446.572294	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2435	SRR048164	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023446	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099633_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099602	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	0	BCM	HMP_production_phase_1
SRS044071.572873	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2936	SRR047722	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044071	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241866	241866	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106786_from_subject_857980665__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106755	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	32	4.2	WUGSC	HMP_production_phase_1
SRS016182.575467	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_807	SRR047416	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016182	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241696	241696	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024839_from_subject_764366428__sex_female_	UBERON:nostril	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024804	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	3.9	WUGSC	HMP_production_phase_1
SRS019013.571902	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1466	SRR044627	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019013	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241778	241778	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037484_from_subject_764305738__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037453	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS047862.573358	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3298	SRR049394	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047862	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241885	241885	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106188_from_subject_823052294__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106171	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS065167.572384	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4641	SRR046556	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241876	241876	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113031_from_subject_764750800__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700113011	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS015621.575367	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_649	SRR044215	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024276_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024245	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.4	WUGSC	HMP_production_phase_1
SRS021217.573602	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1876	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021217	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096764_from_subject_161007791__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096721	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	5	JCVI	HMP_production_phase_1
SRS047177.575456	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3232	SRR046489	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241769	241769	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105276_from_subject_764325968__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105259	n	969	216	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	0	WUGSC	HMP_production_phase_1
SRS011506.573339	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_102	SRR044895	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011506	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016360_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016346	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	4.2	WUGSC	HMP_production_phase_1
SRS022806.575236	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2274	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022806	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098762_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098739	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	JCVI	HMP_production_phase_1
SRS015031.573729	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_505	SRR043987	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015031	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023686_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023650	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	20	4.8	WUGSC	HMP_production_phase_1
SRS011543.572588	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_121	SRR044878	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016643_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016641	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS051241.571224	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3598	SRR048640	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051241	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108580_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108544	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	30	3.9	BCM	HMP_production_phase_1
SRS015263.571609	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_560	SRR043997	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015263	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241729	241729	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023918_from_subject_764143897__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023880	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	4.4	WUGSC	HMP_production_phase_1
SRS043542.574774	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2884	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043542	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110191_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110162	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	38	4.5	JCVI	HMP_production_phase_1
SRS023391.574995	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2422	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023391	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099557_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099525	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	0	JCVI	HMP_production_phase_1
SRS064128.572833	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4504	SRR049568	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064128	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113051_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700113021	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	21	0	WUGSC	HMP_production_phase_1
SRS052897.574368	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3733	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052897	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109358_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109326	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	4.6	JCVI	HMP_production_phase_1
SRS014297.571614	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_340	SRR045783	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014297	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241825	241825	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021886_from_subject_763536994__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700021682	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS020551.574425	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1715	SRR041143	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020551	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095874_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095843	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	BI	HMP_production_phase_1
SRS011521.576216	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_110	SRR045476	20.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016376_from_subject_159005010__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016354	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	20	4.2	WUGSC	HMP_production_phase_1
SRS019267.572944	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1500	SRR044439	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019267	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241800	241800	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037738_from_subject_765034022__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037700	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.2	WUGSC	HMP_production_phase_1
SRS020314.575041	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1656	SRR041704	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020314	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095567_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095536	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	BI	HMP_production_phase_1
SRS023893.574689	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2545	SRR048221	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023893	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241755	241755	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100291_from_subject_158883629__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100248	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	29	4.9	BCM	HMP_production_phase_1
SRS042087.570839	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2759	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042087	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102161_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102126	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	36	3.9	JCVI	HMP_production_phase_1
SRS066144.572927	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043087	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS045945.574613	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3120	SRR058084	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045945	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110263_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110231	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	40	4.9	JCVI	HMP_production_phase_1
SRS048093.572070	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3320	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048093	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241733	241733	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108336_from_subject_160825720__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108300	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	JCVI	HMP_production_phase_1
SRS043508.575182	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2882	SRR048730	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043508	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241671	241671	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107977_from_subject_160056975__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107944	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS017733.576576	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1181	SRR042847	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034826_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034788	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	30	4.1	BI	HMP_production_phase_1
SRS057913.570474	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4153	SRR046805	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057913	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103307_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103279	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	19	4.7	WUGSC	HMP_production_phase_1
SRS011477.570278	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_85	SRR045069	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011477	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016176_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016137	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS044970.576294	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3024	SRR046500	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044970	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241685	241685	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106689_from_subject_764224817__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106660	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	WUGSC	HMP_production_phase_1
SRS052037.573303	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3664	SRR047230	18.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052037	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241874	241874	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106089_from_subject_737052003__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106063	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	18	4.5	WUGSC	HMP_production_phase_1
SRS022241.570450	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2129	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022241	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098010_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097980	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	4.2	JCVI	HMP_production_phase_1
SRS062427.570882	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4231	SRR046888	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241825	241825	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113616_from_subject_763536994__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700113599	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS017772.576233	TCAGACCGGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1188	SRR040794	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034865_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034842	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	0	BI	HMP_production_phase_1
SRS052691.570494	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3723	SRR041598	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052691	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102389_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102363	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS047561.576419	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3265	SRR048629	30.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047561	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241710	241710	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108552_from_subject_160582958__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108530	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	30	3.9	BCM	HMP_production_phase_1
SRS062655.573133	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4271	SRR046313	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114031_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114007	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	36	0	WUGSC	HMP_production_phase_1
SRS011438.570403	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_63	SRR047520	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011438	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016085_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016049	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS017157.573908	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1056	SRR043292	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241814	241814	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033719_from_subject_159551223__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033718	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS021889.574177	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2044	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021889	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241744	241744	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097625_from_subject_161270782__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700097588	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	JCVI	HMP_production_phase_1
SRS011285.573565	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_23	SRR045095	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015280_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700015278	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS015025.570843	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_502	SRR044116	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015025	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023680_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023647	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	20	4.8	WUGSC	HMP_production_phase_1
SRS047636.574638	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3275	SRR047167	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047636	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241861	241861	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106717_from_subject_184349034__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106698	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS022496.574843	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2193	SRR048172	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022496	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098397_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098367	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	30	4.5	BCM	HMP_production_phase_1
SRS023464.572663	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2439	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023464	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099741_from_subject_246515023__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099742	n	969	13	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	38	4.8	JCVI	HMP_production_phase_1
SRS058495.575085	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4197	SRR048687	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058495	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109551_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109519	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	21	0	BCM	HMP_production_phase_1
SRS055744.575561	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3954	SRR043265	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055744	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101343_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101307	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS024106.574735	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2594	SRR041328	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024106	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100571_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100546	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS021402.574673	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1922	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021402	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241774	241774	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097060_from_subject_161028021__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097019	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	25	4.6	JCVI	HMP_production_phase_1
SRS064373.571289	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4535	SRR046540	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064373	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257114	257114	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114501_from_subject_739574095__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114481	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.8	WUGSC	HMP_production_phase_1
SRS020004.574037	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1588	SRR041974	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020004	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095249_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095220	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.3	BI	HMP_production_phase_1
SRS047787.575646	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3293	SRR041697	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101331_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700101301	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS047494.574345	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3260	SRR048665	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047494	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110123_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110095	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	4.3	BCM	HMP_production_phase_1
SRS024179.572886	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2617	SRR040675	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024179	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100647_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100614	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS054821.575429	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3880	SRR048478	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054821	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107413_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107383	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	4.7	BCM	HMP_production_phase_1
SRS013678.574042	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_278	SRR040584	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013678	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016756_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016712	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS023815.570223	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2525	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023815	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100209_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100177	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS058246.571515	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4175	SRR049602	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058246	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103462_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700103438	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	33	0	WUGSC	HMP_production_phase_1
SRS062978.574710	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4321	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062978	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111540_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111513	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	JCVI	HMP_production_phase_1
SRS018531.576383	TCAGTTCCGAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1383	SRR040744	21.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018531	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241667	241667	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035995_from_subject_160259276__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700035952	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	21	4.1	BI	HMP_production_phase_1
SRS050939.570716	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3565	SRR048626	26.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050939	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108157_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108115	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	26	3.9	BCM	HMP_production_phase_1
SRS024649.576282	TCAGAACCTTATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2736	SRR041318	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024649	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101940_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101909	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	0	BI	HMP_production_phase_1
SRS023605.576354	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2468	SRR041858	20.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023605	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241702	241702	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099908_from_subject_159005010__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700099886	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	20	4.9	BI	HMP_production_phase_1
SRS065586.576522	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4709	SRR048810	38.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065586	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268878	268878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111274_from_subject_866653606__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	5	BCM	HMP_production_phase_1
SRS024297.575876	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2647	SRR041945	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024297	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101275_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101240	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	3.7	BI	HMP_production_phase_1
SRS063935.570310	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4469	SRR049588	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063935	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114258_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114224	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	4.5	WUGSC	HMP_production_phase_1
SRS024062.572493	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2587	SRR040967	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024062	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100524_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100488	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	4.7	BI	HMP_production_phase_1
SRS011651.573281	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_177	SRR044920	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011651	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033501_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033499	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.1	WUGSC	HMP_production_phase_1
SRS052265.571668	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3689	SRR048438	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052265	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109969_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109934	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	34	4.6	BCM	HMP_production_phase_1
SRS011436.574539	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_62	SRR045436	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011436	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016083_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016048	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS021083.570607	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1835	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021083	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096630_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096577	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	4.8	JCVI	HMP_production_phase_1
SRS023625.574844	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2474	SRR041013	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099928_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099896	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	20	4.9	BI	HMP_production_phase_1
SRS020196.570959	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1624	SRR048147	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020196	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095449_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095420	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	32	0	BCM	HMP_production_phase_1
SRS020149.573042	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1614	SRR048142	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020149	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241827	241827	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095402_from_subject_158398106__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095368	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	31	0	BCM	HMP_production_phase_1
SRS024408.576009	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2674	SRR041038	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024408	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101554_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101525	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	5.1	BI	HMP_production_phase_1
SRS011499.570345	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_98	SRR044891	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011499	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016339_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016311	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	34	0	WUGSC	HMP_production_phase_1
SRS018445.571354	TCAGAACCGACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1357	SRR041005	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035879_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035851	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS014247.575716	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_325	SRR046188	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014247	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241791	241791	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021836_from_subject_763678604__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700021812	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS058293.570256	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4179	SRR048725	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058293	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107573_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107550	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	0	BCM	HMP_production_phase_1
SRS018169.574877	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1291	SRR042862	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035569_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS015494.570610	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_615	SRR044492	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015494	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241707	241707	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024149_from_subject_764245047__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024129	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.1	WUGSC	HMP_production_phase_1
SRS013738.576321	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_295	SRR042815	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013738	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016816_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016815	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS023256.571605	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2385	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023256	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099414_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099388	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	JCVI	HMP_production_phase_1
SRS019255.572662	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1495	SRR044446	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037726_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037694	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.2	WUGSC	HMP_production_phase_1
SRS019099.573210	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1475	SRR044678	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019099	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037570_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037544	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS024420.570969	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2680	SRR041452	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024420	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101566_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101531	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	5.1	BI	HMP_production_phase_1
SRS019570.574466	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1526	SRR045501	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019570	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038041_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038015	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	37	0	WUGSC	HMP_production_phase_1
SRS011171.570877	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_8	SRR045382	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014988_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700014986	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	0	WUGSC	HMP_production_phase_1
SRS015907.571495	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_726	SRR044618	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015907	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024562_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024543	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS063210.575002	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4352	SRR047106	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063210	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241756	241756	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113160_from_subject_764467579__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700113122	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	24	0	WUGSC	HMP_production_phase_1
SRS042857.575405	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2825	SRR046688	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042857	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241883	241883	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103535_from_subject_132902142__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103497	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	31	5.6	WUGSC	HMP_production_phase_1
SRS019401.573789	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1510	SRR045981	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019401	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241805	241805	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037872_from_subject_765560005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037854	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS013460.574437	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_232	SRR041897	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016391_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016379	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	BI	HMP_production_phase_1
SRS021637.572583	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1980	SRR048364	22.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021637	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241668	241668	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097349_from_subject_158013734__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700097309	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.9	BCM	HMP_production_phase_1
SRS018605.571130	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1405	SRR047653	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018605	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037072_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	19	0	WUGSC	HMP_production_phase_1
SRS023377.570808	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2415	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023377	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099543_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099518	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	0	JCVI	HMP_production_phase_1
SRS044264.570640	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2949	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044264	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109839_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109813	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	JCVI	HMP_production_phase_1
SRS017541.576030	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1143	SRR042904	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017541	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034274_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034242	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS022932.576228	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2301	SRR048100	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022932	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098962_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098936	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	37	4.6	BCM	HMP_production_phase_1
SRS066188.571540	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058092	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS017394.574155	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1104	SRR043268	30.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017394	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241703	241703	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034100_from_subject_160481808__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700034081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	BI	HMP_production_phase_1
SRS015980.575310	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_751	SRR047419	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015980	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024635_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024603	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	0	WUGSC	HMP_production_phase_1
SRS015452.571773	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_606	SRR044677	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015452	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024107_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700024086	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS015864.572922	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_715	SRR046569	39.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015864	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241830	241830	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024519_from_subject_764002286__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024497	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	39	0	WUGSC	HMP_production_phase_1
SRS064317.573450	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4526	SRR048818	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064317	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111787_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111755	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.6	BCM	HMP_production_phase_1
SRS045871.575997	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3107	SRR047694	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103627_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103608	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	19	0	WUGSC	HMP_production_phase_1
SRS022960.575891	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2312	SRR048104	37.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022960	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241781	241781	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098990_from_subject_158236265__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098950	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	37	4.6	BCM	HMP_production_phase_1
SRS057633.572878	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4125	SRR058096	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057633	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109778_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109754	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	JCVI	HMP_production_phase_1
SRS020596.574323	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1724	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020596	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095987_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095962	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	JCVI	HMP_production_phase_1
SRS011438.573939	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_63	SRR047525	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011438	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016085_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016049	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS020362.571505	TCAGAATTCCTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1665	SRR041601	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020362	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095681_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095653	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	32	4.2	BI	HMP_production_phase_1
SRS019679.571485	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1544	SRR043952	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019679	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038152_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038123	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS020010.572986	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1591	SRR041674	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020010	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095255_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095223	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.3	BI	HMP_production_phase_1
SRS046568.572304	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3181	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046568	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110201_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110167	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	38	4.5	JCVI	HMP_production_phase_1
SRS022870.570343	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2287	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022870	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098900_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098872	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	4.6	JCVI	HMP_production_phase_1
SRS023003.571326	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2320	SRR048298	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023003	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099037_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099010	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	0	BCM	HMP_production_phase_1
SRS017154.570736	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1055	SRR041068	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017154	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033716_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033715	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS016862.576610	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_984	SRR041873	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016862	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033223_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS020952.573519	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1810	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020952	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096463_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096431	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS018991.572713	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1457	SRR044602	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018991	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037460_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037441	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS021853.573601	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2031	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241744	241744	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097589_from_subject_161270782__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700097570	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	JCVI	HMP_production_phase_1
SRS015882.576508	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_722	SRR043752	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015882	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024537_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024506	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS023196.571857	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2371	SRR041786	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023196	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099327_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099298	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	33	0	BI	HMP_production_phase_1
SRS019681.575822	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1545	SRR046511	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019681	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038154_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038124	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS014813.570554	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_442	SRR045718	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014813	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023467_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023442	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.1	WUGSC	HMP_production_phase_1
SRS064024.574500	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4487	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064024	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111538_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111512	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	JCVI	HMP_production_phase_1
SRS047280.576378	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3241	SRR058096	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047280	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108084_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108051	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS015129.572408	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_515	SRR045698	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015129	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023784_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023699	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	4.5	WUGSC	HMP_production_phase_1
SRS017529.570391	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1138	SRR041702	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017529	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034262_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034236	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS015178.574807	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_528	SRR043755	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015178	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023833_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023809	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4	WUGSC	HMP_production_phase_1
SRS045211.576220	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3046	SRR048441	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045211	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109955_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109927	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	34	4.6	BCM	HMP_production_phase_1
SRS017912.571616	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1230	SRR043280	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017912	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241799	241799	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035210_from_subject_160441347__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS054649.575053	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3869	SRR043740	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054649	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038516_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038491	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	31	0	WUGSC	HMP_production_phase_1
SRS014540.571740	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_379	SRR046145	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014540	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241730	241730	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023194_from_subject_763638144__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	3.8	WUGSC	HMP_production_phase_1
SRS017833.570261	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1204	SRR041342	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017833	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034938_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034913	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	BI	HMP_production_phase_1
SRS020194.570549	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_1623	SRR048146	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020194	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095447_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095419	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	32	0	BCM	HMP_production_phase_1
SRS023987.570988	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2564	SRR040912	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023987	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100448_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100421	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	0	BI	HMP_production_phase_1
SRS020014.576387	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1593	SRR042796	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020014	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095259_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095225	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.3	BI	HMP_production_phase_1
SRS013672.573786	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_275	SRR043050	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013672	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016750_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700016709	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS018509.572259	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1372	SRR040763	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018509	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035973_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035941	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	4.1	BI	HMP_production_phase_1
SRS023204.574574	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2375	SRR041862	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023204	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099335_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099302	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS046586.570281	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3182	SRR049373	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046586	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105705_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105676	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	31	5	WUGSC	HMP_production_phase_1
SRS020954.573313	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1811	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020954	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241752	241752	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096465_from_subject_161068481__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096432	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS056331.574264	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4008	SRR048717	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056331	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107516_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107493	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BCM	HMP_production_phase_1
SRS065017.573291	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4617	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065017	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110618_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110593	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	JCVI	HMP_production_phase_1
SRS049057.572454	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3393	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049057	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109413_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109387	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	4.8	JCVI	HMP_production_phase_1
SRS016432.572162	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_881	SRR042883	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016432	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032119_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032084	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS044830.574476	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3011	SRR048688	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044830	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109549_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109518	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	21	0	BCM	HMP_production_phase_1
SRS014917.570598	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_472	SRR045724	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014917	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023572_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023548	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	33	0	WUGSC	HMP_production_phase_1
SRS011569.571511	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_134	SRR045356	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011569	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033017_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033015	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.7	WUGSC	HMP_production_phase_1
SRS017855.571390	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1215	SRR042815	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017855	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034960_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700034924	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS017044.571291	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1027	SRR041591	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017044	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241746	241746	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033557_from_subject_159490532__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033556	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS050959.573806	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3567	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050959	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110285_from_subject_161473083__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110242	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	40	4.9	JCVI	HMP_production_phase_1
SRS058714.574205	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4216	SRR048573	19.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058714	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109685_from_subject_160319967__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109642	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	19	4.7	BCM	HMP_production_phase_1
SRS014617.574173	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_404	SRR049868	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241693	241693	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023271_from_subject_763840445__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	4.1	WUGSC	HMP_production_phase_1
SRS015247.573888	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_552	SRR044113	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015247	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241729	241729	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023902_from_subject_764143897__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023872	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.4	WUGSC	HMP_production_phase_1
SRS011180.573931	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_13	SRR045481	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011180	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241686	241686	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015003_from_subject_158822939__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015001	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	38	0	WUGSC	HMP_production_phase_1
SRS064483.574592	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4551	SRR046815	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064483	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113624_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113603	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS051190.576570	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3588	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051190	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257113	257113	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102708_from_subject_840279516__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102674	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS052612.576101	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3715	SRR049598	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052612	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257127	257127	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105640_from_subject_953045535__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700105617	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	3.8	WUGSC	HMP_production_phase_1
SRS065666.573201	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4726	SRR049587	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065666	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241875	241875	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114189_from_subject_289996019__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700114167	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS050604.575142	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3540	SRR058108	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050604	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110205_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700110169	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	38	4.5	JCVI	HMP_production_phase_1
SRS015143.574670	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_521	SRR046089	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015143	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023798_from_subject_763901136__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700023706	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	4.5	WUGSC	HMP_production_phase_1
SRS014601.575510	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_399	SRR045693	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014601	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023255_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	4.1	WUGSC	HMP_production_phase_1
SRS049389.575772	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3427	SRR045932	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049389	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038420_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038395	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	39	0	WUGSC	HMP_production_phase_1
SRS017424.575739	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1115	SRR040592	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017424	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241703	241703	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034130_from_subject_160481808__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034096	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	BI	HMP_production_phase_1
SRS062699.571647	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4278	SRR048430	35.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062699	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241804	241804	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110796_from_subject_158984779__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110768	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	4.6	BCM	HMP_production_phase_1
SRS056913.572544	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4065	SRR058108	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056913	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110339_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110302	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	4.3	JCVI	HMP_production_phase_1
SRS048971.576023	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3386	SRR047153	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048971	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241883	241883	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103501_from_subject_132902142__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103480	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	31	5.6	WUGSC	HMP_production_phase_1
SRS013825.572231	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_312	SRR041822	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013825	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016985_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016984	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	0	BI	HMP_production_phase_1
SRS011375.575492	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_41	SRR047533	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011375	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015665_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700015663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS020380.570596	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1674	SRR041634	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020380	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095699_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095662	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	4.2	BI	HMP_production_phase_1
SRS014355.575949	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_355	SRR046519	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023009_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS014950.570917	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_480	SRR045804	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023605_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023589	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	32	0	WUGSC	HMP_production_phase_1
SRS011577.572940	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_139	SRR045369	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011577	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033032_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033030	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.7	WUGSC	HMP_production_phase_1
SRS018169.572594	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1291	SRR043021	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035569_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS022239.573577	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2128	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022239	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098008_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097979	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	4.2	JCVI	HMP_production_phase_1
SRS022366.572467	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2161	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022366	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098232_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098207	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	35	0	JCVI	HMP_production_phase_1
SRS054461.575014	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3851	SRR046766	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054461	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241871	241871	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106259_from_subject_675950834__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.6	WUGSC	HMP_production_phase_1
SRS015285.571649	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_563	SRR043962	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023940_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023921	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS022820.570658	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2280	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022820	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098776_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	JCVI	HMP_production_phase_1
SRS045277.571832	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3054	SRR047700	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045277	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241887	241887	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106888_from_subject_764811490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106863	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	21	5.3	WUGSC	HMP_production_phase_1
SRS047717.570805	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3285	SRR046370	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047717	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106673_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106652	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	WUGSC	HMP_production_phase_1
SRS014625.572224	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_408	SRR045705	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023279_from_subject_763840445__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	38	4.1	WUGSC	HMP_production_phase_1
SRS051324.573054	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3605	SRR048440	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051324	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109965_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109932	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	34	4.6	BCM	HMP_production_phase_1
SRS016307.574787	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_842	SRR047440	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016307	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241813	241813	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024970_from_subject_765074482__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024952	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	0	WUGSC	HMP_production_phase_1
SRS053617.573696	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3797	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101323_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101297	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS013504.571250	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_243	SRR041084	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013504	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016484_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016463	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS043922.576325	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2923	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043922	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109294_from_subject_638754422__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700109251	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	4.8	JCVI	HMP_production_phase_1
SRS021279.576189	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1891	SRR058095	34.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021279	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241669	241669	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096925_from_subject_161230322__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096884	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	34	5.3	JCVI	HMP_production_phase_1
SRS050034.574216	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3482	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050034	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108822_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108792	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	0	JCVI	HMP_production_phase_1
SRS015556.570291	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_630	SRR049851	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015556	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024211_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024190	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	18	0	WUGSC	HMP_production_phase_1
SRS065415.576078	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4676	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065415	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111853_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111821	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	36	0	JCVI	HMP_production_phase_1
SRS021330.574115	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1903	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021330	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096988_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096956	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS011380.571623	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_44	SRR045431	33.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011380	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241767	241767	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015677_from_subject_158924089__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700015675	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	WUGSC	HMP_production_phase_1
SRS066144.573971	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048295	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS055465.572455	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3930	SRR048685	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055465	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109545_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109516	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	21	0	BCM	HMP_production_phase_1
SRS044827.575929	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3010	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044827	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109443_from_subject_370425937__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109402	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	22	4.8	JCVI	HMP_production_phase_1
SRS020016.574337	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1594	SRR041880	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020016	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095261_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095226	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.3	BI	HMP_production_phase_1
SRS016946.576067	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1007	SRR042822	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016946	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033412_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033378	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS023760.572972	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2511	SRR040971	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023760	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100067_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100035	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS050233.575630	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3500	SRR046480	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050233	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241885	241885	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106190_from_subject_823052294__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS016455.570417	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_885	SRR040851	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032151_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032150	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS018525.572684	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1380	SRR042891	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241667	241667	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035989_from_subject_160259276__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	4.1	BI	HMP_production_phase_1
SRS024062.570335	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2587	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024062	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100524_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100488	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	4.7	BI	HMP_production_phase_1
SRS024511.576341	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2701	SRR048158	25.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024511	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241819	241819	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101657_from_subject_159389382__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700101638	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BCM	HMP_production_phase_1
SRS020145.574672	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1612	SRR048377	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020145	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095398_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095366	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	31	0	BCM	HMP_production_phase_1
SRS063501.576213	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4396	SRR047085	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063501	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114195_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114170	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	0	WUGSC	HMP_production_phase_1
SRS063636.574740	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4417	SRR047089	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063636	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113083_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113061	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	WUGSC	HMP_production_phase_1
SRS065457.574236	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4683	SRR046818	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065457	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241682	241682	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114456_from_subject_764042746__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114430	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	3.9	WUGSC	HMP_production_phase_1
SRS024408.575588	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2674	SRR041988	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024408	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101554_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101525	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	5.1	BI	HMP_production_phase_1
SRS021447.573409	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1931	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097155_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097126	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	32	0	JCVI	HMP_production_phase_1
SRS017669.575476	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1164	SRR040613	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241775	241775	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034684_from_subject_160461578__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034636	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	0	BI	HMP_production_phase_1
SRS014333.574531	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_346	SRR046176	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014333	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241844	241844	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021922_from_subject_763820215__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021896	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	3.9	WUGSC	HMP_production_phase_1
SRS044693.570458	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2994	SRR048436	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044693	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109957_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109928	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	34	4.6	BCM	HMP_production_phase_1
SRS064711.576134	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4578	SRR049519	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064711	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114319_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114283	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	4.5	WUGSC	HMP_production_phase_1
SRS020839.575889	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1783	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020839	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241677	241677	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096313_from_subject_160886410__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096281	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	JCVI	HMP_production_phase_1
SRS057122.574290	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4079	SRR048247	23.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057122	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241837	241837	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102261_from_subject_159166850__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102242	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	0	BCM	HMP_production_phase_1
SRS052326.574479	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3693	SRR046272	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052326	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241844	241844	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105238_from_subject_763820215__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105210	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	4	WUGSC	HMP_production_phase_1
SRS021496.570714	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1942	SRR041582	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021496	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097208_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097183	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS024388.575323	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2668	SRR041961	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241764	241764	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101534_from_subject_159713063__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	y	TCAG	UBERON:feces	700101515	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	5.1	BI	HMP_production_phase_1
SRS042716.575424	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2816	SRR043909	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042716	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038568_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038541	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS055161.571094	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3909	SRR043634	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055161	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038722_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038693	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	3.7	WUGSC	HMP_production_phase_1
SRS019449.571501	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1512	SRR045901	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019449	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241728	241728	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037920_from_subject_765519544__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037902	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	WUGSC	HMP_production_phase_1
SRS042360.574226	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2783	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042360	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257123	257123	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102169_from_subject_414519462__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	36	3.9	JCVI	HMP_production_phase_1
SRS011506.574471	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_102	SRR045127	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011506	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016360_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016346	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	4.2	WUGSC	HMP_production_phase_1
SRS049911.575200	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_3466	SRR040867	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049911	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241792	241792	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107011_from_subject_159450072__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107007	n	969	246	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS022757.576315	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2262	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022757	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098713_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098680	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	4.1	JCVI	HMP_production_phase_1
SRS050055.571322	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3483	SRR049601	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050055	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106362_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106339	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	WUGSC	HMP_production_phase_1
SRS050206.575378	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3495	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050206	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110255_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110227	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	40	4.9	JCVI	HMP_production_phase_1
SRS022309.575766	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2146	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022309	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098149_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098118	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	4.5	JCVI	HMP_production_phase_1
SRS020559.575770	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1719	SRR043029	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095882_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095847	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS054371.572615	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3841	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054371	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108989_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108960	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	4.3	JCVI	HMP_production_phase_1
SRS017191.571061	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1058	SRR041435	29.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017191	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241838	241838	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033797_from_subject_159814214__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033796	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	BI	HMP_production_phase_1
SRS017725.576192	TCAGAAGGAACCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1177	SRR041355	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017725	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034818_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034784	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	30	4.1	BI	HMP_production_phase_1
SRS022940.573411	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2304	SRR048096	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022940	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098970_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098940	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	37	4.6	BCM	HMP_production_phase_1
SRS044788.573044	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3005	SRR047213	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044788	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106103_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106070	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	18	4.5	WUGSC	HMP_production_phase_1
SRS016434.575722	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_882	SRR042800	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241749	241749	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032123_from_subject_159672603__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032086	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS050295.574410	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3510	SRR048452	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050295	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102887_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102858	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	33	0	BCM	HMP_production_phase_1
SRS022193.572515	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2120	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022193	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097962_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.5	JCVI	HMP_production_phase_1
SRS015718.570672	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_678	SRR044292	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015718	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024373_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024346	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	3.6	WUGSC	HMP_production_phase_1
SRS047619.571817	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3271	SRR048244	28.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047619	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241760	241760	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102960_from_subject_159146620__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102923	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BCM	HMP_production_phase_1
SRS064672.570868	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4574	SRR058084	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064672	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110746_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110714	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	JCVI	HMP_production_phase_1
SRS021455.572434	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1935	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097163_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700097130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	32	0	JCVI	HMP_production_phase_1
SRS017294.574790	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1083	SRR041220	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017294	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033969_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS024410.573453	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2675	SRR040764	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024410	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101556_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700101526	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	5.1	BI	HMP_production_phase_1
SRS011177.570963	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_11	SRR044936	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241686	241686	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014997_from_subject_158822939__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700014995	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	38	0	WUGSC	HMP_production_phase_1
SRS017100.574427	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1041	SRR042981	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017100	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241705	241705	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033613_from_subject_159611913__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033577	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS055871.570349	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3969	SRR047161	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241891	241891	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105326_from_subject_516889361__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105308	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS011553.575856	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_126	SRR047494	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011553	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016658_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016656	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS011179.572423	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_12	SRR045376	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011179	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241686	241686	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015000_from_subject_158822939__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700014998	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	0	WUGSC	HMP_production_phase_1
SRS018985.573154	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1454	SRR044589	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018985	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037454_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037438	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS051198.571210	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3589	SRR046769	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051198	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105814_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105783	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.6	WUGSC	HMP_production_phase_1
SRS016095.576115	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_780	SRR044395	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016095	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241701	241701	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024752_from_subject_764588959__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024732	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	4.5	WUGSC	HMP_production_phase_1
SRS011446.574070	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_69	SRR045122	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011446	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016097_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016055	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	20	4.2	WUGSC	HMP_production_phase_1
SRS015872.575240	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_717	SRR047625	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015872	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024527_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024501	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	39	0	WUGSC	HMP_production_phase_1
SRS017304.575372	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1088	SRR041828	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033986_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016468	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS047456.572197	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3256	SRR046474	36.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241862	241862	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106136_from_subject_706846339__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106115	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	36	4.5	WUGSC	HMP_production_phase_1
SRS016625.573681	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_934	SRR041329	31.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032378_from_subject_159915365__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032336	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	31	4.3	BI	HMP_production_phase_1
SRS052973.570863	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3739	SRR046685	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052973	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105506_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105473	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	5	WUGSC	HMP_production_phase_1
SRS011504.573986	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_101	SRR045337	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011504	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016356_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016344	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	20	4.2	WUGSC	HMP_production_phase_1
SRS024598.576426	TCAGCCGTTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2726	SRR040790	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024598	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241833	241833	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101889_from_subject_159591683__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101855	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS014669.570909	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_420	SRR047564	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023323_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700023295	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS064750.571977	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4583	SRR048824	24.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064750	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:268869	268869	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111803_from_subject_872848689__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700111763	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	4.6	BCM	HMP_production_phase_1
SRS064994.572209	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4615	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064994	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111485_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111451	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.8	JCVI	HMP_production_phase_1
SRS023440.575824	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2432	SRR048160	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023440	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099627_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099599	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	0	BCM	HMP_production_phase_1
SRS052485.571433	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3708	SRR046623	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052485	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241823	241823	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038524_from_subject_763476303__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038495	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	31	0	WUGSC	HMP_production_phase_1
SRS052522.571349	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_3710	SRR040936	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052522	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102450_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102422	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS019769.576283	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1556	SRR044109	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019769	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038245_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038222	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS052762.571648	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3726	SRR041943	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052762	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101325_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101298	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS015253.571359	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_555	SRR046086	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015253	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241729	241729	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023908_from_subject_764143897__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023875	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	4.4	WUGSC	HMP_production_phase_1
SRS054441.571217	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3850	SRR046296	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054441	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105435_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105409	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	34	4.2	WUGSC	HMP_production_phase_1
SRS063549.571613	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4405	SRR048787	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063549	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111190_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111162	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.9	BCM	HMP_production_phase_1
SRS017829.572399	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1203	SRR041345	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017829	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034934_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034911	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	BI	HMP_production_phase_1
SRS052337.572337	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3695	SRR058108	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052337	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110211_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700110172	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	38	4.5	JCVI	HMP_production_phase_1
SRS011296.571111	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_30	SRR045351	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011296	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241748	241748	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015301_from_subject_158802708__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700015299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	WUGSC	HMP_production_phase_1
SRS044206.574568	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2945	SRR058084	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109492_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109461	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	31	0	JCVI	HMP_production_phase_1
SRS024490.573318	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2700	SRR041117	38.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024490	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241794	241794	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101636_from_subject_159571453__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700101599	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	38	0	BI	HMP_production_phase_1
SRS023948.576025	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2558	SRR042941	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100346_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100310	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS017157.573922	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1056	SRR043277	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241814	241814	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033719_from_subject_159551223__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033718	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS018749.571348	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1418	SRR044390	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018749	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037216_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037131	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	4.5	WUGSC	HMP_production_phase_1
SRS051364.572365	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3609	SRR046798	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051364	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105946_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700105927	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	0	WUGSC	HMP_production_phase_1
SRS019109.572352	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1480	SRR044671	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019109	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037580_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037549	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS050694.574786	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3547	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050694	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110387_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110359	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	4.4	JCVI	HMP_production_phase_1
SRS013249.572013	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_221	SRR042794	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013249	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015956_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700015955	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS024236.575079	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2631	SRR041955	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024236	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101123_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101090	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS056693.574595	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4043	SRR046587	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056693	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241878	241878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105175_from_subject_612472597__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105150	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	38	4.3	WUGSC	HMP_production_phase_1
SRS057750.571270	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4137	SRR046450	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057750	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241854	241854	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106920_from_subject_517810313__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106407	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS063831.570751	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4451	SRR046737	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063831	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113632_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700113607	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS022055.572460	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2081	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022055	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097795_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097765	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	31	0	JCVI	HMP_production_phase_1
SRS011521.575218	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_110	SRR045427	20.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016376_from_subject_159005010__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700016354	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	20	4.2	WUGSC	HMP_production_phase_1
SRS011292.571834	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_27	SRR045395	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011292	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015292_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015290	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS022609.572904	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2223	SRR041777	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022609	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241820	241820	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098561_from_subject_158499257__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098542	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS019101.575554	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1476	SRR044650	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019101	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037572_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037545	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS016428.573328	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_879	SRR041428	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016428	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032115_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032082	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS046382.571580	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3164	SRR046402	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046382	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241875	241875	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106350_from_subject_289996019__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700106333	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	WUGSC	HMP_production_phase_1
SRS064171.573151	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4507	SRR047342	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064171	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241730	241730	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114295_from_subject_763638144__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114271	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	4.5	WUGSC	HMP_production_phase_1
SRS055431.572937	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3927	SRR043798	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055431	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038556_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038535	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	32	0	WUGSC	HMP_production_phase_1
SRS043701.573160	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2903	SRR041426	29.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043701	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241838	241838	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107059_from_subject_159814214__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	TRUE	n	TCAG	UBERON:feces	700107040	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	BI	HMP_production_phase_1
SRS065544.576567	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4700	SRR046749	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065544	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113124_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113104	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	0	WUGSC	HMP_production_phase_1
SRS011460.573122	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_76	SRR044921	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016158_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016127	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	WUGSC	HMP_production_phase_1
SRS011380.575515	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_44	SRR045319	33.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011380	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241767	241767	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015677_from_subject_158924089__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700015675	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	WUGSC	HMP_production_phase_1
SRS044702.573183	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2996	SRR047221	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044702	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103641_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103615	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	19	0	WUGSC	HMP_production_phase_1
SRS013670.575001	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_274	SRR042983	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013670	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016748_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700016708	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS046216.570941	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3147	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241806	241806	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107836_from_subject_161311242__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107816	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS016557.571801	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_915	SRR040665	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032284_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4	BI	HMP_production_phase_1
SRS054405.574997	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3846	SRR045510	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054405	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038464_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038441	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS062681.576290	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4275	SRR047082	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062681	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114260_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114225	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	4.5	WUGSC	HMP_production_phase_1
SRS048843.574868	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3378	SRR043888	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048843	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038572_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038543	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS022129.572307	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2103	SRR042815	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022129	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241803	241803	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097895_from_subject_158337416__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700097855	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.4	BI	HMP_production_phase_1
SRS042783.576367	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2820	SRR047206	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042783	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241860	241860	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103251_from_subject_465578759__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105977	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	31	4.4	WUGSC	HMP_production_phase_1
SRS023859.573648	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2531	SRR048388	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023859	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100257_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100231	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	4.9	BCM	HMP_production_phase_1
SRS049599.576400	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3442	SRR043925	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038726_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038695	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS043392.572142	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_2870	SRR049464	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043392	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105948_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105928	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	0	WUGSC	HMP_production_phase_1
SRS058403.573638	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4190	SRR048479	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058403	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107411_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107382	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	4.7	BCM	HMP_production_phase_1
SRS056576.574949	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4035	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056576	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109141_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109113	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	4.1	JCVI	HMP_production_phase_1
SRS023930.573514	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2550	SRR041653	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023930	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100328_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100301	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS019846.571914	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1569	SRR045942	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019846	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241790	241790	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038322_from_subject_765661155__sex_female_	UBERON:feces	n	None	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.3	WUGSC	HMP_production_phase_1
SRS044248.573713	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2948	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044248	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109362_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109328	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	4.6	JCVI	HMP_production_phase_1
SRS020176.576090	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_1618	SRR048143	32.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020176	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241762	241762	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095429_from_subject_158418336__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700095410	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	32	0	BCM	HMP_production_phase_1
SRS011169.575230	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_7	SRR044843	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014985_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014983	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	0	WUGSC	HMP_production_phase_1
SRS057515.576276	TCAGAGTAGCGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4112	SRR052699	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057515	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102557_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102527	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	4.6	JCVI	HMP_production_phase_1
SRS021887.571363	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2043	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021887	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097623_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700097587	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	JCVI	HMP_production_phase_1
SRS042320.572727	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2779	SRR046321	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042320	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103704_from_subject_763759525__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103669	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	23	4.8	WUGSC	HMP_production_phase_1
SRS018519.574382	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1377	SRR040740	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018519	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035983_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035946	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	4.1	BI	HMP_production_phase_1
SRS024173.570825	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2614	SRR040636	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024173	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100641_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100611	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS017543.572052	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1144	SRR040677	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017543	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034276_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034243	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS050846.575926	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3560	SRR046183	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050846	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038934_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038910	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	WUGSC	HMP_production_phase_1
SRS016275.573255	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_835	SRR044008	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016275	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024938_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024912	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	WUGSC	HMP_production_phase_1
SRS021484.575748	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1940	SRR041529	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021484	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241722	241722	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097196_from_subject_158479027__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097177	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS049611.576236	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3444	SRR046291	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049611	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105252_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105217	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	4	WUGSC	HMP_production_phase_1
SRS013819.575758	TCAGCGGAACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_310	SRR041785	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013819	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016979_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016978	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	0	BI	HMP_production_phase_1
SRS023764.570857	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2513	SRR042848	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023764	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100071_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100037	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS048332.575952	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3337	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048332	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110393_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110362	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	4.4	JCVI	HMP_production_phase_1
SRS017997.575028	TCAGTTCGGACCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1245	SRR040698	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017997	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241734	241734	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035321_from_subject_160239046__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035297	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS063756.576143	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4433	SRR046757	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063756	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114472_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114438	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	3.9	WUGSC	HMP_production_phase_1
SRS024424.573140	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2682	SRR040668	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024424	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101570_from_subject_159713063__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700101533	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	5.1	BI	HMP_production_phase_1
SRS062616.573016	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4266	SRR049585	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062616	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113089_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113064	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS064079.576499	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4498	SRR046812	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064079	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113138_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113111	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	0	WUGSC	HMP_production_phase_1
SRS015704.572381	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_672	SRR044273	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015704	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024359_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024339	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	3.6	WUGSC	HMP_production_phase_1
SRS066144.574481	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058111	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS014450.575503	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_373	SRR043622	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023104_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023070	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS019095.570739	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1473	SRR044675	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019095	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037566_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037542	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS044272.576047	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2952	SRR049479	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044272	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105510_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105475	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	5	WUGSC	HMP_production_phase_1
SRS022759.572275	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2263	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022759	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098715_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098681	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	4.1	JCVI	HMP_production_phase_1
SRS020030.572850	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1601	SRR040578	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020030	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095275_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095233	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.3	BI	HMP_production_phase_1
SRS049157.576520	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3404	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049157	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257123	257123	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102135_from_subject_414519462__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102113	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	36	3.9	JCVI	HMP_production_phase_1
SRS056351.572703	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4009	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107858_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107827	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	JCVI	HMP_production_phase_1
SRS049278.573127	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3416	SRR048245	28.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049278	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102952_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102919	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BCM	HMP_production_phase_1
SRS015035.575318	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_507	SRR044098	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015035	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023690_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023652	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	20	4.8	WUGSC	HMP_production_phase_1
SRS017151.572584	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1054	SRR041925	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017151	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033713_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033712	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS022574.573622	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2215	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022574	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098479_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098443	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	5	JCVI	HMP_production_phase_1
SRS022189.575341	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2118	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022189	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097958_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097921	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.5	JCVI	HMP_production_phase_1
SRS048807.576028	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3373	SRR048493	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048807	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108634_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108604	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	31	0	BCM	HMP_production_phase_1
SRS056473.572396	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4022	SRR047189	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056473	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103702_from_subject_763759525__sex_female_	UBERON:nostril	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700103668	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	23	4.8	WUGSC	HMP_production_phase_1
SRS045129.575463	TCAGTCGGACCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3032	SRR042796	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045129	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107093_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107057	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS019081.575978	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1468	SRR044684	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019081	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037552_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037535	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS050141.570382	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3490	SRR048760	32.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050141	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241726	241726	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108240_from_subject_160704339__sex_female_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700108218	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	32	4.6	BCM	HMP_production_phase_1
SRS011273.572136	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_17	SRR044970	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011273	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015260_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015257	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	WUGSC	HMP_production_phase_1
SRS014958.575046	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_484	SRR045852	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023613_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023593	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	32	0	WUGSC	HMP_production_phase_1
SRS052323.574994	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3692	SRR048530	25.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052323	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241671	241671	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107985_from_subject_160056975__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107948	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BCM	HMP_production_phase_1
SRS024408.573705	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2674	SRR042832	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024408	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101554_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101525	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	5.1	BI	HMP_production_phase_1
SRS011167.571043	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_6	SRR044975	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014982_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014980	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	0	WUGSC	HMP_production_phase_1
SRS013683.575462	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_281	SRR040732	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013683	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241676	241676	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016761_from_subject_159207311__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016715	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS043369.574105	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2868	SRR047138	20.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043369	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241813	241813	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105590_from_subject_765074482__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105569	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	20	0	WUGSC	HMP_production_phase_1
SRS017675.571900	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1167	SRR041393	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241775	241775	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034690_from_subject_160461578__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034639	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	19	0	BI	HMP_production_phase_1
SRS055828.571595	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3965	SRR046405	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055828	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103599_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103570	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	WUGSC	HMP_production_phase_1
SRS056107.576010	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3990	SRR058112	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056107	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241688	241688	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109798_from_subject_161331472__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109764	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	0	JCVI	HMP_production_phase_1
SRS020447.572125	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1694	SRR041830	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095770_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS020667.576084	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1744	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096092_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096060	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS065223.574448	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4651	SRR046762	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065223	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113628_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113605	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS066144.572550	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058113	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	TRUE	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS046608.572706	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3184	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109019_from_subject_161007791__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108975	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	24	4.3	JCVI	HMP_production_phase_1
SRS018035.570912	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1259	SRR043241	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018035	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035359_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.3	BI	HMP_production_phase_1
SRS017133.576266	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1048	SRR041807	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017133	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033695_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033694	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS064299.573722	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4524	SRR046564	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064299	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113644_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700113613	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Right_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS050320.571944	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3512	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050320	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102346_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102313	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	29	0	JCVI	HMP_production_phase_1
SRS014821.572725	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_446	SRR045707	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014821	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023475_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023446	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.1	WUGSC	HMP_production_phase_1
SRS056515.576372	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4030	SRR049384	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056515	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241856	241856	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105108_from_subject_256789458__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105088	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	5.6	WUGSC	HMP_production_phase_1
SRS047967.575857	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3309	SRR048693	31.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047967	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241679	241679	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109192_from_subject_160765029__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109173	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	31	0	BCM	HMP_production_phase_1
SRS023089.574732	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2347	SRR048126	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023089	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241789	241789	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099123_from_subject_158276726__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099080	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	24	4.1	BCM	HMP_production_phase_1
SRS044415.571480	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2964	SRR046420	31.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044415	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241860	241860	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103328_from_subject_465578759__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105991	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	31	4.4	WUGSC	HMP_production_phase_1
SRS050838.573215	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3558	SRR047568	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050838	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038888_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038863	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS015872.571084	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_717	SRR046653	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015872	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024527_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024501	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	39	0	WUGSC	HMP_production_phase_1
SRS055354.573697	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3925	SRR049596	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055354	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257131	257131	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103577_from_subject_863126187__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103559	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS023813.571312	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2524	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023813	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100207_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700100176	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	JCVI	HMP_production_phase_1
SRS047625.576245	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3272	SRR046803	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105500_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105470	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	5	WUGSC	HMP_production_phase_1
SRS050426.575836	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3527	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050426	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109902_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109873	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	0	JCVI	HMP_production_phase_1
SRS055927.575484	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3976	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055927	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102696_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102668	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	JCVI	HMP_production_phase_1
SRS043077.574694	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2840	SRR048406	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043077	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102621_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102592	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	4.5	BCM	HMP_production_phase_1
SRS018394.575064	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1348	SRR041486	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018394	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035828_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035797	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	0	BI	HMP_production_phase_1
SRS045158.576041	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3037	SRR058084	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045158	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109348_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109321	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	4.6	JCVI	HMP_production_phase_1
SRS021924.573584	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2048	SRR048074	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021924	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097664_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097638	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	0	BCM	HMP_production_phase_1
SRS016598.575458	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_921	SRR041230	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016598	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032351_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032323	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	31	4.3	BI	HMP_production_phase_1
SRS017145.572312	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1052	SRR041185	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017145	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033707_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033706	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS011521.575020	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_110	SRR045073	20.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016376_from_subject_159005010__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700016354	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	20	4.2	WUGSC	HMP_production_phase_1
SRS047341.573701	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3245	SRR048874	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047341	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109963_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109931	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	34	4.6	BCM	HMP_production_phase_1
SRS050481.576357	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3533	SRR043015	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050481	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107003_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102975	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS021105.575249	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1843	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021105	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241694	241694	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096652_from_subject_160866180__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096588	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	25	4.8	JCVI	HMP_production_phase_1
SRS046514.574674	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3175	SRR047207	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046514	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241887	241887	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106896_from_subject_764811490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106867	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	21	5.3	WUGSC	HMP_production_phase_1
SRS065189.571926	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4645	SRR046750	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065189	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241784	241784	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113574_from_subject_764346198__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700113548	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	23	4.1	WUGSC	HMP_production_phase_1
SRS065037.572802	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4619	SRR049518	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065037	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114635_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114606	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	4.3	WUGSC	HMP_production_phase_1
SRS020024.572212	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1598	SRR042796	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020024	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095269_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700095230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.3	BI	HMP_production_phase_1
SRS018349.570547	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1339	SRR042959	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241695	241695	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035783_from_subject_160380657__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS015827.572678	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_706	SRR044706	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015827	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024482_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024455	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	21	0	WUGSC	HMP_production_phase_1
SRS017487.572260	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1131	SRR041240	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017487	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034220_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034182	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	19	5.1	BI	HMP_production_phase_1
SRS054440.573155	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3849	SRR046647	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054440	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105910_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105885	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	WUGSC	HMP_production_phase_1
SRS042698.570287	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2814	SRR045847	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042698	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038876_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	WUGSC	HMP_production_phase_1
SRS016535.573343	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_904	SRR042995	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016535	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032262_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4	BI	HMP_production_phase_1
SRS020843.572043	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1784	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020843	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241677	241677	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096317_from_subject_160886410__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096282	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	JCVI	HMP_production_phase_1
SRS065022.576554	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4618	SRR050219	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065022	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241756	241756	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113148_from_subject_764467579__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700113116	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	0	WUGSC	HMP_production_phase_1
SRS011474.572016	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_83	SRR047495	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016172_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	WUGSC	HMP_production_phase_1
SRS011557.574742	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_128	SRR045330	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241837	241837	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016664_from_subject_159166850__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016662	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	WUGSC	HMP_production_phase_1
SRS020903.572614	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1799	SRR042813	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020903	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096414_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096378	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	0	BI	HMP_production_phase_1
SRS056732.572870	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4047	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056732	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101809_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101779	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	JCVI	HMP_production_phase_1
SRS015241.572316	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_549	SRR043988	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015241	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023896_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023869	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	4.4	WUGSC	HMP_production_phase_1
SRS018214.570641	TCAGTCCGGTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1300	SRR040727	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018214	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035621_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035587	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	0	BI	HMP_production_phase_1
SRS014617.573333	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_404	SRR043935	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241693	241693	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023271_from_subject_763840445__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	4.1	WUGSC	HMP_production_phase_1
SRS015496.574152	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_616	SRR046651	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015496	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241707	241707	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024151_from_subject_764245047__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.1	WUGSC	HMP_production_phase_1
SRS017533.575093	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1139	SRR040710	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017533	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034266_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034238	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS047341.572154	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3245	SRR048437	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047341	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109963_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109931	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	34	4.6	BCM	HMP_production_phase_1
SRS014255.574314	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_327	SRR047638	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014255	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021844_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700021817	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS062799.574300	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4297	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062799	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110868_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110829	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	4.7	JCVI	HMP_production_phase_1
SRS020261.575466	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1643	SRR040628	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020261	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095514_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095481	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS017011.570778	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1016	SRR041619	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017011	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033524_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033523	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS020312.574655	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1655	SRR041850	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020312	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095565_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700095535	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	BI	HMP_production_phase_1
SRS021984.573369	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2060	SRR041983	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021984	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097724_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700097695	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	4.1	BI	HMP_production_phase_1
SRS020302.570373	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1650	SRR041101	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020302	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095555_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	BI	HMP_production_phase_1
SRS023647.575623	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2485	SRR040611	20.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023647	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099950_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099907	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	20	4.9	BI	HMP_production_phase_1
SRS015145.574148	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_522	SRR045678	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015145	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023800_from_subject_763901136__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023707	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	28	4.5	WUGSC	HMP_production_phase_1
SRS057163.573335	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4081	SRR058092	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102352_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	JCVI	HMP_production_phase_1
SRS046477.571278	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3169	SRR041797	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046477	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101337_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101304	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS056207.575479	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3998	SRR047204	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056207	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241860	241860	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105998_from_subject_465578759__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105990	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	31	4.4	WUGSC	HMP_production_phase_1
SRS016072.571665	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_778	SRR044379	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016072	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024729_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024698	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS053700.573062	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3801	SRR048913	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053700	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110143_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700110105	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	4.3	BCM	HMP_production_phase_1
SRS011431.575587	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_58	SRR044916	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011431	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016075_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016044	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS011171.574832	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_8	SRR047528	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014988_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700014986	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	0	WUGSC	HMP_production_phase_1
SRS046131.576467	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3137	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046131	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110259_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110229	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	40	4.9	JCVI	HMP_production_phase_1
SRS022946.575568	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2307	SRR048102	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022946	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098976_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098943	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	37	4.6	BCM	HMP_production_phase_1
SRS017130.570903	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1047	SRR041774	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017130	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033692_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033691	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS024488.576326	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2699	SRR042796	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101634_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101598	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	38	0	BI	HMP_production_phase_1
SRS022454.575726	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2187	SRR048204	27.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022454	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241719	241719	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098329_from_subject_158742018__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098287	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	5.8	BCM	HMP_production_phase_1
SRS020563.573490	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1721	SRR041924	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020563	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241821	241821	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095886_from_subject_160845950__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700095849	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS011443.572756	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_67	SRR045114	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011443	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016092_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016053	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	20	4.2	WUGSC	HMP_production_phase_1
SRS017563.571952	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1153	SRR040648	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017563	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034296_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034253	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	4.1	BI	HMP_production_phase_1
SRS020259.573410	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1642	SRR042006	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020259	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095512_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095480	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	0	BI	HMP_production_phase_1
SRS062969.576506	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4320	SRR048709	35.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062969	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241804	241804	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110808_from_subject_158984779__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110774	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	35	4.6	BCM	HMP_production_phase_1
SRS064663.571967	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4573	SRR046293	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114025_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114004	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	36	0	WUGSC	HMP_production_phase_1
SRS062923.574702	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4314	SRR048776	39.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062923	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268866	268866	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111638_from_subject_937495960__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111595	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	39	4.8	BCM	HMP_production_phase_1
SRS051886.573889	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3652	SRR045851	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038602_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038582	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS017302.575597	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1087	SRR041296	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017302	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241724	241724	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033977_from_subject_159510762__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033940	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS020779.571577	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1768	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020779	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096204_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS021079.570725	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1833	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021079	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096626_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700096575	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	4.8	JCVI	HMP_production_phase_1
SRS047787.571985	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3293	SRR041184	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101331_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101301	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS020028.573882	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1600	SRR040683	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020028	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095273_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.3	BI	HMP_production_phase_1
SRS024712.571432	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2754	SRR058092	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024712	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102092_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102058	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	JCVI	HMP_production_phase_1
SRS024169.573862	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2612	SRR041155	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100637_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100609	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS020545.570885	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1712	SRR041152	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020545	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095868_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095840	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	BI	HMP_production_phase_1
SRS023436.574096	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2431	SRR048311	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023436	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099623_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099597	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	0	BCM	HMP_production_phase_1
SRS045788.571300	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3099	SRR049597	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045788	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241883	241883	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103505_from_subject_132902142__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103482	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	31	5.6	WUGSC	HMP_production_phase_1
SRS020490.574194	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1701	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020490	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095813_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095784	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	JCVI	HMP_production_phase_1
SRS018603.570389	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1404	SRR044400	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018603	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037070_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037040	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	19	0	WUGSC	HMP_production_phase_1
SRS021125.573147	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1849	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096672_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096598	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	20	4.9	JCVI	HMP_production_phase_1
SRS022444.576605	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2184	SRR048203	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241719	241719	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098319_from_subject_158742018__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098282	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	5.8	BCM	HMP_production_phase_1
SRS015854.576212	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_711	SRR043760	39.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015854	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241830	241830	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024509_from_subject_764002286__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024492	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	39	0	WUGSC	HMP_production_phase_1
SRS063426.572500	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4382	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063426	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111069_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111038	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS016517.572220	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_899	SRR041768	23.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016517	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241831	241831	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032244_from_subject_159753524__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700032222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4	BI	HMP_production_phase_1
SRS022898.576231	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2298	SRR058111	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022898	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098928_from_subject_650853796__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098886	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	22	4.6	JCVI	HMP_production_phase_1
SRS011567.572075	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_133	SRR045332	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011567	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033014_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033012	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.7	WUGSC	HMP_production_phase_1
SRS015196.574894	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_537	SRR049433	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015196	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023851_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023818	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4	WUGSC	HMP_production_phase_1
SRS017157.572012	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1056	SRR041685	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241814	241814	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033719_from_subject_159551223__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700033718	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS065481.575052	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4689	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065481	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241742	241742	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111556_from_subject_336497421__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700111521	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	JCVI	HMP_production_phase_1
SRS021320.574543	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1898	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021320	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096978_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096951	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	0	JCVI	HMP_production_phase_1
SRS017912.572574	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1230	SRR043269	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017912	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241799	241799	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035210_from_subject_160441347__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS021378.572530	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1911	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021378	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097036_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097007	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	4.6	JCVI	HMP_production_phase_1
SRS022259.570383	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2137	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022259	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241786	241786	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098028_from_subject_970836795__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097989	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	4.2	JCVI	HMP_production_phase_1
SRS051029.576491	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3575	SRR047133	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051029	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103623_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103606	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	19	0	WUGSC	HMP_production_phase_1
SRS065656.575242	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4724	SRR046320	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065656	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114133_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114109	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	38	4.7	WUGSC	HMP_production_phase_1
SRS057920.570932	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4154	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057920	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109486_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109458	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	31	0	JCVI	HMP_production_phase_1
SRS050155.575447	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3492	SRR045850	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050155	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038936_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038911	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS020763.573716	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1761	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020763	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096188_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096165	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	JCVI	HMP_production_phase_1
SRS047925.572999	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3305	SRR048258	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102295_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102259	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	0	BCM	HMP_production_phase_1
SRS018406.576514	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1351	SRR042898	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241797	241797	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035840_from_subject_160178356__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035803	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	BI	HMP_production_phase_1
SRS023877.576537	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2539	SRR048389	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023877	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100275_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100240	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	4.9	BCM	HMP_production_phase_1
SRS062479.574753	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4242	SRR048428	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062479	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110780_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110760	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	4.6	BCM	HMP_production_phase_1
SRS062955.572814	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4317	SRR048862	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062955	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112016_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111991	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Tongue_dorsum	26	0	BCM	HMP_production_phase_1
SRS017100.571005	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1041	SRR041860	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017100	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241705	241705	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033613_from_subject_159611913__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033577	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS020008.575051	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1590	SRR041954	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020008	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095253_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.3	BI	HMP_production_phase_1
SRS016946.573024	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1007	SRR042796	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016946	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033412_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033378	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS021005.574887	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1822	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021005	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096552_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096522	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	JCVI	HMP_production_phase_1
SRS056433.575280	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4019	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056433	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109908_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109876	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS044027.572464	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2932	SRR049469	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044027	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241861	241861	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106741_from_subject_184349034__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106710	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS063293.574398	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4366	SRR046562	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063293	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241877	241877	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113097_from_subject_764872181__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113068	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS056834.574669	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4059	SRR047217	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056834	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106099_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106068	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	18	4.5	WUGSC	HMP_production_phase_1
SRS016621.573864	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_932	SRR041297	31.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032374_from_subject_159915365__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032334	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	31	4.3	BI	HMP_production_phase_1
SRS024422.573063	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2681	SRR040609	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101568_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101532	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	5.1	BI	HMP_production_phase_1
SRS022643.574549	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2236	SRR041973	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022643	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098595_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098559	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS015113.572902	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_508	SRR049330	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015113	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023768_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023691	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	4.5	WUGSC	HMP_production_phase_1
SRS058474.573978	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4194	SRR046389	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103593_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103567	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	WUGSC	HMP_production_phase_1
SRS023711.570793	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2501	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023711	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100018_from_subject_892969023__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099976	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	28	4.1	JCVI	HMP_production_phase_1
SRS016608.575706	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_926	SRR041269	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032361_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032328	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	31	4.3	BI	HMP_production_phase_1
SRS055088.571360	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3899	SRR048673	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055088	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108264_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108230	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	32	4.6	BCM	HMP_production_phase_1
SRS063275.571197	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4362	SRR049559	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063275	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241890	241890	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114818_from_subject_375450439__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114798	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	4.1	WUGSC	HMP_production_phase_1
SRS043187.576512	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2846	SRR048623	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043187	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108145_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108109	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	3.9	BCM	HMP_production_phase_1
SRS045276.572119	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3053	SRR048614	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045276	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108135_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108104	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	0	BCM	HMP_production_phase_1
SRS021398.572980	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1920	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021398	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241774	241774	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097056_from_subject_161028021__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097017	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	4.6	JCVI	HMP_production_phase_1
SRS024690.576494	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2744	SRR058092	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024690	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102070_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102047	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	30	0	JCVI	HMP_production_phase_1
SRS018809.571007	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1438	SRR044487	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018809	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241731	241731	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037276_from_subject_765135172__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037248	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS063253.573222	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4360	SRR047338	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063253	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114643_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114610	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	4.3	WUGSC	HMP_production_phase_1
SRS016789.570787	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_980	SRR041406	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016789	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241715	241715	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032980_from_subject_160421117__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032943	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS016610.573712	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_927	SRR041205	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016610	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032363_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032329	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	31	4.3	BI	HMP_production_phase_1
SRS017649.573089	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1155	SRR041058	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017649	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034649_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034626	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	19	0	BI	HMP_production_phase_1
SRS014764.572437	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_431	SRR043770	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014764	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023418_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023389	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	4.2	WUGSC	HMP_production_phase_1
SRS063992.575839	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4482	SRR047002	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063992	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241890	241890	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114834_from_subject_375450439__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114806	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	24	4.1	WUGSC	HMP_production_phase_1
SRS011407.574565	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_46	SRR045311	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011407	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015993_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015991	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.7	WUGSC	HMP_production_phase_1
SRS015340.573260	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_579	SRR046082	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015340	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023995_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023971	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	3.7	WUGSC	HMP_production_phase_1
SRS014291.573401	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_338	SRR047640	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014291	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021880_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021679	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS011468.570781	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_80	SRR044898	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016166_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016131	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	WUGSC	HMP_production_phase_1
SRS022749.572581	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2258	SRR058111	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022749	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098705_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098676	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	4.1	JCVI	HMP_production_phase_1
SRS062726.572401	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4284	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062726	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110614_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110591	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	JCVI	HMP_production_phase_1
SRS018327.573045	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1328	SRR041594	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018327	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035761_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035735	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	BI	HMP_production_phase_1
SRS044813.572412	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3009	SRR047576	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044813	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038769_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	5.3	WUGSC	HMP_production_phase_1
SRS022995.571566	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2317	SRR048061	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022995	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099029_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099006	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	0	BCM	HMP_production_phase_1
SRS019576.573022	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1529	SRR043633	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019576	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038047_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700038018	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	37	0	WUGSC	HMP_production_phase_1
SRS015923.572582	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_733	SRR044603	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015923	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024578_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024551	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS062561.570734	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4256	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111546_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700111516	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	JCVI	HMP_production_phase_1
SRS046254.571213	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3149	SRR048885	34.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046254	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109977_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109938	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	34	4.6	BCM	HMP_production_phase_1
SRS064733.572993	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4581	SRR048820	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111793_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111758	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.6	BCM	HMP_production_phase_1
SRS016602.571131	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_923	SRR041253	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016602	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032355_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032325	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	31	4.3	BI	HMP_production_phase_1
SRS045519.572348	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3083	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045519	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109841_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109814	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	JCVI	HMP_production_phase_1
SRS018153.574067	TCAGAACCTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1283	SRR040924	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018153	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035553_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035524	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS057305.571932	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4094	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057305	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241698	241698	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110405_from_subject_650853796__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110368	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.4	JCVI	HMP_production_phase_1
SRS016585.574992	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_918	SRR043223	31.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016585	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241690	241690	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032338_from_subject_159915365__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700032316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	31	4.3	BI	HMP_production_phase_1
SRS066144.571727	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043074	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS044141.570684	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2940	SRR048444	34.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044141	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109973_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109936	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	34	4.6	BCM	HMP_production_phase_1
SRS016868.572622	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_986	SRR041727	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016868	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033229_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS050655.572376	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3546	SRR046848	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050655	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106530_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106498	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	32	4.3	WUGSC	HMP_production_phase_1
SRS050239.575981	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3501	SRR049502	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050239	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103315_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103283	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	19	4.7	WUGSC	HMP_production_phase_1
SRS045281.571747	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3056	SRR046598	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045281	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241890	241890	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105792_from_subject_375450439__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105772	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.6	WUGSC	HMP_production_phase_1
SRS020006.575579	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1589	SRR041776	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020006	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095251_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095221	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.3	BI	HMP_production_phase_1
SRS020447.570480	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1694	SRR042815	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095770_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS018803.574985	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1435	SRR047655	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018803	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037270_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037245	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS015289.573347	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_565	SRR043923	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015289	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023944_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS048843.573096	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3378	SRR043937	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048843	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038572_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038543	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS011435.573134	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_61	SRR045414	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016081_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016047	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS055904.571979	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3974	SRR048276	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055904	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102625_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102594	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	4.5	BCM	HMP_production_phase_1
SRS020549.576423	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1714	SRR041755	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020549	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095872_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700095842	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	BI	HMP_production_phase_1
SRS016787.576370	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_979	SRR043019	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032978_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032942	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS017151.575329	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1054	SRR041141	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017151	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033713_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033712	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS011300.575427	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_31	SRR047479	33.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011300	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241767	241767	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015407_from_subject_158924089__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700015390	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	33	0	WUGSC	HMP_production_phase_1
SRS052219.573292	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3684	SRR043929	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038728_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038696	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	3.7	WUGSC	HMP_production_phase_1
SRS066144.570232	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058112	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS021621.571846	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1974	SRR048049	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097333_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097301	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	4.9	BCM	HMP_production_phase_1
SRS052615.574656	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3716	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109278_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109243	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	4.8	JCVI	HMP_production_phase_1
SRS043596.575843	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2894	SRR040858	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043596	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102468_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102431	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS048334.572373	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3338	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048334	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108076_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108047	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	JCVI	HMP_production_phase_1
SRS056105.575879	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3989	SRR046197	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056105	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038932_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038909	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	WUGSC	HMP_production_phase_1
SRS020901.572546	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1798	SRR043255	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096412_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096377	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	31	0	BI	HMP_production_phase_1
SRS024402.574210	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2671	SRR043242	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024402	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101548_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101522	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	5.1	BI	HMP_production_phase_1
SRS019560.574311	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1522	SRR045520	37.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019560	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241720	241720	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038031_from_subject_763597684__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700038010	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	37	0	WUGSC	HMP_production_phase_1
SRS048671.571804	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3362	SRR045877	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038604_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038583	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS057489.574865	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4109	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057489	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110257_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110228	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	40	4.9	JCVI	HMP_production_phase_1
SRS022175.574256	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2111	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022175	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097944_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097914	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.5	JCVI	HMP_production_phase_1
SRS048972.570216	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3387	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048972	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110028_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109998	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	JCVI	HMP_production_phase_1
SRS017412.572580	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1109	SRR041726	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017412	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034118_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034090	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	30	0	BI	HMP_production_phase_1
SRS023875.575551	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2538	SRR048214	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023875	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100273_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100239	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	4.9	BCM	HMP_production_phase_1
SRS063679.574250	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4422	SRR046966	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063679	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114637_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114607	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	4.3	WUGSC	HMP_production_phase_1
SRS024539.573424	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2711	SRR048322	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024539	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241819	241819	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101685_from_subject_159389382__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101652	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS017082.574218	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1032	SRR041283	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017082	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033595_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033568	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	BI	HMP_production_phase_1
SRS017100.575960	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1041	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017100	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241705	241705	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033613_from_subject_159611913__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700033577	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS062461.574986	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4237	SRR046566	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062461	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241682	241682	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114444_from_subject_764042746__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114424	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	3.9	WUGSC	HMP_production_phase_1
SRS024283.570574	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2640	SRR041963	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024283	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101261_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101233	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	3.7	BI	HMP_production_phase_1
SRS022247.571988	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2132	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022247	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098016_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097983	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	4.2	JCVI	HMP_production_phase_1
SRS019097.575797	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1474	SRR044688	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019097	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037568_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037543	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS062748.570860	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4290	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062748	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110862_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110826	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	4.7	JCVI	HMP_production_phase_1
SRS042272.571341	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2773	SRR048484	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042272	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107421_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107387	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	4.7	BCM	HMP_production_phase_1
SRS054358.573004	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3839	SRR046476	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054358	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103470_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103442	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS011533.572121	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_116	SRR045316	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011533	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016628_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016626	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS011673.571586	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_188	SRR045118	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011673	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033777_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700033740	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.4	WUGSC	HMP_production_phase_1
SRS014950.571663	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_480	SRR046186	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023605_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023589	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	32	0	WUGSC	HMP_production_phase_1
SRS024291.574142	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2644	SRR041779	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024291	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101269_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101237	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	3.7	BI	HMP_production_phase_1
SRS014780.571450	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_436	SRR047398	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014780	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241824	241824	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023434_from_subject_763719065__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023397	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	25	4.2	WUGSC	HMP_production_phase_1
SRS019773.575764	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1558	SRR047439	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019773	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038249_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038224	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	0	WUGSC	HMP_production_phase_1
SRS051229.573342	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3596	SRR045899	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051229	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241853	241853	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038974_from_subject_370027359__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038954	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	0	WUGSC	HMP_production_phase_1
SRS048870.571516	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3381	SRR044103	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048870	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241811	241811	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106056_from_subject_764184357__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106018	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	3.8	WUGSC	HMP_production_phase_1
SRS022558.575557	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2207	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022558	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098463_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098435	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	5	JCVI	HMP_production_phase_1
SRS042803.572349	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2822	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042803	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241670	241670	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109405_from_subject_370425937__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109383	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	4.8	JCVI	HMP_production_phase_1
SRS021684.574504	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1990	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021684	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097396_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097367	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	JCVI	HMP_production_phase_1
SRS020831.576104	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1779	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020831	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096305_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096277	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	JCVI	HMP_production_phase_1
SRS018218.574627	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1302	SRR041165	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018218	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035625_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035589	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS017483.572616	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1129	SRR043044	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017483	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034216_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	5.1	BI	HMP_production_phase_1
SRS020905.570667	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1800	SRR042965	31.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020905	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241679	241679	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096416_from_subject_160765029__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096379	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	31	0	BI	HMP_production_phase_1
SRS020145.572071	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1612	SRR048134	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020145	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095398_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095366	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	31	0	BCM	HMP_production_phase_1
SRS044456.574716	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2969	SRR048643	30.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108594_from_subject_160582958__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108551	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	30	3.9	BCM	HMP_production_phase_1
SRS023192.573976	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2369	SRR041738	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023192	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099323_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099296	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	33	0	BI	HMP_production_phase_1
SRS023742.573897	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2504	SRR040902	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023742	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100049_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100026	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS023011.575448	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2324	SRR048063	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023011	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099045_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099014	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	BCM	HMP_production_phase_1
SRS055123.572877	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3902	SRR044002	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106024_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106002	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	3.8	WUGSC	HMP_production_phase_1
SRS044299.574978	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2955	SRR040908	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044299	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102977_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102962	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS011677.575859	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_190	SRR045420	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011677	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033781_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700033742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.4	WUGSC	HMP_production_phase_1
SRS024525.573168	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2704	SRR048321	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024525	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101671_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101645	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BCM	HMP_production_phase_1
SRS057212.575194	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4083	SRR040958	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102462_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102428	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS047886.576481	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3300	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241735	241735	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109920_from_subject_161351702__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109882	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	0	JCVI	HMP_production_phase_1
SRS015283.574123	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_562	SRR046154	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015283	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023938_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023920	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS023067.571787	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2337	SRR048114	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023067	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099101_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099069	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	4.1	BCM	HMP_production_phase_1
SRS017949.575364	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1235	SRR043006	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017949	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035270_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035244	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS016305.575922	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_841	SRR044465	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016305	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241813	241813	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024968_from_subject_765074482__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024951	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	0	WUGSC	HMP_production_phase_1
SRS051031.574296	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3576	SRR046376	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051031	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241845	241845	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105372_from_subject_764487809__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105355	n	969	234	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	WUGSC	HMP_production_phase_1
SRS017284.572497	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1078	SRR041255	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017284	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033959_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033931	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS020938.570540	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1803	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020938	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096449_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096424	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	0	JCVI	HMP_production_phase_1
SRS011508.572603	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_103	SRR045094	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011508	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016362_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016347	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	4.2	WUGSC	HMP_production_phase_1
SRS062431.573985	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4232	SRR046553	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062431	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241858	241858	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114415_from_subject_764953101__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114385	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS015472.575383	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_614	SRR044673	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024127_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024096	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS017539.570635	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1142	SRR041164	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017539	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034272_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034241	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS048785.576258	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3372	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048785	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108088_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108053	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS016547.571150	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_910	SRR040606	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016547	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032274_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4	BI	HMP_production_phase_1
SRS018313.575129	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1325	SRR041495	23.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018313	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241695	241695	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035747_from_subject_160380657__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035728	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	BI	HMP_production_phase_1
SRS011609.572089	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_156	SRR047474	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011609	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033185_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033146	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4.3	WUGSC	HMP_production_phase_1
SRS023932.572403	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2551	SRR041541	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023932	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100330_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100302	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS017661.572896	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1160	SRR042026	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034661_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034632	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	19	0	BI	HMP_production_phase_1
SRS019099.575315	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1475	SRR044649	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019099	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037570_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037544	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS022125.573691	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2101	SRR042966	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097891_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097853	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	4.4	BI	HMP_production_phase_1
SRS017667.576128	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1163	SRR041006	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034682_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	19	0	BI	HMP_production_phase_1
SRS056677.571573	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4041	SRR048743	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107812_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107776	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS016432.576016	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_881	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016432	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032119_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032084	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS011638.571453	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_170	SRR044977	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011638	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033477_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033475	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS056181.571538	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3997	SRR048488	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056181	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107427_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107390	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	4.7	BCM	HMP_production_phase_1
SRS024721.572809	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2758	SRR048313	25.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024721	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241709	241709	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102104_from_subject_158964549__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102103	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BCM	HMP_production_phase_1
SRS023635.573954	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2479	SRR040633	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023635	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099938_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099901	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	20	4.9	BI	HMP_production_phase_1
SRS015194.574813	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_536	SRR043878	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015194	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023849_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023817	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4	WUGSC	HMP_production_phase_1
SRS023206.573870	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2376	SRR041916	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099337_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099303	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS021883.575980	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2041	SRR058111	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021883	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097619_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097585	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS017359.575959	TCAGTTCCGAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1096	SRR041210	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017359	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034065_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034035	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	BI	HMP_production_phase_1
SRS065069.575153	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4623	SRR049645	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065069	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114399_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114377	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	32	0	WUGSC	HMP_production_phase_1
SRS013676.570620	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_277	SRR040645	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013676	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016754_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016711	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS018151.575663	TCAGAATTCCTAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1282	SRR040900	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018151	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035551_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035523	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS023991.573219	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2566	SRR040940	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023991	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100452_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100423	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	0	BI	HMP_production_phase_1
SRS020210.572748	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1631	SRR048155	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020210	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241762	241762	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095463_from_subject_158418336__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700095427	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	0	BCM	HMP_production_phase_1
SRS042290.576606	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2777	SRR048434	34.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042290	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241673	241673	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109943_from_subject_159085930__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109921	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	34	4.6	BCM	HMP_production_phase_1
SRS016596.570626	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_920	SRR041302	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016596	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032349_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032322	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	31	4.3	BI	HMP_production_phase_1
SRS062514.573304	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4247	SRR046821	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062514	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113136_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113110	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	0	WUGSC	HMP_production_phase_1
SRS020555.573704	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1717	SRR041763	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095878_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095845	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS051657.571954	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3628	SRR046682	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241891	241891	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105340_from_subject_516889361__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	19	0	WUGSC	HMP_production_phase_1
SRS063807.575011	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4444	SRR058114	22.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063807	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241698	241698	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110375_from_subject_650853796__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110353	n	969	166	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	0	JCVI	HMP_production_phase_1
SRS058175.571152	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_4167	SRR040974	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058175	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102987_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102967	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS045479.571239	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3078	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045479	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241867	241867	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101821_from_subject_514014184__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101785	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	4.2	JCVI	HMP_production_phase_1
SRS017784.571193	TCAGTCGGTTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1193	SRR041177	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017784	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034877_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034848	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	0	BI	HMP_production_phase_1
SRS015901.576583	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_724	SRR044599	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024556_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024540	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS016166.571670	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_802	SRR044203	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016166	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024823_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024796	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	3.9	WUGSC	HMP_production_phase_1
SRS011380.571378	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_44	SRR047518	33.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011380	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241767	241767	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015677_from_subject_158924089__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700015675	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	WUGSC	HMP_production_phase_1
SRS021396.576051	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1919	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021396	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241774	241774	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097054_from_subject_161028021__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097016	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	4.6	JCVI	HMP_production_phase_1
SRS014667.575531	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_419	SRR043966	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023321_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023294	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS054762.576118	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3876	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054762	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110325_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700110295	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	4.3	JCVI	HMP_production_phase_1
SRS021555.572880	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1957	SRR048085	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097267_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097241	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	BCM	HMP_production_phase_1
SRS017898.570790	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1223	SRR042796	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017898	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035196_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035167	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	BI	HMP_production_phase_1
SRS017731.575237	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1180	SRR041226	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017731	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034824_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034787	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	4.1	BI	HMP_production_phase_1
SRS013662.573790	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_270	SRR041642	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013662	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016740_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016704	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	33	0	BI	HMP_production_phase_1
SRS044978.572198	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3025	SRR049466	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044978	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241883	241883	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103533_from_subject_132902142__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103496	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	31	5.6	WUGSC	HMP_production_phase_1
SRS021992.573253	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2064	SRR040752	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021992	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097732_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097699	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	4.1	BI	HMP_production_phase_1
SRS023569.576116	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2461	SRR041289	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023569	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099846_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099815	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS050602.574272	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3539	SRR048618	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050602	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108141_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108107	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	0	BCM	HMP_production_phase_1
SRS023448.572481	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2436	SRR048163	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023448	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099635_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099603	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	0	BCM	HMP_production_phase_1
SRS011499.570448	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_98	SRR045416	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011499	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016339_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016311	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	34	0	WUGSC	HMP_production_phase_1
SRS019500.572705	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1516	SRR051587	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241818	241818	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037971_from_subject_765317243__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037950	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	3.8	WUGSC	HMP_production_phase_1
SRS049216.574964	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3411	SRR048740	24.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241798	241798	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107814_from_subject_160400887__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107777	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	0	BCM	HMP_production_phase_1
SRS021338.571323	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1906	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021338	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096996_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096960	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	JCVI	HMP_production_phase_1
SRS016767.576411	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_969	SRR041483	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016767	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032958_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032932	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	BI	HMP_production_phase_1
SRS022966.571187	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2315	SRR048108	37.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022966	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241781	241781	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098996_from_subject_158236265__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098953	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	37	4.6	BCM	HMP_production_phase_1
SRS053366.576396	TCAGTCCGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3772	SRR040852	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053366	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102452_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102423	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS045406.572058	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3070	SRR045507	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038476_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038447	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS013711.570881	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_286	SRR041621	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013711	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016789_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016788	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS021275.574449	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1889	SRR058095	34.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021275	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241669	241669	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096921_from_subject_161230322__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096882	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	34	5.3	JCVI	HMP_production_phase_1
SRS018390.574343	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1346	SRR041465	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018390	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035824_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035795	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	0	BI	HMP_production_phase_1
SRS024657.572897	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2740	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101948_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101913	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS013780.572990	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_302	SRR048291	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013780	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016939_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016911	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BCM	HMP_production_phase_1
SRS014554.570500	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_386	SRR045723	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014554	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023208_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023179	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	3.8	WUGSC	HMP_production_phase_1
SRS017266.574666	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1073	SRR041335	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017266	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241724	241724	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033941_from_subject_159510762__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033922	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS013211.572256	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_212	SRR043254	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013211	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015910_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015874	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS055124.570539	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3903	SRR046047	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055124	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038990_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038962	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	30	0	WUGSC	HMP_production_phase_1
SRS016467.575665	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_889	SRR041279	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016467	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032163_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032162	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS018745.576424	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1416	SRR044451	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018745	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037212_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037129	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	4.5	WUGSC	HMP_production_phase_1
SRS015442.570484	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_603	SRR044666	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015442	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024097_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS016753.575947	TCAGTCCGAACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_966	SRR041461	21.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016753	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241715	241715	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032944_from_subject_160421117__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700032925	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	BI	HMP_production_phase_1
SRS014456.575807	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_375	SRR043955	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023110_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023073	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	3.4	WUGSC	HMP_production_phase_1
SRS022948.575317	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2308	SRR048101	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022948	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098978_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098944	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	37	4.6	BCM	HMP_production_phase_1
SRS018041.571948	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1262	SRR042960	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018041	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035365_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035319	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.3	BI	HMP_production_phase_1
SRS062943.572553	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4315	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062943	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111608_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111580	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	39	4.8	JCVI	HMP_production_phase_1
SRS047615.572572	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3270	SRR049510	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241856	241856	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105118_from_subject_256789458__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105093	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	20	5.6	WUGSC	HMP_production_phase_1
SRS014357.571264	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_356	SRR043879	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023011_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021289	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS024167.576405	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2611	SRR041752	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100635_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100608	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS018521.572139	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1378	SRR043229	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035985_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035947	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	4.1	BI	HMP_production_phase_1
SRS062961.572443	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4318	SRR048792	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062961	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268876	268876	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111208_from_subject_257905678__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111171	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.9	BCM	HMP_production_phase_1
SRS062620.570985	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4268	SRR047091	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062620	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114836_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114807	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	4.1	WUGSC	HMP_production_phase_1
SRS011661.573879	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_182	SRR044879	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011661	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033765_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.4	WUGSC	HMP_production_phase_1
SRS046612.572442	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3185	SRR048536	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046612	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109602_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109573	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	0	BCM	HMP_production_phase_1
SRS023805.573833	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2520	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023805	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100199_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	JCVI	HMP_production_phase_1
SRS023873.575875	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2537	SRR048215	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023873	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100271_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100238	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	4.9	BCM	HMP_production_phase_1
SRS052377.572628	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3696	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052377	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108985_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108958	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	4.3	JCVI	HMP_production_phase_1
SRS023149.571021	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2364	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023149	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241757	241757	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099280_from_subject_441369442__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099287	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.3	JCVI	HMP_production_phase_1
SRS043596.573981	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2894	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043596	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102468_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700102431	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS052245.576072	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3687	SRR046680	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052245	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241863	241863	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105017_from_subject_275382046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106987	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	0	WUGSC	HMP_production_phase_1
SRS019259.573482	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1497	SRR044427	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019259	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037730_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037696	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.2	WUGSC	HMP_production_phase_1
SRS021802.575672	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2017	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021802	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097515_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097487	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	40	0	JCVI	HMP_production_phase_1
SRS022568.575068	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2212	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022568	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098473_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098440	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	5	JCVI	HMP_production_phase_1
SRS053553.576181	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3789	SRR046490	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053553	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241845	241845	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105394_from_subject_764487809__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105366	n	969	234	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS020934.570856	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1802	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020934	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096445_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096422	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	0	JCVI	HMP_production_phase_1
SRS022101.574170	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2090	SRR041600	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022101	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097867_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097841	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	4.4	BI	HMP_production_phase_1
SRS049278.571484	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3416	SRR048400	28.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049278	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102952_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102919	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BCM	HMP_production_phase_1
SRS017489.570688	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1132	SRR041352	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017489	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034222_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	19	5.1	BI	HMP_production_phase_1
SRS048113.574851	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3322	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048113	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257133	257133	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102575_from_subject_937415040__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102536	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	38	4.6	JCVI	HMP_production_phase_1
SRS013674.571074	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_276	SRR041552	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013674	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241672	241672	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016752_from_subject_159288231__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700016710	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS011677.573667	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_190	SRR047492	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011677	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033781_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700033742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.4	WUGSC	HMP_production_phase_1
SRS045792.571822	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3100	SRR048481	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045792	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107417_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107385	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	4.7	BCM	HMP_production_phase_1
SRS043968.575877	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2927	SRR047725	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043968	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241859	241859	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105480_from_subject_643185023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	5	WUGSC	HMP_production_phase_1
SRS054709.575902	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3873	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054709	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109153_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109119	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	4.1	JCVI	HMP_production_phase_1
SRS011634.574140	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_168	SRR049318	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011634	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033471_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033469	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4.1	WUGSC	HMP_production_phase_1
SRS013466.570924	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_235	SRR041934	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016397_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016382	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	BI	HMP_production_phase_1
SRS014877.574847	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_464	SRR046570	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023531_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023504	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS051423.571211	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3612	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051423	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108517_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108485	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	32	0	JCVI	HMP_production_phase_1
SRS065508.573518	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4697	SRR047096	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065508	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114203_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114174	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	WUGSC	HMP_production_phase_1
SRS015974.571467	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_748	SRR044014	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015974	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024629_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024600	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	0	WUGSC	HMP_production_phase_1
SRS022315.574769	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2149	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022315	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098155_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098121	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	4.5	JCVI	HMP_production_phase_1
SRS017845.575402	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1210	SRR041216	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017845	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034950_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034919	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	BI	HMP_production_phase_1
SRS017878.574593	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1217	SRR041476	33.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017878	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241799	241799	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035176_from_subject_160441347__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035157	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	33	0	BI	HMP_production_phase_1
SRS018591.571033	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1398	SRR044422	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018591	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037058_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037034	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	19	0	WUGSC	HMP_production_phase_1
SRS044041.575936	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2935	SRR046039	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044041	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038777_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038749	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	5.3	WUGSC	HMP_production_phase_1
SRS019095.572444	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1473	SRR044646	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019095	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037566_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037542	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS018807.570852	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1437	SRR044508	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018807	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241731	241731	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037274_from_subject_765135172__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037247	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS022000.571277	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2068	SRR040593	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022000	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241747	241747	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097740_from_subject_158256496__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097703	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	4.1	BI	HMP_production_phase_1
SRS065558.571208	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4702	SRR048805	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065558	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111256_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	5	BCM	HMP_production_phase_1
SRS019576.570273	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1529	SRR045539	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019576	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038047_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700038018	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	37	0	WUGSC	HMP_production_phase_1
SRS015710.572003	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_674	SRR044237	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015710	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024365_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024342	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	3.6	WUGSC	HMP_production_phase_1
SRS019099.570694	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1475	SRR044713	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019099	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037570_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037544	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS062628.572554	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4269	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062628	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111616_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111584	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	39	4.8	JCVI	HMP_production_phase_1
SRS014774.570665	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_434	SRR046161	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014774	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241824	241824	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023428_from_subject_763719065__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023394	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	4.2	WUGSC	HMP_production_phase_1
SRS053142.573674	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3754	SRR046581	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053142	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106532_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106499	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	32	4.3	WUGSC	HMP_production_phase_1
SRS043278.574802	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2856	SRR047160	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043278	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241893	241893	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105055_from_subject_178713055__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.5	WUGSC	HMP_production_phase_1
SRS062575.576133	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4257	SRR048841	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062575	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111330_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111302	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	39	4.8	BCM	HMP_production_phase_1
SRS020022.572310	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1597	SRR040676	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020022	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095267_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700095229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4.3	BI	HMP_production_phase_1
SRS066188.571731	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058090	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS017709.573178	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1170	SRR040975	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017709	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034802_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034776	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	30	4.1	BI	HMP_production_phase_1
SRS018999.574577	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1461	SRR044587	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037468_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037445	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS044018.570537	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2930	SRR048890	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044018	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108652_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108613	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	31	4	BCM	HMP_production_phase_1
SRS017971.574828	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1244	SRR042890	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017971	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241809	241809	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035292_from_subject_158357646__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035255	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS024363.575124	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2665	SRR042928	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024363	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101398_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101363	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS066188.574532	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR052699	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS024488.573556	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2699	SRR043016	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101634_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700101598	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	38	0	BI	HMP_production_phase_1
SRS013199.576420	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_206	SRR040850	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013199	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015898_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700015868	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	BI	HMP_production_phase_1
SRS043769.572060	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2911	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043769	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241759	241759	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108802_from_subject_160987560__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108782	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	0	JCVI	HMP_production_phase_1
SRS058373.575193	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4183	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058373	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109437_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109399	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	4.8	JCVI	HMP_production_phase_1
SRS015907.573034	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_726	SRR044588	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015907	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024562_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024543	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS065474.573811	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4685	SRR049425	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241865	241865	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114725_from_subject_764831721__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114705	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	0	WUGSC	HMP_production_phase_1
SRS018811.572389	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1439	SRR044478	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018811	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241731	241731	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037278_from_subject_765135172__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037249	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS017541.573135	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1143	SRR042796	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017541	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034274_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034242	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS016785.574981	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_978	SRR042951	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016785	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032976_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032941	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS022129.572347	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2103	SRR043024	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022129	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241803	241803	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097895_from_subject_158337416__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097855	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.4	BI	HMP_production_phase_1
SRS018400.575156	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1350	SRR041399	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018400	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035834_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035800	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS042974.574066	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2831	SRR046460	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042974	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241861	241861	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106713_from_subject_184349034__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106696	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS019890.574578	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1575	SRR044401	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019890	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038366_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038344	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS024661.571733	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2742	SRR041273	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241705	241705	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101952_from_subject_159611913__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700101915	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS014613.575883	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_403	SRR045715	38.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241693	241693	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023267_from_subject_763840445__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	4.1	WUGSC	HMP_production_phase_1
SRS020247.571457	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1636	SRR042796	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020247	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095500_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095474	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	0	BI	HMP_production_phase_1
SRS019844.576080	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1568	SRR046198	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019844	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241790	241790	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038320_from_subject_765661155__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700038283	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	4.3	WUGSC	HMP_production_phase_1
SRS021265.573644	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1885	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021265	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096911_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096877	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	34	5.3	JCVI	HMP_production_phase_1
SRS017555.571024	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1149	SRR041485	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017555	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034288_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034249	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	4.1	BI	HMP_production_phase_1
SRS011361.574827	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_34	SRR045371	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015644_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015642	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	33	0	WUGSC	HMP_production_phase_1
SRS062693.571401	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4277	SRR048427	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062693	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110790_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110765	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	35	4.6	BCM	HMP_production_phase_1
SRS021873.575785	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2037	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097609_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097580	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	JCVI	HMP_production_phase_1
SRS022562.576581	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2209	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022562	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098467_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098437	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	5	JCVI	HMP_production_phase_1
SRS020326.573298	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1662	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020326	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241829	241829	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095579_from_subject_160663879__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700095542	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS055007.575604	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3894	SRR058108	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055007	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109500_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109465	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	31	0	JCVI	HMP_production_phase_1
SRS047581.572578	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3266	SRR046492	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047581	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241717	241717	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105707_from_subject_763456073__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105677	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	5	WUGSC	HMP_production_phase_1
SRS022480.570395	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2189	SRR048171	30.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022480	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241810	241810	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098381_from_subject_158458797__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098359	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	30	4.5	BCM	HMP_production_phase_1
SRS049620.570987	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3445	SRR045854	32.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049620	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241727	241727	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038578_from_subject_763880905__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038546	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	32	0	WUGSC	HMP_production_phase_1
SRS018525.572053	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1380	SRR042852	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241667	241667	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035989_from_subject_160259276__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	4.1	BI	HMP_production_phase_1
SRS021676.570623	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1986	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021676	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097388_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097363	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	JCVI	HMP_production_phase_1
SRS013508.570342	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_245	SRR041831	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013508	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016488_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016465	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS014911.575258	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_469	SRR045669	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014911	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023566_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023545	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	33	0	WUGSC	HMP_production_phase_1
SRS046963.575804	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3211	SRR049398	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046963	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241871	241871	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106263_from_subject_675950834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.6	WUGSC	HMP_production_phase_1
SRS015311.574775	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_575	SRR043757	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015311	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023966_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023934	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS048816.574297	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3374	SRR046307	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048816	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105864_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105838	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	30	0	WUGSC	HMP_production_phase_1
SRS021461.572327	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1938	SRR058111	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021461	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097169_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097133	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	32	0	JCVI	HMP_production_phase_1
SRS023770.573041	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2516	SRR043039	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023770	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241773	241773	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100077_from_subject_158721788__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100040	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS011441.574274	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_65	SRR044900	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011441	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016089_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016051	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS051180.575717	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3587	SRR048905	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051180	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108208_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108175	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	21	0	BCM	HMP_production_phase_1
SRS054288.575810	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3837	SRR049392	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054288	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103468_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103441	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS023799.576516	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2518	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023799	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100192_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100169	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	JCVI	HMP_production_phase_1
SRS023750.571987	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2507	SRR040993	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023750	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100057_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100030	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS053925.571553	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3819	SRR047613	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038986_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038960	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	30	0	WUGSC	HMP_production_phase_1
SRS057634.575882	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4126	SRR049477	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057634	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105197_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105161	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	4.3	WUGSC	HMP_production_phase_1
SRS050410.572653	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3523	SRR048541	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050410	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109594_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109569	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	0	BCM	HMP_production_phase_1
SRS049973.576179	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3475	SRR046192	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049973	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038878_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	WUGSC	HMP_production_phase_1
SRS017953.573523	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1237	SRR041610	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017953	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035274_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035246	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS049659.570910	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3452	SRR058108	38.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049659	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110213_from_subject_246515023__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700110173	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	38	4.5	JCVI	HMP_production_phase_1
SRS050737.572710	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3551	SRR046065	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050737	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038512_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038489	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	31	0	WUGSC	HMP_production_phase_1
SRS022520.575355	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2203	SRR048186	30.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022520	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241810	241810	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098421_from_subject_158458797__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098379	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	30	4.5	BCM	HMP_production_phase_1
SRS063340.574927	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4374	SRR046893	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063340	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241824	241824	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113533_from_subject_763719065__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700113499	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS013502.576044	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_242	SRR040670	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013502	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016482_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016462	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS016488.572222	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_896	SRR042815	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032184_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS018288.574164	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1322	SRR041227	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018288	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241785	241785	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035695_from_subject_160137896__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700035654	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	26	3.9	BI	HMP_production_phase_1
SRS023017.570628	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2327	SRR048068	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023017	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241700	241700	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099051_from_subject_158114885__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099017	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	0	BCM	HMP_production_phase_1
SRS046799.574756	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3197	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046799	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109266_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109237	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	4.8	JCVI	HMP_production_phase_1
SRS016545.572872	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_909	SRR040615	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032272_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032236	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4	BI	HMP_production_phase_1
SRS017345.572217	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1090	SRR041256	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017345	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034051_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034028	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	BI	HMP_production_phase_1
SRS047260.574010	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3239	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047260	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102694_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102667	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	JCVI	HMP_production_phase_1
SRS047354.571009	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3246	SRR047139	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047354	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103456_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103435	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	33	0	WUGSC	HMP_production_phase_1
SRS044286.570745	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2953	SRR048761	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044286	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108256_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108226	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	32	4.6	BCM	HMP_production_phase_1
SRS043792.576425	TCAGTCCTGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2912	SRR041530	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043792	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102391_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102364	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS062803.573998	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4299	SRR046897	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062803	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114629_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114603	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	4.3	WUGSC	HMP_production_phase_1
SRS015762.574848	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_686	SRR049863	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015762	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024417_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024398	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	WUGSC	HMP_production_phase_1
SRS019566.574278	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1524	SRR045543	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019566	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038037_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038013	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	37	0	WUGSC	HMP_production_phase_1
SRS013825.574118	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_312	SRR041024	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013825	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016985_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016984	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	0	BI	HMP_production_phase_1
SRS022245.572046	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2131	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022245	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098014_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097982	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	4.2	JCVI	HMP_production_phase_1
SRS011277.572839	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_19	SRR045450	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011277	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015268_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700015266	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	WUGSC	HMP_production_phase_1
SRS017837.571666	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1206	SRR041350	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017837	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034942_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034915	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	BI	HMP_production_phase_1
SRS063318.570763	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4372	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063318	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111622_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111587	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	39	4.8	JCVI	HMP_production_phase_1
SRS056433.572030	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4019	SRR058096	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056433	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109908_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109876	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS063499.574385	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4395	SRR047086	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063499	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114254_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	4.5	WUGSC	HMP_production_phase_1
SRS021752.574945	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2008	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021752	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241706	241706	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097465_from_subject_161493313__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097429	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.1	JCVI	HMP_production_phase_1
SRS023198.576345	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2372	SRR041815	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023198	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099329_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700099299	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	33	0	BI	HMP_production_phase_1
SRS019105.572368	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1478	SRR044720	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019105	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037576_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037547	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS064876.574201	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4597	SRR046759	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064876	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113511_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700113488	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS017414.570334	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1110	SRR041036	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017414	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034120_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034091	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	30	0	BI	HMP_production_phase_1
SRS044673.575592	TCAGTACGGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2990	SRR041481	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044673	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107089_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107055	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	0	BI	HMP_production_phase_1
SRS064328.576560	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4530	SRR047055	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064328	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114735_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114710	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	0	WUGSC	HMP_production_phase_1
SRS021601.573747	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_1968	SRR048045	22.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021601	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241668	241668	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097313_from_subject_158013734__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097291	n	969	255	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	0	BCM	HMP_production_phase_1
SRS065593.572386	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4711	SRR048860	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065593	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112028_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111997	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Supragingival_plaque	26	0	BCM	HMP_production_phase_1
SRS013551.574025	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_250	SRR048265	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013551	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016572_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016546	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	4.7	BCM	HMP_production_phase_1
SRS063138.571059	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4343	SRR048778	27.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063138	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:268876	268876	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111178_from_subject_257905678__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111156	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.9	BCM	HMP_production_phase_1
SRS023863.572214	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2532	SRR048216	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023863	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100261_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100233	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	4.9	BCM	HMP_production_phase_1
SRS020655.570660	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1738	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096080_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096054	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	JCVI	HMP_production_phase_1
SRS024466.576218	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2688	SRR041189	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101612_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101587	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	38	0	BI	HMP_production_phase_1
SRS019447.572821	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1511	SRR045891	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241728	241728	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037918_from_subject_765519544__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037901	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	0	WUGSC	HMP_production_phase_1
SRS024130.575977	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2606	SRR041303	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024130	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241724	241724	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100595_from_subject_159510762__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100558	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS054800.573199	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3879	SRR046399	18.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054800	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241874	241874	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106085_from_subject_737052003__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700106061	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	18	4.5	WUGSC	HMP_production_phase_1
SRS050020.570594	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3480	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050020	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109892_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109868	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	0	JCVI	HMP_production_phase_1
SRS024347.570886	TCAGTCCTGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2657	SRR041095	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024347	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101382_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101355	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS062539.572439	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4252	SRR046559	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062539	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257108	257108	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114878_from_subject_682102541__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	WUGSC	HMP_production_phase_1
SRS018005.574573	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1246	SRR040783	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018005	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035329_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035301	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS014239.570836	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_323	SRR043932	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014239	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021828_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700021809	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS016461.571652	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_887	SRR041196	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016461	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032157_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032156	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS017851.575615	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1213	SRR041496	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017851	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034956_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034922	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	29	0	BI	HMP_production_phase_1
SRS022866.573766	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2286	SRR058086	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022866	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098896_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098870	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	4.6	JCVI	HMP_production_phase_1
SRS019568.573346	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1525	SRR043619	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019568	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038039_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038014	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	37	0	WUGSC	HMP_production_phase_1
SRS019308.575508	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1502	SRR046515	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019308	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241848	241848	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037779_from_subject_765377934__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037749	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	35	4.1	WUGSC	HMP_production_phase_1
SRS015184.572299	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_531	SRR047401	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015184	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023839_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023812	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4	WUGSC	HMP_production_phase_1
SRS023512.573462	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2449	SRR048230	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023512	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099789_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099758	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BCM	HMP_production_phase_1
SRS015466.574507	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_611	SRR047450	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024121_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024093	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS045158.571174	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3037	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045158	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109348_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109321	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	4.6	JCVI	HMP_production_phase_1
SRS018224.570970	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1305	SRR041442	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035631_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS045970.572367	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3122	SRR046488	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045970	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241885	241885	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106192_from_subject_823052294__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS014929.575063	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_478	SRR043915	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014929	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023584_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	WUGSC	HMP_production_phase_1
SRS024480.575130	TCAGAACCTTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2695	SRR041675	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024480	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101626_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101594	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	38	0	BI	HMP_production_phase_1
SRS054372.574939	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3842	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054372	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110349_from_subject_892969023__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110307	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	28	4.3	JCVI	HMP_production_phase_1
SRS043664.574591	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2899	SRR047130	26.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043664	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257131	257131	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103585_from_subject_863126187__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700103563	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	WUGSC	HMP_production_phase_1
SRS051865.570380	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3647	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051865	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241744	241744	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108094_from_subject_161270782__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700108056	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	JCVI	HMP_production_phase_1
SRS024547.574159	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2714	SRR048415	25.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024547	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241819	241819	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101693_from_subject_159389382__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700101656	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BCM	HMP_production_phase_1
SRS022436.572313	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2180	SRR048387	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022436	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098311_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098278	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	5.8	BCM	HMP_production_phase_1
SRS016678.574646	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_948	SRR042858	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016678	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032462_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700032461	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	5	BI	HMP_production_phase_1
SRS045874.570731	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3108	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045874	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109439_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109400	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	4.8	JCVI	HMP_production_phase_1
SRS015405.574529	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_597	SRR047561	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015405	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024060_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024032	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	3.6	WUGSC	HMP_production_phase_1
SRS047313.572431	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3242	SRR048592	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047313	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107792_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107766	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	0	BCM	HMP_production_phase_1
SRS011421.570864	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_53	SRR044858	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011421	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016065_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS017545.575800	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1145	SRR042893	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034278_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034244	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS066144.575888	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043077	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS013819.572141	TCAGCGGAACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_310	SRR041161	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013819	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016979_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016978	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	0	BI	HMP_production_phase_1
SRS055203.574967	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3912	SRR046317	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055203	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103458_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103436	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	33	0	WUGSC	HMP_production_phase_1
SRS062464.573084	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4239	SRR047080	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241876	241876	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113035_from_subject_764750800__sex_male_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700113013	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	21	0	WUGSC	HMP_production_phase_1
SRS062618.574788	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4267	SRR048784	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062618	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111204_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111169	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.9	BCM	HMP_production_phase_1
SRS014430.573316	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_365	SRR045536	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014430	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023084_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023060	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	3.4	WUGSC	HMP_production_phase_1
SRS021459.572548	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1937	SRR058111	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021459	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097167_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	0	JCVI	HMP_production_phase_1
SRS011529.575498	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_114	SRR044912	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011529	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241837	241837	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016610_from_subject_159166850__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016608	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS016561.576164	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_917	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032288_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS015821.571589	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_703	SRR044709	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015821	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024476_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024452	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	21	0	WUGSC	HMP_production_phase_1
SRS015334.571697	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_577	SRR044463	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015334	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023989_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700023968	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	3.7	WUGSC	HMP_production_phase_1
SRS052555.574767	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3711	SRR048645	29.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241711	241711	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108858_from_subject_160603188__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108839	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	BCM	HMP_production_phase_1
SRS023395.573692	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2424	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023395	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099561_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099527	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	0	JCVI	HMP_production_phase_1
SRS024273.571685	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2636	SRR041908	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024273	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101251_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101228	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	3.7	BI	HMP_production_phase_1
SRS066144.573484	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043072	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS064478.571293	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4549	SRR048785	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064478	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111202_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111168	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.9	BCM	HMP_production_phase_1
SRS023567.572173	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2460	SRR041212	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023567	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099844_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099814	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS018037.571570	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1260	SRR042889	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018037	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035361_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035317	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.3	BI	HMP_production_phase_1
SRS045846.571106	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3103	SRR042878	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045846	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102466_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102430	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS024151.575546	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2607	SRR041187	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024151	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241676	241676	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100619_from_subject_159207311__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700100600	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS055531.574721	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3934	SRR049610	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055531	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106378_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106347	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS013563.573813	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_255	SRR048404	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013563	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016584_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	4.7	BCM	HMP_production_phase_1
SRS050258.571053	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3505	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110265_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110232	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	40	4.9	JCVI	HMP_production_phase_1
SRS020500.572849	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1705	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020500	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241733	241733	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095823_from_subject_160825720__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	JCVI	HMP_production_phase_1
SRS016732.575572	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_965	SRR040869	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016732	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241836	241836	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032677_from_subject_160016515__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700032652	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.3	BI	HMP_production_phase_1
SRS016373.570812	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_866	SRR043240	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016373	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032037_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS024486.571642	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2698	SRR042819	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024486	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101632_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101597	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	38	0	BI	HMP_production_phase_1
SRS014962.574625	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_486	SRR045793	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014962	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023617_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700023595	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	32	0	WUGSC	HMP_production_phase_1
SRS051731.576145	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3634	SRR040980	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051731	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102460_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102427	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS011421.571162	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_53	SRR045084	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011421	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016065_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS023196.571768	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2371	SRR041764	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023196	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099327_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099298	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	33	0	BI	HMP_production_phase_1
SRS014235.573815	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_321	SRR045919	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014235	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241791	241791	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021824_from_subject_763678604__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	NA	y	TCAG	UBERON:feces	700021807	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS014877.573917	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_464	SRR043880	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023531_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023504	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS017794.573569	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1198	SRR040788	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017794	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241782	241782	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034887_from_subject_160542498__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034853	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS020835.574869	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1781	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020835	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096309_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096279	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	0	JCVI	HMP_production_phase_1
SRS017721.574099	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1175	SRR040878	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017721	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034814_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034782	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	30	4.1	BI	HMP_production_phase_1
SRS011279.576265	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_20	SRR044988	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011279	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015271_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015269	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	WUGSC	HMP_production_phase_1
SRS015176.573425	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_527	SRR043754	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015176	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023831_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023808	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4	WUGSC	HMP_production_phase_1
SRS014752.572085	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_426	SRR046170	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014752	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023406_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023383	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	4.2	WUGSC	HMP_production_phase_1
SRS049634.572906	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3447	SRR046639	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049634	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105193_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105159	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	4.3	WUGSC	HMP_production_phase_1
SRS048957.572587	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3384	SRR046310	30.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048957	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241736	241736	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105854_from_subject_763516763__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105833	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	30	0	WUGSC	HMP_production_phase_1
SRS051093.572788	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3580	SRR048288	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051093	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102645_from_subject_159227541__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102604	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	22	4.5	BCM	HMP_production_phase_1
SRS015831.576349	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_708	SRR044701	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015831	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024486_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024457	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	21	0	WUGSC	HMP_production_phase_1
SRS019251.575149	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1493	SRR047431	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019251	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037722_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037692	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.2	WUGSC	HMP_production_phase_1
SRS013468.574537	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_236	SRR041847	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016399_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016383	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	BI	HMP_production_phase_1
SRS051203.573395	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3590	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051203	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110333_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110299	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	4.3	JCVI	HMP_production_phase_1
SRS011171.572336	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_8	SRR045363	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014988_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700014986	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	0	WUGSC	HMP_production_phase_1
SRS052584.575210	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3713	SRR047225	36.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052584	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241862	241862	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106120_from_subject_706846339__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106120	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	36	4.5	WUGSC	HMP_production_phase_1
SRS019554.572494	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1519	SRR043958	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019554	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038025_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038007	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS017076.573631	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1029	SRR041222	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017076	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033589_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033565	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	BI	HMP_production_phase_1
SRS064510.573262	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4553	SRR048431	35.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064510	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241804	241804	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110802_from_subject_158984779__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110771	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	35	4.6	BCM	HMP_production_phase_1
SRS020137.570915	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_1608	SRR048131	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020137	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095390_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095362	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	31	0	BCM	HMP_production_phase_1
SRS062608.574707	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4263	SRR046471	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241693	241693	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114147_from_subject_763840445__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114116	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	38	4.7	WUGSC	HMP_production_phase_1
SRS023188.575359	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2367	SRR041928	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023188	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099319_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099294	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	33	0	BI	HMP_production_phase_1
SRS065669.575657	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4727	SRR058108	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241816	241816	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110640_from_subject_295137534__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110604	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	JCVI	HMP_production_phase_1
SRS024159.573916	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2608	SRR041869	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100627_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100604	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS051224.576001	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3595	SRR047201	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051224	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106105_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106071	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	18	4.5	WUGSC	HMP_production_phase_1
SRS016209.574999	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_811	SRR044499	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016209	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241687	241687	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024872_from_subject_764649650__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024849	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.1	WUGSC	HMP_production_phase_1
SRS022641.576500	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2235	SRR041756	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022641	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098593_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098558	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS021828.573715	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2028	SRR058120	40.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021828	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097541_from_subject_161473083__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097500	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	40	5.1	JCVI	HMP_production_phase_1
SRS013234.574132	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_216	SRR040741	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013234	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015941_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015940	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS045880.574650	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3110	SRR045756	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045880	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106046_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106013	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	3.8	WUGSC	HMP_production_phase_1
SRS018914.574054	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1447	SRR045896	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018914	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241732	241732	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037383_from_subject_765216093__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037354	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	19	0	WUGSC	HMP_production_phase_1
SRS014954.570606	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_482	SRR047654	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014954	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023609_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023591	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	32	0	WUGSC	HMP_production_phase_1
SRS016678.571625	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_948	SRR042913	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016678	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032462_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700032461	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	5	BI	HMP_production_phase_1
SRS011271.575925	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_16	SRR049646	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011271	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241748	241748	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015250_from_subject_158802708__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700015245	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	WUGSC	HMP_production_phase_1
SRS018104.572479	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1275	SRR041453	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018104	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241671	241671	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035428_from_subject_160056975__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035387	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS015305.570973	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_572	SRR048946	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015305	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023960_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023931	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	37	0	WUGSC	HMP_production_phase_1
SRS013203.574575	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_208	SRR040955	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013203	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015902_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015870	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	0	BI	HMP_production_phase_1
SRS016651.570655	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_939	SRR041617	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016651	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032435_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032434	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	5	BI	HMP_production_phase_1
SRS066144.575304	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058089	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS055687.571803	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3950	SRR041814	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055687	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101333_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101302	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS011611.571792	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_157	SRR045407	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011611	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033187_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033147	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.3	WUGSC	HMP_production_phase_1
SRS043821.573562	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_2915	SRR046368	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043821	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106617_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106600	n	969	184	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	37	0	WUGSC	HMP_production_phase_1
SRS015661.571764	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_661	SRR044238	26.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241845	241845	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024316_from_subject_764487809__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024295	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	WUGSC	HMP_production_phase_1
SRS016414.572281	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_872	SRR042836	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016414	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032101_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032075	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS062583.571301	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4258	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062583	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110744_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110713	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	0	JCVI	HMP_production_phase_1
SRS020310.571897	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1654	SRR041129	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020310	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095563_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095534	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	BI	HMP_production_phase_1
SRS022771.572246	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2269	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022771	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098727_from_subject_370425937__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098687	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	JCVI	HMP_production_phase_1
SRS011409.570636	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_47	SRR044964	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011409	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015999_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015997	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.7	WUGSC	HMP_production_phase_1
SRS063301.574019	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4368	SRR048836	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063301	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111338_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111306	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	39	4.8	BCM	HMP_production_phase_1
SRS011655.572054	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_179	SRR044881	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011655	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033757_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033730	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.4	WUGSC	HMP_production_phase_1
SRS018989.575905	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1456	SRR044621	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018989	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037458_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037440	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS065278.570379	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4658	SRR046752	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065278	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114621_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114599	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	4.3	WUGSC	HMP_production_phase_1
SRS013264.572804	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_226	SRR040731	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013264	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241833	241833	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015971_from_subject_159591683__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015970	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS015127.576329	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_514	SRR045749	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015127	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023782_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023698	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	4.5	WUGSC	HMP_production_phase_1
SRS042884.571500	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2826	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042884	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102698_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102669	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	JCVI	HMP_production_phase_1
SRS017408.575122	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1107	SRR041731	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034114_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034088	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	30	0	BI	HMP_production_phase_1
SRS020382.576517	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1675	SRR042815	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020382	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095701_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700095663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	4.2	BI	HMP_production_phase_1
SRS023893.573659	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2545	SRR048391	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023893	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241755	241755	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100291_from_subject_158883629__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100248	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	29	4.9	BCM	HMP_production_phase_1
SRS018985.570443	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1454	SRR044619	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018985	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037454_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037438	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS023322.572158	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2401	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023322	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099484_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099452	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.3	JCVI	HMP_production_phase_1
SRS013261.572512	TCAGTTCAAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_225	SRR040735	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013261	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241833	241833	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015968_from_subject_159591683__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015967	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS062719.575973	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4282	SRR047044	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062719	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114401_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114378	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	32	0	WUGSC	HMP_production_phase_1
SRS017233.573463	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1068	SRR041381	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017233	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033839_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033838	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	29	0	BI	HMP_production_phase_1
SRS020885.574502	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1790	SRR041590	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020885	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096396_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096369	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	31	0	BI	HMP_production_phase_1
SRS011163.576221	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4	SRR045361	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014976_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014974	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	0	WUGSC	HMP_production_phase_1
SRS022135.570316	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2106	SRR041560	22.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022135	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241803	241803	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097901_from_subject_158337416__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097858	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	22	4.4	BI	HMP_production_phase_1
SRS016663.572174	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_943	SRR041553	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016663	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032447_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032446	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	5	BI	HMP_production_phase_1
SRS052843.572095	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3729	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052843	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257133	257133	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102583_from_subject_937415040__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102540	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	38	4.6	JCVI	HMP_production_phase_1
SRS062793.573187	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4295	SRR049583	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062793	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114405_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114380	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS024301.571837	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2649	SRR041877	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024301	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101279_from_subject_158944319__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700101242	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	3.7	BI	HMP_production_phase_1
SRS022570.572451	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2213	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022570	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098475_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098441	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	5	JCVI	HMP_production_phase_1
SRS016048.572277	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_767	SRR044507	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016048	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241741	241741	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024703_from_subject_764508039__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024685	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS056814.573627	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4056	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056814	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110251_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110225	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	40	4.9	JCVI	HMP_production_phase_1
SRS015669.574144	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_664	SRR044202	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024324_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	WUGSC	HMP_production_phase_1
SRS011559.572879	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_129	SRR045463	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033002_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.7	WUGSC	HMP_production_phase_1
SRS020785.571325	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1771	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020785	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241780	241780	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096210_from_subject_161412393__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096176	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS062777.570408	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4293	SRR046287	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062777	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114029_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114006	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	36	0	WUGSC	HMP_production_phase_1
SRS022876.570344	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2290	SRR058086	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022876	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098906_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098875	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	4.6	JCVI	HMP_production_phase_1
SRS053278.575420	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3763	SRR046629	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053278	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105199_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105162	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	4.3	WUGSC	HMP_production_phase_1
SRS015182.573454	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_530	SRR048947	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015182	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023837_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023811	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4	WUGSC	HMP_production_phase_1
SRS050470.571290	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3531	SRR043590	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050470	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038720_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038692	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	3.7	WUGSC	HMP_production_phase_1
SRS024308.576122	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2651	SRR041823	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024308	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101286_from_subject_158944319__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101282	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	24	3.7	BI	HMP_production_phase_1
SRS020791.572293	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1773	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020791	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241780	241780	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096216_from_subject_161412393__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700096179	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	JCVI	HMP_production_phase_1
SRS063827.570637	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4449	SRR049581	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063827	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241877	241877	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113093_from_subject_764872181__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700113066	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	WUGSC	HMP_production_phase_1
SRS017096.571281	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1039	SRR042923	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033609_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033575	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS016623.572249	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_933	SRR041344	31.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032376_from_subject_159915365__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032335	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	31	4.3	BI	HMP_production_phase_1
SRS017245.575398	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1072	SRR043012	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017245	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241838	241838	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033851_from_subject_159814214__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033850	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS044355.575025	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2960	SRR045857	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038928_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038907	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	WUGSC	HMP_production_phase_1
SRS065597.570951	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4714	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065597	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241742	241742	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111552_from_subject_336497421__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700111519	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	JCVI	HMP_production_phase_1
SRS064406.575650	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4541	SRR048794	27.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064406	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268876	268876	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111220_from_subject_257905678__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111177	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.9	BCM	HMP_production_phase_1
SRS020665.570268	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1743	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096090_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096059	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS052116.575641	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3672	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052116	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108824_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108793	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	0	JCVI	HMP_production_phase_1
SRS016219.573473	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_816	SRR044387	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241687	241687	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024882_from_subject_764649650__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024854	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.1	WUGSC	HMP_production_phase_1
SRS045614.573020	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3089	SRR048684	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045614	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109543_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109515	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	21	0	BCM	HMP_production_phase_1
SRS018212.571893	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1299	SRR042815	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035619_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:mucus	700035586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	BI	HMP_production_phase_1
SRS015911.574784	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_728	SRR044615	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015911	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241778	241778	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024566_from_subject_764305738__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024545	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS062749.572773	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4291	SRR049429	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062749	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114313_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114280	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	4.5	WUGSC	HMP_production_phase_1
SRS023217.570372	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2379	SRR048369	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023217	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241700	241700	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099348_from_subject_158114885__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099345	n	969	319	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	29	4.2	BCM	HMP_production_phase_1
SRS057789.570842	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4140	SRR049501	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057789	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105142_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105105	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	5.6	WUGSC	HMP_production_phase_1
SRS020535.575752	TCAGACCGGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1708	SRR041707	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020535	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095858_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095835	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	BI	HMP_production_phase_1
SRS064959.575081	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4608	SRR048852	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064959	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111475_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111446	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.8	BCM	HMP_production_phase_1
SRS057608.571486	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4122	SRR049460	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105826_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.6	WUGSC	HMP_production_phase_1
SRS053637.572190	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3799	SRR047158	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053637	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257127	257127	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105634_from_subject_953045535__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105614	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	29	3.8	WUGSC	HMP_production_phase_1
SRS050980.574541	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3569	SRR048742	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050980	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107806_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107773	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	0	BCM	HMP_production_phase_1
SRS056656.570760	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4039	SRR048448	33.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056656	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241672	241672	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102867_from_subject_159288231__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700102848	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	33	0	BCM	HMP_production_phase_1
SRS014671.572881	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_421	SRR046076	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023325_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS014536.573807	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_377	SRR046152	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014536	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241730	241730	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023190_from_subject_763638144__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023170	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	3.8	WUGSC	HMP_production_phase_1
SRS017491.575293	TCAGTCCGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1133	SRR041331	19.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017491	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034224_from_subject_160319967__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034184	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	19	5.1	BI	HMP_production_phase_1
SRS018039.572161	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1261	SRR042947	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018039	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035363_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035318	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.3	BI	HMP_production_phase_1
SRS020261.574663	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1643	SRR040702	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020261	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095514_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095481	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS017549.572811	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1147	SRR040646	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017549	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034282_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034246	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	4.1	BI	HMP_production_phase_1
SRS021571.573561	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1965	SRR048305	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021571	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241843	241843	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097283_from_subject_158216035__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097249	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	0	BCM	HMP_production_phase_1
SRS024547.576306	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2714	SRR048202	25.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024547	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241819	241819	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101693_from_subject_159389382__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700101656	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BCM	HMP_production_phase_1
SRS013776.572463	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_300	SRR048319	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013776	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016935_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016909	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BCM	HMP_production_phase_1
SRS048396.575799	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3341	SRR046781	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048396	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105942_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105925	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	0	WUGSC	HMP_production_phase_1
SRS021690.571459	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1993	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021690	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097402_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097370	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	JCVI	HMP_production_phase_1
SRS017094.571351	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1038	SRR041322	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017094	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033607_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033574	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS065292.571838	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4659	SRR049582	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065292	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113079_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113059	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	WUGSC	HMP_production_phase_1
SRS024071.576150	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2590	SRR040950	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024071	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100536_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100532	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	4.7	BI	HMP_production_phase_1
SRS047094.575565	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3225	SRR046209	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047094	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038872_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	WUGSC	HMP_production_phase_1
SRS011589.573188	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_146	SRR044966	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011589	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033164_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033136	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.3	WUGSC	HMP_production_phase_1
SRS044581.575567	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2977	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044581	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108993_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108962	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	4.3	JCVI	HMP_production_phase_1
SRS020604.575203	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1728	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020604	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095995_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095966	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	JCVI	HMP_production_phase_1
SRS022777.576219	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2272	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022777	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098733_from_subject_370425937__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098690	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	22	0	JCVI	HMP_production_phase_1
SRS014863.570639	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_457	SRR043776	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014863	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023517_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023497	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	39	0	WUGSC	HMP_production_phase_1
SRS063797.574234	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4443	SRR048853	26.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063797	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241724	241724	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112004_from_subject_159510762__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111985	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Stool	26	0	BCM	HMP_production_phase_1
SRS021007.572471	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1823	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021007	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096554_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096523	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS054740.574856	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3875	SRR047176	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054740	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241872	241872	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105898_from_subject_668248235__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105879	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	WUGSC	HMP_production_phase_1
SRS056170.571047	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3996	SRR046801	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056170	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241861	241861	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106737_from_subject_184349034__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106708	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS054549.572928	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3858	SRR049505	32.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054549	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241879	241879	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106516_from_subject_553359145__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106491	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	32	4.3	WUGSC	HMP_production_phase_1
SRS023641.573056	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2482	SRR040598	20.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023641	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099944_from_subject_159005010__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099904	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	20	4.9	BI	HMP_production_phase_1
SRS018013.575087	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1249	SRR040758	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018013	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035337_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035305	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS065577.573190	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4705	SRR048783	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065577	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111186_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111160	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.9	BCM	HMP_production_phase_1
SRS022814.574083	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2277	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022814	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098770_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098743	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	JCVI	HMP_production_phase_1
SRS051688.573383	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3630	SRR058112	32.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051688	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241754	241754	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108525_from_subject_160967330__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700108489	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	32	0	JCVI	HMP_production_phase_1
SRS011512.570332	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_105	SRR044941	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011512	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016366_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016349	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	4.2	WUGSC	HMP_production_phase_1
SRS013498.575101	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_241	SRR041025	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013498	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016478_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS054405.573666	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3846	SRR043631	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054405	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038464_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038441	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS015452.575102	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_606	SRR047456	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015452	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024107_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024086	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS062463.575136	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4238	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062463	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110687_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110656	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	30	0	JCVI	HMP_production_phase_1
SRS020557.571463	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1718	SRR041796	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095880_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS022707.575943	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2252	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022707	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241689	241689	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098659_from_subject_432193348__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098618	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	26	4.6	JCVI	HMP_production_phase_1
SRS013246.571284	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_220	SRR040738	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013246	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015953_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015952	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS024279.571148	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2638	SRR041811	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024279	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101257_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101231	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	3.7	BI	HMP_production_phase_1
SRS016895.570246	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_995	SRR041691	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016895	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241745	241745	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033256_from_subject_159308461__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033255	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS018625.572969	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1407	SRR046163	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018625	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241692	241692	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037092_from_subject_765155402__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037075	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	18	0	WUGSC	HMP_production_phase_1
SRS011496.572361	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_95	SRR047478	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011496	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016333_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016308	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	34	0	WUGSC	HMP_production_phase_1
SRS063921.575363	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4464	SRR046760	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063921	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241824	241824	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113541_from_subject_763719065__sex_female_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700113503	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS015033.573128	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_506	SRR044011	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015033	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023688_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	4.8	WUGSC	HMP_production_phase_1
SRS051220.572761	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3594	SRR048669	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051220	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110153_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700110110	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	24	4.3	BCM	HMP_production_phase_1
SRS020561.572019	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1720	SRR041901	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095884_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095848	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS050634.574841	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3543	SRR046299	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050634	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241717	241717	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105719_from_subject_763456073__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105683	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	31	5	WUGSC	HMP_production_phase_1
SRS021510.573430	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1949	SRR041635	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021510	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097222_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097190	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS024220.571978	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2623	SRR041987	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024220	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101107_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101082	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS051711.570378	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3632	SRR048753	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051711	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110127_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110097	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	4.3	BCM	HMP_production_phase_1
SRS054390.575145	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3844	SRR047208	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054390	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106101_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106069	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	18	4.5	WUGSC	HMP_production_phase_1
SRS053956.575647	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_3820	SRR041450	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053956	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241749	241749	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101309_from_subject_159672603__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101290	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS011512.570884	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_105	SRR045324	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011512	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016366_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016349	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	4.2	WUGSC	HMP_production_phase_1
SRS062667.574819	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4274	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062667	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111841_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111815	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	36	0	JCVI	HMP_production_phase_1
SRS056424.574816	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4017	SRR046452	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056424	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241880	241880	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105964_from_subject_658594300__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	WUGSC	HMP_production_phase_1
SRS020946.572597	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1807	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020946	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096457_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096428	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	0	JCVI	HMP_production_phase_1
SRS015307.574680	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_573	SRR043750	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015307	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023962_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700023932	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	37	0	WUGSC	HMP_production_phase_1
SRS011413.572250	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_49	SRR049235	20.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011413	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241702	241702	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016021_from_subject_159005010__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016004	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	20	4.2	WUGSC	HMP_production_phase_1
SRS042550.576386	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2796	SRR048675	32.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042550	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108276_from_subject_160704339__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700108236	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	32	4.6	BCM	HMP_production_phase_1
SRS019681.575207	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1545	SRR043948	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019681	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038154_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038124	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS055039.570233	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3897	SRR058112	23.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055039	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241688	241688	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109806_from_subject_161331472__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700109768	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	23	0	JCVI	HMP_production_phase_1
SRS011456.573478	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_74	SRR044953	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011456	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016154_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016125	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	WUGSC	HMP_production_phase_1
SRS019079.572593	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1467	SRR044662	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019079	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037550_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037534	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS015958.574453	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_741	SRR044101	22.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241769	241769	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024613_from_subject_764325968__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	WUGSC	HMP_production_phase_1
SRS056608.570983	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4037	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241867	241867	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101829_from_subject_514014184__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700101789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	4.2	JCVI	HMP_production_phase_1
SRS023553.573682	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2454	SRR041267	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023553	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099830_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099807	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS014972.573420	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_490	SRR043919	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014972	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023627_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023600	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS022554.574899	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2206	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022554	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098459_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098433	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	5	JCVI	HMP_production_phase_1
SRS018523.574074	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1379	SRR041408	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018523	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035987_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700035948	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	4.1	BI	HMP_production_phase_1
SRS054112.574321	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3828	SRR048547	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054112	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108929_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108903	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BCM	HMP_production_phase_1
SRS014629.571878	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_410	SRR045687	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023283_from_subject_763840445__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023245	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	38	4.1	WUGSC	HMP_production_phase_1
SRS011296.571526	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_30	SRR044980	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011296	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241748	241748	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015301_from_subject_158802708__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700015299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	WUGSC	HMP_production_phase_1
SRS023891.570308	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2544	SRR048220	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023891	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241755	241755	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100289_from_subject_158883629__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100247	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	29	4.9	BCM	HMP_production_phase_1
SRS020324.573368	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1661	SRR041363	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020324	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095577_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095541	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS063697.572675	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4424	SRR050136	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063697	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113505_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700113485	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	WUGSC	HMP_production_phase_1
SRS011462.573982	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_77	SRR045074	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016160_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016128	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	WUGSC	HMP_production_phase_1
SRS024052.576620	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2583	SRR040930	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024052	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100514_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100483	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	4.7	BI	HMP_production_phase_1
SRS063173.575057	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4349	SRR049590	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063173	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114395_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114375	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	32	0	WUGSC	HMP_production_phase_1
SRS055141.571452	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3906	SRR045868	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055141	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038763_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	5.3	WUGSC	HMP_production_phase_1
SRS018529.571881	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1382	SRR040796	21.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018529	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241667	241667	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035993_from_subject_160259276__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700035951	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	21	4.1	BI	HMP_production_phase_1
SRS051724.574938	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3633	SRR046601	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051724	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105920_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105890	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	WUGSC	HMP_production_phase_1
SRS042248.576475	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2770	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042248	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241698	241698	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110403_from_subject_650853796__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110367	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	4.4	JCVI	HMP_production_phase_1
SRS057461.575871	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4105	SRR046278	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057461	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103452_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103433	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	33	0	WUGSC	HMP_production_phase_1
SRS065675.572179	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4728	SRR047337	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241877	241877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113073_from_subject_764872181__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113056	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	WUGSC	HMP_production_phase_1
SRS020443.574736	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1692	SRR040872	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020443	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095766_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095732	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS020016.570759	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1594	SRR041027	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020016	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095261_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095226	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.3	BI	HMP_production_phase_1
SRS020833.574002	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1780	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020833	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096307_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096278	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	JCVI	HMP_production_phase_1
SRS058581.573334	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4203	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058581	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110027_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109997	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	JCVI	HMP_production_phase_1
SRS024541.576180	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2712	SRR048416	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024541	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241819	241819	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101687_from_subject_159389382__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101653	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS063310.576056	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4371	SRR046508	30.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063310	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257118	257118	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114933_from_subject_561079058__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114908	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	30	4.1	WUGSC	HMP_production_phase_1
SRS050871.570894	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3561	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107216_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107193	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	JCVI	HMP_production_phase_1
SRS019910.573732	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1584	SRR044428	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241772	241772	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038386_from_subject_764892411__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038354	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS023422.575327	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2428	SRR048157	24.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023422	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241766	241766	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099609_from_subject_158438567__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099590	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	0	BCM	HMP_production_phase_1
SRS019399.571418	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1509	SRR046600	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019399	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241805	241805	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037870_from_subject_765560005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037853	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS049622.575233	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3446	SRR046797	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049622	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103325_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	19	4.7	WUGSC	HMP_production_phase_1
SRS020382.571851	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1675	SRR043047	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020382	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095701_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	TRUE	y	TCAG	UBERON:sebum	700095663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	4.2	BI	HMP_production_phase_1
SRS016121.571166	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_789	SRR044385	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016121	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024778_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	4.5	WUGSC	HMP_production_phase_1
SRS047042.571684	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3220	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047042	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109419_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109390	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	4.8	JCVI	HMP_production_phase_1
SRS056523.575759	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4031	SRR047146	34.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056523	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241761	241761	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105447_from_subject_763557224__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700105415	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	34	4.2	WUGSC	HMP_production_phase_1
SRS055187.572837	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3910	SRR048677	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055187	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108270_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108233	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	32	4.6	BCM	HMP_production_phase_1
SRS015362.572763	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_588	SRR043989	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015362	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024017_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023982	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	3.7	WUGSC	HMP_production_phase_1
SRS011498.570697	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_97	SRR045442	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011498	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016337_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016310	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS064025.575143	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4488	SRR049570	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064025	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114852_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114815	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	4.1	WUGSC	HMP_production_phase_1
SRS022249.573803	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2133	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022249	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098018_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097984	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	4.2	JCVI	HMP_production_phase_1
SRS017406.576443	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1106	SRR040657	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034112_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034087	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	0	BI	HMP_production_phase_1
SRS018801.571328	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1434	SRR046184	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018801	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037268_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037244	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS054824.570214	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3881	SRR046710	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054824	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241863	241863	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105025_from_subject_275382046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106991	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	0	WUGSC	HMP_production_phase_1
SRS056770.572745	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4052	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056770	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241694	241694	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109368_from_subject_160866180__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109331	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	4.6	JCVI	HMP_production_phase_1
SRS018331.570553	TCAGAACCTTCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1330	SRR041583	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018331	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035765_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035737	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	BI	HMP_production_phase_1
SRS011561.573026	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_130	SRR045089	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011561	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033005_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033003	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.7	WUGSC	HMP_production_phase_1
SRS063239.573965	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4357	SRR058092	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063239	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257122	257122	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111073_from_subject_686765762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111040	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS011443.573308	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_67	SRR045412	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011443	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016092_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016053	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	20	4.2	WUGSC	HMP_production_phase_1
SRS018274.571175	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1315	SRR041294	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018274	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035681_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035647	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	3.9	BI	HMP_production_phase_1
SRS022950.571251	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2309	SRR048417	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022950	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098980_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700098945	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	37	4.6	BCM	HMP_production_phase_1
SRS019091.575915	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1472	SRR044744	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019091	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037562_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037540	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS021386.572404	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1915	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021386	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097044_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097011	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	4.6	JCVI	HMP_production_phase_1
SRS064082.573259	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4499	SRR047030	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064082	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114363_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114335	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	21	0	WUGSC	HMP_production_phase_1
SRS020728.574781	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1758	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020728	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096153_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096119	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	JCVI	HMP_production_phase_1
SRS055825.572599	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3964	SRR046303	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055825	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241761	241761	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105453_from_subject_763557224__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105418	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	34	4.2	WUGSC	HMP_production_phase_1
SRS024028.574350	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2575	SRR041584	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024028	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241834	241834	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100490_from_subject_159247771__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700100471	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	4.7	BI	HMP_production_phase_1
SRS017835.573079	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1205	SRR041282	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017835	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034940_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034914	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	BI	HMP_production_phase_1
SRS064354.571083	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4534	SRR048775	39.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064354	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268866	268866	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111636_from_subject_937495960__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111594	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	39	4.8	BCM	HMP_production_phase_1
SRS057901.571477	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_4151	SRR041646	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241746	241746	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102375_from_subject_159490532__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102356	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS023762.573784	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2512	SRR040987	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023762	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100069_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100036	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS017212.576461	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1061	SRR041478	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033818_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033817	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	29	0	BI	HMP_production_phase_1
SRS021692.570692	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1994	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021692	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241688	241688	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097404_from_subject_161331472__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097371	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	JCVI	HMP_production_phase_1
SRS014817.576027	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_444	SRR045734	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014817	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023471_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023444	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.1	WUGSC	HMP_production_phase_1
SRS015508.572255	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_620	SRR044269	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015508	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241707	241707	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024163_from_subject_764245047__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024136	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.1	WUGSC	HMP_production_phase_1
SRS021203.576588	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1871	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021203	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241842	241842	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096750_from_subject_161007791__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096714	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	5	JCVI	HMP_production_phase_1
SRS014756.574682	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_427	SRR043762	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014756	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023410_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023385	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	4.2	WUGSC	HMP_production_phase_1
SRS024604.573709	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2727	SRR043225	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024604	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241833	241833	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101895_from_subject_159591683__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	NA	y	TCAG	UBERON:nasal mucus	700101858	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS022414.574380	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2173	SRR048189	27.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022414	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241719	241719	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098289_from_subject_158742018__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098267	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	5.8	BCM	HMP_production_phase_1
SRS054072.571064	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3825	SRR048496	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054072	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108638_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108606	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	31	0	BCM	HMP_production_phase_1
SRS023013.573538	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2325	SRR048365	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023013	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099047_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099015	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	BCM	HMP_production_phase_1
SRS015137.571209	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_519	SRR043912	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015137	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023792_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023703	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	4.5	WUGSC	HMP_production_phase_1
SRS024293.575173	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2645	SRR041748	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024293	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101271_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101238	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	3.7	BI	HMP_production_phase_1
SRS044681.575783	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2992	SRR046475	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044681	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241708	241708	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105763_from_subject_764447348__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105735	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS049959.573354	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3473	SRR046215	39.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049959	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241884	241884	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038414_from_subject_765701615__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038392	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	39	0	WUGSC	HMP_production_phase_1
SRS024273.575165	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2636	SRR041706	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024273	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101251_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101228	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	3.7	BI	HMP_production_phase_1
SRS051849.574340	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3645	SRR046840	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051849	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105512_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105476	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	5	WUGSC	HMP_production_phase_1
SRS011427.575684	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_56	SRR045101	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016071_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS015911.572245	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_728	SRR044585	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015911	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241778	241778	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024566_from_subject_764305738__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024545	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS056430.572014	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4018	SRR044482	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056430	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106040_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106010	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	3.8	WUGSC	HMP_production_phase_1
SRS015708.571368	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_673	SRR044247	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015708	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024363_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024341	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	3.6	WUGSC	HMP_production_phase_1
SRS016004.572187	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_754	SRR047417	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016004	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024659_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024639	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	WUGSC	HMP_production_phase_1
SRS048439.571062	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3342	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048439	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102157_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102124	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	36	3.9	JCVI	HMP_production_phase_1
SRS017906.572172	TCAGAACGTTCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1227	SRR041427	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017906	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241799	241799	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035204_from_subject_160441347__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035171	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS017473.572752	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1124	SRR041281	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017473	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034206_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	5.1	BI	HMP_production_phase_1
SRS017483.573731	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1129	SRR041265	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017483	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034216_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	5.1	BI	HMP_production_phase_1
SRS016217.575060	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_815	SRR044377	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016217	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241687	241687	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024880_from_subject_764649650__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024853	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.1	WUGSC	HMP_production_phase_1
SRS021853.576597	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2031	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241744	241744	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097589_from_subject_161270782__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700097570	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	JCVI	HMP_production_phase_1
SRS022303.572354	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2143	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022303	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098143_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098115	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	4.5	JCVI	HMP_production_phase_1
SRS017298.570874	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1085	SRR043031	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017298	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033973_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033938	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS015611.575097	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_646	SRR044255	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015611	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241784	241784	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024266_from_subject_764346198__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4.4	WUGSC	HMP_production_phase_1
SRS014253.571260	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_326	SRR051590	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014253	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021842_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700021816	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS014239.574301	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_323	SRR049434	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014239	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021828_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700021809	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS058627.574117	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4209	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058627	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102330_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102305	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	JCVI	HMP_production_phase_1
SRS065628.572596	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4720	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065628	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241753	241753	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110663_from_subject_368533040__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110644	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	30	0	JCVI	HMP_production_phase_1
SRS011571.572516	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_135	SRR044960	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011571	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033020_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033018	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.7	WUGSC	HMP_production_phase_1
SRS022691.573371	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2245	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022691	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098643_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098610	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	4.6	JCVI	HMP_production_phase_1
SRS055620.575033	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3938	SRR048471	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055620	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107530_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107500	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BCM	HMP_production_phase_1
SRS022878.574932	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2291	SRR058086	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022878	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098908_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098876	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	4.6	JCVI	HMP_production_phase_1
SRS065194.574825	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4647	SRR049916	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065194	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241824	241824	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113531_from_subject_763719065__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700113498	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS062532.573501	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4250	SRR046557	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062532	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241805	241805	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114345_from_subject_765560005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114326	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS018343.572063	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1336	SRR042879	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018343	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035777_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035743	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS014671.576293	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_421	SRR045757	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023325_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700023296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS014281.570421	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_336	SRR045515	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014281	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021870_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700021358	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS058543.572143	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4202	SRR058096	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110015_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109991	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	0	JCVI	HMP_production_phase_1
SRS016865.574316	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_985	SRR042024	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016865	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033226_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033225	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS017278.575724	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1075	SRR041275	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017278	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033953_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033928	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS022643.570972	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2236	SRR041885	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022643	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098595_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098559	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS048684.574870	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3364	SRR048749	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048684	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108586_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108547	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	30	3.9	BCM	HMP_production_phase_1
SRS021875.570656	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2038	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021875	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097611_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700097581	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	JCVI	HMP_production_phase_1
SRS064884.575545	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4599	SRR058113	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064884	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110620_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110594	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	JCVI	HMP_production_phase_1
SRS020773.570241	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1765	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020773	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096198_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096170	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	JCVI	HMP_production_phase_1
SRS055904.571098	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3974	SRR048407	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055904	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102625_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102594	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	4.5	BCM	HMP_production_phase_1
SRS021324.574101	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1900	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021324	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096982_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096953	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	0	JCVI	HMP_production_phase_1
SRS016016.574241	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_760	SRR049447	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016016	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024671_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024645	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS064093.575472	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4501	SRR048433	35.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064093	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241804	241804	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110806_from_subject_158984779__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110773	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	35	4.6	BCM	HMP_production_phase_1
SRS043898.570356	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2921	SRR040977	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043898	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102993_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102970	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS020781.572164	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1769	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020781	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096206_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS019554.572184	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1519	SRR045547	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019554	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038025_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038007	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS019906.572078	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1582	SRR044378	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019906	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038382_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038352	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS019103.570469	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1477	SRR044683	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037574_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037546	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS047237.573486	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3237	SRR045778	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047237	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	TRUE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038500_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038483	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	31	0	WUGSC	HMP_production_phase_1
SRS062739.574522	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4286	SRR049561	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062739	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241890	241890	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114832_from_subject_375450439__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114805	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	24	4.1	WUGSC	HMP_production_phase_1
SRS021830.574842	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2029	SRR058120	40.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021830	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097543_from_subject_161473083__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097501	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	40	5.1	JCVI	HMP_production_phase_1
SRS066144.573076	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058120	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS049949.575471	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3470	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049949	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241754	241754	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108493_from_subject_160967330__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700108473	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	32	0	JCVI	HMP_production_phase_1
SRS058387.573009	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4187	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058387	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102559_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	4.6	JCVI	HMP_production_phase_1
SRS021680.574951	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1988	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021680	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097392_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097365	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	JCVI	HMP_production_phase_1
SRS015011.574387	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_496	SRR049852	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015011	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241718	241718	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023666_from_subject_764062976__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	20	4.8	WUGSC	HMP_production_phase_1
SRS053477.576394	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3782	SRR049638	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053477	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241893	241893	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105073_from_subject_178713055__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.5	WUGSC	HMP_production_phase_1
SRS042504.574041	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_2792	SRR047696	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042504	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106095_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106066	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	18	4.5	WUGSC	HMP_production_phase_1
SRS011684.571191	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_193	SRR044935	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011684	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033789_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700033746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.4	WUGSC	HMP_production_phase_1
SRS018739.573662	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1414	SRR044410	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018739	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037206_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037126	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	4.5	WUGSC	HMP_production_phase_1
SRS043688.572278	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2902	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043688	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257133	257133	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102571_from_subject_937415040__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102534	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	4.6	JCVI	HMP_production_phase_1
SRS016553.575183	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_913	SRR040617	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016553	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032280_from_subject_159753524__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4	BI	HMP_production_phase_1
SRS047419.575270	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3251	SRR049871	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047419	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038480_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038449	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS016279.572567	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_837	SRR043977	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016279	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024942_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024914	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	WUGSC	HMP_production_phase_1
SRS063965.575229	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4476	SRR050112	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063965	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113037_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113014	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	21	0	WUGSC	HMP_production_phase_1
SRS024472.571427	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2691	SRR041194	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101618_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101590	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	38	0	BI	HMP_production_phase_1
SRS057730.571330	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4134	SRR047226	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057730	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103629_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103609	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	19	0	WUGSC	HMP_production_phase_1
SRS017853.571235	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1214	SRR042815	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034958_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700034923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS021201.573174	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1870	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021201	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096748_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096713	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	5	JCVI	HMP_production_phase_1
SRS064445.573753	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4546	SRR048871	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064445	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110782_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110761	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	4.6	BCM	HMP_production_phase_1
SRS015968.574457	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_745	SRR044013	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015968	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024623_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024597	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	0	WUGSC	HMP_production_phase_1
SRS056891.575117	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4064	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056891	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107220_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107195	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	JCVI	HMP_production_phase_1
SRS021127.570416	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1850	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021127	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096674_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096599	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	4.9	JCVI	HMP_production_phase_1
SRS011497.575707	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_96	SRR045441	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011497	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016335_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016309	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS017910.573912	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1229	SRR042796	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241799	241799	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035208_from_subject_160441347__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS017493.570324	TCAGAAGTCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1134	SRR041320	19.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017493	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034226_from_subject_160319967__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034185	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	19	5.1	BI	HMP_production_phase_1
SRS064479.571559	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4550	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064479	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110734_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110708	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	0	JCVI	HMP_production_phase_1
SRS053518.574622	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3787	SRR046040	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053518	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241864	241864	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038793_from_subject_508703490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700038757	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	5.3	WUGSC	HMP_production_phase_1
SRS050571.571996	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3537	SRR048909	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050571	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108876_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700108848	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	BCM	HMP_production_phase_1
SRS019239.573778	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1487	SRR047436	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019239	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241800	241800	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037710_from_subject_765034022__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037686	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.2	WUGSC	HMP_production_phase_1
SRS016938.573810	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1003	SRR040999	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016938	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033404_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033374	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS023691.570949	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2492	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023691	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099998_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099966	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	4.1	JCVI	HMP_production_phase_1
SRS024537.575385	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2710	SRR048182	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101683_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101651	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BCM	HMP_production_phase_1
SRS015913.575791	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_729	SRR044630	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015913	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024568_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024546	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS058765.572867	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4219	SRR048459	33.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058765	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102895_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700102862	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	33	0	BCM	HMP_production_phase_1
SRS017189.570706	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1057	SRR045489	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017189	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033783_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700033743	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.4	WUGSC	HMP_production_phase_1
SRS016773.576437	TCAGACGGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_972	SRR041457	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016773	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032964_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032935	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	BI	HMP_production_phase_1
SRS047736.573839	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3288	SRR048539	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047736	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109606_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109575	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	0	BCM	HMP_production_phase_1
SRS020320.570735	TCAGCCGACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1659	SRR041865	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020320	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095573_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095539	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS022681.574916	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2240	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022681	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098633_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098605	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	4.6	JCVI	HMP_production_phase_1
SRS013656.574608	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_267	SRR041535	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013656	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016734_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016701	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	33	0	BI	HMP_production_phase_1
SRS018406.576088	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1351	SRR042994	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241797	241797	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035840_from_subject_160178356__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035803	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	BI	HMP_production_phase_1
SRS020202.576503	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1627	SRR048149	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020202	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095455_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095423	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	32	0	BCM	HMP_production_phase_1
SRS066144.570253	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043073	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS022317.570845	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2150	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022317	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098157_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098122	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	4.5	JCVI	HMP_production_phase_1
SRS011371.572800	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_39	SRR044950	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011371	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015659_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015657	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS015663.574452	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_662	SRR044257	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241845	241845	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024318_from_subject_764487809__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	WUGSC	HMP_production_phase_1
SRS024169.575344	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2612	SRR041920	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100637_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100609	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS015870.576459	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_716	SRR043795	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015870	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024525_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024500	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	39	0	WUGSC	HMP_production_phase_1
SRS024702.573180	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2749	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024702	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102082_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102053	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	30	0	JCVI	HMP_production_phase_1
SRS019257.574990	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1496	SRR044404	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019257	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037728_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037695	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.2	WUGSC	HMP_production_phase_1
SRS018451.574474	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1360	SRR041175	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018451	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035885_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035854	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS049441.573488	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3433	SRR048731	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049441	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241671	241671	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107983_from_subject_160056975__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107947	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS013267.574976	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_227	SRR041423	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013267	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241833	241833	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015974_from_subject_159591683__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015973	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS014837.571544	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_453	SRR047556	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014837	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241793	241793	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023491_from_subject_763921366__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023454	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.1	WUGSC	HMP_production_phase_1
SRS057473.573064	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4107	SRR046522	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057473	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038416_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038393	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	39	0	WUGSC	HMP_production_phase_1
SRS022123.573520	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2100	SRR043052	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097889_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097852	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.4	BI	HMP_production_phase_1
SRS011498.574585	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_97	SRR047523	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011498	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016337_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016310	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS065156.576510	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4637	SRR047674	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065156	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114019_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114001	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	36	0	WUGSC	HMP_production_phase_1
SRS011586.570758	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_144	SRR044971	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011586	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241783	241783	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033153_from_subject_159733294__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.3	WUGSC	HMP_production_phase_1
SRS023701.575171	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2497	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023701	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100008_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099971	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	4.1	JCVI	HMP_production_phase_1
SRS021149.573025	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1859	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021149	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241801	241801	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096696_from_subject_160744799__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096610	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	20	4.9	JCVI	HMP_production_phase_1
SRS024657.575214	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2740	SRR041280	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101948_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101913	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS018599.574824	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1402	SRR044408	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018599	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037066_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037038	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	19	0	WUGSC	HMP_production_phase_1
SRS022494.576224	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2192	SRR048173	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022494	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098395_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098366	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	30	4.5	BCM	HMP_production_phase_1
SRS065500.572377	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4693	SRR058084	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241751	241751	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110309_from_subject_892969023__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110287	n	969	120	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	JCVI	HMP_production_phase_1
SRS016612.572428	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_928	SRR041354	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016612	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032365_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032330	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	31	4.3	BI	HMP_production_phase_1
SRS058182.571737	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4168	SRR040988	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058182	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102405_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102371	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS011417.570780	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_51	SRR044943	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011417	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016059_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	WUGSC	HMP_production_phase_1
SRS024056.570686	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2585	SRR042816	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024056	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100518_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700100485	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	4.7	BI	HMP_production_phase_1
SRS053513.573307	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3786	SRR058096	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053513	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109276_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109242	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	4.8	JCVI	HMP_production_phase_1
SRS016543.575570	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_908	SRR041699	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016543	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032270_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032235	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4	BI	HMP_production_phase_1
SRS023268.571065	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2391	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023268	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099426_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099394	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS015015.573230	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_498	SRR044105	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015015	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241718	241718	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023670_from_subject_764062976__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023642	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	20	4.8	WUGSC	HMP_production_phase_1
SRS022159.574664	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2107	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022159	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241683	241683	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097928_from_subject_638754422__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700097906	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.5	JCVI	HMP_production_phase_1
SRS011624.570298	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_164	SRR045341	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011624	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033455_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033454	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.1	WUGSC	HMP_production_phase_1
SRS024367.576170	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2667	SRR041960	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241814	241814	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101402_from_subject_159551223__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700101365	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS016261.572598	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_828	SRR044809	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016261	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024924_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024905	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	WUGSC	HMP_production_phase_1
SRS066144.576318	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043083	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS011609.575226	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_156	SRR045418	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011609	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033185_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033146	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4.3	WUGSC	HMP_production_phase_1
SRS043706.575552	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2905	SRR058112	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043706	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107868_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107832	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS044945.571744	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3022	SRR048574	19.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044945	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109681_from_subject_160319967__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109640	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	19	4.7	BCM	HMP_production_phase_1
SRS014597.574348	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_397	SRR045750	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014597	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023251_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	4.1	WUGSC	HMP_production_phase_1
SRS019083.571658	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1469	SRR044664	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019083	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037554_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037536	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS014921.574818	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_474	SRR045702	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014921	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023576_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023550	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS023999.573213	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2570	SRR042859	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100460_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100427	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS046755.574230	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3193	SRR047152	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046755	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257127	257127	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105636_from_subject_953045535__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105615	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	29	3.8	WUGSC	HMP_production_phase_1
SRS011365.576399	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_36	SRR045373	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011365	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015650_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015648	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	33	0	WUGSC	HMP_production_phase_1
SRS019302.571392	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1501	SRR046512	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019302	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241848	241848	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037773_from_subject_765377934__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	4.1	WUGSC	HMP_production_phase_1
SRS016886.573660	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_992	SRR041676	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033247_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033246	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS065123.575026	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4631	SRR049426	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114641_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114609	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	4.3	WUGSC	HMP_production_phase_1
SRS053271.574213	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3762	SRR049509	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053271	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105818_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105785	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.6	WUGSC	HMP_production_phase_1
SRS024478.576544	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2694	SRR041120	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024478	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101624_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101593	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	38	0	BI	HMP_production_phase_1
SRS019562.574864	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1523	SRR045784	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019562	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038033_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038011	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	37	0	WUGSC	HMP_production_phase_1
SRS011609.574795	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_156	SRR047527	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011609	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033185_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033146	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4.3	WUGSC	HMP_production_phase_1
SRS047158.571965	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3231	SRR046775	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047158	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241893	241893	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105085_from_subject_178713055__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105048	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.5	WUGSC	HMP_production_phase_1
SRS011525.570338	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_112	SRR045070	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016504_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016499	n	969	23	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	34	3.6	WUGSC	HMP_production_phase_1
SRS014235.575451	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_321	SRR049364	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014235	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241791	241791	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021824_from_subject_763678604__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700021807	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS024476.572450	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2693	SRR041682	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024476	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101622_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700101592	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	38	0	BI	HMP_production_phase_1
SRS018029.573570	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1257	SRR043283	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018029	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241734	241734	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035353_from_subject_160239046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS014434.572002	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_367	SRR043600	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014434	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023088_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023062	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	3.4	WUGSC	HMP_production_phase_1
SRS047054.570589	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3221	SRR048249	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047054	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102279_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102251	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	0	BCM	HMP_production_phase_1
SRS024714.571646	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2755	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024714	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102094_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102059	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	30	0	JCVI	HMP_production_phase_1
SRS052906.572334	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3734	SRR048895	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052906	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109614_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109579	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS020706.574857	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1748	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020706	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096131_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096108	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	0	JCVI	HMP_production_phase_1
SRS050470.575281	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3531	SRR045522	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050470	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038720_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038692	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	3.7	WUGSC	HMP_production_phase_1
SRS051359.572968	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3608	SRR049450	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051359	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241893	241893	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105083_from_subject_178713055__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105047	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.5	WUGSC	HMP_production_phase_1
SRS011671.572779	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_187	SRR044981	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011671	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033775_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033739	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.4	WUGSC	HMP_production_phase_1
SRS020249.575900	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1637	SRR041971	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020249	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095502_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095475	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	0	BI	HMP_production_phase_1
SRS065478.575208	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4686	SRR048872	35.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065478	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241804	241804	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110800_from_subject_158984779__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110770	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	4.6	BCM	HMP_production_phase_1
SRS063023.571736	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4329	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063023	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110677_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110651	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	30	0	JCVI	HMP_production_phase_1
SRS020561.570691	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1720	SRR041167	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095884_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095848	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS048275.576257	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3334	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048275	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257133	257133	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102579_from_subject_937415040__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102538	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	38	4.6	JCVI	HMP_production_phase_1
SRS021814.570948	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2023	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021814	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097527_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097493	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	40	0	JCVI	HMP_production_phase_1
SRS066188.575917	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048658	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS011436.574693	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_62	SRR045082	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011436	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016083_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016048	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS015528.570803	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_628	SRR044248	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015528	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024183_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024146	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.1	WUGSC	HMP_production_phase_1
SRS019111.573476	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1481	SRR044693	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019111	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037582_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024089	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS054426.572803	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3847	SRR048254	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054426	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102283_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102253	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	0	BCM	HMP_production_phase_1
SRS014655.574515	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_413	SRR046102	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023309_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	37	0	WUGSC	HMP_production_phase_1
SRS023627.572563	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2475	SRR041474	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099930_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099897	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	20	4.9	BI	HMP_production_phase_1
SRS062615.570215	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4265	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111859_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111824	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	36	0	JCVI	HMP_production_phase_1
SRS015603.571132	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_642	SRR044481	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015603	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241784	241784	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024258_from_subject_764346198__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024236	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.4	WUGSC	HMP_production_phase_1
SRS014927.574631	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_477	SRR046673	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014927	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023582_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS014570.570402	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_393	SRR046153	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014570	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023224_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023187	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	3.8	WUGSC	HMP_production_phase_1
SRS063059.571810	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4332	SRR046997	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063059	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257130	257130	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114234_from_subject_663835652__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114212	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	4.5	WUGSC	HMP_production_phase_1
SRS017557.572608	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1150	SRR040604	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034290_from_subject_160502038__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034250	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	4.1	BI	HMP_production_phase_1
SRS016064.574516	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_774	SRR044218	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016064	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024721_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024694	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	WUGSC	HMP_production_phase_1
SRS050224.576323	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3499	SRR049388	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050224	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241844	241844	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105224_from_subject_763820215__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105203	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	4	WUGSC	HMP_production_phase_1
SRS020445.576107	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1693	SRR042915	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095768_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095733	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS018439.574283	TCAGTCCGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1354	SRR041984	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018439	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035873_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035848	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS022761.573161	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2264	SRR058114	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022761	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098717_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098682	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	4.1	JCVI	HMP_production_phase_1
SRS021617.574728	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1972	SRR048046	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097329_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097299	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	4.9	BCM	HMP_production_phase_1
SRS014623.572385	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_407	SRR046165	38.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023277_from_subject_763840445__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	38	4.1	WUGSC	HMP_production_phase_1
SRS062811.575324	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4300	SRR048797	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062811	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111260_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	5	BCM	HMP_production_phase_1
SRS065329.572988	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4665	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065329	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111532_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111509	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	JCVI	HMP_production_phase_1
SRS057638.570629	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4127	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057638	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110395_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110363	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	4.4	JCVI	HMP_production_phase_1
SRS057548.572635	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4114	SRR048726	22.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057548	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241765	241765	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107601_from_subject_160097436__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700107564	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	0	BCM	HMP_production_phase_1
SRS045258.573112	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3052	SRR046052	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038767_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	5.3	WUGSC	HMP_production_phase_1
SRS065132.571262	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4634	SRR049923	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065132	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257132	257132	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114777_from_subject_901775393__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700114755	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS020819.576363	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1775	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020819	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096293_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096271	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	JCVI	HMP_production_phase_1
SRS023707.576584	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2499	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023707	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100014_from_subject_892969023__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700099974	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	4.1	JCVI	HMP_production_phase_1
SRS051454.574399	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3617	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051454	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102561_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102529	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	4.6	JCVI	HMP_production_phase_1
SRS022872.574588	TCAGCTACGCATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2288	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022872	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098902_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098873	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	4.6	JCVI	HMP_production_phase_1
SRS019677.576109	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1543	SRR046640	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038150_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038122	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS044546.574599	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2974	SRR047178	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044546	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241878	241878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105169_from_subject_612472597__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105147	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	38	4.3	WUGSC	HMP_production_phase_1
SRS017659.574872	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1159	SRR041816	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034659_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034631	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	0	BI	HMP_production_phase_1
SRS021500.575512	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1944	SRR041593	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021500	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097212_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097185	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS022171.575220	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2109	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022171	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097940_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097912	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.5	JCVI	HMP_production_phase_1
SRS017020.573456	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1019	SRR041519	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017020	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033533_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS056140.574971	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3991	SRR047668	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056140	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103460_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103437	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	33	0	WUGSC	HMP_production_phase_1
SRS017307.573991	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1089	SRR040886	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017307	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241839	241839	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033989_from_subject_159632143__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033988	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS047499.570495	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3261	SRR048504	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047499	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108646_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108610	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	4	BCM	HMP_production_phase_1
SRS023575.573481	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2464	SRR041332	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023575	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099852_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099818	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS016555.573471	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_914	SRR040756	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016555	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032282_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032241	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4	BI	HMP_production_phase_1
SRS011571.574263	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_135	SRR045336	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011571	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033020_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033018	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.7	WUGSC	HMP_production_phase_1
SRS020659.575987	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1740	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096084_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096056	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	JCVI	HMP_production_phase_1
SRS018198.573211	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1293	SRR040711	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018198	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035605_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035579	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	0	BI	HMP_production_phase_1
SRS015350.574064	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_583	SRR044012	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015350	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024005_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023976	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	3.7	WUGSC	HMP_production_phase_1
SRS017302.576201	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1087	SRR042881	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017302	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241724	241724	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033977_from_subject_159510762__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700033940	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS042585.571808	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2801	SRR048564	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042585	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109669_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109634	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	19	4.7	BCM	HMP_production_phase_1
SRS016235.572044	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_823	SRR044429	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016235	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024898_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024862	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4.1	WUGSC	HMP_production_phase_1
SRS053832.576416	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3813	SRR048274	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053832	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102623_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102593	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	4.5	BCM	HMP_production_phase_1
SRS024657.576262	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2740	SRR041834	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101948_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101913	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS058242.575128	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4174	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058242	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109366_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109330	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	4.6	JCVI	HMP_production_phase_1
SRS057692.573302	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4131	SRR040921	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057692	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102444_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102419	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS018396.574712	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1349	SRR041455	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018396	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035830_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035798	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	0	BI	HMP_production_phase_1
SRS023623.571682	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2473	SRR041799	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099926_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099895	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	20	4.9	BI	HMP_production_phase_1
SRS022695.573264	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2247	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022695	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098647_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098612	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	4.6	JCVI	HMP_production_phase_1
SRS048043.570613	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3314	SRR048453	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048043	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102875_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102852	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	33	0	BCM	HMP_production_phase_1
SRS048284.573329	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3335	SRR043606	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048284	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038458_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038438	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS020370.570492	TCAGACGGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1669	SRR041554	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020370	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095689_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095657	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	32	4.2	BI	HMP_production_phase_1
SRS017373.571205	TCAGAACCGGATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1103	SRR041321	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017373	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241674	241674	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034079_from_subject_160340197__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS017557.573152	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1150	SRR040751	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034290_from_subject_160502038__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034250	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	4.1	BI	HMP_production_phase_1
SRS016924.575853	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_997	SRR040927	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016924	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033390_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033367	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS064905.575113	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4601	SRR046755	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064905	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241784	241784	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113568_from_subject_764346198__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113545	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	4.1	WUGSC	HMP_production_phase_1
SRS042527.573675	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2793	SRR048555	25.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042527	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241826	241826	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108951_from_subject_160218816__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700108914	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BCM	HMP_production_phase_1
SRS045752.571057	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3096	SRR043959	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045752	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038730_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038697	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	3.7	WUGSC	HMP_production_phase_1
SRS022263.576187	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2138	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022263	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241786	241786	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098032_from_subject_970836795__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097991	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	29	4.2	JCVI	HMP_production_phase_1
SRS011502.574186	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_100	SRR045105	34.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011502	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016343_from_subject_159085930__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016313	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	34	0	WUGSC	HMP_production_phase_1
SRS014237.573487	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_322	SRR043964	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014237	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021826_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700021808	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS022858.574406	TCAGACTCTGTGAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2285	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022858	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241698	241698	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098888_from_subject_650853796__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098866	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	4.6	JCVI	HMP_production_phase_1
SRS015188.571136	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_533	SRR043788	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023843_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023814	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4	WUGSC	HMP_production_phase_1
SRS015560.573030	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_631	SRR044009	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015560	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024215_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024192	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	18	0	WUGSC	HMP_production_phase_1
SRS014271.573756	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_331	SRR047364	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014271	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021860_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS015772.572031	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_690	SRR044277	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024427_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024402	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	WUGSC	HMP_production_phase_1
SRS052098.570564	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3670	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052098	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109003_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108967	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	4.3	JCVI	HMP_production_phase_1
SRS014130.572069	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_317	SRR046178	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014130	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021689_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021684	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	3.9	WUGSC	HMP_production_phase_1
SRS048749.575972	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3370	SRR046678	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048749	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106534_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106500	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	32	4.3	WUGSC	HMP_production_phase_1
SRS014923.575333	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_475	SRR045709	33.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014923	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241808	241808	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023578_from_subject_763860675__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023551	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	33	0	WUGSC	HMP_production_phase_1
SRS019180.571167	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1482	SRR045986	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019180	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241684	241684	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037651_from_subject_765398164__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037634	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS023506.572636	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2446	SRR048226	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023506	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099783_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099755	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BCM	HMP_production_phase_1
SRS043503.572314	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2881	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043503	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241842	241842	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109009_from_subject_161007791__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108970	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	4.3	JCVI	HMP_production_phase_1
SRS049973.571029	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3475	SRR045848	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049973	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038878_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	WUGSC	HMP_production_phase_1
SRS064882.576278	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4598	SRR047673	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064882	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114157_from_subject_763840445__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114121	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	38	4.7	WUGSC	HMP_production_phase_1
SRS062500.574726	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4245	SRR047078	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062500	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114729_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114707	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	0	WUGSC	HMP_production_phase_1
SRS048103.576229	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3321	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110462_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110431	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	JCVI	HMP_production_phase_1
SRS023514.574130	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2450	SRR048394	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023514	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099791_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099759	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BCM	HMP_production_phase_1
SRS021910.573604	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2045	SRR048072	24.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241739	241739	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097650_from_subject_158155345__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097631	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	0	BCM	HMP_production_phase_1
SRS022265.574280	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2139	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022265	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241786	241786	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098034_from_subject_970836795__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097992	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	29	4.2	JCVI	HMP_production_phase_1
SRS045171.572701	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3040	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102350_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	JCVI	HMP_production_phase_1
SRS046313.573233	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3156	SRR046726	19.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046313	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241891	241891	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105334_from_subject_516889361__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	19	0	WUGSC	HMP_production_phase_1
SRS015460.570633	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_608	SRR044712	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024115_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024090	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS047554.576203	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3264	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047554	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109910_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109877	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS064792.571884	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4589	SRR049540	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064792	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114371_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114339	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS023940.575023	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2555	SRR041533	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023940	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100338_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100306	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS013762.575688	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_297	SRR048289	25.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013762	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241819	241819	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016921_from_subject_159389382__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700016902	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	BCM	HMP_production_phase_1
SRS064122.572234	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4503	SRR048710	35.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064122	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241804	241804	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110810_from_subject_158984779__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110775	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	35	4.6	BCM	HMP_production_phase_1
SRS014873.573554	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_462	SRR047399	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023527_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023502	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS044683.572954	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2993	SRR048583	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044683	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107918_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107886	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	0	BCM	HMP_production_phase_1
SRS051758.572576	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3638	SRR047210	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051758	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105658_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105626	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	3.8	WUGSC	HMP_production_phase_1
SRS011551.570826	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_125	SRR047470	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011551	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016655_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016653	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS019091.573829	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1472	SRR044652	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019091	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037562_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037540	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS016712.570618	TCAGAACGGTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_955	SRR040865	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016712	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032657_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032642	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.3	BI	HMP_production_phase_1
SRS019091.573826	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1472	SRR044716	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019091	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037562_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037540	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS015500.571105	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_617	SRR045761	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241707	241707	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024155_from_subject_764245047__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.1	WUGSC	HMP_production_phase_1
SRS016714.571980	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_956	SRR040891	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016714	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032659_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032643	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.3	BI	HMP_production_phase_1
SRS018860.572869	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1443	SRR046589	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018860	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241716	241716	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037327_from_subject_765256553__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	18	3.8	WUGSC	HMP_production_phase_1
SRS019243.572411	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1489	SRR044393	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019243	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241800	241800	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037714_from_subject_765034022__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037688	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.2	WUGSC	HMP_production_phase_1
SRS054007.570840	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3821	SRR048770	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054007	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109224_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109189	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	31	0	BCM	HMP_production_phase_1
SRS057895.575192	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4148	SRR046456	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057895	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241857	241857	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106565_from_subject_208027353__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106544	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	4.3	WUGSC	HMP_production_phase_1
SRS050481.576488	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3533	SRR042796	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050481	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107003_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102975	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS011584.574005	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_143	SRR044914	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011584	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033044_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.7	WUGSC	HMP_production_phase_1
SRS011440.575232	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_64	SRR045112	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011440	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241709	241709	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016087_from_subject_158964549__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016050	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS014369.575805	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_360	SRR043785	30.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014369	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241736	241736	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023023_from_subject_763516763__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700021295	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	WUGSC	HMP_production_phase_1
SRS024698.575407	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2747	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024698	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102078_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102051	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	30	0	JCVI	HMP_production_phase_1
SRS022291.574760	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2141	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022291	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241841	241841	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098131_from_subject_533247696__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098109	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	4.5	JCVI	HMP_production_phase_1
SRS022438.573974	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2181	SRR048196	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022438	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098313_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098279	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	5.8	BCM	HMP_production_phase_1
SRS015125.571221	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_513	SRR045735	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023780_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023697	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	4.5	WUGSC	HMP_production_phase_1
SRS058251.570499	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4176	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058251	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109914_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109879	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS015720.572657	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_679	SRR044289	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015720	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024375_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024347	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	3.6	WUGSC	HMP_production_phase_1
SRS019369.570325	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1507	SRR045898	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019369	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241771	241771	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037840_from_subject_765337473__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037808	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.5	WUGSC	HMP_production_phase_1
SRS054669.576548	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3871	SRR049351	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054669	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038781_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038751	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	5.3	WUGSC	HMP_production_phase_1
SRS020496.576100	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1704	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020496	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095819_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095787	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS058603.570782	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4207	SRR046714	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058603	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103317_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	4.7	WUGSC	HMP_production_phase_1
SRS020133.575833	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1606	SRR048130	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020133	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095386_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095360	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	31	0	BCM	HMP_production_phase_1
SRS022382.574518	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2169	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022382	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241768	241768	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098248_from_subject_492786515__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098215	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	35	0	JCVI	HMP_production_phase_1
SRS018165.574628	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1289	SRR043295	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018165	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035565_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS058193.570752	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4171	SRR047721	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058193	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241890	241890	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105798_from_subject_375450439__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105775	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.6	WUGSC	HMP_production_phase_1
SRS049406.571968	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3429	SRR046788	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049406	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105136_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105102	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	5.6	WUGSC	HMP_production_phase_1
SRS017410.571619	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1108	SRR041020	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017410	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034116_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034089	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	30	0	BI	HMP_production_phase_1
SRS015194.572050	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_536	SRR043927	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015194	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023849_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023817	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4	WUGSC	HMP_production_phase_1
SRS057795.571402	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4142	SRR046787	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057795	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106960_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106937	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	0	WUGSC	HMP_production_phase_1
SRS024682.575524	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2743	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024682	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241753	241753	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102062_from_subject_368533040__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102043	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	JCVI	HMP_production_phase_1
SRS020384.571579	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1676	SRR043009	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020384	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095703_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	TRUE	y	TCAG	UBERON:sebum	700095664	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	32	4.2	BI	HMP_production_phase_1
SRS063766.573623	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4434	SRR049572	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063766	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114739_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114712	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	0	WUGSC	HMP_production_phase_1
SRS053525.572269	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3788	SRR058096	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053525	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241735	241735	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109884_from_subject_161351702__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109864	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	0	JCVI	HMP_production_phase_1
SRS045999.573276	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3125	SRR043274	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102997_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102972	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS015454.574266	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_607	SRR044657	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024109_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024087	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS015442.574505	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_603	SRR044729	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015442	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024097_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS015233.572860	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_545	SRR044016	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015233	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023888_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023865	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	4.4	WUGSC	HMP_production_phase_1
SRS043428.576455	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2876	SRR048465	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043428	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107524_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107497	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	BCM	HMP_production_phase_1
SRS065444.571479	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4681	SRR049405	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257117	257117	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114590_from_subject_875002022__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700114555	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	21	0	WUGSC	HMP_production_phase_1
SRS022500.572535	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2195	SRR048175	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098401_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098369	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	30	4.5	BCM	HMP_production_phase_1
SRS021885.575661	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2042	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021885	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097621_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	JCVI	HMP_production_phase_1
SRS052906.575686	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3734	SRR048732	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052906	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109614_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109579	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS015180.573617	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_529	SRR043767	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015180	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241675	241675	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023835_from_subject_763759525__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023810	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4	WUGSC	HMP_production_phase_1
SRS018747.575786	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1417	SRR049308	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018747	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037214_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	4.5	WUGSC	HMP_production_phase_1
SRS017408.572557	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1107	SRR041030	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034114_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034088	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	30	0	BI	HMP_production_phase_1
SRS056736.575904	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4049	SRR048660	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056736	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110131_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110099	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	4.3	BCM	HMP_production_phase_1
SRS054661.572780	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3870	SRR048745	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108212_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108177	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	21	0	BCM	HMP_production_phase_1
SRS017420.571170	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1113	SRR041026	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017420	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034126_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034094	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	30	0	BI	HMP_production_phase_1
SRS057423.574889	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4101	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057423	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109360_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109327	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	4.6	JCVI	HMP_production_phase_1
SRS020899.575990	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1797	SRR041526	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020899	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096410_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096376	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	31	0	BI	HMP_production_phase_1
SRS023619.570809	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2471	SRR041122	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099922_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099893	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	20	4.9	BI	HMP_production_phase_1
SRS064351.574043	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4533	SRR058108	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110693_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110659	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	30	0	JCVI	HMP_production_phase_1
SRS051280.571707	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3602	SRR058108	40.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051280	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241849	241849	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110273_from_subject_161473083__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110236	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	40	4.9	JCVI	HMP_production_phase_1
SRS044902.575279	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3018	SRR044205	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044902	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241696	241696	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024845_from_subject_764366428__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024807	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	3.9	WUGSC	HMP_production_phase_1
SRS013460.571482	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_232	SRR041714	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016391_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016379	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	BI	HMP_production_phase_1
SRS053001.570424	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3741	SRR043751	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053001	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038560_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038537	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	32	0	WUGSC	HMP_production_phase_1
SRS051099.575005	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3582	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051099	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109912_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109878	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS024351.575107	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2659	SRR043226	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101386_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101357	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS024108.572240	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2595	SRR041209	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024108	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100573_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100547	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS049935.574852	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3467	SRR048664	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049935	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110133_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700110100	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	4.3	BCM	HMP_production_phase_1
SRS022167.573156	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2108	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022167	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097936_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097910	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.5	JCVI	HMP_production_phase_1
SRS057422.570575	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4100	SRR048283	22.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102643_from_subject_159227541__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102603	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.5	BCM	HMP_production_phase_1
SRS018250.572026	TCAGTTCAACGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1307	SRR041356	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018250	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241785	241785	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035657_from_subject_160137896__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	3.9	BI	HMP_production_phase_1
SRS051464.571531	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3618	SRR048572	19.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051464	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109683_from_subject_160319967__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109641	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	19	4.7	BCM	HMP_production_phase_1
SRS053901.576246	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3816	SRR047196	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103633_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103611	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	19	0	WUGSC	HMP_production_phase_1
SRS048998.570823	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3390	SRR048577	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048998	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107906_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107880	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	0	BCM	HMP_production_phase_1
SRS014428.571525	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_364	SRR045503	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014428	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023082_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023059	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	3.4	WUGSC	HMP_production_phase_1
SRS024519.572714	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2702	SRR048170	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024519	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101665_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101642	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BCM	HMP_production_phase_1
SRS011653.575556	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_178	SRR044915	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011653	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241764	241764	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033749_from_subject_159713063__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700033726	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.4	WUGSC	HMP_production_phase_1
SRS045915.575384	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3114	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045915	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109290_from_subject_638754422__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700109249	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	4.8	JCVI	HMP_production_phase_1
SRS065479.571950	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4687	SRR048863	26.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065479	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241724	241724	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112040_from_subject_159510762__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700112003	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Anterior_nares	26	0	BCM	HMP_production_phase_1
SRS016785.573960	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_978	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016785	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032976_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032941	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS020431.571738	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1686	SRR040873	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020431	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095754_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095726	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	0	BI	HMP_production_phase_1
SRS016916.571068	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_996	SRR040953	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016916	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241792	241792	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033382_from_subject_159450072__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033363	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS043455.570785	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2878	SRR047181	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241880	241880	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105960_from_subject_658594300__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105934	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	WUGSC	HMP_production_phase_1
SRS023561.575074	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2457	SRR041201	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099838_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099811	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS066144.571100	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043084	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS047667.575300	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3280	SRR046055	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038996_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS016779.576334	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_975	SRR041397	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016779	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032970_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032938	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	BI	HMP_production_phase_1
SRS056363.576535	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4011	SRR049413	19.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056363	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241855	241855	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103305_from_subject_682449369__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103278	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	19	4.7	WUGSC	HMP_production_phase_1
SRS042365.571799	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2784	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042365	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241697	241697	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110177_from_subject_246515023__sex_female_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700110155	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	38	4.5	JCVI	HMP_production_phase_1
SRS063926.572841	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4466	SRR049396	36.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063926	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241815	241815	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114041_from_subject_763395383__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114012	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	36	0	WUGSC	HMP_production_phase_1
SRS042627.571168	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2807	SRR046280	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042627	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103454_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103434	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	33	0	WUGSC	HMP_production_phase_1
SRS064804.573158	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4590	SRR048843	39.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064804	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268877	268877	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111350_from_subject_763721271__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700111312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	39	4.8	BCM	HMP_production_phase_1
SRS058770.574639	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_4220	SRR040853	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058770	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241828	241828	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102432_from_subject_160158126__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102413	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS016479.575863	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_893	SRR041246	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016479	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032175_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS022617.575417	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2224	SRR041857	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098569_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098546	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS055632.574523	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3943	SRR048549	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055632	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108935_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108906	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BCM	HMP_production_phase_1
SRS042558.572955	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2797	SRR047129	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042558	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241887	241887	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106906_from_subject_764811490__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700106872	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	21	5.3	WUGSC	HMP_production_phase_1
SRS013778.576468	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_301	SRR048290	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013778	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016937_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016910	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	BCM	HMP_production_phase_1
SRS022123.572765	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2100	SRR041571	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097889_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097852	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.4	BI	HMP_production_phase_1
SRS019253.573891	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1494	SRR044437	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019253	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037724_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037693	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.2	WUGSC	HMP_production_phase_1
SRS015811.573637	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_699	SRR044703	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015811	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241763	241763	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024466_from_subject_763435843__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024447	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS051892.575685	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3653	SRR058084	40.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051892	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241849	241849	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110243_from_subject_161473083__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110221	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	40	4.9	JCVI	HMP_production_phase_1
SRS013727.572750	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_291	SRR041631	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013727	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016805_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016806	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS018212.575195	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1299	SRR042814	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035619_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700035586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	BI	HMP_production_phase_1
SRS044351.570871	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2959	SRR058084	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044351	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110399_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110365	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	4.4	JCVI	HMP_production_phase_1
SRS015954.572388	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_740	SRR044501	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015954	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241769	241769	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024609_from_subject_764325968__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024590	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	WUGSC	HMP_production_phase_1
SRS024169.574237	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2612	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100637_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100609	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS016129.574189	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_793	SRR044376	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016129	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024786_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024749	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	4.5	WUGSC	HMP_production_phase_1
SRS063560.570328	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4408	SRR047335	26.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063560	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257130	257130	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114244_from_subject_663835652__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114217	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	4.5	WUGSC	HMP_production_phase_1
SRS015450.572274	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_605	SRR044732	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015450	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024105_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS042619.572853	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2806	SRR046137	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042619	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038432_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038401	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS048022.574120	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3313	SRR048738	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048022	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107926_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107890	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	0	BCM	HMP_production_phase_1
SRS023746.573294	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2505	SRR040998	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023746	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100053_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100028	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS015001.571830	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_494	SRR049355	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015001	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241718	241718	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023656_from_subject_764062976__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700023635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	4.8	WUGSC	HMP_production_phase_1
SRS023198.573014	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2372	SRR041810	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023198	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099329_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700099299	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	33	0	BI	HMP_production_phase_1
SRS048173.571461	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3325	SRR048485	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048173	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107419_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107386	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	4.7	BCM	HMP_production_phase_1
SRS020869.573690	TCAGAACCGGATAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1786	SRR041542	31.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020869	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241679	241679	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096380_from_subject_160765029__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096361	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	31	0	BI	HMP_production_phase_1
SRS016379.570873	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_868	SRR040923	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016379	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241839	241839	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032043_from_subject_159632143__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS023077.571945	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2342	SRR048124	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023077	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241789	241789	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099111_from_subject_158276726__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099074	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	4.1	BCM	HMP_production_phase_1
SRS055144.573440	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3907	SRR045748	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055144	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038562_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038538	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	0	WUGSC	HMP_production_phase_1
SRS050023.573400	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3481	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050023	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110189_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110161	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	38	4.5	JCVI	HMP_production_phase_1
SRS013464.575490	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_234	SRR041770	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016395_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016381	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	BI	HMP_production_phase_1
SRS047830.573477	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3296	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047830	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110185_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110159	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	38	4.5	JCVI	HMP_production_phase_1
SRS023254.573559	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2384	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023254	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099412_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099387	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	JCVI	HMP_production_phase_1
SRS014958.575644	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_484	SRR047646	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023613_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023593	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	32	0	WUGSC	HMP_production_phase_1
SRS048838.571581	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3377	SRR046418	20.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048838	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241863	241863	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105001_from_subject_275382046__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106979	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	20	0	WUGSC	HMP_production_phase_1
SRS024406.573434	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2673	SRR042796	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024406	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101552_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101524	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	5.1	BI	HMP_production_phase_1
SRS050248.575779	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3503	SRR048692	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050248	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109555_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109521	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	21	0	BCM	HMP_production_phase_1
SRS018226.573119	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1306	SRR040753	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018226	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241765	241765	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035633_from_subject_160097436__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700035593	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS014349.570453	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_352	SRR043744	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023003_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021285	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	30	0	WUGSC	HMP_production_phase_1
SRS014657.572768	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_414	SRR043629	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023311_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023289	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	37	0	WUGSC	HMP_production_phase_1
SRS045877.575035	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3109	SRR046406	37.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241787	241787	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106647_from_subject_763982056__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700106615	n	969	184	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	37	0	WUGSC	HMP_production_phase_1
SRS064321.574734	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4527	SRR047340	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064321	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257132	257132	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114767_from_subject_901775393__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700114750	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	WUGSC	HMP_production_phase_1
SRS013490.572039	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_240	SRR041732	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013490	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241676	241676	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016470_from_subject_159207311__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700016456	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS056167.573337	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3995	SRR048483	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056167	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107423_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107388	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	4.7	BCM	HMP_production_phase_1
SRS017367.575244	TCAGTCGGTTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1100	SRR041223	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241674	241674	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034073_from_subject_160340197__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS019558.573285	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1521	SRR049333	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019558	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038029_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038009	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS057069.575394	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4075	SRR046048	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057069	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038614_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038588	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS021672.570919	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1985	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021672	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097384_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097361	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	0	JCVI	HMP_production_phase_1
SRS011582.572101	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_142	SRR047516	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011582	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033041_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.7	WUGSC	HMP_production_phase_1
SRS056063.571568	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3986	SRR048460	33.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056063	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102897_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700102863	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	33	0	BCM	HMP_production_phase_1
SRS014132.572559	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_318	SRR045716	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014132	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021691_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021685	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	3.9	WUGSC	HMP_production_phase_1
SRS016321.575309	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_847	SRR044430	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016321	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024984_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024959	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	0	WUGSC	HMP_production_phase_1
SRS016152.575818	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_795	SRR044258	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016152	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241696	241696	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024809_from_subject_764366428__sex_female_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	3.9	WUGSC	HMP_production_phase_1
SRS057612.572747	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4123	SRR046789	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057612	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241891	241891	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105342_from_subject_516889361__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	19	0	WUGSC	HMP_production_phase_1
SRS020316.575736	TCAGACCTCCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1657	SRR041813	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020316	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095569_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095537	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	BI	HMP_production_phase_1
SRS018039.571438	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1261	SRR043233	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018039	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035363_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035318	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4.3	BI	HMP_production_phase_1
SRS023989.571627	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2565	SRR040890	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023989	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100450_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100422	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	0	BI	HMP_production_phase_1
SRS014760.571243	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_429	SRR048948	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014760	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023414_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700023387	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	4.2	WUGSC	HMP_production_phase_1
SRS015530.575140	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_629	SRR047410	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015530	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024185_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024147	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.1	WUGSC	HMP_production_phase_1
SRS014432.574106	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_366	SRR045524	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014432	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023086_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023061	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	3.4	WUGSC	HMP_production_phase_1
SRS048941.573567	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3383	SRR046497	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048941	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105848_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105830	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS024462.574912	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2687	SRR041998	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101608_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101585	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	38	0	BI	HMP_production_phase_1
SRS044742.574153	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3000	SRR046312	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044742	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103708_from_subject_763759525__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103671	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	23	4.8	WUGSC	HMP_production_phase_1
SRS055001.570557	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3892	SRR047170	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055001	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241878	241878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105165_from_subject_612472597__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105145	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	38	4.3	WUGSC	HMP_production_phase_1
SRS051886.572430	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3652	SRR046029	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038602_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038582	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS023815.575452	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2525	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023815	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100209_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100177	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS024363.573865	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2665	SRR041021	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024363	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101398_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101363	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS016006.572088	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_755	SRR047415	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016006	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024661_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	WUGSC	HMP_production_phase_1
SRS017549.571280	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1147	SRR040660	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017549	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034282_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034246	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	4.1	BI	HMP_production_phase_1
SRS015147.574245	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_523	SRR045703	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015147	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023802_from_subject_763901136__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023708	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	28	4.5	WUGSC	HMP_production_phase_1
SRS016221.571618	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_817	SRR044443	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016221	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024884_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.1	WUGSC	HMP_production_phase_1
SRS014339.571705	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_347	SRR045695	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014339	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241844	241844	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021928_from_subject_763820215__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700021899	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	25	3.9	WUGSC	HMP_production_phase_1
SRS019001.570319	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1462	SRR044606	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019001	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037470_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037446	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS021826.575747	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2027	SRR058111	40.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021826	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097539_from_subject_161473083__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097499	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	40	0	JCVI	HMP_production_phase_1
SRS046980.573179	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3214	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046980	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109896_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109870	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	0	JCVI	HMP_production_phase_1
SRS011523.571521	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_111	SRR044873	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011523	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016502_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016498	n	969	23	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	34	3.6	WUGSC	HMP_production_phase_1
SRS016642.570844	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_937	SRR041586	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016642	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032426_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032425	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	5	BI	HMP_production_phase_1
SRS018916.571598	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1448	SRR045882	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018916	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241732	241732	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037385_from_subject_765216093__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037355	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	19	0	WUGSC	HMP_production_phase_1
SRS021340.573656	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1907	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021340	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241735	241735	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096998_from_subject_161351702__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096961	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	JCVI	HMP_production_phase_1
SRS023914.571128	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2546	SRR041629	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023914	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241725	241725	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100312_from_subject_159268001__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700100293	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS042322.571882	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2780	SRR048642	30.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042322	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108592_from_subject_160582958__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108550	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	30	3.9	BCM	HMP_production_phase_1
SRS018343.573724	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1336	SRR041497	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018343	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035777_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035743	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS044714.570630	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2997	SRR042920	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044714	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102409_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102373	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS062796.571754	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4296	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062796	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111479_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111448	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.8	JCVI	HMP_production_phase_1
SRS051892.575307	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3653	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051892	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241849	241849	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110243_from_subject_161473083__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110221	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	40	4.9	JCVI	HMP_production_phase_1
SRS014450.571161	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_373	SRR043950	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023104_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023070	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS021629.570265	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1978	SRR048296	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241668	241668	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097341_from_subject_158013734__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097305	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	4.9	BCM	HMP_production_phase_1
SRS016323.574635	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_848	SRR044419	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016323	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024986_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024960	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	20	0	WUGSC	HMP_production_phase_1
SRS054553.571417	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3859	SRR046717	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054553	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241883	241883	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103513_from_subject_132902142__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103486	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	31	5.6	WUGSC	HMP_production_phase_1
SRS019765.570401	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1554	SRR049876	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019765	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038241_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038220	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	WUGSC	HMP_production_phase_1
SRS018577.573436	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1392	SRR044458	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018577	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037044_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037027	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS017659.575287	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1159	SRR042989	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034659_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034631	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	0	BI	HMP_production_phase_1
SRS065158.574089	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4638	SRR048846	39.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065158	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268877	268877	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111348_from_subject_763721271__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700111311	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	39	4.8	BCM	HMP_production_phase_1
SRS017304.574040	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1088	SRR041079	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033986_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016468	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS063157.572966	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4347	SRR046738	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063157	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114317_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114282	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	4.5	WUGSC	HMP_production_phase_1
SRS055868.574175	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3968	SRR046054	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055868	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038610_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS051921.575369	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3654	SRR046057	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051921	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241864	241864	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038797_from_subject_508703490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700038759	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	5.3	WUGSC	HMP_production_phase_1
SRS024102.574545	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2593	SRR041242	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024102	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100567_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100544	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS017412.572448	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1109	SRR041106	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017412	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034118_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034090	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	30	0	BI	HMP_production_phase_1
SRS014450.575425	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_373	SRR045521	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023104_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023070	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS020253.573470	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1639	SRR041128	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020253	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095506_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095477	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	0	BI	HMP_production_phase_1
SRS018112.572062	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1276	SRR041271	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018112	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241671	241671	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035436_from_subject_160056975__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035391	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS014343.572679	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_349	SRR045699	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014343	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241844	241844	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021932_from_subject_763820215__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700021901	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	25	3.9	WUGSC	HMP_production_phase_1
SRS014456.574069	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_375	SRR043910	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023110_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023073	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	3.4	WUGSC	HMP_production_phase_1
SRS011417.572328	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_51	SRR045326	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011417	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016059_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	WUGSC	HMP_production_phase_1
SRS054708.571678	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3872	SRR058112	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054708	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110466_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110433	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	0	JCVI	HMP_production_phase_1
SRS011563.574400	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_131	SRR045125	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011563	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033008_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033006	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.7	WUGSC	HMP_production_phase_1
SRS013676.572876	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_277	SRR040616	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013676	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016754_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016711	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS019846.570854	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1569	SRR046221	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019846	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241790	241790	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038322_from_subject_765661155__sex_female_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.3	WUGSC	HMP_production_phase_1
SRS049949.573920	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3470	SRR058096	32.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049949	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241754	241754	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108493_from_subject_160967330__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700108473	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	32	0	JCVI	HMP_production_phase_1
SRS047607.570634	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3269	SRR049478	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047607	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106418_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106399	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS011452.570650	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_72	SRR045327	28.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011452	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241760	241760	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016142_from_subject_159146620__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016136	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	WUGSC	HMP_production_phase_1
SRS014827.574745	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_449	SRR046646	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014827	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241793	241793	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023481_from_subject_763921366__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023449	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.1	WUGSC	HMP_production_phase_1
SRS019081.571869	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1468	SRR044719	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019081	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037552_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037535	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS020600.576193	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1726	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020600	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095991_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	JCVI	HMP_production_phase_1
SRS024295.573582	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2646	SRR041992	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024295	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101273_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101239	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	3.7	BI	HMP_production_phase_1
SRS022041.576011	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2075	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022041	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097781_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097758	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	31	0	JCVI	HMP_production_phase_1
SRS022237.575094	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2127	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022237	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098006_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097978	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	4.2	JCVI	HMP_production_phase_1
SRS022621.571004	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2225	SRR041948	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022621	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098573_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098548	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS045922.574327	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3117	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045922	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109480_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109455	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	31	0	JCVI	HMP_production_phase_1
SRS016771.571870	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_971	SRR041371	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016771	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032962_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032934	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	BI	HMP_production_phase_1
SRS015255.571873	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_556	SRR046063	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241729	241729	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023910_from_subject_764143897__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023876	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	4.4	WUGSC	HMP_production_phase_1
SRS015470.574459	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_613	SRR044670	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024125_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024095	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS014424.572379	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_362	SRR043637	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014424	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023078_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023057	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	3.4	WUGSC	HMP_production_phase_1
SRS020253.572057	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1639	SRR041715	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020253	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095506_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095477	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	0	BI	HMP_production_phase_1
SRS020547.574310	TCAGTCGGTTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1713	SRR041996	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020547	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095870_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095841	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	BI	HMP_production_phase_1
SRS016367.574988	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_864	SRR043035	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032031_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032030	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS013732.572807	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_293	SRR041518	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013732	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016810_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700016809	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS011443.574167	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_67	SRR045438	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011443	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016092_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016053	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	20	4.2	WUGSC	HMP_production_phase_1
SRS063783.573759	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4440	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063783	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110671_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110648	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	30	0	JCVI	HMP_production_phase_1
SRS052084.571514	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3669	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052084	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109790_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109760	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	0	JCVI	HMP_production_phase_1
SRS056264.575296	TCAGACGGAACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_4003	SRR040862	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056264	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102440_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102417	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS024297.573209	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2647	SRR041962	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024297	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101275_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101240	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	3.7	BI	HMP_production_phase_1
SRS064192.571693	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4511	SRR047088	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064192	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114403_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114379	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	0	WUGSC	HMP_production_phase_1
SRS015401.573664	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_595	SRR045686	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015401	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024056_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024030	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	3.6	WUGSC	HMP_production_phase_1
SRS045214.571825	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3048	SRR048689	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045214	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109537_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109512	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	21	0	BCM	HMP_production_phase_1
SRS063456.570777	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4388	SRR048791	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268876	268876	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111212_from_subject_257905678__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.9	BCM	HMP_production_phase_1
SRS017790.572183	TCAGAAGGAACCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1196	SRR040699	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017790	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034883_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034851	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	0	BI	HMP_production_phase_1
SRS057453.574590	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4104	SRR043771	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057453	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038554_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038534	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	32	0	WUGSC	HMP_production_phase_1
SRS018264.576572	TCAGTTCGTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1310	SRR041234	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018264	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035671_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035642	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	3.9	BI	HMP_production_phase_1
SRS013237.572332	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_217	SRR040716	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013237	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015944_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015943	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS064289.570294	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4521	SRR048809	38.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064289	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268878	268878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111278_from_subject_866653606__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700111239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	38	5	BCM	HMP_production_phase_1
SRS015578.571615	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_639	SRR043983	18.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015578	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241802	241802	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024233_from_subject_764285508__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024201	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	18	0	WUGSC	HMP_production_phase_1
SRS020539.573820	TCAGAACGTTCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1709	SRR041087	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020539	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095862_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095837	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	BI	HMP_production_phase_1
SRS044676.572634	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2991	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044676	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109356_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109325	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	4.6	JCVI	HMP_production_phase_1
SRS016131.571991	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_794	SRR044397	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016131	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024788_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024750	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	4.5	WUGSC	HMP_production_phase_1
SRS049123.571460	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3402	SRR048720	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107429_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107391	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	4.7	BCM	HMP_production_phase_1
SRS019556.572081	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1520	SRR045751	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019556	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038027_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038008	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS020318.574077	TCAGTTCCGAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1658	SRR041874	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020318	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095571_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095538	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS011647.573575	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_175	SRR044925	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011647	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241795	241795	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033495_from_subject_159470302__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033493	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4.1	WUGSC	HMP_production_phase_1
SRS015633.575692	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_655	SRR044240	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015633	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024288_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024251	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.4	WUGSC	HMP_production_phase_1
SRS063624.574562	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4415	SRR058092	28.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063624	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257122	257122	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111081_from_subject_686765762__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700111044	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	JCVI	HMP_production_phase_1
SRS023083.575625	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2344	SRR048120	24.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023083	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241789	241789	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099117_from_subject_158276726__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099077	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	4.1	BCM	HMP_production_phase_1
SRS064030.574176	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4489	SRR048867	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064030	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112034_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700112000	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Right_Retroauricular_crease	26	0	BCM	HMP_production_phase_1
SRS046160.574708	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3144	SRR048523	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046160	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107967_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107939	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BCM	HMP_production_phase_1
SRS057278.576117	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4090	SRR046794	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057278	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241856	241856	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105120_from_subject_256789458__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105094	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	20	5.6	WUGSC	HMP_production_phase_1
SRS015444.571909	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_604	SRR044748	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015444	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024099_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024082	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS018216.570352	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1301	SRR040739	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035623_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035588	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	0	BI	HMP_production_phase_1
SRS019574.574027	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1528	SRR045527	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019574	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038045_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038017	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	37	0	WUGSC	HMP_production_phase_1
SRS013646.573719	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_263	SRR041531	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013646	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016724_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016696	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	33	0	BI	HMP_production_phase_1
SRS011613.571653	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_158	SRR044967	24.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033189_from_subject_159733294__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033148	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	4.3	WUGSC	HMP_production_phase_1
SRS058104.575979	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4162	SRR047228	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058104	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106111_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106074	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	18	4.5	WUGSC	HMP_production_phase_1
SRS054932.576172	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3887	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054932	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109284_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700109246	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	4.8	JCVI	HMP_production_phase_1
SRS024222.571227	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2624	SRR041891	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024222	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101109_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101083	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS016050.571218	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_768	SRR044477	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016050	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241741	241741	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024705_from_subject_764508039__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024686	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS011375.575715	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_41	SRR047537	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011375	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015665_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS053706.576075	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3802	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053706	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241867	241867	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101823_from_subject_514014184__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101786	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	4.2	JCVI	HMP_production_phase_1
SRS015653.576327	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_657	SRR044486	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241845	241845	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024308_from_subject_764487809__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024291	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS018698.574948	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1409	SRR045906	40.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018698	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241723	241723	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037165_from_subject_765195863__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037191	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	40	4.6	WUGSC	HMP_production_phase_1
SRS057258.572794	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4085	SRR058084	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241694	241694	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109340_from_subject_160866180__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109317	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS057569.572429	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4117	SRR046271	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057569	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105876_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105844	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS042830.574192	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2823	SRR048769	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042830	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109559_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109523	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	21	0	BCM	HMP_production_phase_1
SRS018505.571766	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1370	SRR040773	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018505	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035969_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035939	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	4.1	BI	HMP_production_phase_1
SRS046385.573959	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3166	SRR048501	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046385	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108640_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108607	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	31	0	BCM	HMP_production_phase_1
SRS011615.570545	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_159	SRR045349	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033191_from_subject_159733294__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033149	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.3	WUGSC	HMP_production_phase_1
SRS022639.573013	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2234	SRR042020	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022639	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098591_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098557	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS021451.574393	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1933	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021451	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097159_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097128	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	32	0	JCVI	HMP_production_phase_1
SRS045353.573837	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3061	SRR048435	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045353	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109959_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109929	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	34	4.6	BCM	HMP_production_phase_1
SRS011497.571714	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_96	SRR045415	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011497	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016335_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016309	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS045119.574252	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3031	SRR046520	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241864	241864	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038785_from_subject_508703490__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038753	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	5.3	WUGSC	HMP_production_phase_1
SRS063612.573568	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4412	SRR047094	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063612	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	TRUE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114205_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:mucus	700114175	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	0	WUGSC	HMP_production_phase_1
SRS023559.576338	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2456	SRR043228	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099836_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099810	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS044435.576582	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2966	SRR045855	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038434_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038402	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS018503.571698	TCAGACGGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1369	SRR040737	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018503	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035967_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035938	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	4.1	BI	HMP_production_phase_1
SRS021806.574506	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2019	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021806	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097519_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097489	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	40	0	JCVI	HMP_production_phase_1
SRS056932.576360	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4067	SRR045795	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056932	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038882_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038860	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	WUGSC	HMP_production_phase_1
SRS023194.576450	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2370	SRR041826	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023194	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099325_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099297	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	33	0	BI	HMP_production_phase_1
SRS064647.574785	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4570	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064647	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257122	257122	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111045_from_subject_686765762__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111026	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	JCVI	HMP_production_phase_1
SRS016361.572905	TCAGTTGTTGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_862	SRR040911	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032025_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032024	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS020010.573105	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1591	SRR041116	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020010	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095255_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095223	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.3	BI	HMP_production_phase_1
SRS042102.573388	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2762	SRR048241	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042102	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102948_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102917	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	0	BCM	HMP_production_phase_1
SRS021145.573736	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1857	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021145	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241801	241801	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096692_from_subject_160744799__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700096608	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	20	4.9	JCVI	HMP_production_phase_1
SRS053828.572685	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3812	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053828	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109149_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109117	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	4.1	JCVI	HMP_production_phase_1
SRS047765.571845	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3290	SRR048650	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047765	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108884_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108852	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	BCM	HMP_production_phase_1
SRS065621.570433	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4719	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065621	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111548_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111517	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS018335.574624	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1332	SRR041502	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018335	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035769_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035739	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	BI	HMP_production_phase_1
SRS023621.574581	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2472	SRR041180	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099924_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099894	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	20	4.9	BI	HMP_production_phase_1
SRS021269.572309	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1887	SRR058095	34.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021269	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241669	241669	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096915_from_subject_161230322__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096879	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	34	5.3	JCVI	HMP_production_phase_1
SRS011578.571298	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_140	SRR045424	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011578	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033035_from_subject_159247771__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.7	WUGSC	HMP_production_phase_1
SRS050472.571357	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3532	SRR047227	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050472	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241860	241860	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105994_from_subject_465578759__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105988	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	31	4.4	WUGSC	HMP_production_phase_1
SRS018161.572508	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1287	SRR041836	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018161	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035561_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS014351.574048	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_353	SRR043775	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023005_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021286	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	30	0	WUGSC	HMP_production_phase_1
SRS045364.572008	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3063	SRR046838	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045364	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241861	241861	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106743_from_subject_184349034__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106711	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS023950.572526	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2559	SRR041516	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241725	241725	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100348_from_subject_159268001__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100311	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS046988.574660	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3216	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046988	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109843_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109815	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	JCVI	HMP_production_phase_1
SRS020445.571943	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1693	SRR042870	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095768_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700095733	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS021639.575847	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1981	SRR048058	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021639	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241668	241668	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097351_from_subject_158013734__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097310	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	22	4.9	BCM	HMP_production_phase_1
SRS057265.573325	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4087	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057265	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107230_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107200	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	JCVI	HMP_production_phase_1
SRS021563.575461	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1961	SRR048091	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021563	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097275_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097245	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	0	BCM	HMP_production_phase_1
SRS066144.570385	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058086	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS050374.573413	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3518	SRR058096	29.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050374	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241786	241786	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109129_from_subject_970836795__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109107	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	4.1	JCVI	HMP_production_phase_1
SRS011665.574618	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_184	SRR045325	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011665	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033769_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033736	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.4	WUGSC	HMP_production_phase_1
SRS057704.575118	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4132	SRR047693	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057704	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241887	241887	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106892_from_subject_764811490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700106865	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	21	5.3	WUGSC	HMP_production_phase_1
SRS017477.573650	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1126	SRR041348	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017477	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034210_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034177	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	19	5.1	BI	HMP_production_phase_1
SRS020259.573359	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1642	SRR041074	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020259	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095512_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095480	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	0	BI	HMP_production_phase_1
SRS021694.573510	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1995	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021694	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241688	241688	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097406_from_subject_161331472__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097372	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	JCVI	HMP_production_phase_1
SRS019661.571844	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1535	SRR046189	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038132_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038113	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	WUGSC	HMP_production_phase_1
SRS016720.575411	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_959	SRR040895	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016720	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032665_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032646	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.3	BI	HMP_production_phase_1
SRS044474.576108	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2970	SRR040991	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241746	241746	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102411_from_subject_159490532__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102374	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS020559.570219	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1719	SRR041964	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095882_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095847	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS042258.573417	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_2771	SRR049446	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106522_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106494	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	32	4.3	WUGSC	HMP_production_phase_1
SRS017535.573746	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1140	SRR041403	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017535	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034268_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034239	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS015395.571275	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_592	SRR045675	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015395	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024050_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024027	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	3.6	WUGSC	HMP_production_phase_1
SRS018555.572951	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1389	SRR046620	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018555	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241851	241851	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037022_from_subject_764710340__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037006	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4	WUGSC	HMP_production_phase_1
SRS016168.573362	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_803	SRR044263	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016168	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024825_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024797	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	3.9	WUGSC	HMP_production_phase_1
SRS021869.573437	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2035	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021869	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097605_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097578	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	JCVI	HMP_production_phase_1
SRS049196.576435	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3408	SRR048279	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049196	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102633_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102598	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	4.5	BCM	HMP_production_phase_1
SRS017908.571014	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1228	SRR041440	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017908	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241799	241799	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035206_from_subject_160441347__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS021808.573429	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2020	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021808	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097521_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097490	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	40	0	JCVI	HMP_production_phase_1
SRS023208.574512	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2377	SRR043034	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099339_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700099304	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS024480.576097	TCAGAACCTTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2695	SRR041126	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024480	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101626_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101594	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	38	0	BI	HMP_production_phase_1
SRS023208.573236	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2377	SRR041375	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099339_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099304	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS020208.572192	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1630	SRR048310	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241762	241762	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095461_from_subject_158418336__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095426	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	32	0	BCM	HMP_production_phase_1
SRS022641.570286	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2235	SRR041721	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022641	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098593_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098558	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS023389.573502	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2421	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023389	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099555_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099524	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	0	JCVI	HMP_production_phase_1
SRS024238.573830	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2632	SRR041917	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024238	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101125_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101091	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS022069.575313	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2088	SRR058111	31.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022069	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241738	241738	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097809_from_subject_161554003__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097772	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	31	0	JCVI	HMP_production_phase_1
SRS015878.575575	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_720	SRR043746	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015878	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024533_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024504	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	39	0	WUGSC	HMP_production_phase_1
SRS014929.574046	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_478	SRR046510	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014929	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023584_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	WUGSC	HMP_production_phase_1
SRS011659.570722	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_181	SRR045086	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011659	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033763_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033733	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.4	WUGSC	HMP_production_phase_1
SRS015817.571868	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_702	SRR044698	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015817	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024472_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024450	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	21	0	WUGSC	HMP_production_phase_1
SRS022362.572106	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2160	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022362	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098228_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098205	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	35	0	JCVI	HMP_production_phase_1
SRS021065.570555	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1830	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021065	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241694	241694	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096612_from_subject_160866180__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096568	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	4.8	JCVI	HMP_production_phase_1
SRS017559.576251	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1151	SRR040588	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034292_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034251	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	26	4.1	BI	HMP_production_phase_1
SRS052501.575370	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3709	SRR046030	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052501	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038994_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	0	WUGSC	HMP_production_phase_1
SRS023936.575522	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2553	SRR041555	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023936	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100334_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100304	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS019087.571327	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1470	SRR047452	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019087	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037558_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037538	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS024388.575933	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2668	SRR043264	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241764	241764	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101534_from_subject_159713063__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700101515	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	5.1	BI	HMP_production_phase_1
SRS017641.575969	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1154	SRR041130	19.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017641	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241775	241775	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034641_from_subject_160461578__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034622	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	19	0	BI	HMP_production_phase_1
SRS016358.571959	TCAGTACGGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_861	SRR040861	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016358	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032022_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032021	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS017955.575353	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1238	SRR041508	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017955	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035276_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035247	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS049118.573773	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3400	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049118	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109286_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700109247	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	4.8	JCVI	HMP_production_phase_1
SRS017026.573207	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1021	SRR041616	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017026	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033539_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033538	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS017741.571782	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1185	SRR041217	30.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017741	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034834_from_subject_160582958__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034792	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	30	4.1	BI	HMP_production_phase_1
SRS023983.570548	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2562	SRR040939	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023983	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100444_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100419	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	0	BI	HMP_production_phase_1
SRS024541.573516	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2712	SRR048233	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024541	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241819	241819	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101687_from_subject_159389382__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101653	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS011575.570893	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_137	SRR045293	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011575	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033026_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033024	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.7	WUGSC	HMP_production_phase_1
SRS024277.575502	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2637	SRR041844	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024277	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101255_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101230	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	3.7	BI	HMP_production_phase_1
SRS062898.576446	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4311	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062898	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241742	241742	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111560_from_subject_336497421__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700111523	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	JCVI	HMP_production_phase_1
SRS018607.575108	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1406	SRR046202	19.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018607	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241758	241758	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037074_from_subject_765094712__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037042	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	19	0	WUGSC	HMP_production_phase_1
SRS011157.576495	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1	SRR044955	38.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241686	241686	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014956_from_subject_158822939__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700014954	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	0	WUGSC	HMP_production_phase_1
SRS018791.571847	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1429	SRR047649	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018791	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037258_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	WUGSC	HMP_production_phase_1
SRS011497.571085	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_96	SRR045133	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011497	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016335_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016309	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS020298.574446	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1649	SRR041686	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020298	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095551_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	BI	HMP_production_phase_1
SRS050106.571173	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3486	SRR046720	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050106	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241857	241857	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106575_from_subject_208027353__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106549	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	28	4.3	WUGSC	HMP_production_phase_1
SRS015342.574695	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_580	SRR049354	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015342	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241811	241811	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023997_from_subject_764184357__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023972	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	3.7	WUGSC	HMP_production_phase_1
SRS020948.573657	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1808	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096459_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700096429	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	0	JCVI	HMP_production_phase_1
SRS024406.576542	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2673	SRR041092	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024406	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101552_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101524	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	5.1	BI	HMP_production_phase_1
SRS016458.574231	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_886	SRR041358	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032154_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032153	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS011438.571654	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_63	SRR049232	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011438	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016085_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016049	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS017677.575741	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1168	SRR040630	19.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241775	241775	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034692_from_subject_160461578__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	19	0	BI	HMP_production_phase_1
SRS057073.570311	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4076	SRR048237	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057073	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102942_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102914	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	BCM	HMP_production_phase_1
SRS044938.576540	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3020	SRR046802	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044938	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106948_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106931	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	20	0	WUGSC	HMP_production_phase_1
SRS065101.574339	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4629	SRR046758	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065101	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114474_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114439	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	3.9	WUGSC	HMP_production_phase_1
SRS015285.575168	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_563	SRR043917	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023940_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023921	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS053304.575180	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3768	SRR048765	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053304	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108272_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108234	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	32	4.6	BCM	HMP_production_phase_1
SRS018517.576619	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1376	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018517	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035981_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035945	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	4.1	BI	HMP_production_phase_1
SRS022633.571268	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2231	SRR041898	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022633	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098585_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098554	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS017561.571917	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1152	SRR040769	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017561	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034294_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034252	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.1	BI	HMP_production_phase_1
SRS054401.571628	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3845	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054401	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109484_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109457	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	31	0	JCVI	HMP_production_phase_1
SRS017428.570702	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1117	SRR040653	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017428	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241703	241703	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034134_from_subject_160481808__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034098	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	0	BI	HMP_production_phase_1
SRS016537.573444	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_905	SRR041842	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016537	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032264_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4	BI	HMP_production_phase_1
SRS063304.575740	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4369	SRR058092	36.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063304	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257123	257123	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111869_from_subject_414519462__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700111829	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	36	4.7	JCVI	HMP_production_phase_1
SRS017414.573654	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1110	SRR041827	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017414	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034120_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034091	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	30	0	BI	HMP_production_phase_1
SRS018910.575887	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1445	SRR049416	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241732	241732	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037379_from_subject_765216093__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037352	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS058191.573344	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4169	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058191	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110283_from_subject_161473083__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110241	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	40	4.9	JCVI	HMP_production_phase_1
SRS016002.572941	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_753	SRR044274	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016002	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024657_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024638	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	WUGSC	HMP_production_phase_1
SRS048610.570355	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3356	SRR044290	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048610	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241696	241696	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024843_from_subject_764366428__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024806	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	3.9	WUGSC	HMP_production_phase_1
SRS011419.570827	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_52	SRR044928	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011419	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016063_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016038	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	WUGSC	HMP_production_phase_1
SRS062851.575906	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4306	SRR046740	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062851	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113130_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113107	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	0	WUGSC	HMP_production_phase_1
SRS014448.571745	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_372	SRR043607	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014448	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023102_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023069	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	25	3.4	WUGSC	HMP_production_phase_1
SRS014456.571624	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_375	SRR045740	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023110_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023073	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	3.4	WUGSC	HMP_production_phase_1
SRS065402.574794	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4675	SRR046751	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065402	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257114	257114	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114511_from_subject_739574095__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114486	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.8	WUGSC	HMP_production_phase_1
SRS017463.575491	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1120	SRR041351	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017463	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034196_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034170	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	19	5.1	BI	HMP_production_phase_1
SRS017418.571546	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1112	SRR041690	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017418	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034124_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034093	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	30	0	BI	HMP_production_phase_1
SRS047455.574032	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3255	SRR048439	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047455	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109967_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109933	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	34	4.6	BCM	HMP_production_phase_1
SRS047419.575176	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3251	SRR043967	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047419	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038480_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038449	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS024349.574119	TCAGTTCAAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2658	SRR041923	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101384_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101356	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS024122.571774	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2602	SRR041211	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024122	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100587_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100554	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS065341.571267	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4667	SRR048817	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065341	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111785_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111754	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.6	BCM	HMP_production_phase_1
SRS044606.576342	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_2983	SRR047191	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044606	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103587_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103564	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	WUGSC	HMP_production_phase_1
SRS015023.573071	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_501	SRR046530	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015023	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023678_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023646	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	4.8	WUGSC	HMP_production_phase_1
SRS046325.572682	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3157	SRR058092	36.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046325	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257123	257123	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102167_from_subject_414519462__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102129	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	36	3.9	JCVI	HMP_production_phase_1
SRS016211.574160	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_812	SRR044497	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016211	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241687	241687	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024874_from_subject_764649650__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024850	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.1	WUGSC	HMP_production_phase_1
SRS015716.571066	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_677	SRR044219	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015716	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024371_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024345	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	3.6	WUGSC	HMP_production_phase_1
SRS048595.572285	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3353	SRR048733	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048595	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109616_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109580	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS017543.572427	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1144	SRR040629	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017543	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034276_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034243	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS011425.574898	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_55	SRR044949	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011425	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016069_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS016170.573583	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_804	SRR046064	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016170	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024827_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024798	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	3.9	WUGSC	HMP_production_phase_1
SRS019667.574698	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1538	SRR046193	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038138_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038116	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS057565.572416	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4116	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057565	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108326_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108295	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	JCVI	HMP_production_phase_1
SRS015872.572273	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_717	SRR045785	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015872	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024527_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024501	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	39	0	WUGSC	HMP_production_phase_1
SRS013213.572369	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_213	SRR042826	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013213	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241704	241704	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015912_from_subject_159369152__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700015875	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS016684.572669	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_950	SRR041597	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016684	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241713	241713	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032468_from_subject_160036745__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032467	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	5	BI	HMP_production_phase_1
SRS020119.575886	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_1603	SRR048128	31.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020119	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241827	241827	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095372_from_subject_158398106__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700095353	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	31	0	BCM	HMP_production_phase_1
SRS051921.572605	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3654	SRR045926	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051921	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241864	241864	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038797_from_subject_508703490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700038759	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	5.3	WUGSC	HMP_production_phase_1
SRS066144.574386	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043079	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS024287.573506	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2642	SRR041994	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024287	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101265_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101235	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	3.7	BI	HMP_production_phase_1
SRS011441.570815	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_65	SRR045423	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011441	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016089_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016051	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS020304.576299	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1651	SRR041148	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095557_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095531	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	BI	HMP_production_phase_1
SRS019677.572025	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1543	SRR043961	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038150_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038122	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS047113.573082	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3227	SRR041431	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047113	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107083_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107052	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	BI	HMP_production_phase_1
SRS014913.573299	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_470	SRR045733	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014913	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023568_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023546	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	33	0	WUGSC	HMP_production_phase_1
SRS011410.572647	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_48	SRR044946	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011410	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241709	241709	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016012_from_subject_158964549__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS022008.576448	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2071	SRR040685	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022008	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097748_from_subject_158256496__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097707	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	4.1	BI	HMP_production_phase_1
SRS011442.572660	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_66	SRR044903	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016091_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016052	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS013456.570558	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_231	SRR041729	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013456	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016387_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016377	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	BI	HMP_production_phase_1
SRS022952.571372	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2310	SRR048374	37.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022952	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241781	241781	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098982_from_subject_158236265__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098946	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	4.6	BCM	HMP_production_phase_1
SRS015460.571585	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_608	SRR044647	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024115_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024090	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS015452.570749	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_606	SRR044740	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015452	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024107_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024086	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS018068.575993	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1264	SRR040884	23.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018068	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241836	241836	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035392_from_subject_160016515__sex_female_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700035369	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.3	BI	HMP_production_phase_1
SRS024163.574583	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2609	SRR040679	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100631_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100606	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS064618.570605	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4564	SRR048849	39.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064618	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268877	268877	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111356_from_subject_763721271__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700111315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	39	4.8	BCM	HMP_production_phase_1
SRS022629.572602	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2229	SRR041939	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022629	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098581_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098552	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS017154.575135	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1055	SRR041989	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017154	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033716_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033715	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS018439.574489	TCAGTCCGAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1354	SRR041174	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018439	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035873_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035848	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS056396.572402	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4014	SRR046722	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056396	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105144_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105106	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	20	5.6	WUGSC	HMP_production_phase_1
SRS018459.576476	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1364	SRR042932	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018459	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035893_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700035858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS021189.573357	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1864	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021189	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096736_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096707	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	5	JCVI	HMP_production_phase_1
SRS064006.572670	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4484	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064006	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268865	268865	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111501_from_subject_451588811__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111459	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.8	JCVI	HMP_production_phase_1
SRS015976.572329	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_749	SRR043990	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015976	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024631_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024601	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	WUGSC	HMP_production_phase_1
SRS022586.571319	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2221	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022586	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098491_from_subject_809635352__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098449	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	5	JCVI	HMP_production_phase_1
SRS011601.572852	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_152	SRR044957	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011601	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033176_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033142	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	4.3	WUGSC	HMP_production_phase_1
SRS044214.573647	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2946	SRR048696	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044214	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109210_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109182	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	31	0	BCM	HMP_production_phase_1
SRS044750.571529	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3002	SRR046279	31.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044750	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241717	241717	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105717_from_subject_763456073__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105682	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	31	5	WUGSC	HMP_production_phase_1
SRS016418.572610	TCAGTCCTGGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_874	SRR041480	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016418	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032105_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032077	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS016111.571841	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_786	SRR044399	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016111	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241701	241701	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024768_from_subject_764588959__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024740	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	21	4.5	WUGSC	HMP_production_phase_1
SRS043408.571151	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2873	SRR045771	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024999_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023544	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	33	0	WUGSC	HMP_production_phase_1
SRS065594.571391	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4712	SRR048422	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065594	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110786_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110763	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	4.6	BCM	HMP_production_phase_1
SRS066144.574653	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR057609	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS013678.576382	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_278	SRR040748	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013678	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016756_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016712	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS066144.574651	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043088	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS050653.571739	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3545	SRR048505	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050653	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108648_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108611	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	31	4	BCM	HMP_production_phase_1
SRS057595.575730	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4120	SRR046670	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057595	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105918_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105889	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	WUGSC	HMP_production_phase_1
SRS022962.570913	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2313	SRR048109	37.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022962	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241781	241781	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098992_from_subject_158236265__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098951	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	37	4.6	BCM	HMP_production_phase_1
SRS017290.575216	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1081	SRR041206	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017290	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033965_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033934	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS051071.572798	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3577	SRR046631	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051071	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106589_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106556	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	4.3	WUGSC	HMP_production_phase_1
SRS023430.573374	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2429	SRR048162	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023430	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099617_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099594	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	0	BCM	HMP_production_phase_1
SRS011460.570481	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_76	SRR045301	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016158_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016127	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	WUGSC	HMP_production_phase_1
SRS017547.573277	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1146	SRR041108	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017547	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034280_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034245	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS011464.573442	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_78	SRR045113	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016162_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016129	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	WUGSC	HMP_production_phase_1
SRS011438.574414	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_63	SRR045087	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011438	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016085_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016049	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS024472.570425	TCAGAATACCGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2691	SRR041795	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101618_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101590	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	38	0	BI	HMP_production_phase_1
SRS064399.571426	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4539	SRR058108	35.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064399	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241768	241768	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110748_from_subject_492786515__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110715	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	JCVI	HMP_production_phase_1
SRS014287.574014	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_337	SRR045506	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241825	241825	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021876_from_subject_763536994__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700021677	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS014275.574417	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_333	SRR043642	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014275	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021864_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021314	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS015251.573924	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_554	SRR044476	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015251	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241729	241729	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023906_from_subject_764143897__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023874	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	4.4	WUGSC	HMP_production_phase_1
SRS014675.570277	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_422	SRR045537	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023329_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023298	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS011539.574958	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_119	SRR047493	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011539	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016637_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS065719.573143	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4734	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065719	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110848_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110819	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	4.7	JCVI	HMP_production_phase_1
SRS049597.573618	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3441	SRR049436	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049597	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241878	241878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105177_from_subject_612472597__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105151	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	38	4.3	WUGSC	HMP_production_phase_1
SRS019582.575523	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1532	SRR045516	37.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019582	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241720	241720	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038053_from_subject_763597684__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700038021	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	37	0	WUGSC	HMP_production_phase_1
SRS047943.573451	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3306	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047943	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110219_from_subject_246515023__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700110176	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	38	4.5	JCVI	HMP_production_phase_1
SRS044526.572252	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2973	SRR047193	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044526	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103637_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700103613	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	19	0	WUGSC	HMP_production_phase_1
SRS021549.575504	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_1955	SRR048088	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021549	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097261_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097238	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	0	BCM	HMP_production_phase_1
SRS020527.573698	TCAGAACCGGATAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1707	SRR041105	21.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020527	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241821	241821	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095850_from_subject_160845950__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700095831	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	BI	HMP_production_phase_1
SRS018278.574649	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1317	SRR042945	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018278	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035685_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035649	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	3.9	BI	HMP_production_phase_1
SRS018543.574313	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1384	SRR047437	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018543	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241851	241851	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037010_from_subject_764710340__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4	WUGSC	HMP_production_phase_1
SRS047701.576590	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3282	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047701	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108810_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108786	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	0	JCVI	HMP_production_phase_1
SRS046495.572331	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3171	SRR041946	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046495	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101335_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101303	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS018455.573734	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1362	SRR042796	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035889_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS016678.574030	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_948	SRR042802	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016678	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032462_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032461	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	5	BI	HMP_production_phase_1
SRS011380.573707	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_44	SRR044937	33.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011380	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241767	241767	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015677_from_subject_158924089__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700015675	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	33	0	WUGSC	HMP_production_phase_1
SRS021382.576057	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1913	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021382	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097040_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097009	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	4.6	JCVI	HMP_production_phase_1
SRS047278.575690	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3240	SRR058112	22.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047278	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241759	241759	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108838_from_subject_160987560__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700108800	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	0	JCVI	HMP_production_phase_1
SRS062741.575584	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4287	SRR049514	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062741	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241865	241865	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114723_from_subject_764831721__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114704	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	0	WUGSC	HMP_production_phase_1
SRS043580.574874	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2891	SRR048445	34.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043580	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109983_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109941	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	34	4.6	BCM	HMP_production_phase_1
SRS045746.571230	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3095	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045746	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109015_from_subject_161007791__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108973	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	24	4.3	JCVI	HMP_production_phase_1
SRS018337.575352	TCAGTCCACCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1333	SRR041608	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018337	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035771_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035740	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	BI	HMP_production_phase_1
SRS015813.575742	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_700	SRR044708	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015813	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241763	241763	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024468_from_subject_763435843__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024448	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	21	0	WUGSC	HMP_production_phase_1
SRS055161.576301	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3909	SRR047539	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055161	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038722_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038693	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	3.7	WUGSC	HMP_production_phase_1
SRS022936.572068	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2302	SRR048103	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022936	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098966_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098938	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	37	4.6	BCM	HMP_production_phase_1
SRS024706.570427	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2751	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024706	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102086_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102055	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	30	0	JCVI	HMP_production_phase_1
SRS011613.571986	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_158	SRR045340	24.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033189_from_subject_159733294__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033148	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	4.3	WUGSC	HMP_production_phase_1
SRS054989.576577	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3891	SRR048489	23.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054989	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107437_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700107395	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	23	4.7	BCM	HMP_production_phase_1
SRS022572.576355	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2214	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022572	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098477_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098442	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	5	JCVI	HMP_production_phase_1
SRS021404.570274	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1923	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021404	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241774	241774	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097062_from_subject_161028021__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097020	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	25	4.6	JCVI	HMP_production_phase_1
SRS047320.574478	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3243	SRR047724	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047320	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241872	241872	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105896_from_subject_668248235__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105878	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS054576.573402	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3863	SRR045874	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054576	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038596_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038579	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	WUGSC	HMP_production_phase_1
SRS054236.575638	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3833	SRR058112	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054236	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107866_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107831	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS022121.575928	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2099	SRR041561	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022121	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097887_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097851	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	4.4	BI	HMP_production_phase_1
SRS020251.573745	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1638	SRR041156	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020251	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095504_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095476	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	0	BI	HMP_production_phase_1
SRS023613.576156	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2469	SRR041046	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099916_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099890	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	20	4.9	BI	HMP_production_phase_1
SRS024234.576017	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2630	SRR042000	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024234	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101121_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101089	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS014651.575961	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_411	SRR045514	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014651	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023305_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023286	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	37	0	WUGSC	HMP_production_phase_1
SRS063488.571099	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4393	SRR048828	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063488	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268869	268869	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111797_from_subject_872848689__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111760	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.6	BCM	HMP_production_phase_1
SRS016708.575024	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_954	SRR041991	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016708	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032653_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.3	BI	HMP_production_phase_1
SRS058584.571796	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4204	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058584	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109788_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109759	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	0	JCVI	HMP_production_phase_1
SRS064961.571040	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4610	SRR046561	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064961	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257108	257108	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114876_from_subject_682102541__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	WUGSC	HMP_production_phase_1
SRS022434.572698	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2179	SRR048193	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022434	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098309_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098277	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	5.8	BCM	HMP_production_phase_1
SRS056458.570671	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4020	SRR048907	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056458	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108584_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108546	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	30	3.9	BCM	HMP_production_phase_1
SRS021394.572021	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1918	SRR058111	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021394	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241774	241774	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097052_from_subject_161028021__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097015	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	4.6	JCVI	HMP_production_phase_1
SRS016333.573787	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_853	SRR044405	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016333	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024996_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	20	0	WUGSC	HMP_production_phase_1
SRS066188.572188	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048868	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS024062.573543	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2587	SRR042888	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024062	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100524_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100488	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	4.7	BI	HMP_production_phase_1
SRS024171.575054	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2613	SRR042944	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100639_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100610	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS042659.570955	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2811	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109784_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109757	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	0	JCVI	HMP_production_phase_1
SRS022057.572564	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2082	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022057	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097797_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097766	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	31	0	JCVI	HMP_production_phase_1
SRS050327.572233	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3514	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050327	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109292_from_subject_638754422__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700109250	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	27	4.8	JCVI	HMP_production_phase_1
SRS014621.573120	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_406	SRR046174	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241693	241693	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023275_from_subject_763840445__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023241	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	38	4.1	WUGSC	HMP_production_phase_1
SRS023605.573845	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2468	SRR043227	20.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023605	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241702	241702	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099908_from_subject_159005010__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099886	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	20	4.9	BI	HMP_production_phase_1
SRS014261.571661	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_329	SRR045798	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014261	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021850_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:mucus	700021820	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS018009.574801	TCAGTTCCGTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1247	SRR040787	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018009	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035333_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035303	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BI	HMP_production_phase_1
SRS013502.574778	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_242	SRR040686	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013502	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016482_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016462	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS022576.573768	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2216	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022576	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098481_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098444	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	5	JCVI	HMP_production_phase_1
SRS018349.571172	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1339	SRR041567	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241695	241695	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035783_from_subject_160380657__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	BI	HMP_production_phase_1
SRS023069.572973	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2338	SRR048306	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023069	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099103_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099070	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	4.1	BCM	HMP_production_phase_1
SRS018029.574095	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1257	SRR043288	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018029	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241734	241734	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035353_from_subject_160239046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS021183.571090	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1862	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021183	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096730_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096704	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	5	JCVI	HMP_production_phase_1
SRS011431.574579	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_58	SRR045297	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011431	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016075_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016044	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS018791.572397	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1429	SRR045861	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018791	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037258_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	WUGSC	HMP_production_phase_1
SRS020127.574259	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_1604	SRR048133	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020127	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095380_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095357	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	31	0	BCM	HMP_production_phase_1
SRS015714.571806	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_676	SRR044212	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015714	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024369_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024344	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	3.6	WUGSC	HMP_production_phase_1
SRS023508.570406	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2447	SRR048227	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023508	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099785_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099756	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BCM	HMP_production_phase_1
SRS013660.574391	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_269	SRR041556	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013660	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016738_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700016703	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	33	0	BI	HMP_production_phase_1
SRS013498.570774	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_241	SRR041893	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013498	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016478_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS051443.572696	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3614	SRR058108	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051443	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241786	241786	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109157_from_subject_970836795__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109121	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	4.1	JCVI	HMP_production_phase_1
SRS019556.575387	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1520	SRR043882	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019556	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038027_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038008	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS050307.570567	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3511	SRR058112	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050307	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110468_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110434	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	0	JCVI	HMP_production_phase_1
SRS066188.570581	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058113	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS063142.573615	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4344	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063142	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111483_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700111450	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4.8	JCVI	HMP_production_phase_1
SRS015516.576377	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_622	SRR044264	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015516	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024171_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024140	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.1	WUGSC	HMP_production_phase_1
SRS019087.570525	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1470	SRR044642	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019087	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037558_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700037538	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS022566.570699	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2211	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022566	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098471_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098439	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	5	JCVI	HMP_production_phase_1
SRS019245.571719	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1490	SRR049222	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019245	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241800	241800	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037716_from_subject_765034022__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037689	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.2	WUGSC	HMP_production_phase_1
SRS047225.573999	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3236	SRR042796	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047225	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241838	241838	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107095_from_subject_159814214__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700107058	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS022645.570562	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2237	SRR041722	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022645	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241820	241820	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098597_from_subject_158499257__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098560	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS018017.571189	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1251	SRR040722	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018017	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035341_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035307	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS013472.574884	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_238	SRR041724	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016403_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016385	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	BI	HMP_production_phase_1
SRS011621.574052	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_162	SRR045302	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241795	241795	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033438_from_subject_159470302__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033436	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.1	WUGSC	HMP_production_phase_1
SRS056702.572793	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4045	SRR048238	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056702	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102944_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102915	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	BCM	HMP_production_phase_1
SRS021688.571919	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1992	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021688	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097400_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097369	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	JCVI	HMP_production_phase_1
SRS020712.572364	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1750	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020712	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096137_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096111	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	0	JCVI	HMP_production_phase_1
SRS016154.574552	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_796	SRR044268	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016154	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024811_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024790	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	3.9	WUGSC	HMP_production_phase_1
SRS049070.572838	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3395	SRR046210	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049070	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038920_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038903	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	WUGSC	HMP_production_phase_1
SRS024482.571120	TCAGTTCGGACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2696	SRR041967	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024482	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101628_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101595	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	38	0	BI	HMP_production_phase_1
SRS014879.574169	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_465	SRR047639	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014879	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023533_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023505	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS051345.576364	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3606	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051345	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108999_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108965	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	4.3	JCVI	HMP_production_phase_1
SRS045980.574936	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3123	SRR046058	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045980	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038992_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038963	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	30	0	WUGSC	HMP_production_phase_1
SRS046269.573805	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3151	SRR048482	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046269	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107405_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107379	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	4.7	BCM	HMP_production_phase_1
SRS011371.574056	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_39	SRR047512	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011371	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015659_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015657	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS013508.572382	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_245	SRR041017	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013508	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016488_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016465	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS051879.574893	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3649	SRR048524	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051879	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107969_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107940	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BCM	HMP_production_phase_1
SRS065236.571207	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4653	SRR049489	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065236	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113523_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700113494	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS022307.574846	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2145	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022307	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098147_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098117	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	4.5	JCVI	HMP_production_phase_1
SRS057843.572517	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4144	SRR047730	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057843	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241892	241892	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106316_from_subject_550534656__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106286	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.2	WUGSC	HMP_production_phase_1
SRS011514.570818	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_106	SRR045116	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011514	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016368_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016350	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	4.2	WUGSC	HMP_production_phase_1
SRS066144.571856	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048773	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS013786.575970	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_305	SRR048123	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013786	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016946_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016914	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BCM	HMP_production_phase_1
SRS049738.571469	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3455	SRR046226	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049738	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038930_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038908	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	WUGSC	HMP_production_phase_1
SRS015119.573997	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_510	SRR045711	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023774_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023694	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	4.5	WUGSC	HMP_production_phase_1
SRS064411.573744	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4542	SRR049630	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064411	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257126	257126	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114983_from_subject_103092734__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700114963	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	0	WUGSC	HMP_production_phase_1
SRS014436.571777	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_368	SRR043624	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014436	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023090_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700023063	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	3.4	WUGSC	HMP_production_phase_1
SRS023928.573594	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2549	SRR041559	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023928	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100326_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100300	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS050522.574571	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3535	SRR046314	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050522	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103706_from_subject_763759525__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700103670	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	23	4.8	WUGSC	HMP_production_phase_1
SRS023221.571517	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2381	SRR048070	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023221	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241700	241700	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099352_from_subject_158114885__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099347	n	969	319	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	29	4.2	BCM	HMP_production_phase_1
SRS011634.574023	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_168	SRR044972	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011634	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033471_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033469	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4.1	WUGSC	HMP_production_phase_1
SRS049589.574462	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3440	SRR045495	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049589	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038712_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038688	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	3.7	WUGSC	HMP_production_phase_1
SRS011442.570237	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_66	SRR045135	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016091_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016052	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS016066.571811	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_775	SRR044246	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016066	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024723_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024695	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	WUGSC	HMP_production_phase_1
SRS024331.574224	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2653	SRR041132	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024331	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241814	241814	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101366_from_subject_159551223__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101347	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS015366.570858	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_589	SRR044001	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015366	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024021_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023984	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	3.7	WUGSC	HMP_production_phase_1
SRS021261.576444	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1883	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021261	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096907_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096875	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	34	5.3	JCVI	HMP_production_phase_1
SRS013729.571259	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_292	SRR041587	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013729	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016807_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016803	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS020478.576541	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1697	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020478	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095801_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095778	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	JCVI	HMP_production_phase_1
SRS053764.574580	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3807	SRR046461	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053764	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241882	241882	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106451_from_subject_338793263__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106430	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	4.9	WUGSC	HMP_production_phase_1
SRS017371.570375	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1102	SRR042925	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017371	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241674	241674	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034077_from_subject_160340197__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS046244.574407	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3148	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046244	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102155_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102123	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	36	3.9	JCVI	HMP_production_phase_1
SRS014746.574845	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_424	SRR047406	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014746	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023400_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023380	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	4.2	WUGSC	HMP_production_phase_1
SRS020698.571008	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1747	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020698	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241759	241759	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096123_from_subject_160987560__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096104	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	0	JCVI	HMP_production_phase_1
SRS015444.575050	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_604	SRR049226	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015444	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024099_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024082	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS047094.574420	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3225	SRR049438	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047094	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038872_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	WUGSC	HMP_production_phase_1
SRS053208.573504	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3756	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108078_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108048	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	JCVI	HMP_production_phase_1
SRS051219.572067	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3593	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109260_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109234	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	4.8	JCVI	HMP_production_phase_1
SRS021255.571888	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1880	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096901_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096872	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	34	5.3	JCVI	HMP_production_phase_1
SRS020204.574165	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1628	SRR048154	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020204	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241762	241762	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095457_from_subject_158418336__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095424	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	32	0	BCM	HMP_production_phase_1
SRS019107.575146	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1479	SRR044643	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019107	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037578_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037548	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS052485.576352	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3708	SRR043895	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052485	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241823	241823	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038524_from_subject_763476303__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038495	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	31	0	WUGSC	HMP_production_phase_1
SRS042121.574621	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2764	SRR046059	29.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042121	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241873	241873	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038948_from_subject_355657046__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038917	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	WUGSC	HMP_production_phase_1
SRS016517.576573	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_899	SRR041077	23.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016517	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241831	241831	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032244_from_subject_159753524__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700032222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4	BI	HMP_production_phase_1
SRS017663.575350	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1161	SRR040576	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034678_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034633	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	19	0	BI	HMP_production_phase_1
SRS017098.573574	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1040	SRR042861	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017098	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033611_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033576	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS024044.575221	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2579	SRR040960	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024044	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100506_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100479	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	4.7	BI	HMP_production_phase_1
SRS046697.571827	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3189	SRR048712	34.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046697	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109951_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109925	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	34	4.6	BCM	HMP_production_phase_1
SRS017148.574026	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1053	SRR041716	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017148	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033710_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033709	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS022125.571032	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2101	SRR042815	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097891_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097853	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	4.4	BI	HMP_production_phase_1
SRS058527.570895	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4200	SRR045914	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058527	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038608_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038585	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS011475.572301	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_84	SRR044904	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011475	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016174_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016135	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS020543.575160	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1711	SRR041740	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095866_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095839	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	BI	HMP_production_phase_1
SRS015758.571016	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_685	SRR044261	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015758	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024413_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024396	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	WUGSC	HMP_production_phase_1
SRS020322.576222	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1660	SRR042811	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020322	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241829	241829	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095575_from_subject_160663879__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095540	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS052630.576281	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3718	SRR048538	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052630	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109608_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109576	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	0	BCM	HMP_production_phase_1
SRS050761.574104	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3552	SRR043899	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050761	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038574_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038544	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS024208.572355	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2621	SRR041783	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241745	241745	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101095_from_subject_159308461__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101076	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS020724.572210	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1756	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020724	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096149_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096117	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	0	JCVI	HMP_production_phase_1
SRS066144.573176	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048707	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS063221.570646	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4354	SRR048830	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063221	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268869	268869	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111809_from_subject_872848689__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111766	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.6	BCM	HMP_production_phase_1
SRS024042.570866	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2578	SRR040844	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024042	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100504_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100478	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	4.7	BI	HMP_production_phase_1
SRS043642.571428	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2898	SRR046796	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043642	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241893	241893	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105071_from_subject_178713055__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.5	WUGSC	HMP_production_phase_1
SRS022506.575374	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2198	SRR048177	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022506	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098407_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098372	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	30	4.5	BCM	HMP_production_phase_1
SRS013831.571273	TCAGCCGTTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_313	SRR041879	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013831	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016991_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016990	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	0	BI	HMP_production_phase_1
SRS050336.575247	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3516	SRR048512	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050336	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107583_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107555	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	0	BCM	HMP_production_phase_1
SRS017239.574528	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1070	SRR043261	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017239	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033845_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033844	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS044226.572056	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2947	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044226	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101805_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101777	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	JCVI	HMP_production_phase_1
SRS065533.570550	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4699	SRR046811	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065533	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241877	241877	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113099_from_subject_764872181__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700113069	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS051255.573730	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3600	SRR043625	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038734_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700038699	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	25	3.7	WUGSC	HMP_production_phase_1
SRS065584.575076	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4708	SRR046823	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065584	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114470_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114437	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	3.9	WUGSC	HMP_production_phase_1
SRS016684.575116	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_950	SRR043001	23.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016684	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241713	241713	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032468_from_subject_160036745__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032467	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	5	BI	HMP_production_phase_1
SRS017961.572378	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1241	SRR041640	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017961	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035282_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035250	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS015204.574093	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_541	SRR043799	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015204	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023859_from_subject_763759525__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023822	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4	WUGSC	HMP_production_phase_1
SRS062492.574925	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4243	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062492	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110628_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110598	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	JCVI	HMP_production_phase_1
SRS054558.570604	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3860	SRR046675	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054558	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106528_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106497	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	32	4.3	WUGSC	HMP_production_phase_1
SRS018989.571963	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1456	SRR044591	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018989	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037458_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037440	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS018993.572923	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1458	SRR044620	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018993	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037462_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037442	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS066188.573350	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048919	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS056240.571935	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4001	SRR046459	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056240	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241863	241863	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105003_from_subject_275382046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106980	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	0	WUGSC	HMP_production_phase_1
SRS014442.574962	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_369	SRR045494	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014442	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241812	241812	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023096_from_subject_763698834__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700023066	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	3.4	WUGSC	HMP_production_phase_1
SRS051600.576440	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3624	SRR049606	19.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051600	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241758	241758	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103651_from_subject_765094712__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700103620	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	19	0	WUGSC	HMP_production_phase_1
SRS011527.575481	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_113	SRR045099	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011527	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016506_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016500	n	969	23	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	34	3.6	WUGSC	HMP_production_phase_1
SRS020608.573317	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1730	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020608	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095999_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095968	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS065500.573416	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4693	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241751	241751	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110309_from_subject_892969023__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110287	n	969	120	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	JCVI	HMP_production_phase_1
SRS043395.576611	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2871	SRR045499	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043395	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038736_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700038700	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	25	3.7	WUGSC	HMP_production_phase_1
SRS021137.573370	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1855	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021137	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241801	241801	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096684_from_subject_160744799__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096604	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	4.9	JCVI	HMP_production_phase_1
SRS056255.572719	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4002	SRR048611	26.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241691	241691	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108117_from_subject_160502038__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108095	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	3.9	BCM	HMP_production_phase_1
SRS021565.576275	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1962	SRR048090	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021565	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097277_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097246	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	BCM	HMP_production_phase_1
SRS055821.572018	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3963	SRR049399	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055821	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241887	241887	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106898_from_subject_764811490__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106868	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	21	5.3	WUGSC	HMP_production_phase_1
SRS022173.571640	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2110	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022173	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097942_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097913	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.5	JCVI	HMP_production_phase_1
SRS023942.575931	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2556	SRR041509	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023942	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100340_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100307	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS016488.571412	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_896	SRR043041	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032184_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS023605.571332	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2468	SRR043294	20.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023605	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241702	241702	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099908_from_subject_159005010__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099886	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	20	4.9	BI	HMP_production_phase_1
SRS057361.570798	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4096	SRR046808	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057361	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241856	241856	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105132_from_subject_256789458__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105100	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	5.6	WUGSC	HMP_production_phase_1
SRS011623.576291	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_163	SRR045354	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033450_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033448	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.1	WUGSC	HMP_production_phase_1
SRS020942.576531	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1805	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020942	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096453_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096426	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	0	JCVI	HMP_production_phase_1
SRS017800.576421	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1201	SRR042853	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017800	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241782	241782	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034893_from_subject_160542498__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS011444.572542	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_68	SRR045421	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016095_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016054	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	4.2	WUGSC	HMP_production_phase_1
SRS016373.571592	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_866	SRR042823	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016373	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032037_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS047699.570359	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3281	SRR046494	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047699	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103649_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103619	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	19	0	WUGSC	HMP_production_phase_1
SRS020899.575034	TCAGACCGGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1797	SRR042810	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020899	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096410_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096376	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	31	0	BI	HMP_production_phase_1
SRS017467.573489	TCAGTTCCAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1121	SRR041336	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017467	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034200_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	19	5.1	BI	HMP_production_phase_1
SRS052566.574676	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3712	SRR047155	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052566	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241860	241860	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103265_from_subject_465578759__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105984	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	31	4.4	WUGSC	HMP_production_phase_1
SRS023212.573077	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2378	SRR041941	33.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241767	241767	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099343_from_subject_158924089__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700099306	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	33	0	BI	HMP_production_phase_1
SRS044021.572649	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2931	SRR048718	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044021	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107540_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107505	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	BCM	HMP_production_phase_1
SRS023695.575032	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2494	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023695	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100002_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099968	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	4.1	JCVI	HMP_production_phase_1
SRS050447.572004	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3529	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110021_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109994	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	JCVI	HMP_production_phase_1
SRS011545.573108	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_122	SRR044959	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011545	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016646_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016644	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS064467.573663	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4548	SRR049642	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064467	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241877	241877	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113103_from_subject_764872181__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700113071	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	WUGSC	HMP_production_phase_1
SRS023934.571465	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2552	SRR041570	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023934	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100332_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100303	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS022006.570249	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2070	SRR040612	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022006	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097746_from_subject_158256496__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097706	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	4.1	BI	HMP_production_phase_1
SRS016789.572859	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_980	SRR042914	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016789	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241715	241715	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032980_from_subject_160421117__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032943	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS011592.575435	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_147	SRR049231	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011592	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033167_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033137	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.3	WUGSC	HMP_production_phase_1
SRS024003.576173	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2572	SRR043287	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024003	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100464_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100429	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS015524.576068	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_626	SRR044244	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015524	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024179_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024144	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.1	WUGSC	HMP_production_phase_1
SRS016592.573165	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_919	SRR041314	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016592	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032345_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032320	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	31	4.3	BI	HMP_production_phase_1
SRS017014.572322	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1017	SRR041537	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017014	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033527_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033526	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS042924.574837	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2828	SRR046401	36.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042924	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241862	241862	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106142_from_subject_706846339__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700106118	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	36	4.5	WUGSC	HMP_production_phase_1
SRS020614.573163	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1732	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020614	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241740	241740	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096005_from_subject_160906640__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095971	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	JCVI	HMP_production_phase_1
SRS057421.571430	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4099	SRR047720	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057421	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241879	241879	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106508_from_subject_553359145__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106487	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	4.3	WUGSC	HMP_production_phase_1
SRS019580.576060	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1531	SRR043597	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019580	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038051_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038020	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS021978.571990	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2058	SRR041745	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021978	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097718_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700097692	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	4.1	BI	HMP_production_phase_1
SRS022633.575399	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2231	SRR041806	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022633	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098585_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098554	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS047139.575953	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3229	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047139	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108816_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108789	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	0	JCVI	HMP_production_phase_1
SRS024208.572618	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2621	SRR041965	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241745	241745	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101095_from_subject_159308461__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101076	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS053403.573940	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3774	SRR058108	40.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053403	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110279_from_subject_161473083__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700110239	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	40	4.9	JCVI	HMP_production_phase_1
SRS015297.571957	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_568	SRR043803	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015297	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023952_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023927	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	37	0	WUGSC	HMP_production_phase_1
SRS049292.571999	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3419	SRR048473	27.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049292	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241839	241839	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107544_from_subject_159632143__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107507	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BCM	HMP_production_phase_1
SRS046144.576428	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3140	SRR046142	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106020_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106000	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	3.8	WUGSC	HMP_production_phase_1
SRS014815.574963	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_443	SRR045728	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014815	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023469_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023443	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.1	WUGSC	HMP_production_phase_1
SRS052122.574044	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3673	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052122	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109476_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109453	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	31	0	JCVI	HMP_production_phase_1
SRS058175.573898	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_4167	SRR042974	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058175	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102987_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102967	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS022502.575048	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2196	SRR048179	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022502	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098403_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098370	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	30	4.5	BCM	HMP_production_phase_1
SRS023061.571732	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2334	SRR048112	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023061	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099095_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099066	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	4.1	BCM	HMP_production_phase_1
SRS019182.574262	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1483	SRR045881	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019182	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241684	241684	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037653_from_subject_765398164__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS022181.576612	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2114	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022181	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097950_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700097917	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.5	JCVI	HMP_production_phase_1
SRS019552.570705	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1518	SRR046571	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019552	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038023_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038006	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS045770.574984	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3097	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045770	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108066_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107997	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	JCVI	HMP_production_phase_1
SRS014623.571156	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_407	SRR047557	38.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023277_from_subject_763840445__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	38	4.1	WUGSC	HMP_production_phase_1
SRS014665.572393	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_418	SRR047624	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023319_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023293	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS050481.574482	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3533	SRR041429	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050481	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107003_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102975	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS063700.574285	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4425	SRR048844	39.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063700	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268877	268877	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111346_from_subject_763721271__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700111310	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	39	4.8	BCM	HMP_production_phase_1
SRS057065.573059	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4074	SRR049853	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057065	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241811	241811	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106052_from_subject_764184357__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106016	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	23	3.8	WUGSC	HMP_production_phase_1
SRS017098.573966	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1040	SRR042910	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017098	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033611_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033576	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS021631.571542	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1979	SRR048297	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241668	241668	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097343_from_subject_158013734__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097306	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.9	BCM	HMP_production_phase_1
SRS064596.575109	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4561	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064596	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110728_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110705	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	35	0	JCVI	HMP_production_phase_1
SRS064934.574107	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4607	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064934	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110630_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110599	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS057813.574082	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4143	SRR043604	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057813	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038462_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038440	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS022193.573246	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2120	SRR058111	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022193	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097962_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700097923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.5	JCVI	HMP_production_phase_1
SRS052055.575652	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3665	SRR048891	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052055	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107597_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700107562	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	0	BCM	HMP_production_phase_1
SRS017853.576264	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1214	SRR043032	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034958_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS015444.572029	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_604	SRR044659	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015444	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024099_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024082	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS065144.572426	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4635	SRR048835	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111336_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111305	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	39	4.8	BCM	HMP_production_phase_1
SRS019884.574687	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1572	SRR044513	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019884	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241772	241772	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038360_from_subject_764892411__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700038341	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS050220.573948	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3498	SRR047197	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050220	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241887	241887	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106912_from_subject_764811490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106875	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	21	5.3	WUGSC	HMP_production_phase_1
SRS017475.576390	TCAGAACCGACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1125	SRR041300	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017475	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034208_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034176	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	19	5.1	BI	HMP_production_phase_1
SRS064859.575271	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4596	SRR046270	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064859	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114033_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114008	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	36	0	WUGSC	HMP_production_phase_1
SRS014956.574720	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_483	SRR046190	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014956	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023611_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	32	0	WUGSC	HMP_production_phase_1
SRS022584.571472	TCAGTATAGCGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2220	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022584	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098489_from_subject_809635352__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098448	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	26	5	JCVI	HMP_production_phase_1
SRS018751.572813	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1419	SRR044431	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018751	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037218_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	4.5	WUGSC	HMP_production_phase_1
SRS016376.572626	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_867	SRR042815	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016376	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032040_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS011433.572687	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_59	SRR045315	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011433	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016077_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016045	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS015299.573406	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_569	SRR048945	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015299	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023954_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023928	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	37	0	WUGSC	HMP_production_phase_1
SRS013770.571831	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_298	SRR048293	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013770	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016929_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016906	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BCM	HMP_production_phase_1
SRS053562.572884	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3790	SRR058113	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053562	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109916_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109880	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	0	JCVI	HMP_production_phase_1
SRS022952.576202	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2310	SRR048105	37.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022952	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241781	241781	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098982_from_subject_158236265__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098946	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	4.6	BCM	HMP_production_phase_1
SRS048549.571997	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3349	SRR048576	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048549	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107908_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107881	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	0	BCM	HMP_production_phase_1
SRS016346.574768	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_857	SRR041001	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016346	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032010_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032009	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS015500.571523	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_617	SRR046078	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241707	241707	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024155_from_subject_764245047__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.1	WUGSC	HMP_production_phase_1
SRS011279.573446	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_20	SRR045358	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011279	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015271_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015269	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	WUGSC	HMP_production_phase_1
SRS016491.574675	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_897	SRR042975	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016491	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241846	241846	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032187_from_subject_159429842__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032186	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS020732.570509	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1759	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020732	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096157_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096121	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	JCVI	HMP_production_phase_1
SRS016525.572650	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_900	SRR041684	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032252_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032226	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4	BI	HMP_production_phase_1
SRS022900.574793	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2299	SRR058086	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022900	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098930_from_subject_650853796__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098887	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	22	4.6	JCVI	HMP_production_phase_1
SRS016561.576599	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_917	SRR041466	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016561	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032288_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS024357.573218	TCAGTACGGATTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2662	SRR041767	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101392_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101360	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS015196.572589	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_537	SRR043940	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015196	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023851_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023818	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4	WUGSC	HMP_production_phase_1
SRS019775.576587	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1559	SRR044489	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019775	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038251_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038225	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	0	WUGSC	HMP_production_phase_1
SRS055772.576393	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3956	SRR048235	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102940_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102913	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	BCM	HMP_production_phase_1
SRS044314.573955	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2956	SRR046852	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044314	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103311_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103281	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	19	4.7	WUGSC	HMP_production_phase_1
SRS062607.571555	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4262	SRR048822	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062607	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111789_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700111756	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.6	BCM	HMP_production_phase_1
SRS011657.575693	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_180	SRR047513	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011657	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033761_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033732	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.4	WUGSC	HMP_production_phase_1
SRS053335.574838	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3769	SRR046056	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053335	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241864	241864	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038761_from_subject_508703490__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038741	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	5.3	WUGSC	HMP_production_phase_1
SRS053518.575601	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3787	SRR045871	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053518	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241864	241864	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038793_from_subject_508703490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700038757	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	5.3	WUGSC	HMP_production_phase_1
SRS016716.572754	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_957	SRR040937	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016716	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032661_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032644	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.3	BI	HMP_production_phase_1
SRS044834.575935	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3012	SRR045907	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044834	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241889	241889	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038820_from_subject_765640925__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038799	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	39	5.3	WUGSC	HMP_production_phase_1
SRS017127.570765	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1046	SRR041012	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017127	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033689_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033688	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS020233.575311	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1633	SRR041766	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020233	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241798	241798	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095486_from_subject_160400887__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700095467	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	0	BI	HMP_production_phase_1
SRS062836.575413	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4303	SRR048808	38.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062836	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268878	268878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111272_from_subject_866653606__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111236	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	38	5	BCM	HMP_production_phase_1
SRS013096.573459	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_196	SRR049324	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015674_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015672	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	33	0	WUGSC	HMP_production_phase_1
SRS020657.573193	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1739	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096082_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096055	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	JCVI	HMP_production_phase_1
SRS022311.571382	TCAGTCTGTGACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2147	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022311	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098151_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098119	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	4.5	JCVI	HMP_production_phase_1
SRS015121.572624	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_511	SRR045717	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015121	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023776_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023695	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	4.5	WUGSC	HMP_production_phase_1
SRS015766.571590	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_688	SRR044266	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015766	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024421_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024400	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	WUGSC	HMP_production_phase_1
SRS054907.576302	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3884	SRR046327	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054907	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105256_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105219	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	4	WUGSC	HMP_production_phase_1
SRS021109.576014	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1845	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021109	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241801	241801	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096656_from_subject_160744799__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096590	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	20	4.9	JCVI	HMP_production_phase_1
SRS016984.574908	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1012	SRR047517	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016984	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241795	241795	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033489_from_subject_159470302__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033487	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.1	WUGSC	HMP_production_phase_1
SRS063513.575131	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4398	SRR046892	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063513	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113636_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113609	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS022631.570902	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2230	SRR041931	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022631	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098583_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098553	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS045359.574000	TCAGTTCAAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3062	SRR041364	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045359	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107079_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107050	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	BI	HMP_production_phase_1
SRS018753.573039	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1420	SRR044442	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018753	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037220_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037133	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	4.5	WUGSC	HMP_production_phase_1
SRS055787.575702	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3958	SRR045990	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241873	241873	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038940_from_subject_355657046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038913	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	29	0	WUGSC	HMP_production_phase_1
SRS014960.570560	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_485	SRR046187	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014960	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023615_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023594	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	32	0	WUGSC	HMP_production_phase_1
SRS064715.575732	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4580	SRR047102	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064715	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114199_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114172	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	0	WUGSC	HMP_production_phase_1
SRS021885.570396	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2042	SRR058111	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021885	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097621_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700097586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	JCVI	HMP_production_phase_1
SRS058390.574447	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4188	SRR048487	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058390	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107425_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107389	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	4.7	BCM	HMP_production_phase_1
SRS014663.572206	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_417	SRR043621	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023317_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700023292	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	37	0	WUGSC	HMP_production_phase_1
SRS022067.571180	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2087	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022067	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097807_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097771	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	0	JCVI	HMP_production_phase_1
SRS020006.572671	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1589	SRR041044	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020006	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095251_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095221	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.3	BI	HMP_production_phase_1
SRS056919.571195	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4066	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056919	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108092_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700108055	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	0	JCVI	HMP_production_phase_1
SRS011608.571095	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_155	SRR044850	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033183_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033145	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.3	WUGSC	HMP_production_phase_1
SRS044041.570400	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2935	SRR045870	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044041	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038777_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700038749	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	5.3	WUGSC	HMP_production_phase_1
SRS011617.570928	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_160	SRR045306	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033193_from_subject_159733294__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033150	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.3	WUGSC	HMP_production_phase_1
SRS062610.573115	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4264	SRR048832	39.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062610	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:268877	268877	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111318_from_subject_763721271__sex_female_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700111296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	39	4.8	BCM	HMP_production_phase_1
SRS058159.572034	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4164	SRR049365	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241852	241852	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038900_from_subject_861967750__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038869	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	WUGSC	HMP_production_phase_1
SRS054512.572321	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3857	SRR048597	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054512	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107800_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107770	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	0	BCM	HMP_production_phase_1
SRS062443.576154	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4233	SRR046555	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062443	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241824	241824	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113529_from_subject_763719065__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700113497	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS017394.575884	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1104	SRR043247	30.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017394	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241703	241703	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034100_from_subject_160481808__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	BI	HMP_production_phase_1
SRS011521.571974	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_110	SRR044848	20.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016376_from_subject_159005010__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700016354	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	20	4.2	WUGSC	HMP_production_phase_1
SRS054669.573720	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3871	SRR045925	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054669	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038781_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038751	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	5.3	WUGSC	HMP_production_phase_1
SRS011514.572387	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_106	SRR044885	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011514	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016368_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016350	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	20	4.2	WUGSC	HMP_production_phase_1
SRS023573.573175	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2463	SRR041266	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023573	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099850_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099817	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS049286.570586	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3418	SRR040909	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049286	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102981_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102964	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS011523.572919	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_111	SRR045103	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011523	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016502_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016498	n	969	23	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	34	3.6	WUGSC	HMP_production_phase_1
SRS014952.574697	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_481	SRR046216	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014952	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023607_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023590	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	32	0	WUGSC	HMP_production_phase_1
SRS015903.573739	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_725	SRR044622	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015903	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024558_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024541	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS056223.570908	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4000	SRR048517	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056223	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107577_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107552	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	0	BCM	HMP_production_phase_1
SRS024224.573934	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2625	SRR041966	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101111_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101084	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS016940.574600	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1004	SRR040898	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016940	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033406_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033375	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS023015.571424	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2326	SRR048067	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023015	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241700	241700	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099049_from_subject_158114885__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099016	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	0	BCM	HMP_production_phase_1
SRS016708.576210	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_954	SRR042884	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016708	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032653_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032640	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.3	BI	HMP_production_phase_1
SRS052185.576453	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3680	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052185	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109441_from_subject_370425937__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109401	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.8	JCVI	HMP_production_phase_1
SRS022701.573472	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2250	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022701	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241689	241689	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098653_from_subject_432193348__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098615	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	4.6	JCVI	HMP_production_phase_1
SRS047650.571720	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3277	SRR048410	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047650	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102619_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102591	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	4.5	BCM	HMP_production_phase_1
SRS052153.572942	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3676	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052153	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108322_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108293	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	JCVI	HMP_production_phase_1
SRS014770.574121	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_432	SRR046157	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014770	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241824	241824	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023424_from_subject_763719065__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023392	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	4.2	WUGSC	HMP_production_phase_1
SRS018864.572064	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1444	SRR045905	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018864	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241716	241716	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037331_from_subject_765256553__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037298	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	18	3.8	WUGSC	HMP_production_phase_1
SRS043804.573505	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2914	SRR045921	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043804	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241886	241886	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038626_from_subject_404239096__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038594	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS018100.575134	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1273	SRR041969	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018100	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035424_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035385	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS019998.573639	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1586	SRR041818	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019998	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095243_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700095217	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.3	BI	HMP_production_phase_1
SRS011555.573572	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_127	SRR045434	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016661_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016659	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS024388.575649	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2668	SRR041171	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241764	241764	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101534_from_subject_159713063__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700101515	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	5.1	BI	HMP_production_phase_1
SRS024359.570990	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2663	SRR041735	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024359	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101394_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101361	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS065711.574088	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4732	SRR058092	36.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065711	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257123	257123	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111867_from_subject_414519462__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111828	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	36	4.7	JCVI	HMP_production_phase_1
SRS016325.574134	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_849	SRR044445	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016325	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024988_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024961	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	0	WUGSC	HMP_production_phase_1
SRS018453.576618	TCAGTTCCGTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1361	SRR041113	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018453	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035887_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS019767.572558	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1555	SRR044019	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019767	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038243_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038221	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	0	WUGSC	HMP_production_phase_1
SRS043550.572473	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2885	SRR046323	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043550	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105248_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105215	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	4	WUGSC	HMP_production_phase_1
SRS021514.571073	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1951	SRR041550	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021514	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241722	241722	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097226_from_subject_158479027__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097192	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS017115.574357	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1043	SRR041127	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017115	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033677_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033676	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS011285.573861	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_23	SRR045444	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015280_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700015278	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS066188.570306	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058114	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS048987.576223	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3389	SRR049387	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048987	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241892	241892	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106322_from_subject_550534656__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106289	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.2	WUGSC	HMP_production_phase_1
SRS015123.574782	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_512	SRR045731	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023778_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023696	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	4.5	WUGSC	HMP_production_phase_1
SRS017096.571527	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1039	SRR042976	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033609_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033575	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS023617.570981	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2470	SRR040579	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099920_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099892	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	20	4.9	BI	HMP_production_phase_1
SRS023202.573885	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2374	SRR041688	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023202	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099333_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099301	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	33	0	BI	HMP_production_phase_1
SRS011375.574346	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_41	SRR045399	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011375	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015665_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700015663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS042263.574366	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2772	SRR047220	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042263	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103635_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103612	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	19	0	WUGSC	HMP_production_phase_1
SRS054465.571102	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3853	SRR048552	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054465	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108939_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108908	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BCM	HMP_production_phase_1
SRS011441.573001	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_65	SRR045448	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011441	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016089_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016051	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	20	4.2	WUGSC	HMP_production_phase_1
SRS055625.576207	TCAGAAGTCGGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3940	SRR040935	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055625	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102458_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102426	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS021328.575197	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1902	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021328	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096986_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096955	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	0	JCVI	HMP_production_phase_1
SRS013717.574324	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_288	SRR041596	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013717	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016795_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016794	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS015137.570595	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_519	SRR043957	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015137	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023792_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023703	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	4.5	WUGSC	HMP_production_phase_1
SRS011173.573031	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_9	SRR044963	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011173	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014991_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014989	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	0	WUGSC	HMP_production_phase_1
SRS016491.570238	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_897	SRR042876	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016491	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241846	241846	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032187_from_subject_159429842__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700032186	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS047650.573394	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3277	SRR048282	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047650	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102619_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102591	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	4.5	BCM	HMP_production_phase_1
SRS058507.573700	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4199	SRR049608	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058507	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106107_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106072	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	18	4.5	WUGSC	HMP_production_phase_1
SRS022765.572155	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2266	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022765	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098721_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098684	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	JCVI	HMP_production_phase_1
SRS022560.572111	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2208	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022560	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098465_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098436	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	5	JCVI	HMP_production_phase_1
SRS024545.575555	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2713	SRR048323	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024545	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241819	241819	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101691_from_subject_159389382__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101655	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS042288.575844	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2775	SRR046641	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042288	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241854	241854	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106428_from_subject_517810313__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700106404	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS055727.571030	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3952	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055727	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241738	241738	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109468_from_subject_161554003__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109449	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	31	0	JCVI	HMP_production_phase_1
SRS065010.572006	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4616	SRR047095	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065010	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114207_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114176	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS043112.573740	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2841	SRR058113	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043112	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110323_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110294	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	4.3	JCVI	HMP_production_phase_1
SRS017545.572435	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1145	SRR041183	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034278_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034244	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS065219.574567	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4650	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065219	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111067_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700111037	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	JCVI	HMP_production_phase_1
SRS062410.574110	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4229	SRR047092	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062410	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114389_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114372	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	32	0	WUGSC	HMP_production_phase_1
SRS014661.570503	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_416	SRR045528	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023315_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023291	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	37	0	WUGSC	HMP_production_phase_1
SRS013270.573184	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_228	SRR040695	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013270	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241833	241833	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015977_from_subject_159591683__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700015976	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS049589.572630	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3440	SRR043617	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049589	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038712_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038688	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	3.7	WUGSC	HMP_production_phase_1
SRS050243.570455	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3502	SRR048694	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050243	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109208_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109181	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	31	0	BCM	HMP_production_phase_1
SRS014607.575449	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_402	SRR045712	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014607	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023261_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	4.1	WUGSC	HMP_production_phase_1
SRS018916.571025	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1448	SRR046580	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018916	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241732	241732	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037385_from_subject_765216093__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037355	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	19	0	WUGSC	HMP_production_phase_1
SRS024396.574544	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2669	SRR041190	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024396	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101542_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101519	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	27	5.1	BI	HMP_production_phase_1
SRS064252.570326	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4517	SRR047028	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064252	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114848_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114813	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	4.1	WUGSC	HMP_production_phase_1
SRS020671.574706	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1745	SRR058109	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241776	241776	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096096_from_subject_160947100__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096062	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	JCVI	HMP_production_phase_1
SRS021197.575267	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1868	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021197	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096744_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096711	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	5	JCVI	HMP_production_phase_1
SRS020710.574195	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1749	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020710	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096135_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096110	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	0	JCVI	HMP_production_phase_1
SRS055744.570364	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3954	SRR043256	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055744	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101343_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700101307	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS018455.574038	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1362	SRR041968	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035889_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS021316.574084	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1896	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021316	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096974_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	0	JCVI	HMP_production_phase_1
SRS022125.570761	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2101	SRR043017	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097891_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097853	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	4.4	BI	HMP_production_phase_1
SRS014341.575166	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_348	SRR045670	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014341	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241844	241844	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021930_from_subject_763820215__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700021900	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	25	3.9	WUGSC	HMP_production_phase_1
SRS011663.570619	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_183	SRR045355	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011663	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033767_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033735	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.4	WUGSC	HMP_production_phase_1
SRS022705.570312	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2251	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022705	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241689	241689	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098657_from_subject_432193348__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098617	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	4.6	JCVI	HMP_production_phase_1
SRS064185.572102	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4510	SRR048426	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064185	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110792_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110766	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	4.6	BCM	HMP_production_phase_1
SRS046855.572371	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3200	SRR043614	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046855	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038716_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038690	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	3.7	WUGSC	HMP_production_phase_1
SRS020887.574220	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1791	SRR041622	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020887	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096398_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096370	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	31	0	BI	HMP_production_phase_1
SRS022735.571961	TCAGTATAGCGTCT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2255	SRR058120	22.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022735	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241670	241670	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098691_from_subject_370425937__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098669	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	0	JCVI	HMP_production_phase_1
SRS043994.575348	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2928	SRR048503	31.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043994	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108654_from_subject_159915365__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700108614	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	31	4	BCM	HMP_production_phase_1
SRS057267.575643	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4088	SRR045869	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057267	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241873	241873	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038950_from_subject_355657046__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038918	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	WUGSC	HMP_production_phase_1
SRS053440.570837	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3779	SRR048667	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053440	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110141_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700110104	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	4.3	BCM	HMP_production_phase_1
SRS056219.574294	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3999	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109417_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109389	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	4.8	JCVI	HMP_production_phase_1
SRS015231.574902	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_544	SRR044004	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015231	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023886_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023864	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	4.4	WUGSC	HMP_production_phase_1
SRS011608.571955	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_155	SRR045075	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033183_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033145	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.3	WUGSC	HMP_production_phase_1
SRS048237.575434	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3331	SRR046369	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048237	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106683_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106657	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS023071.571687	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2339	SRR048117	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023071	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241789	241789	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099105_from_subject_158276726__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099071	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	4.1	BCM	HMP_production_phase_1
SRS019556.576277	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1520	SRR043931	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019556	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038027_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038008	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS011619.576124	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_161	SRR045313	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033195_from_subject_159733294__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033151	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.3	WUGSC	HMP_production_phase_1
SRS024110.572468	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2596	SRR041324	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024110	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100575_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100548	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS020374.574665	TCAGAAGTCGGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1671	SRR041521	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020374	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095693_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095659	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	32	4.2	BI	HMP_production_phase_1
SRS016787.572011	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_979	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032978_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032942	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS017649.575157	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1155	SRR041671	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017649	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034649_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034626	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	19	0	BI	HMP_production_phase_1
SRS062495.575721	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4244	SRR048864	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062495	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112036_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700112001	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Left_Antecubital_fossa	26	0	BCM	HMP_production_phase_1
SRS013687.574921	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_282	SRR041527	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013687	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241725	241725	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016765_from_subject_159268001__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016764	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS064335.576415	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4531	SRR048850	23.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064335	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:268865	268865	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111461_from_subject_451588811__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111439	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.8	BCM	HMP_production_phase_1
SRS045007.573492	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3028	SRR049494	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045007	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106526_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106496	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	32	4.3	WUGSC	HMP_production_phase_1
SRS044177.576348	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2943	SRR048515	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107589_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107558	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	0	BCM	HMP_production_phase_1
SRS018815.573742	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1440	SRR047652	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018815	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241731	241731	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037282_from_subject_765135172__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037251	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	WUGSC	HMP_production_phase_1
SRS047634.573475	TCAGTTCAACGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3274	SRR040901	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047634	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102456_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102425	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS019247.572766	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1491	SRR044412	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019247	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241800	241800	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037718_from_subject_765034022__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037690	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.2	WUGSC	HMP_production_phase_1
SRS020269.570585	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1647	SRR040780	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020269	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241798	241798	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095522_from_subject_160400887__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095485	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	BI	HMP_production_phase_1
SRS021093.574071	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1840	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021093	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241694	241694	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096640_from_subject_160866180__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096582	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	4.8	JCVI	HMP_production_phase_1
SRS016311.571316	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_844	SRR044468	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016311	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241813	241813	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024974_from_subject_765074482__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024954	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	0	WUGSC	HMP_production_phase_1
SRS044605.570831	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2982	SRR043894	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044605	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038570_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038542	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS021427.576368	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1925	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241754	241754	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097135_from_subject_160967330__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700097116	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	32	0	JCVI	HMP_production_phase_1
SRS057481.571091	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4108	SRR058112	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057481	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107864_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107830	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	JCVI	HMP_production_phase_1
SRS018593.575246	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1399	SRR044407	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018593	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037060_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037035	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	19	0	WUGSC	HMP_production_phase_1
SRS015677.570502	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_668	SRR044270	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015677	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024332_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024303	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	WUGSC	HMP_production_phase_1
SRS020769.573282	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1763	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020769	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096194_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096168	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	JCVI	HMP_production_phase_1
SRS022623.575787	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2226	SRR041854	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022623	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098575_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098549	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS022179.571494	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2113	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022179	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097948_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097916	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.5	JCVI	HMP_production_phase_1
SRS019101.573240	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1476	SRR044742	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019101	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037572_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037545	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS017130.575771	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1047	SRR041061	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017130	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033692_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033691	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS054477.572796	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3855	SRR047128	31.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054477	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241717	241717	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105715_from_subject_763456073__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105681	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	31	5	WUGSC	HMP_production_phase_1
SRS018286.575201	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1321	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018286	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241785	241785	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035693_from_subject_160137896__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035653	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	3.9	BI	HMP_production_phase_1
SRS049964.572118	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3474	SRR044242	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049964	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241696	241696	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024841_from_subject_764366428__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024805	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	3.9	WUGSC	HMP_production_phase_1
SRS046495.573310	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3171	SRR041140	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046495	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101335_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101303	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS024048.576413	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2581	SRR040887	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024048	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100510_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100481	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	4.7	BI	HMP_production_phase_1
SRS020447.570904	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1694	SRR042936	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095770_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS056542.572027	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4033	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056542	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257122	257122	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107238_from_subject_686765762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107204	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS018347.571574	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1338	SRR042851	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018347	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035781_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS045536.574003	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3085	SRR047169	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045536	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241893	241893	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105051_from_subject_178713055__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105031	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.5	WUGSC	HMP_production_phase_1
SRS020771.573945	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1764	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020771	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096196_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096169	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	JCVI	HMP_production_phase_1
SRS013191.572832	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_202	SRR040984	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013191	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015890_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015864	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	0	BI	HMP_production_phase_1
SRS020241.572537	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1634	SRR041819	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020241	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095494_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095471	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	0	BI	HMP_production_phase_1
SRS024582.573225	TCAGTACGGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2718	SRR040730	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024582	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101873_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101847	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS018435.571724	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1353	SRR041151	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018435	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035869_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS018169.573608	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1291	SRR042930	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035569_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035532	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS055470.570762	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3931	SRR046473	36.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055470	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241862	241862	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106134_from_subject_706846339__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106114	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	36	4.5	WUGSC	HMP_production_phase_1
SRS066144.574699	TCAGCTACGCATCG	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058093	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS056067.573385	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3987	SRR046498	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056067	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241871	241871	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106261_from_subject_675950834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.6	WUGSC	HMP_production_phase_1
SRS011600.576497	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_151	SRR047468	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011600	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033175_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033141	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.3	WUGSC	HMP_production_phase_1
SRS016400.574860	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_869	SRR041382	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016400	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241749	241749	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032087_from_subject_159672603__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700032068	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS011169.571742	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_7	SRR045068	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011169	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014985_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014983	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	0	WUGSC	HMP_production_phase_1
SRS021557.573053	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1958	SRR048084	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021557	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097269_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097242	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	0	BCM	HMP_production_phase_1
SRS022898.572202	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2298	SRR058086	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022898	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098928_from_subject_650853796__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700098886	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	22	4.6	JCVI	HMP_production_phase_1
SRS065644.573336	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4723	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065644	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110831	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	26	4.7	JCVI	HMP_production_phase_1
SRS054608.570991	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3866	SRR046413	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054608	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241893	241893	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105087_from_subject_178713055__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105049	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.5	WUGSC	HMP_production_phase_1
SRS023202.571019	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2374	SRR041760	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023202	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099333_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099301	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	33	0	BI	HMP_production_phase_1
SRS050005.574440	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3479	SRR046858	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050005	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105183_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105154	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	38	4.3	WUGSC	HMP_production_phase_1
SRS064076.575954	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4496	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064076	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111857_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111823	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	36	0	JCVI	HMP_production_phase_1
SRS063252.572959	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4359	SRR048779	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063252	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111194_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111164	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.9	BCM	HMP_production_phase_1
SRS020999.572888	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1819	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096546_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096519	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	JCVI	HMP_production_phase_1
SRS057093.575735	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4078	SRR048239	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057093	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102932_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102909	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	BCM	HMP_production_phase_1
SRS066144.576182	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048324	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS018459.576569	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1364	SRR043030	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018459	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035893_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS053434.571921	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3777	SRR048476	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107538_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107504	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BCM	HMP_production_phase_1
SRS048822.574752	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3376	SRR048697	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048822	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109212_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109183	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	31	0	BCM	HMP_production_phase_1
SRS015740.575360	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_684	SRR047421	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015740	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241756	241756	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024395_from_subject_764467579__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024357	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	3.6	WUGSC	HMP_production_phase_1
SRS047149.574729	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3230	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047149	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107848_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107822	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	JCVI	HMP_production_phase_1
SRS011635.572759	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_169	SRR044973	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011635	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033473_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033472	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS058238.571027	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4173	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058238	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110391_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110361	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	4.4	JCVI	HMP_production_phase_1
SRS019552.573496	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1518	SRR045753	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019552	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038023_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038006	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS011477.576126	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_85	SRR045417	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011477	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016176_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016137	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS046027.572134	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3128	SRR047231	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046027	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105596_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105572	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	20	0	WUGSC	HMP_production_phase_1
SRS023260.571802	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2387	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023260	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099418_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099390	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	JCVI	HMP_production_phase_1
SRS013565.573312	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_256	SRR048268	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013565	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016586_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	4.7	BCM	HMP_production_phase_1
SRS065309.570228	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4661	SRR048432	35.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065309	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241804	241804	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110798_from_subject_158984779__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110769	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	4.6	BCM	HMP_production_phase_1
SRS023764.570336	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2513	SRR040941	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023764	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100071_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100037	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS017142.572169	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1051	SRR041060	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017142	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033704_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033703	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS052787.574271	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3727	SRR047407	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038552_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038533	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	32	0	WUGSC	HMP_production_phase_1
SRS016014.571728	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_759	SRR044272	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016014	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024669_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024644	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS015673.570229	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_666	SRR044286	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015673	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024328_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024301	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	WUGSC	HMP_production_phase_1
SRS014819.576439	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_445	SRR045690	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014819	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023473_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023445	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.1	WUGSC	HMP_production_phase_1
SRS050362.575626	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3517	SRR045530	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050362	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038708_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038686	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	3.7	WUGSC	HMP_production_phase_1
SRS051154.573591	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3584	SRR048671	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051154	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108260_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108228	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	32	4.6	BCM	HMP_production_phase_1
SRS024232.575984	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2629	SRR041421	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024232	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101119_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101088	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS015929.576320	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_736	SRR044638	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015929	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024584_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS024462.574727	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2687	SRR041166	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101608_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101585	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	38	0	BI	HMP_production_phase_1
SRS022677.575292	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2239	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022677	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098629_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700098603	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	4.6	JCVI	HMP_production_phase_1
SRS042359.571730	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2782	SRR049437	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042359	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106593_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106558	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	4.3	WUGSC	HMP_production_phase_1
SRS048045.576392	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3316	SRR048243	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048045	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102936_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102911	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	BCM	HMP_production_phase_1
SRS020308.575703	TCAGAATTCCTAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1653	SRR041146	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020308	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095561_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095533	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	BI	HMP_production_phase_1
SRS015462.575914	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_609	SRR047458	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024117_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024091	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS019552.572721	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1518	SRR046072	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019552	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038023_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038006	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS045378.571569	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3065	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045378	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109013_from_subject_161007791__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700108972	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	4.3	JCVI	HMP_production_phase_1
SRS024433.573677	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2685	SRR040655	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024433	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101579_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700101574	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	5.1	BI	HMP_production_phase_1
SRS049388.574961	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3426	SRR049375	33.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049388	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241808	241808	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103476_from_subject_763860675__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700103445	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	33	0	WUGSC	HMP_production_phase_1
SRS019365.573797	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1505	SRR045897	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019365	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241771	241771	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037836_from_subject_765337473__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037806	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.5	WUGSC	HMP_production_phase_1
SRS052408.572176	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3698	SRR048551	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108941_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108909	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BCM	HMP_production_phase_1
SRS054837.573563	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_3883	SRR041412	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054837	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107077_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107049	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	BI	HMP_production_phase_1
SRS015962.575291	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_743	SRR045786	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015962	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024617_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024594	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	0	WUGSC	HMP_production_phase_1
SRS016313.575125	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_845	SRR044436	20.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016313	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241813	241813	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024976_from_subject_765074482__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024955	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	20	0	WUGSC	HMP_production_phase_1
SRS049660.571711	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3453	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049660	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257123	257123	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102175_from_subject_414519462__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102133	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	36	3.9	JCVI	HMP_production_phase_1
SRS016012.573191	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_758	SRR044287	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016012	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024667_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024643	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS017041.570927	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1026	SRR043266	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017041	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033554_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS043531.570592	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_2883	SRR046770	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043531	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241863	241863	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105013_from_subject_275382046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106985	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	20	0	WUGSC	HMP_production_phase_1
SRS015506.574871	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_619	SRR047413	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015506	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241707	241707	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024161_from_subject_764245047__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024135	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.1	WUGSC	HMP_production_phase_1
SRS048240.570846	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3332	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048240	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108330_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108297	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS011578.571522	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_140	SRR045305	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011578	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033035_from_subject_159247771__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700033033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.7	WUGSC	HMP_production_phase_1
SRS016491.574652	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_897	SRR042815	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016491	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241846	241846	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032187_from_subject_159429842__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700032186	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS064540.574255	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4555	SRR048823	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064540	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111779_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111751	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.6	BCM	HMP_production_phase_1
SRS023766.570740	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2514	SRR040854	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023766	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100073_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100038	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS020543.571413	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1711	SRR041018	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095866_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095839	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	BI	HMP_production_phase_1
SRS056509.575913	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4027	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056509	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102686_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	JCVI	HMP_production_phase_1
SRS063679.576053	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4422	SRR046565	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063679	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114637_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700114607	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	4.3	WUGSC	HMP_production_phase_1
SRS056694.570724	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4044	SRR058108	22.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056694	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110411_from_subject_650853796__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:nasal mucus	700110371	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.4	JCVI	HMP_production_phase_1
SRS048577.570224	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3351	SRR049496	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048577	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105504_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105472	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	5	WUGSC	HMP_production_phase_1
SRS011547.571079	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_123	SRR045314	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011547	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016649_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016647	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS013216.572775	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_214	SRR040793	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241833	241833	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015923_from_subject_159591683__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700015922	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS063388.575262	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4378	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063388	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111604_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111578	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	39	4.8	JCVI	HMP_production_phase_1
SRS017084.574405	TCAGTTCTTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1033	SRR041304	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017084	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033597_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033569	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	BI	HMP_production_phase_1
SRS063933.570848	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4468	SRR046470	36.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063933	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241815	241815	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114045_from_subject_763395383__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114014	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	36	0	WUGSC	HMP_production_phase_1
SRS063509.576395	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4397	SRR048859	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063509	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112030_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111998	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Subgingival_plaque	26	0	BCM	HMP_production_phase_1
SRS024718.570654	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2757	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024718	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241753	241753	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102098_from_subject_368533040__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700102061	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	0	JCVI	HMP_production_phase_1
SRS018384.574243	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1343	SRR041459	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018384	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035818_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035792	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	0	BI	HMP_production_phase_1
SRS058824.571017	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4226	SRR048567	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058824	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109655_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109627	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	19	4.7	BCM	HMP_production_phase_1
SRS023496.574197	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2442	SRR048228	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023496	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099773_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099750	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BCM	HMP_production_phase_1
SRS050791.570506	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3554	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050791	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110415_from_subject_650853796__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110373	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	22	4.4	JCVI	HMP_production_phase_1
SRS018345.574081	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1337	SRR043221	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018345	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035779_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS058273.574129	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4178	SRR048881	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058273	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108210_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108176	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	21	0	BCM	HMP_production_phase_1
SRS015259.571369	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_558	SRR044020	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015259	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241729	241729	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023914_from_subject_764143897__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023878	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	26	4.4	WUGSC	HMP_production_phase_1
SRS022629.571602	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2229	SRR041838	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022629	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098581_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098552	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS022225.570741	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2125	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022225	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241786	241786	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097994_from_subject_970836795__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097972	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	4.2	JCVI	HMP_production_phase_1
SRS018860.573595	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1443	SRR045985	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018860	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241716	241716	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037327_from_subject_765256553__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	18	3.8	WUGSC	HMP_production_phase_1
SRS062652.574017	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4270	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062652	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268865	268865	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111503_from_subject_451588811__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.8	JCVI	HMP_production_phase_1
SRS018595.576550	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1400	SRR047433	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018595	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037062_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	19	0	WUGSC	HMP_production_phase_1
SRS050262.571199	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3506	SRR049534	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050262	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105924_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105892	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS053266.572366	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3761	SRR048754	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053266	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110125_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110096	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	4.3	BCM	HMP_production_phase_1
SRS020555.575700	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1717	SRR041078	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095878_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095845	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS020304.573499	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1651	SRR042009	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095557_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095531	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	BI	HMP_production_phase_1
SRS054341.573678	TCAGACATAGTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3838	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054341	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241698	241698	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110417_from_subject_650853796__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110374	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	22	4.4	JCVI	HMP_production_phase_1
SRS043799.572950	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2913	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043799	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257123	257123	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102177_from_subject_414519462__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	36	3.9	JCVI	HMP_production_phase_1
SRS024363.571037	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2665	SRR041705	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024363	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101398_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101363	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS014452.571048	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_374	SRR049867	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014452	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023106_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023071	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	3.4	WUGSC	HMP_production_phase_1
SRS019107.570638	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1479	SRR044735	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019107	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037578_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037548	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS052471.571491	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3707	SRR049366	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052471	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241852	241852	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038902_from_subject_861967750__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038870	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	0	WUGSC	HMP_production_phase_1
SRS016170.572524	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_804	SRR045744	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016170	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024827_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024798	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	3.9	WUGSC	HMP_production_phase_1
SRS018597.572113	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1401	SRR044452	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018597	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037064_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037037	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	0	WUGSC	HMP_production_phase_1
SRS063079.571054	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4336	SRR046563	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063079	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241756	241756	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113150_from_subject_764467579__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113117	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	0	WUGSC	HMP_production_phase_1
SRS020263.572683	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1644	SRR040621	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020263	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095516_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095482	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS063053.571634	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4331	SRR047341	30.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063053	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257118	257118	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114931_from_subject_561079058__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114907	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	4.1	WUGSC	HMP_production_phase_1
SRS049893.571820	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3465	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049893	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108513_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108483	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	32	0	JCVI	HMP_production_phase_1
SRS018084.571885	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1266	SRR041163	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018084	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035408_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035377	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS043873.575426	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2918	SRR043045	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043873	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102464_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102429	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS016367.571190	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_864	SRR040892	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032031_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032030	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS046142.575397	TCAGTAGTGTAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3139	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046142	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109282_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700109245	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	4.8	JCVI	HMP_production_phase_1
SRS021732.573881	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2000	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021732	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097445_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097419	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.1	JCVI	HMP_production_phase_1
SRS013666.570967	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_272	SRR041575	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013666	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241672	241672	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016744_from_subject_159288231__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700016706	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS057949.572099	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4157	SRR046043	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057949	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038988_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038961	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	30	0	WUGSC	HMP_production_phase_1
SRS049012.572323	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3392	SRR047209	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049012	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241887	241887	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106890_from_subject_764811490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106864	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	21	5.3	WUGSC	HMP_production_phase_1
SRS017849.571973	TCAGTTCCGTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1212	SRR041626	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017849	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034954_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034921	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	29	0	BI	HMP_production_phase_1
SRS023397.574078	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2425	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023397	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099563_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700099528	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	38	0	JCVI	HMP_production_phase_1
SRS018451.572625	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1360	SRR041761	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018451	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035885_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035854	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS019777.570452	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1560	SRR047438	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019777	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241681	241681	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038253_from_subject_764669880__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700038226	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	WUGSC	HMP_production_phase_1
SRS045931.576093	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3118	SRR047683	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045931	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105378_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105358	n	969	234	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	WUGSC	HMP_production_phase_1
SRS016559.572866	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_916	SRR040605	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032286_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4	BI	HMP_production_phase_1
SRS045280.575861	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3055	SRR046491	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045280	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241685	241685	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106687_from_subject_764224817__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106659	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS057450.571674	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4103	SRR045509	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057450	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038470_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038444	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS057656.576185	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4128	SRR048648	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057656	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108878_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108849	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	BCM	HMP_production_phase_1
SRS016355.572533	TCAGTCCTGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_860	SRR040880	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032019_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032018	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS017839.574247	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1207	SRR041224	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017839	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034944_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034916	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	BI	HMP_production_phase_1
SRS049668.576021	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3454	SRR043885	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049668	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038474_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038446	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS023019.571533	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2328	SRR048301	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023019	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241700	241700	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099053_from_subject_158114885__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099018	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	BCM	HMP_production_phase_1
SRS024151.576140	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2607	SRR041787	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024151	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241676	241676	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100619_from_subject_159207311__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700100600	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS052228.572282	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3685	SRR046728	26.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052228	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241872	241872	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105902_from_subject_668248235__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105881	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	WUGSC	HMP_production_phase_1
SRS022824.575995	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2282	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022824	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098780_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098748	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS013683.573494	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_281	SRR040659	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013683	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241676	241676	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016761_from_subject_159207311__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016715	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS020620.572977	TCAGCTACAGAGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1734	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020620	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241740	241740	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096011_from_subject_160906640__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095974	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	JCVI	HMP_production_phase_1
SRS063462.574525	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4390	SRR049374	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114027_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114005	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	36	0	WUGSC	HMP_production_phase_1
SRS043411.575709	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2874	SRR047142	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043411	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241675	241675	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103710_from_subject_763759525__sex_female_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700103672	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	4.8	WUGSC	HMP_production_phase_1
SRS022313.574415	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2148	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022313	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098153_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098120	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	4.5	JCVI	HMP_production_phase_1
SRS057943.576239	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4156	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057943	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241733	241733	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108334_from_subject_160825720__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108299	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	JCVI	HMP_production_phase_1
SRS063125.576384	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4341	SRR049522	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063125	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114309_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114278	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	4.5	WUGSC	HMP_production_phase_1
SRS048228.571664	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3330	SRR046300	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048228	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105250_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105216	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	4	WUGSC	HMP_production_phase_1
SRS015466.572949	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_611	SRR044665	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024121_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024093	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS063924.576177	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4465	SRR048833	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063924	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111334_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111304	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	39	4.8	BCM	HMP_production_phase_1
SRS022059.573825	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2083	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022059	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097799_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097767	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	31	0	JCVI	HMP_production_phase_1
SRS051745.575609	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3636	SRR048408	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051745	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102627_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102595	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	4.5	BCM	HMP_production_phase_1
SRS018557.572117	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1390	SRR044485	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241851	241851	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037024_from_subject_764710340__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037007	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4	WUGSC	HMP_production_phase_1
SRS023637.572449	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2480	SRR042796	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023637	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099940_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099902	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	20	4.9	BI	HMP_production_phase_1
SRS023488.572611	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2441	SRR048223	25.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241709	241709	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099765_from_subject_158964549__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099746	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BCM	HMP_production_phase_1
SRS046835.573816	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3198	SRR048571	19.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046835	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109673_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109636	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	19	4.7	BCM	HMP_production_phase_1
SRS020663.571201	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1742	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096088_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096058	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	JCVI	HMP_production_phase_1
SRS018447.571018	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1358	SRR041162	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035881_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035852	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS050803.573941	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3556	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050803	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110450_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110425	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	0	JCVI	HMP_production_phase_1
SRS050617.570719	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3542	SRR049507	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105956_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105932	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	0	WUGSC	HMP_production_phase_1
SRS051667.574338	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3629	SRR048531	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241671	241671	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107979_from_subject_160056975__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107945	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS022117.575285	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2097	SRR041546	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022117	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097883_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097849	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	4.4	BI	HMP_production_phase_1
SRS045403.570322	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3069	SRR048897	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045403	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108947_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108912	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS023565.574293	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2459	SRR041395	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023565	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099842_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099813	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS011287.571364	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_24	SRR045439	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015283_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700015281	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS049174.571288	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3407	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049174	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109264_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700109236	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	4.8	JCVI	HMP_production_phase_1
SRS022773.572036	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2270	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022773	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098729_from_subject_370425937__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098688	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	22	0	JCVI	HMP_production_phase_1
SRS019671.576333	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1540	SRR046182	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038144_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038119	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS057689.571082	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4130	SRR046804	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057689	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241863	241863	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106997_from_subject_275382046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106993	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	0	WUGSC	HMP_production_phase_1
SRS011444.574178	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_68	SRR044851	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016095_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016054	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	4.2	WUGSC	HMP_production_phase_1
SRS019671.573857	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1540	SRR049335	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038144_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700038119	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS011543.573121	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_121	SRR045108	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016643_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016641	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS042483.576037	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2790	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042483	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102549_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102523	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	38	4.6	JCVI	HMP_production_phase_1
SRS051945.571691	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3657	SRR047184	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051945	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241856	241856	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105112_from_subject_256789458__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105090	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	20	5.6	WUGSC	HMP_production_phase_1
SRS017735.574428	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1182	SRR042796	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017735	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034828_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700034789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	4.1	BI	HMP_production_phase_1
SRS024007.572762	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2574	SRR040973	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024007	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241704	241704	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100468_from_subject_159369152__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100431	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS024058.571931	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2586	SRR040860	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024058	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100520_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100486	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	4.7	BI	HMP_production_phase_1
SRS024531.575282	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2707	SRR048169	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024531	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101677_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101648	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BCM	HMP_production_phase_1
SRS014823.573220	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_447	SRR045736	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014823	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241793	241793	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023477_from_subject_763921366__sex_female_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023447	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.1	WUGSC	HMP_production_phase_1
SRS014770.570934	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_432	SRR043897	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014770	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241824	241824	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023424_from_subject_763719065__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023392	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	4.2	WUGSC	HMP_production_phase_1
SRS024285.572363	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2641	SRR041942	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024285	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101263_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101234	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	3.7	BI	HMP_production_phase_1
SRS011484.573286	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_88	SRR045102	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011484	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016319_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016301	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	34	0	WUGSC	HMP_production_phase_1
SRS046051.574377	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3130	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046051	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110383_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110357	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	4.4	JCVI	HMP_production_phase_1
SRS024402.570961	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2671	SRR043230	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024402	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101548_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101522	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	5.1	BI	HMP_production_phase_1
SRS011486.571677	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_90	SRR045422	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011486	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016323_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016303	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	34	0	WUGSC	HMP_production_phase_1
SRS065478.576609	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4686	SRR048429	35.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065478	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241804	241804	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110800_from_subject_158984779__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110770	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	4.6	BCM	HMP_production_phase_1
SRS049637.573142	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3448	SRR048451	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049637	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102885_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102857	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	33	0	BCM	HMP_production_phase_1
SRS023502.570681	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2444	SRR048393	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023502	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099779_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099753	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BCM	HMP_production_phase_1
SRS051012.570742	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3573	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051012	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241867	241867	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101835_from_subject_514014184__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101792	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	21	4.2	JCVI	HMP_production_phase_1
SRS024299.573635	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2648	SRR041886	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024299	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101277_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101241	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	3.7	BI	HMP_production_phase_1
SRS024171.576525	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2613	SRR043246	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024171	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100639_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100610	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS021318.576595	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1897	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021318	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096976_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096950	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	0	JCVI	HMP_production_phase_1
SRS023342.570388	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2411	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023342	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241835	241835	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099504_from_subject_206906765__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099462	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.3	JCVI	HMP_production_phase_1
SRS011604.575838	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_153	SRR045347	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011604	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033179_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033143	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.3	WUGSC	HMP_production_phase_1
SRS023819.573868	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2527	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023819	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241742	241742	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100213_from_subject_336497421__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700100179	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	JCVI	HMP_production_phase_1
SRS065685.572135	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4730	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065685	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111063_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111035	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	JCVI	HMP_production_phase_1
SRS022243.570466	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2130	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022243	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241786	241786	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098012_from_subject_970836795__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097981	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	4.2	JCVI	HMP_production_phase_1
SRS055157.573167	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3908	SRR049468	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105914_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105887	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	WUGSC	HMP_production_phase_1
SRS020257.576263	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1641	SRR041035	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020257	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095510_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095479	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	0	BI	HMP_production_phase_1
SRS023184.572862	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2366	SRR041710	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023184	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099315_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099292	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	33	0	BI	HMP_production_phase_1
SRS011555.575224	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_127	SRR045096	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016661_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016659	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS015301.570814	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_570	SRR043756	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015301	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023956_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023929	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	37	0	WUGSC	HMP_production_phase_1
SRS014434.572353	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_367	SRR045546	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014434	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023088_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023062	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	3.4	WUGSC	HMP_production_phase_1
SRS015609.570221	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_645	SRR046162	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015609	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241784	241784	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024264_from_subject_764346198__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024239	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4.4	WUGSC	HMP_production_phase_1
SRS023647.573695	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2485	SRR040680	20.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023647	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099950_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099907	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	20	4.9	BI	HMP_production_phase_1
SRS024643.575840	TCAGTTCAAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2733	SRR041311	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024643	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101934_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101906	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	0	BI	HMP_production_phase_1
SRS024641.573542	TCAGTCCTGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2732	SRR041338	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024641	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101932_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101905	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	0	BI	HMP_production_phase_1
SRS045919.574703	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3115	SRR048470	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045919	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107532_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107501	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	BCM	HMP_production_phase_1
SRS016335.574806	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_854	SRR044424	20.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016335	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241813	241813	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024998_from_subject_765074482__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024966	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	20	0	WUGSC	HMP_production_phase_1
SRS021758.571258	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2010	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021758	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241706	241706	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097471_from_subject_161493313__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097432	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.1	JCVI	HMP_production_phase_1
SRS045607.576274	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3087	SRR046421	32.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045607	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241866	241866	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106784_from_subject_857980665__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106754	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	32	4.2	WUGSC	HMP_production_phase_1
SRS055136.573148	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3904	SRR048606	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055136	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108204_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108173	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	21	0	BCM	HMP_production_phase_1
SRS055605.573323	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3937	SRR048649	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055605	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108866_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108843	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	0	BCM	HMP_production_phase_1
SRS022133.573157	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2105	SRR041643	22.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022133	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241803	241803	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097899_from_subject_158337416__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097857	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	22	4.4	BI	HMP_production_phase_1
SRS043044.574965	TCAGTGTGATCGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2837	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043044	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102334_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102307	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	JCVI	HMP_production_phase_1
SRS048074.576235	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3317	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048074	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110458_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110429	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	0	JCVI	HMP_production_phase_1
SRS042639.572105	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2808	SRR058112	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042639	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108836_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108799	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	0	JCVI	HMP_production_phase_1
SRS022492.574455	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2191	SRR048180	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022492	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098393_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098365	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	30	4.5	BCM	HMP_production_phase_1
SRS048090.576076	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3319	SRR043609	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048090	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038714_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038689	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	3.7	WUGSC	HMP_production_phase_1
SRS011369.575090	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_38	SRR044880	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011369	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015656_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700015654	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	33	0	WUGSC	HMP_production_phase_1
SRS050408.573223	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3522	SRR048469	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107534_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107502	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	BCM	HMP_production_phase_1
SRS056678.574162	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4042	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056678	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241694	241694	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109380_from_subject_160866180__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109337	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	25	4.6	JCVI	HMP_production_phase_1
SRS044714.572982	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2997	SRR040893	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044714	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102409_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102373	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS024353.575583	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2660	SRR041683	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024353	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101388_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700101358	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS062733.573796	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4285	SRR058092	36.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257123	257123	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111863_from_subject_414519462__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111826	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	36	4.7	JCVI	HMP_production_phase_1
SRS049123.573320	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3402	SRR048887	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107429_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107391	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	4.7	BCM	HMP_production_phase_1
SRS018220.571186	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1303	SRR042793	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018220	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035627_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035590	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS045992.570906	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3124	SRR048898	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045992	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108949_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108913	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS017090.573422	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1036	SRR041219	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017090	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033603_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033572	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	BI	HMP_production_phase_1
SRS015768.576551	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_689	SRR044249	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015768	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024423_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024401	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	WUGSC	HMP_production_phase_1
SRS016657.574472	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_941	SRR041623	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016657	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241713	241713	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032441_from_subject_160036745__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032440	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	5	BI	HMP_production_phase_1
SRS051295.573003	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3603	SRR048876	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051295	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107587_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700107557	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	0	BCM	HMP_production_phase_1
SRS016675.570591	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_947	SRR042829	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016675	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241713	241713	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032459_from_subject_160036745__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032458	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	5	BI	HMP_production_phase_1
SRS056932.572947	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4067	SRR047636	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056932	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038882_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038860	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	WUGSC	HMP_production_phase_1
SRS015027.573110	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_503	SRR044117	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015027	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023682_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023648	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	4.8	WUGSC	HMP_production_phase_1
SRS021400.570757	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1921	SRR058111	25.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021400	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241774	241774	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097058_from_subject_161028021__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097018	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	4.6	JCVI	HMP_production_phase_1
SRS050421.574424	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3525	SRR048449	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050421	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102883_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102856	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	33	0	BCM	HMP_production_phase_1
SRS016229.575086	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_820	SRR044413	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016229	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241687	241687	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024892_from_subject_764649650__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024859	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.1	WUGSC	HMP_production_phase_1
SRS042606.574212	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2804	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042606	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102553_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102525	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	4.6	JCVI	HMP_production_phase_1
SRS019671.572447	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1540	SRR049430	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038144_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038119	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS054488.574137	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3856	SRR048464	27.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241839	241839	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107508_from_subject_159632143__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107489	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BCM	HMP_production_phase_1
SRS062773.575629	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4292	SRR058092	36.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062773	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257123	257123	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111861_from_subject_414519462__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111825	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	36	4.7	JCVI	HMP_production_phase_1
SRS023791.575870	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2517	SRR058086	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023791	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241742	241742	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100184_from_subject_336497421__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700100165	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	JCVI	HMP_production_phase_1
SRS052469.575939	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3706	SRR046851	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052469	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103319_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103285	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	19	4.7	WUGSC	HMP_production_phase_1
SRS014277.571786	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_334	SRR045525	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014277	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021866_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS054232.576132	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3832	SRR058112	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054232	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241759	241759	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108832_from_subject_160987560__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108797	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	0	JCVI	HMP_production_phase_1
SRS024359.574542	TCAGAAGGAACTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2663	SRR041029	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024359	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101394_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101361	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS046588.575738	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3183	SRR048540	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046588	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109604_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109574	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	0	BCM	HMP_production_phase_1
SRS019552.570295	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1518	SRR043896	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019552	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038023_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038006	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS011444.571551	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_68	SRR045446	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016095_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016054	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	4.2	WUGSC	HMP_production_phase_1
SRS015200.573764	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_539	SRR043766	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015200	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023855_from_subject_763759525__sex_female_	UBERON:nostril	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023820	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4	WUGSC	HMP_production_phase_1
SRS019578.573074	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1530	SRR045496	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019578	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038049_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038019	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS015833.576515	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_709	SRR044702	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015833	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024488_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024458	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS022093.571862	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2089	SRR041491	22.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022093	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241803	241803	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097859_from_subject_158337416__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700097837	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	4.4	BI	HMP_production_phase_1
SRS022767.571146	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2267	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022767	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098723_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098685	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	JCVI	HMP_production_phase_1
SRS022812.572419	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2276	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022812	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098768_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	JCVI	HMP_production_phase_1
SRS065385.575437	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4674	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065385	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111849_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111819	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	36	0	JCVI	HMP_production_phase_1
SRS015117.575489	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_509	SRR045694	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015117	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023772_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023693	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	4.5	WUGSC	HMP_production_phase_1
SRS042788.576324	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2821	SRR047126	31.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042788	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241860	241860	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105992_from_subject_465578759__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105987	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	31	4.4	WUGSC	HMP_production_phase_1
SRS042093.570661	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2761	SRR045911	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042093	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038779_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038750	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	24	5.3	WUGSC	HMP_production_phase_1
SRS020247.573008	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1636	SRR042921	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020247	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095500_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095474	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	0	BI	HMP_production_phase_1
SRS062998.570965	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4326	SRR046820	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062998	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257117	257117	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114586_from_subject_875002022__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS015681.574258	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_670	SRR044285	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015681	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024336_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024305	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS016886.572926	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_992	SRR041903	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033247_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033246	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS047193.576501	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3234	SRR045512	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047193	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038468_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038443	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS016458.571835	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_886	SRR042815	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032154_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032153	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS054661.570870	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3870	SRR048904	21.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108212_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108177	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	21	0	BCM	HMP_production_phase_1
SRS023467.573351	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2440	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023467	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099744_from_subject_246515023__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099745	n	969	13	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	38	4.8	JCVI	HMP_production_phase_1
SRS043032.570771	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2834	SRR047616	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043032	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038938_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038912	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS020316.571034	TCAGACCTCCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1657	SRR041182	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020316	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095569_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095537	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	BI	HMP_production_phase_1
SRS047414.572945	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3249	SRR045941	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047414	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038426_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038398	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	39	0	WUGSC	HMP_production_phase_1
SRS019109.576436	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1480	SRR044733	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019109	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037580_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037549	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS023887.572680	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2542	SRR048390	29.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023887	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241755	241755	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100285_from_subject_158883629__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100245	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	4.9	BCM	HMP_production_phase_1
SRS054361.575628	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3840	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054361	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108995_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108963	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	4.3	JCVI	HMP_production_phase_1
SRS064276.575695	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4519	SRR046311	38.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064276	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241693	241693	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114125_from_subject_763840445__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114105	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	38	4.7	WUGSC	HMP_production_phase_1
SRS017394.572238	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1104	SRR041039	30.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017394	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241703	241703	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034100_from_subject_160481808__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	BI	HMP_production_phase_1
SRS024069.576026	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2589	SRR040961	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024069	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100534_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700100531	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	4.7	BI	HMP_production_phase_1
SRS024236.574125	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2631	SRR041701	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024236	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101123_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101090	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS023458.570387	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2437	SRR048167	24.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241766	241766	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099645_from_subject_158438567__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099608	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	0	BCM	HMP_production_phase_1
SRS011161.572681	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3	SRR047481	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011161	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014973_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014971	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	0	WUGSC	HMP_production_phase_1
SRS011682.575621	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_192	SRR045288	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011682	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033787_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700033745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.4	WUGSC	HMP_production_phase_1
SRS063942.575535	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4470	SRR046558	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063942	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241877	241877	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113101_from_subject_764872181__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113070	n	969	240	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS018222.573673	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1304	SRR041487	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018222	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035629_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035591	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS022999.571127	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2318	SRR048065	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022999	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099033_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099008	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	29	0	BCM	HMP_production_phase_1
SRS057537.572971	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4113	SRR043267	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057537	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101341_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700101306	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS049434.571821	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3432	SRR048475	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107542_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107506	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BCM	HMP_production_phase_1
SRS016889.570363	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_993	SRR041436	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016889	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033250_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033249	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS018445.572659	TCAGAACCGACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1357	SRR041878	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035879_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035851	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS021986.573111	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2061	SRR041773	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021986	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097726_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700097696	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	4.1	BI	HMP_production_phase_1
SRS016529.572228	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_901	SRR040656	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016529	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032256_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4	BI	HMP_production_phase_1
SRS016535.575162	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_904	SRR042906	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016535	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032262_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700032231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4	BI	HMP_production_phase_1
SRS022580.570510	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2218	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022580	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098485_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700098446	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	5	JCVI	HMP_production_phase_1
SRS017402.570407	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1105	SRR042004	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017402	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034108_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	30	0	BI	HMP_production_phase_1
SRS052010.576470	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3663	SRR058096	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052010	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108070_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107999	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	JCVI	HMP_production_phase_1
SRS020606.575044	TCAGCTCGTGACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1729	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020606	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095997_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095967	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	JCVI	HMP_production_phase_1
SRS015399.574998	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_594	SRR045719	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015399	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024054_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024029	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	3.6	WUGSC	HMP_production_phase_1
SRS065492.576147	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4691	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065492	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111855_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700111822	n	969	98	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	36	0	JCVI	HMP_production_phase_1
SRS053635.571246	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3798	SRR046667	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053635	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105906_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105883	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	WUGSC	HMP_production_phase_1
SRS022390.570770	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2172	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022390	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241768	241768	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098256_from_subject_492786515__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098219	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	35	0	JCVI	HMP_production_phase_1
SRS018272.573145	TCAGAACGGTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1314	SRR041299	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018272	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035679_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035646	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	3.9	BI	HMP_production_phase_1
SRS020028.571311	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1600	SRR040678	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020028	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095273_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.3	BI	HMP_production_phase_1
SRS053487.574890	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3784	SRR043769	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053487	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241823	241823	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038508_from_subject_763476303__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038487	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	31	0	WUGSC	HMP_production_phase_1
SRS021147.576358	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1858	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021147	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241801	241801	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096694_from_subject_160744799__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096609	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	20	4.9	JCVI	HMP_production_phase_1
SRS065127.571534	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4633	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065127	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111544_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111515	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	JCVI	HMP_production_phase_1
SRS056329.571022	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4007	SRR047224	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056329	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103631_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103610	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	19	0	WUGSC	HMP_production_phase_1
SRS049891.575645	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3464	SRR046636	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049891	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241854	241854	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106928_from_subject_517810313__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700106411	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	WUGSC	HMP_production_phase_1
SRS019582.573708	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1532	SRR047363	37.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019582	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241720	241720	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038053_from_subject_763597684__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700038021	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	37	0	WUGSC	HMP_production_phase_1
SRS053288.576066	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3765	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053288	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110401_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110366	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	4.4	JCVI	HMP_production_phase_1
SRS016203.576485	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_808	SRR044423	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016203	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241687	241687	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024866_from_subject_764649650__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.1	WUGSC	HMP_production_phase_1
SRS016883.573261	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_991	SRR041958	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016883	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033244_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS058780.571848	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4222	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058780	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241733	241733	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108338_from_subject_160825720__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108301	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	JCVI	HMP_production_phase_1
SRS042543.573612	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2795	SRR045935	39.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042543	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241884	241884	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038412_from_subject_765701615__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700038391	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	39	0	WUGSC	HMP_production_phase_1
SRS021267.571135	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1886	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021267	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096913_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096878	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	34	5.3	JCVI	HMP_production_phase_1
SRS020956.575530	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1812	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020956	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241752	241752	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096467_from_subject_161068481__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096433	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	JCVI	HMP_production_phase_1
SRS021812.571905	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2022	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021812	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097525_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097492	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	40	0	JCVI	HMP_production_phase_1
SRS016841.574223	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_981	SRR042025	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016841	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241745	241745	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033202_from_subject_159308461__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033201	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS014907.575710	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_468	SRR049331	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014907	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023562_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023543	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	33	0	WUGSC	HMP_production_phase_1
SRS052219.571813	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3684	SRR049828	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038728_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038696	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	3.7	WUGSC	HMP_production_phase_1
SRS064048.573507	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4495	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064048	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110685_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110655	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	30	0	JCVI	HMP_production_phase_1
SRS062896.571541	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4310	SRR048831	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062896	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268869	268869	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111805_from_subject_872848689__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111764	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.6	BCM	HMP_production_phase_1
SRS024216.576353	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2622	SRR041843	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024216	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101103_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101080	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS014762.576256	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_430	SRR043749	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014762	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241824	241824	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023416_from_subject_763719065__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023388	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	4.2	WUGSC	HMP_production_phase_1
SRS046703.576146	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3190	SRR048497	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046703	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108644_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108609	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	31	0	BCM	HMP_production_phase_1
SRS014138.571632	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_319	SRR046062	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014138	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021697_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021282	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	0	WUGSC	HMP_production_phase_1
SRS016853.573651	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_982	SRR041870	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016853	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033214_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033213	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS019001.574987	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1462	SRR044636	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019001	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037470_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037446	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS019759.576280	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1551	SRR047644	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019759	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038235_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038217	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	WUGSC	HMP_production_phase_1
SRS064920.573578	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4604	SRR046834	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064920	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113630_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113606	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS022637.572485	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2233	SRR041866	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022637	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098589_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098556	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS015007.573392	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_495	SRR046172	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015007	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241718	241718	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023662_from_subject_764062976__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700023638	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	4.8	WUGSC	HMP_production_phase_1
SRS019081.574388	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1468	SRR044655	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019081	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037552_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037535	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS020350.575544	TCAGTCCGAACAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1663	SRR041494	32.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020350	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241726	241726	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095669_from_subject_160704339__sex_female_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700095647	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	32	4.2	BI	HMP_production_phase_1
SRS015397.573823	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_593	SRR045696	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015397	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024052_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024028	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	3.6	WUGSC	HMP_production_phase_1
SRS018443.571562	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1356	SRR041034	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018443	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035877_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035850	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS017737.571756	TCAGACCTTCCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1183	SRR042909	30.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017737	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034830_from_subject_160582958__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034790	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	4.1	BI	HMP_production_phase_1
SRS055687.572629	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3950	SRR041045	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055687	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101333_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101302	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS065078.570992	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4627	SRR049891	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065078	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114645_from_subject_763901136__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114611	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	4.3	WUGSC	HMP_production_phase_1
SRS021449.571783	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1932	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021449	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097157_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700097127	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	32	0	JCVI	HMP_production_phase_1
SRS021209.576578	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1872	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021209	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241842	241842	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096756_from_subject_161007791__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096717	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	5	JCVI	HMP_production_phase_1
SRS013466.575611	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_235	SRR041905	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016397_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016382	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	BI	HMP_production_phase_1
SRS024306.570569	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2650	SRR041720	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024306	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101284_from_subject_158944319__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101281	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	24	3.7	BI	HMP_production_phase_1
SRS051979.572465	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3660	SRR048741	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051979	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107810_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107775	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS050002.575728	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3478	SRR048527	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050002	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107973_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107942	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	BCM	HMP_production_phase_1
SRS024234.570572	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2630	SRR041692	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024234	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101121_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101089	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS056460.575273	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4021	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056460	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110199_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700110166	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	38	4.5	JCVI	HMP_production_phase_1
SRS045999.573432	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3125	SRR042952	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102997_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102972	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS056480.570231	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4023	SRR048248	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056480	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102277_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102250	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	0	BCM	HMP_production_phase_1
SRS049760.575944	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3457	SRR047540	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049760	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038724_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038694	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS011496.571437	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_95	SRR045290	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011496	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016333_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016308	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	34	0	WUGSC	HMP_production_phase_1
SRS014426.574632	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_363	SRR045504	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014426	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023080_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023058	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	3.4	WUGSC	HMP_production_phase_1
SRS020263.571361	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1644	SRR040682	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020263	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095516_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095482	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS013735.572827	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_294	SRR041372	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013735	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016813_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016812	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS015442.573138	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_603	SRR044692	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015442	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024097_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS043122.571304	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2842	SRR046454	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043122	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241872	241872	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105894_from_subject_668248235__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105877	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	WUGSC	HMP_production_phase_1
SRS047084.571087	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3223	SRR048281	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047084	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102629_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102596	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	4.5	BCM	HMP_production_phase_1
SRS016539.575445	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_906	SRR042831	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016539	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032266_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700032233	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4	BI	HMP_production_phase_1
SRS016539.575444	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_906	SRR043222	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016539	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032266_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032233	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4	BI	HMP_production_phase_1
SRS020649.571513	TCAGACATAGTAGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1736	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020649	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096074_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096051	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	JCVI	HMP_production_phase_1
SRS019900.573396	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1579	SRR044388	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019900	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038376_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038349	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS066144.570305	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043078	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS047507.575422	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3262	SRR058108	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047507	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110207_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700110170	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	38	4.5	JCVI	HMP_production_phase_1
SRS021427.570998	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1925	SRR058114	32.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241754	241754	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097135_from_subject_160967330__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700097116	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	32	0	JCVI	HMP_production_phase_1
SRS053756.572699	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3806	SRR046846	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053756	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241857	241857	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106591_from_subject_208027353__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106557	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	4.3	WUGSC	HMP_production_phase_1
SRS018443.573268	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1356	SRR042007	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018443	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035877_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035850	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS043886.573273	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_2920	SRR046784	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043886	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241891	241891	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105346_from_subject_516889361__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105318	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	0	WUGSC	HMP_production_phase_1
SRS011275.570357	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_18	SRR045295	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011275	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015265_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015263	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	WUGSC	HMP_production_phase_1
SRS022440.573711	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2182	SRR048195	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022440	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098315_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098280	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	5.8	BCM	HMP_production_phase_1
SRS022197.575873	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2122	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022197	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097966_from_subject_638754422__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700097925	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.5	JCVI	HMP_production_phase_1
SRS063665.572436	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4419	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063665	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111614_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111583	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	39	4.8	JCVI	HMP_production_phase_1
SRS015514.575400	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_621	SRR044217	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015514	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024169_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024139	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.1	WUGSC	HMP_production_phase_1
SRS052181.574016	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3679	SRR046732	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052181	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241893	241893	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105059_from_subject_178713055__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700105035	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	4.5	WUGSC	HMP_production_phase_1
SRS018159.571532	TCAGTTCGGACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1286	SRR040864	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035559_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035526	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS020429.574349	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1685	SRR040903	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020429	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095752_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095725	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	0	BI	HMP_production_phase_1
SRS011359.571824	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_33	SRR049320	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011359	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015641_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015639	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	33	0	WUGSC	HMP_production_phase_1
SRS046349.571012	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3159	SRR047580	30.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241853	241853	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038978_from_subject_370027359__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038956	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	30	0	WUGSC	HMP_production_phase_1
SRS011494.570516	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_94	SRR045322	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011494	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016331_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016307	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	34	0	WUGSC	HMP_production_phase_1
SRS017713.573132	TCAGCCGACCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1171	SRR040978	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017713	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034806_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034778	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	4.1	BI	HMP_production_phase_1
SRS013650.574432	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_264	SRR041650	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013650	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016728_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016698	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	33	0	BI	HMP_production_phase_1
SRS017539.573254	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1142	SRR041872	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017539	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034272_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034241	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS017857.576184	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1216	SRR041609	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017857	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241711	241711	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034962_from_subject_160603188__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034925	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS016117.574667	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_787	SRR044426	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016117	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024774_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024743	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	4.5	WUGSC	HMP_production_phase_1
SRS053092.575566	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3747	SRR049594	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053092	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105872_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105842	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	30	0	WUGSC	HMP_production_phase_1
SRS015782.570244	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_693	SRR044216	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015782	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241685	241685	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024437_from_subject_764224817__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024408	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	WUGSC	HMP_production_phase_1
SRS016408.570718	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_870	SRR041373	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032095_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032072	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS047193.574629	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3234	SRR043644	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047193	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038468_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038443	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS020024.571228	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1598	SRR041396	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020024	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095269_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	y	TCAG	UBERON:sebum	700095230	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.3	BI	HMP_production_phase_1
SRS064620.575250	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4565	SRR058092	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064620	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268865	268865	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111489_from_subject_451588811__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111453	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.8	JCVI	HMP_production_phase_1
SRS017965.571488	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1243	SRR041507	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017965	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241809	241809	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035286_from_subject_158357646__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035252	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS043289.575015	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2857	SRR058096	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043289	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110267_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110233	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	40	4.9	JCVI	HMP_production_phase_1
SRS018345.575923	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1337	SRR042939	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018345	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035779_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS063885.572073	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4457	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063885	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110846_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110818	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	4.7	JCVI	HMP_production_phase_1
SRS021492.570960	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1941	SRR041639	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021492	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097204_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097181	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS022107.572704	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2092	SRR041498	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022107	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097873_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097844	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	4.4	BI	HMP_production_phase_1
SRS021559.576105	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_1959	SRR048086	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241843	241843	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097271_from_subject_158216035__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097243	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	BCM	HMP_production_phase_1
SRS018041.575362	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1262	SRR042946	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018041	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035365_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035319	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.3	BI	HMP_production_phase_1
SRS023768.571895	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2515	SRR040896	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023768	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100075_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100039	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS018960.576035	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1450	SRR045989	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018960	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241737	241737	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037429_from_subject_765276783__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037401	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS013510.570573	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_246	SRR041380	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013510	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016490_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016466	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	BI	HMP_production_phase_1
SRS018817.576371	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1441	SRR046200	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018817	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241731	241731	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037284_from_subject_765135172__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037252	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	WUGSC	HMP_production_phase_1
SRS043325.573169	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2861	SRR043996	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043325	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106032_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106006	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	3.8	WUGSC	HMP_production_phase_1
SRS062742.574966	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4288	SRR048856	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062742	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112022_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111994	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Attached_Keratinized_gingiva	26	0	BCM	HMP_production_phase_1
SRS053335.576563	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3769	SRR049343	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053335	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241864	241864	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038761_from_subject_508703490__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700038741	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	5.3	WUGSC	HMP_production_phase_1
SRS050493.572276	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3534	SRR047198	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050493	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241874	241874	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106113_from_subject_737052003__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106075	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	18	4.5	WUGSC	HMP_production_phase_1
SRS020032.575538	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1602	SRR040607	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020032	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095277_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.3	BI	HMP_production_phase_1
SRS065055.575823	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4621	SRR048789	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065055	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268876	268876	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111210_from_subject_257905678__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700111172	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.9	BCM	HMP_production_phase_1
SRS055342.573194	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3922	SRR048695	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055342	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109206_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109180	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	31	0	BCM	HMP_production_phase_1
SRS015243.571722	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_550	SRR043993	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015243	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023898_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023870	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	4.4	WUGSC	HMP_production_phase_1
SRS017800.575345	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1201	SRR040703	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017800	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241782	241782	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034893_from_subject_160542498__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS019998.576482	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1586	SRR041056	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019998	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095243_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095217	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.3	BI	HMP_production_phase_1
SRS017657.576110	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1158	SRR041979	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034657_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034630	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	19	0	BI	HMP_production_phase_1
SRS015522.572726	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_625	SRR044206	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015522	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024177_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024143	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.1	WUGSC	HMP_production_phase_1
SRS011675.573483	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_189	SRR044899	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011675	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033779_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700033741	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.4	WUGSC	HMP_production_phase_1
SRS064628.573621	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4567	SRR049575	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064628	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114367_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114337	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	21	0	WUGSC	HMP_production_phase_1
SRS053094.574701	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3748	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053094	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257133	257133	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102569_from_subject_937415040__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102533	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	38	4.6	JCVI	HMP_production_phase_1
SRS019111.572836	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1481	SRR044667	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019111	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037582_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024089	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS063746.572575	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4430	SRR048861	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063746	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112026_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700111996	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Throat	26	0	BCM	HMP_production_phase_1
SRS014355.572561	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_355	SRR046167	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023009_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS065568.571046	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4704	SRR046890	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065568	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114311_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114279	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	4.5	WUGSC	HMP_production_phase_1
SRS052937.576123	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3737	SRR043743	31.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052937	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241823	241823	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038530_from_subject_763476303__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038498	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	31	0	WUGSC	HMP_production_phase_1
SRS011285.573534	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_23	SRR047473	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015280_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700015278	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS047950.573238	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3307	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257120	257120	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102318_from_subject_604812005__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700102299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	JCVI	HMP_production_phase_1
SRS021283.572847	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1893	SRR058095	34.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021283	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241669	241669	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096929_from_subject_161230322__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096886	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	34	5.3	JCVI	HMP_production_phase_1
SRS063755.575704	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4432	SRR049520	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063755	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241784	241784	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113576_from_subject_764346198__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700113549	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	23	4.1	WUGSC	HMP_production_phase_1
SRS042427.572472	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2787	SRR045866	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038984_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038959	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	30	0	WUGSC	HMP_production_phase_1
SRS020026.570504	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1599	SRR040768	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020026	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095271_from_subject_160643649__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700095231	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	4.3	BI	HMP_production_phase_1
SRS049668.575217	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3454	SRR043934	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049668	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038474_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038446	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS043596.572601	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2894	SRR042922	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043596	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102468_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102431	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS048865.575190	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3380	SRR048705	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048865	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109222_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109188	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	31	0	BCM	HMP_production_phase_1
SRS020233.571448	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1633	SRR041135	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020233	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241798	241798	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095486_from_subject_160400887__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700095467	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	0	BI	HMP_production_phase_1
SRS066188.575849	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048581	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS018581.571708	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1394	SRR044491	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018581	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037048_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037029	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	19	0	WUGSC	HMP_production_phase_1
SRS044780.571960	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3003	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044780	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107850_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107823	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	JCVI	HMP_production_phase_1
SRS023330.574715	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2405	SRR058092	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023330	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241835	241835	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099492_from_subject_206906765__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099456	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	JCVI	HMP_production_phase_1
SRS013197.571222	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_205	SRR040990	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013197	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015896_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015867	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	0	BI	HMP_production_phase_1
SRS021627.574654	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_1977	SRR048051	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097339_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097304	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	4.9	BCM	HMP_production_phase_1
SRS017239.574906	TCAGCCGAACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1070	SRR042856	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017239	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241838	241838	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033845_from_subject_159814214__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033844	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS018282.572492	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1319	SRR042796	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018282	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035689_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	3.9	BI	HMP_production_phase_1
SRS024523.572191	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2703	SRR048200	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024523	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101669_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101644	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BCM	HMP_production_phase_1
SRS023699.572848	TCAGTATGACAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2496	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023699	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100006_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099970	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	4.1	JCVI	HMP_production_phase_1
SRS044635.572655	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2986	SRR043611	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044635	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038460_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038439	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS013834.575206	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_314	SRR041121	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013834	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016994_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016993	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	0	BI	HMP_production_phase_1
SRS023579.570431	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2466	SRR042999	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023579	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099856_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099820	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS043192.573557	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2848	SRR048537	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043192	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109590_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109567	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	0	BCM	HMP_production_phase_1
SRS017304.574533	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1088	SRR042877	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033986_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016468	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS015864.571715	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_715	SRR046079	39.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015864	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241830	241830	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024519_from_subject_764002286__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024497	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	39	0	WUGSC	HMP_production_phase_1
SRS011565.574404	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_132	SRR044969	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011565	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033011_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033009	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.7	WUGSC	HMP_production_phase_1
SRS021512.571315	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1950	SRR041501	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021512	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241722	241722	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097224_from_subject_158479027__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097191	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS013774.576519	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_299	SRR048141	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013774	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016933_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016908	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	BCM	HMP_production_phase_1
SRS064226.575231	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4513	SRR047098	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064226	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114201_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700114173	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	WUGSC	HMP_production_phase_1
SRS064396.574257	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4538	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064396	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110852_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110821	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	4.7	JCVI	HMP_production_phase_1
SRS064557.571894	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4556	SRR046745	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241682	241682	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114480_from_subject_764042746__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114442	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	3.9	WUGSC	HMP_production_phase_1
SRS046254.571971	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3149	SRR048714	34.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046254	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109977_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700109938	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	34	4.6	BCM	HMP_production_phase_1
SRS055028.576139	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3895	SRR058112	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055028	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241776	241776	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109855_from_subject_160947100__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109821	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	26	0	JCVI	HMP_production_phase_1
SRS018096.574761	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1271	SRR041359	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035420_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035383	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS014964.575223	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_487	SRR045875	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014964	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023619_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023596	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS014355.573770	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_355	SRR043911	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023009_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS014925.574982	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_476	SRR046524	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023580_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS058695.574968	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4215	SRR046679	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058695	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241859	241859	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105502_from_subject_643185023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105471	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	28	5	WUGSC	HMP_production_phase_1
SRS024478.573628	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2694	SRR041824	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024478	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101624_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101593	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	38	0	BI	HMP_production_phase_1
SRS011425.571667	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_55	SRR047511	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011425	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016069_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016041	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS017547.571056	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1146	SRR041975	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017547	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034280_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034245	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS013567.571829	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_257	SRR048267	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013567	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016588_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	4.7	BCM	HMP_production_phase_1
SRS017489.576006	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1132	SRR042901	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017489	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034222_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	19	5.1	BI	HMP_production_phase_1
SRS053301.573341	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3767	SRR048681	21.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053301	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241821	241821	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109525_from_subject_160845950__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109506	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	21	0	BCM	HMP_production_phase_1
SRS065293.572664	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4660	SRR048800	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065293	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111264_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	5	BCM	HMP_production_phase_1
SRS057494.576141	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_4110	SRR040995	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057494	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241792	241792	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107005_from_subject_159450072__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102976	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS053602.573733	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3796	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053602	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241697	241697	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110217_from_subject_246515023__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700110175	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	38	4.5	JCVI	HMP_production_phase_1
SRS024468.575837	TCAGAACGGTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2689	SRR041008	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101614_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101588	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	38	0	BI	HMP_production_phase_1
SRS023458.572918	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2437	SRR048381	24.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241766	241766	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099645_from_subject_158438567__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099608	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	0	BCM	HMP_production_phase_1
SRS024429.576463	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2683	SRR040736	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024429	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101575_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700101572	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	5.1	BI	HMP_production_phase_1
SRS023971.574520	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2560	SRR040944	22.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023971	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241704	241704	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100432_from_subject_159369152__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700100413	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	0	BI	HMP_production_phase_1
SRS044226.572291	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2947	SRR058114	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044226	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101805_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101777	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	21	0	JCVI	HMP_production_phase_1
SRS011294.574758	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_29	SRR045377	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011294	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015298_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700015296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS021575.571966	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1966	SRR048372	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021575	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241843	241843	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097287_from_subject_158216035__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097251	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	BCM	HMP_production_phase_1
SRS013834.572009	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_314	SRR041851	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013834	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016994_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700016993	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	0	BI	HMP_production_phase_1
SRS022504.576332	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2197	SRR048178	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022504	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241810	241810	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098405_from_subject_158458797__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098371	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	30	4.5	BCM	HMP_production_phase_1
SRS017288.575469	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1080	SRR042801	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017288	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033963_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033933	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS015289.575040	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_565	SRR043968	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015289	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023944_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS021195.574344	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1867	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021195	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096742_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096710	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	5	JCVI	HMP_production_phase_1
SRS014548.573367	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_383	SRR045721	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014548	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241730	241730	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023202_from_subject_763638144__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023176	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	3.8	WUGSC	HMP_production_phase_1
SRS022177.571519	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2112	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022177	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241683	241683	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097946_from_subject_638754422__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097915	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.5	JCVI	HMP_production_phase_1
SRS021760.571718	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2011	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021760	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241706	241706	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097473_from_subject_161493313__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097433	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	4.1	JCVI	HMP_production_phase_1
SRS043339.576316	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2864	SRR058112	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043339	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110470_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110435	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	JCVI	HMP_production_phase_1
SRS015289.571203	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_565	SRR046513	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015289	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023944_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023923	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS019683.573767	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1546	SRR046219	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019683	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241791	241791	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038156_from_subject_763678604__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	NA	y	TCAG	UBERON:nasal mucus	700038125	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS046528.574371	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3178	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046528	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107852_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107824	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	0	JCVI	HMP_production_phase_1
SRS063768.572357	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4435	SRR049963	24.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063768	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257126	257126	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114987_from_subject_103092734__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	WUGSC	HMP_production_phase_1
SRS016585.575781	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_918	SRR043249	31.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016585	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241690	241690	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032338_from_subject_159915365__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700032316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	31	4.3	BI	HMP_production_phase_1
SRS013474.573185	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_239	SRR041809	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016405_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016386	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	BI	HMP_production_phase_1
SRS049760.571334	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3457	SRR049833	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049760	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038724_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038694	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS018224.571520	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1305	SRR042918	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035631_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS049766.576553	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3458	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049766	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241688	241688	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109770_from_subject_161331472__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109750	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	0	JCVI	HMP_production_phase_1
SRS045413.576194	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3071	SRR048566	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045413	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109665_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109632	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	19	4.7	BCM	HMP_production_phase_1
SRS050412.574008	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3524	SRR046290	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050412	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105697_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105672	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	31	5	WUGSC	HMP_production_phase_1
SRS022049.575618	TCAGTGAGTATGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2078	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022049	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097789_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097762	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	31	0	JCVI	HMP_production_phase_1
SRS047627.571644	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3273	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047627	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110018_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109993	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	JCVI	HMP_production_phase_1
SRS047280.573894	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3241	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047280	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108084_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108051	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS016416.570515	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_873	SRR041467	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016416	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032103_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032076	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS058590.576032	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4205	SRR048914	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058590	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110145_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700110106	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	24	4.3	BCM	HMP_production_phase_1
SRS011669.575099	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_186	SRR047514	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011669	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033773_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033738	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.4	WUGSC	HMP_production_phase_1
SRS015856.572072	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_712	SRR043965	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015856	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024511_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024493	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS018388.572035	TCAGTTCGGACCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1345	SRR041378	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018388	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035822_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035794	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	0	BI	HMP_production_phase_1
SRS044719.573393	TCAGCACGATAGCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2999	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044719	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108511_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108482	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	32	0	JCVI	HMP_production_phase_1
SRS016928.574050	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_998	SRR040920	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016928	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033394_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033369	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS014422.572875	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_361	SRR045552	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023076_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023056	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	3.4	WUGSC	HMP_production_phase_1
SRS024365.570520	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2666	SRR041929	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024365	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101400_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101364	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS015450.571324	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_605	SRR044695	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015450	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024105_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700024085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS011665.575377	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_184	SRR044942	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011665	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033769_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033736	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	4.4	WUGSC	HMP_production_phase_1
SRS019453.576539	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1514	SRR045991	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019453	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241728	241728	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037924_from_subject_765519544__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037904	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	WUGSC	HMP_production_phase_1
SRS015978.576565	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_750	SRR044006	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015978	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024633_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024602	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	22	0	WUGSC	HMP_production_phase_1
SRS024424.576036	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2682	SRR040671	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024424	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101570_from_subject_159713063__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700101533	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	5.1	BI	HMP_production_phase_1
SRS051010.574484	TCAGTGTAGAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3572	SRR058090	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051010	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109488_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109459	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	31	0	JCVI	HMP_production_phase_1
SRS021623.572812	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1975	SRR048053	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021623	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097335_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097302	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	4.9	BCM	HMP_production_phase_1
SRS022964.576287	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2314	SRR048375	37.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022964	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241781	241781	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098994_from_subject_158236265__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098952	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	37	4.6	BCM	HMP_production_phase_1
SRS057762.570269	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4139	SRR043610	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057762	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038466_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038442	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS016789.572123	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_980	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016789	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241715	241715	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032980_from_subject_160421117__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700032943	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS023999.575830	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2570	SRR040915	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100460_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100427	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS022329.575755	TCAGATCGTAGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2156	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022329	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241841	241841	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098169_from_subject_533247696__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098128	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	25	4.5	JCVI	HMP_production_phase_1
SRS046272.576523	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3152	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046272	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110193_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110163	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	38	4.5	JCVI	HMP_production_phase_1
SRS016892.572350	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_994	SRR041422	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016892	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033253_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033252	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS055574.573652	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3936	SRR046223	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055574	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038924_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038905	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	WUGSC	HMP_production_phase_1
SRS057949.571981	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4157	SRR045876	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057949	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038988_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038961	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	30	0	WUGSC	HMP_production_phase_1
SRS045752.574465	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3096	SRR043914	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045752	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038730_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038697	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	3.7	WUGSC	HMP_production_phase_1
SRS019556.571303	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1520	SRR046070	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019556	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038027_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038008	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS051017.571020	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3574	SRR048729	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051017	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241671	241671	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107981_from_subject_160056975__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107946	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	BCM	HMP_production_phase_1
SRS011575.575141	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_137	SRR044911	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011575	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033026_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033024	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.7	WUGSC	HMP_production_phase_1
SRS018507.575251	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1371	SRR040724	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018507	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035971_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035940	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	4.1	BI	HMP_production_phase_1
SRS011474.574276	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_83	SRR044906	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016172_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	28	0	WUGSC	HMP_production_phase_1
SRS058399.572691	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4189	SRR048242	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058399	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102946_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102916	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	BCM	HMP_production_phase_1
SRS056421.575821	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4016	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056421	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102326_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102303	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	29	0	JCVI	HMP_production_phase_1
SRS044602.571271	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2981	SRR049400	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044602	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106639_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700106611	n	969	184	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS023192.576005	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2369	SRR041798	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023192	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099323_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099296	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	33	0	BI	HMP_production_phase_1
SRS023762.573821	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2512	SRR042797	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023762	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241773	241773	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100069_from_subject_158721788__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100036	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS024163.573624	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2609	SRR040726	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100631_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100606	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS020184.572015	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_1619	SRR048148	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020184	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095437_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095414	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	32	0	BCM	HMP_production_phase_1
SRS016109.570561	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_785	SRR044406	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016109	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241701	241701	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024766_from_subject_764588959__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024739	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	21	4.5	WUGSC	HMP_production_phase_1
SRS015283.570675	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_562	SRR043891	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015283	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023938_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023920	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS058663.570679	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4213	SRR058108	31.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241738	241738	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109504_from_subject_161554003__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109467	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	31	0	JCVI	HMP_production_phase_1
SRS020940.572478	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1804	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020940	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241752	241752	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096451_from_subject_161068481__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096425	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	0	JCVI	HMP_production_phase_1
SRS023697.572219	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2495	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023697	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100004_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099969	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	4.1	JCVI	HMP_production_phase_1
SRS048224.571446	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3328	SRR045892	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241886	241886	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038622_from_subject_404239096__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS014347.573373	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_351	SRR043768	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014347	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023001_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	30	0	WUGSC	HMP_production_phase_1
SRS020755.570974	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1760	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020755	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241780	241780	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096180_from_subject_161412393__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096161	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS023803.571442	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2519	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023803	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100197_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100171	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	JCVI	HMP_production_phase_1
SRS014367.571815	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_359	SRR048944	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023021_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021294	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS017124.576004	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1045	SRR041147	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017124	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033686_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033685	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS013720.572730	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_289	SRR041562	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013720	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016798_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016797	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS053355.571456	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3771	SRR048278	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053355	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102615_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102589	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	22	4.5	BCM	HMP_production_phase_1
SRS021871.571608	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2036	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021871	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097607_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097579	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	JCVI	HMP_production_phase_1
SRS064418.573275	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4544	SRR048790	27.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064418	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268876	268876	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111206_from_subject_257905678__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111170	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.9	BCM	HMP_production_phase_1
SRS013557.570611	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_252	SRR048403	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016578_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016549	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	4.7	BCM	HMP_production_phase_1
SRS023577.571121	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2465	SRR043022	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023577	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099854_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099819	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS013681.572193	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_280	SRR041389	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013681	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016759_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016714	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS013831.576527	TCAGCCGTTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_313	SRR041159	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013831	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016991_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016990	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	0	BI	HMP_production_phase_1
SRS011458.575511	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_75	SRR044874	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016156_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016126	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	WUGSC	HMP_production_phase_1
SRS016434.575612	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_882	SRR041398	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241749	241749	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032123_from_subject_159672603__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032086	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS064281.574431	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4520	SRR047671	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064281	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114145_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114115	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	38	4.7	WUGSC	HMP_production_phase_1
SRS015919.571041	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_731	SRR044634	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015919	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024574_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024549	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS017545.576039	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1145	SRR042796	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017545	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034278_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034244	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS053525.573309	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3788	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053525	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241735	241735	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109884_from_subject_161351702__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109864	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	0	JCVI	HMP_production_phase_1
SRS011159.572846	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_2	SRR044847	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014968_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	38	0	WUGSC	HMP_production_phase_1
SRS018463.574184	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1365	SRR041912	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018463	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241826	241826	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035897_from_subject_160218816__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035860	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS049939.572541	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3468	SRR057609	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049939	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108515_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700108484	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	0	JCVI	HMP_production_phase_1
SRS052060.574830	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3666	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052060	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110464_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110432	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	JCVI	HMP_production_phase_1
SRS021810.571723	TCAGACATAGTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2021	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021810	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097523_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097491	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	40	0	JCVI	HMP_production_phase_1
SRS062408.575475	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4228	SRR047087	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062408	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113043_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113017	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	21	0	WUGSC	HMP_production_phase_1
SRS017541.573377	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1143	SRR041188	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017541	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034274_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034242	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS062521.575095	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4249	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110842_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110816	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	4.7	JCVI	HMP_production_phase_1
SRS050378.574007	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3519	SRR046860	38.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050378	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241878	241878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105173_from_subject_612472597__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105149	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	38	4.3	WUGSC	HMP_production_phase_1
SRS023811.575339	TCAGCTACGCATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2523	SRR058086	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023811	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100205_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100175	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	JCVI	HMP_production_phase_1
SRS020584.572609	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1722	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020584	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241740	241740	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095975_from_subject_160906640__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700095956	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS011367.574150	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_37	SRR044857	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015653_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	WUGSC	HMP_production_phase_1
SRS024349.574509	TCAGTTCAAGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2658	SRR041081	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024349	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101384_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101356	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS043306.572921	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2860	SRR048663	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043306	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110135_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110101	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	4.3	BCM	HMP_production_phase_1
SRS017715.571643	TCAGACCTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1172	SRR040868	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017715	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034808_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034779	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	30	4.1	BI	HMP_production_phase_1
SRS011177.574548	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_11	SRR045318	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241686	241686	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014997_from_subject_158822939__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700014995	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	38	0	WUGSC	HMP_production_phase_1
SRS019003.576015	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1463	SRR044628	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019003	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241778	241778	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037472_from_subject_764305738__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037447	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS019898.575796	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1578	SRR044383	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019898	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038374_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038348	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	0	WUGSC	HMP_production_phase_1
SRS043190.573278	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2847	SRR041154	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043190	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241749	241749	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101345_from_subject_159672603__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700101308	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS013506.576303	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_244	SRR041023	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013506	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016486_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016464	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	BI	HMP_production_phase_1
SRS014538.574289	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_378	SRR046144	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014538	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241730	241730	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023192_from_subject_763638144__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023171	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	3.8	WUGSC	HMP_production_phase_1
SRS011638.572652	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_170	SRR045348	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011638	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033477_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033475	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS018551.574409	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1387	SRR044495	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018551	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241851	241851	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037018_from_subject_764710340__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037004	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4	WUGSC	HMP_production_phase_1
SRS013738.572199	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_295	SRR042841	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013738	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016816_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016815	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS022635.575898	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2232	SRR041794	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022635	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098587_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098555	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS051755.575757	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3637	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051755	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257133	257133	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102573_from_subject_937415040__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102535	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	38	4.6	JCVI	HMP_production_phase_1
SRS045406.572394	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3070	SRR043930	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045406	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038476_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038447	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS062682.574435	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4276	SRR049631	24.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062682	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241890	241890	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114828_from_subject_375450439__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114803	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	4.1	WUGSC	HMP_production_phase_1
SRS055295.573874	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3917	SRR048698	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055295	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109200_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109177	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	31	0	BCM	HMP_production_phase_1
SRS062540.572459	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4253	SRR047347	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062540	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114464_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114434	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	3.9	WUGSC	HMP_production_phase_1
SRS018208.575252	TCAGAACGGTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1297	SRR040777	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018208	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035615_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035583	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	0	BI	HMP_production_phase_1
SRS065362.571942	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4672	SRR048865	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065362	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700112032_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111999	n	969	329	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Left_Retroauricular_crease	26	0	BCM	HMP_production_phase_1
SRS024003.572370	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2572	SRR043243	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024003	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100464_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700100429	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS024108.572288	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2595	SRR042867	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024108	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100573_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100547	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS013680.573878	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_279	SRR041409	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013680	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241676	241676	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016758_from_subject_159207311__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016713	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS014430.571212	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_365	SRR043593	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014430	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023084_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023060	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	3.4	WUGSC	HMP_production_phase_1
SRS017103.573710	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1042	SRR041765	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241814	241814	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033665_from_subject_159551223__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700033664	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS024361.573245	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2664	SRR041049	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101396_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101362	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS016529.574547	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_901	SRR040580	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016529	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032256_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4	BI	HMP_production_phase_1
SRS021938.575110	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2055	SRR048370	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021938	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241739	241739	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097678_from_subject_158155345__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097645	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	0	BCM	HMP_production_phase_1
SRS020610.570350	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1731	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020610	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096001_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095969	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS057977.575431	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4158	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057977	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107228_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107199	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	28	0	JCVI	HMP_production_phase_1
SRS050761.571274	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3552	SRR043949	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050761	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038574_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038544	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS042569.575089	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2799	SRR048456	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042569	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102889_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700102859	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	33	0	BCM	HMP_production_phase_1
SRS015190.574603	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_534	SRR047400	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015190	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241675	241675	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023845_from_subject_763759525__sex_female_	UBERON:feces	n	None	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023815	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4	WUGSC	HMP_production_phase_1
SRS044808.575243	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3007	SRR058112	29.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044808	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257120	257120	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110474_from_subject_604812005__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700110437	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	JCVI	HMP_production_phase_1
SRS013723.571314	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_290	SRR041536	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013723	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016801_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016800	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS018489.573389	TCAGTTAATTCCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1366	SRR041239	21.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018489	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241667	241667	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035953_from_subject_160259276__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035931	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	4.1	BI	HMP_production_phase_1
SRS024414.574006	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2677	SRR041950	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024414	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101560_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700101528	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	5.1	BI	HMP_production_phase_1
SRS022199.575326	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2123	SRR058120	27.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022199	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241683	241683	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097968_from_subject_638754422__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700097926	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.5	JCVI	HMP_production_phase_1
SRS053911.576002	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3817	SRR058108	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053911	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109502_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109466	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	31	0	JCVI	HMP_production_phase_1
SRS020251.571734	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1638	SRR041696	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020251	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095504_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095476	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	0	BI	HMP_production_phase_1
SRS020447.571688	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1694	SRR042803	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095770_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS019990.575633	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1585	SRR041915	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019990	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241847	241847	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095235_from_subject_160643649__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	y	TCAG	UBERON:feces	700095213	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.3	BI	HMP_production_phase_1
SRS050269.573893	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3507	SRR058113	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050269	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108820_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108791	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	22	0	JCVI	HMP_production_phase_1
SRS021700.572160	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1998	SRR058111	23.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021700	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241688	241688	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097412_from_subject_161331472__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097375	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	JCVI	HMP_production_phase_1
SRS065506.575305	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4695	SRR048806	38.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065506	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:268878	268878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111280_from_subject_866653606__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700111240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	38	5	BCM	HMP_production_phase_1
SRS065151.570642	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4636	SRR046318	36.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065151	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241815	241815	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114037_from_subject_763395383__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114010	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	36	0	WUGSC	HMP_production_phase_1
SRS043032.573038	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2834	SRR047578	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043032	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038938_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038912	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS019681.574403	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1545	SRR043898	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019681	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038154_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038124	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS013141.575813	TCAGATTGTTAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_197	SRR041062	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013141	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015770_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016999	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	0	BI	HMP_production_phase_1
SRS064975.574709	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4612	SRR046989	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064975	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257130	257130	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114232_from_subject_663835652__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114211	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.5	WUGSC	HMP_production_phase_1
SRS021441.571124	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1928	SRR058111	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021441	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097149_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097123	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	32	0	JCVI	HMP_production_phase_1
SRS011173.572279	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_9	SRR049317	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011173	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014991_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014989	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	0	WUGSC	HMP_production_phase_1
SRS065343.575234	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4668	SRR058085	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065343	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110683_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110654	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	30	0	JCVI	HMP_production_phase_1
SRS042595.574594	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2802	SRR046694	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042595	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103313_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103282	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	19	4.7	WUGSC	HMP_production_phase_1
SRS021516.576312	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1952	SRR041572	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021516	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241722	241722	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097228_from_subject_158479027__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097193	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS011559.576361	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_129	SRR045471	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241834	241834	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033002_from_subject_159247771__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.7	WUGSC	HMP_production_phase_1
SRS023577.576259	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2465	SRR042979	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023577	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099854_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099819	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS021312.575550	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1895	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021312	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096970_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096947	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	0	JCVI	HMP_production_phase_1
SRS024433.571231	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2685	SRR040714	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024433	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101579_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700101574	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	5.1	BI	HMP_production_phase_1
SRS055191.574803	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3911	SRR048588	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055191	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107920_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107887	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	0	BCM	HMP_production_phase_1
SRS014875.570612	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_463	SRR043774	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014875	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023529_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023503	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS057676.574615	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4129	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057676	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241683	241683	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109252_from_subject_638754422__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700109230	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	4.8	JCVI	HMP_production_phase_1
SRS023009.574943	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2323	SRR048064	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023009	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099043_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700099013	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	29	0	BCM	HMP_production_phase_1
SRS024293.574303	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2645	SRR041899	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024293	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101271_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101238	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	3.7	BI	HMP_production_phase_1
SRS018497.576340	TCAGTTCGGACCAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1367	SRR041347	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018497	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035961_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035935	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	4.1	BI	HMP_production_phase_1
SRS021085.575964	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1836	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021085	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096632_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096578	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	4.8	JCVI	HMP_production_phase_1
SRS049355.571651	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3423	SRR048316	28.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102958_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102922	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	0	BCM	HMP_production_phase_1
SRS046988.575265	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3216	SRR058096	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046988	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109843_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109815	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	26	0	JCVI	HMP_production_phase_1
SRS016859.574658	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_983	SRR041733	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016859	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033220_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033219	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS014811.575457	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_441	SRR045680	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014811	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023465_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023441	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	4.1	WUGSC	HMP_production_phase_1
SRS024339.575664	TCAGTTGTTGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2654	SRR041956	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024339	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101374_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101351	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS023643.572934	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2483	SRR040623	20.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023643	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099946_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099905	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	20	4.9	BI	HMP_production_phase_1
SRS023926.571951	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2548	SRR041633	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023926	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100324_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100299	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	BI	HMP_production_phase_1
SRS019498.573515	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1515	SRR045984	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019498	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241818	241818	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037969_from_subject_765317243__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	3.8	WUGSC	HMP_production_phase_1
SRS014976.570779	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_491	SRR046222	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014976	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241727	241727	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023631_from_subject_763880905__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700023602	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	0	WUGSC	HMP_production_phase_1
SRS017424.573419	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1115	SRR040601	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017424	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241703	241703	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034130_from_subject_160481808__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034096	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	BI	HMP_production_phase_1
SRS019789.570789	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1565	SRR046211	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019789	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038265_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038117	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS057267.575683	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4088	SRR046037	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057267	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241873	241873	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038950_from_subject_355657046__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038918	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	WUGSC	HMP_production_phase_1
SRS020789.571650	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1772	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020789	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241780	241780	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096214_from_subject_161412393__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700096178	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS021922.576307	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2047	SRR048080	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021922	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097662_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097637	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	0	BCM	HMP_production_phase_1
SRS062723.574492	TCAGTCATCGAGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4283	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062723	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110736_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110709	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	0	JCVI	HMP_production_phase_1
SRS024295.572734	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2646	SRR041909	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024295	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241712	241712	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101273_from_subject_158944319__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101239	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	24	3.7	BI	HMP_production_phase_1
SRS014915.571591	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_471	SRR045779	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014915	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023570_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023547	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	WUGSC	HMP_production_phase_1
SRS013565.574972	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_256	SRR048405	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013565	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016586_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	4.7	BCM	HMP_production_phase_1
SRS043596.573597	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2894	SRR041772	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043596	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241828	241828	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102468_from_subject_160158126__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700102431	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS015454.570968	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_607	SRR047449	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024109_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024087	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS011165.576029	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_5	SRR044923	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011165	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014979_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014977	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	0	WUGSC	HMP_production_phase_1
SRS015309.575767	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_574	SRR043745	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015309	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241787	241787	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023964_from_subject_763982056__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023933	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS018987.572960	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1455	SRR044639	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018987	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037456_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037439	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS015257.573694	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_557	SRR046155	26.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015257	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241729	241729	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023912_from_subject_764143897__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023877	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	4.4	WUGSC	HMP_production_phase_1
SRS013569.574941	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_258	SRR048266	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013569	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016590_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016555	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	4.7	BCM	HMP_production_phase_1
SRS024310.570828	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2652	SRR041845	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024310	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101288_from_subject_158944319__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101283	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	24	3.7	BI	HMP_production_phase_1
SRS018427.575694	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1352	SRR041118	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241826	241826	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035861_from_subject_160218816__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035842	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS042289.576260	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2776	SRR048246	28.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042289	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102954_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102920	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	BCM	HMP_production_phase_1
SRS046542.576227	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3180	SRR046700	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046542	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105820_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105786	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.6	WUGSC	HMP_production_phase_1
SRS016476.574490	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_892	SRR041238	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016476	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032172_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032171	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS011667.571454	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_185	SRR044870	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011667	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033771_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700033737	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.4	WUGSC	HMP_production_phase_1
SRS014655.571388	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_413	SRR045498	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023309_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	37	0	WUGSC	HMP_production_phase_1
SRS055868.570723	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3968	SRR045923	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055868	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038610_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700038586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS047424.571038	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3253	SRR046782	32.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047424	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241879	241879	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106518_from_subject_553359145__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106492	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	32	4.3	WUGSC	HMP_production_phase_1
SRS045752.571911	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3096	SRR046093	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045752	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038730_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038697	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	3.7	WUGSC	HMP_production_phase_1
SRS062544.575042	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4254	SRR046741	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062544	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113622_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113602	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS017723.573270	TCAGTTCCGAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1176	SRR040888	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017723	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034816_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034783	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	4.1	BI	HMP_production_phase_1
SRS014782.570498	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_437	SRR043759	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014782	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241824	241824	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023436_from_subject_763719065__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023398	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	25	4.2	WUGSC	HMP_production_phase_1
SRS017127.570918	TCAGTTGGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1046	SRR041995	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017127	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033689_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033688	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS045138.572538	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3034	SRR048739	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045138	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107786_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107763	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	0	BCM	HMP_production_phase_1
SRS020716.572746	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1752	SRR058109	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020716	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096141_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096113	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	0	JCVI	HMP_production_phase_1
SRS020553.571003	TCAGAAGGAACCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1716	SRR041073	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020553	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095876_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095844	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	BI	HMP_production_phase_1
SRS063029.570230	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4330	SRR048811	38.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063029	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268878	268878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111284_from_subject_866653606__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	38	5	BCM	HMP_production_phase_1
SRS014659.570377	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_415	SRR045497	37.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241720	241720	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023313_from_subject_763597684__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700023290	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	37	0	WUGSC	HMP_production_phase_1
SRS018226.573047	TCAGCCGTCGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1306	SRR042809	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018226	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241765	241765	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035633_from_subject_160097436__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700035593	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS045517.572716	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3082	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045517	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102143_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102117	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	36	3.9	JCVI	HMP_production_phase_1
SRS056095.575896	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3988	SRR048442	34.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056095	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109979_from_subject_159085930__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109939	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	34	4.6	BCM	HMP_production_phase_1
SRS042498.574996	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2791	SRR046080	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042498	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038478_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038448	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS013243.575920	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_219	SRR040759	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013243	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015950_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS016615.570666	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_929	SRR041337	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032368_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032331	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	31	4.3	BI	HMP_production_phase_1
SRS048653.574540	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3359	SRR040946	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102985_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102966	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	BI	HMP_production_phase_1
SRS011611.571347	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_157	SRR044852	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011611	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033187_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033147	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.3	WUGSC	HMP_production_phase_1
SRS051821.573909	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3642	SRR057609	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051821	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241735	241735	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109906_from_subject_161351702__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109875	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	0	JCVI	HMP_production_phase_1
SRS043804.574131	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2914	SRR046050	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043804	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241886	241886	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038626_from_subject_404239096__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038594	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS014807.576613	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_439	SRR045713	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014807	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023461_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023439	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.1	WUGSC	HMP_production_phase_1
SRS015671.573315	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_665	SRR044276	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024326_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024300	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	WUGSC	HMP_production_phase_1
SRS055686.572395	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3949	SRR040945	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055686	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102983_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102965	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS046379.571612	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3163	SRR048622	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046379	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108149_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108111	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	3.9	BCM	HMP_production_phase_1
SRS021133.571858	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1853	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021133	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096680_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096602	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	4.9	JCVI	HMP_production_phase_1
SRS056304.572810	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4006	SRR049360	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038884_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038861	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	WUGSC	HMP_production_phase_1
SRS011470.571192	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_81	SRR045299	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016168_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	WUGSC	HMP_production_phase_1
SRS016880.572985	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_990	SRR041944	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016880	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033241_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033240	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS015909.572665	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_727	SRR044631	23.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015909	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241778	241778	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024564_from_subject_764305738__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024544	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	WUGSC	HMP_production_phase_1
SRS022954.574950	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2311	SRR048106	37.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022954	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241781	241781	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098984_from_subject_158236265__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098947	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	37	4.6	BCM	HMP_production_phase_1
SRS024604.571583	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2727	SRR043003	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024604	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241833	241833	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101895_from_subject_159591683__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700101858	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS015462.571710	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_609	SRR044653	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024117_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700024091	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS017943.572194	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1233	SRR041602	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017943	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035264_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035241	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BI	HMP_production_phase_1
SRS056511.576309	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4028	SRR046712	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056511	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241883	241883	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103521_from_subject_132902142__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103490	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	31	5.6	WUGSC	HMP_production_phase_1
SRS049491.573103	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3435	SRR048287	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049491	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102649_from_subject_159227541__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102606	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	22	4.5	BCM	HMP_production_phase_1
SRS017353.570867	TCAGAATTCCTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1093	SRR041312	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017353	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034059_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034032	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	0	BI	HMP_production_phase_1
SRS046864.574012	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3201	SRR046146	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046864	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241811	241811	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106042_from_subject_764184357__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106011	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	3.8	WUGSC	HMP_production_phase_1
SRS053114.572676	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3751	SRR048585	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053114	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241695	241695	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107914_from_subject_160380657__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107884	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	0	BCM	HMP_production_phase_1
SRS023942.575751	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2556	SRR041951	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023942	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241725	241725	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100340_from_subject_159268001__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100307	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS024289.572953	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2643	SRR041999	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024289	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101267_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101236	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	3.7	BI	HMP_production_phase_1
SRS042602.576042	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2803	SRR048918	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042602	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109226_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109190	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	31	0	BCM	HMP_production_phase_1
SRS019761.574214	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1552	SRR044099	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019761	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038237_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038218	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	0	WUGSC	HMP_production_phase_1
SRS013386.571797	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_229	SRR041993	29.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013386	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241666	241666	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016214_from_subject_159328691__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016210	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	29	0	BI	HMP_production_phase_1
SRS015712.571871	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_675	SRR044241	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015712	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241756	241756	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024367_from_subject_764467579__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024343	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	3.6	WUGSC	HMP_production_phase_1
SRS018799.570270	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1433	SRR046133	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018799	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037266_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	WUGSC	HMP_production_phase_1
SRS022874.570523	TCAGAGTAGCGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2289	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022874	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098904_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098874	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	4.6	JCVI	HMP_production_phase_1
SRS020030.576473	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1601	SRR040734	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020030	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095275_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095233	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	4.3	BI	HMP_production_phase_1
SRS015496.572799	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_616	SRR044490	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015496	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241707	241707	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024151_from_subject_764245047__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.1	WUGSC	HMP_production_phase_1
SRS014560.574910	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_388	SRR045729	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014560	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023214_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023182	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	3.8	WUGSC	HMP_production_phase_1
SRS011466.574361	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_79	SRR044867	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011466	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016164_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	WUGSC	HMP_production_phase_1
SRS021613.570300	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1970	SRR048363	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021613	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241668	241668	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097325_from_subject_158013734__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097297	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	22	4.9	BCM	HMP_production_phase_1
SRS014140.572638	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_320	SRR047405	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014140	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021699_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021283	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	30	0	WUGSC	HMP_production_phase_1
SRS018019.570234	TCAGTCCAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1252	SRR040766	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018019	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035343_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035308	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS018286.574714	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1321	SRR042842	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018286	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241785	241785	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035693_from_subject_160137896__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035653	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	3.9	BI	HMP_production_phase_1
SRS017298.571729	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1085	SRR042917	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017298	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033973_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033938	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS048692.575687	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3366	SRR047192	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048692	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103448_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700103431	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	33	0	WUGSC	HMP_production_phase_1
SRS063535.573702	TCAGTCGAGCACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4404	SRR058114	36.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063535	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257123	257123	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111875_from_subject_414519462__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111832	n	969	104	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	36	4.7	JCVI	HMP_production_phase_1
SRS016974.574080	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1011	SRR044896	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016974	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033468_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033466	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.1	WUGSC	HMP_production_phase_1
SRS053420.571594	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3776	SRR046799	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053420	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241859	241859	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105494_from_subject_643185023__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105467	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	28	5	WUGSC	HMP_production_phase_1
SRS020386.570414	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1677	SRR042958	32.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020386	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095705_from_subject_160704339__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700095665	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	4.2	BI	HMP_production_phase_1
SRS044605.571721	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2982	SRR043942	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044605	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038570_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038542	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS013191.572320	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_202	SRR042950	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013191	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015890_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015864	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	0	BI	HMP_production_phase_1
SRS021249.573984	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1878	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021249	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096895_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096869	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	34	5.3	JCVI	HMP_production_phase_1
SRS022689.572074	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2244	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022689	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098641_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098609	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	4.6	JCVI	HMP_production_phase_1
SRS055952.573204	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3978	SRR047149	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055952	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105425_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105404	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	34	4.2	WUGSC	HMP_production_phase_1
SRS063449.573311	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4387	SRR048851	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063449	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111477_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111447	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.8	BCM	HMP_production_phase_1
SRS062510.573361	TCAGCGCGCTACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4246	SRR058108	25.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062510	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241816	241816	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110642_from_subject_295137534__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700110605	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	JCVI	HMP_production_phase_1
SRS022625.572114	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2227	SRR041742	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022625	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098577_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098550	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS018521.575815	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1378	SRR043053	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035985_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035947	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	4.1	BI	HMP_production_phase_1
SRS047255.572656	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3238	SRR047729	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241855	241855	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103293_from_subject_682449369__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103272	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	4.7	WUGSC	HMP_production_phase_1
SRS023338.570563	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2409	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023338	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241835	241835	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099500_from_subject_206906765__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099460	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	23	0	JCVI	HMP_production_phase_1
SRS015738.570804	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_683	SRR044288	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015738	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241756	241756	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024393_from_subject_764467579__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024356	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	3.6	WUGSC	HMP_production_phase_1
SRS023637.575613	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2480	SRR043060	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023637	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099940_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099902	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	20	4.9	BI	HMP_production_phase_1
SRS020206.570907	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1629	SRR048156	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241762	241762	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095459_from_subject_158418336__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095425	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	32	0	BCM	HMP_production_phase_1
SRS019528.573118	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1517	SRR049410	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019528	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241818	241818	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037999_from_subject_765317243__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037964	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	3.8	WUGSC	HMP_production_phase_1
SRS051086.570767	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3578	SRR058085	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051086	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241776	241776	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109827_from_subject_160947100__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109807	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	JCVI	HMP_production_phase_1
SRS018165.570222	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1289	SRR043272	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018165	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035565_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS065501.572757	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4694	SRR048780	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065501	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111192_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111163	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.9	BCM	HMP_production_phase_1
SRS016783.570346	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_977	SRR041402	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016783	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241715	241715	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032974_from_subject_160421117__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032940	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	0	BI	HMP_production_phase_1
SRS053469.574018	TCAGTATAGCGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3781	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053469	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257123	257123	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102173_from_subject_414519462__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	36	3.9	JCVI	HMP_production_phase_1
SRS018224.572529	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1305	SRR042796	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035631_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035592	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS049760.571863	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3457	SRR043951	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049760	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038724_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038694	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS050958.571380	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3566	SRR046650	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050958	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106540_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106503	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	32	4.3	WUGSC	HMP_production_phase_1
SRS019554.570743	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1519	SRR043640	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019554	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038025_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038007	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS045526.575924	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3084	SRR046319	31.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045526	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241717	241717	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105723_from_subject_763456073__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105685	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	31	5	WUGSC	HMP_production_phase_1
SRS011592.570485	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_147	SRR045081	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011592	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033167_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033137	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.3	WUGSC	HMP_production_phase_1
SRS054953.572159	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3888	SRR048563	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054953	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109651_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109625	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	19	4.7	BCM	HMP_production_phase_1
SRS063153.575092	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4345	SRR046889	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063153	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241824	241824	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113539_from_subject_763719065__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700113502	n	969	359	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	25	0	WUGSC	HMP_production_phase_1
SRS019079.573141	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1467	SRR044751	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019079	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037550_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037534	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS017286.574737	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1079	SRR041251	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017286	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033961_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033932	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS056999.575937	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_4069	SRR048602	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056999	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108198_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108170	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	21	0	BCM	HMP_production_phase_1
SRS014444.571219	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_370	SRR043616	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023098_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023067	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	25	3.4	WUGSC	HMP_production_phase_1
SRS064564.572790	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4558	SRR049556	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064564	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114397_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114376	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	32	0	WUGSC	HMP_production_phase_1
SRS043149.571232	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2843	SRR046795	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043149	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105912_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105886	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	WUGSC	HMP_production_phase_1
SRS014566.575521	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_391	SRR045704	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014566	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023220_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023185	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	3.8	WUGSC	HMP_production_phase_1
SRS064402.572686	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4540	SRR048834	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064402	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111332_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111303	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	39	4.8	BCM	HMP_production_phase_1
SRS018347.572816	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1338	SRR043278	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018347	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035781_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS018555.571689	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1389	SRR044493	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018555	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241851	241851	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037022_from_subject_764710340__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700037006	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	24	4	WUGSC	HMP_production_phase_1
SRS018190.571470	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1292	SRR040755	22.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018190	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241765	241765	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035594_from_subject_160097436__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700035575	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	22	0	BI	HMP_production_phase_1
SRS017469.572049	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1122	SRR041353	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017469	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034202_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	19	5.1	BI	HMP_production_phase_1
SRS057473.571939	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4107	SRR045930	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057473	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038416_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038393	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	39	0	WUGSC	HMP_production_phase_1
SRS051745.573182	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3636	SRR048277	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051745	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102627_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102595	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	4.5	BCM	HMP_production_phase_1
SRS017735.574141	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1182	SRR041259	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017735	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034828_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	4.1	BI	HMP_production_phase_1
SRS049647.573842	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3450	SRR058108	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049647	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109498_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109464	n	969	168	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	31	0	JCVI	HMP_production_phase_1
SRS011615.573509	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_159	SRR044978	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241783	241783	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033191_from_subject_159733294__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033149	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	4.3	WUGSC	HMP_production_phase_1
SRS019107.575332	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1479	SRR047453	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019107	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037578_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037548	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS048195.574798	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3327	SRR048699	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048195	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109218_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109186	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	31	0	BCM	HMP_production_phase_1
SRS011555.576298	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_127	SRR045410	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016661_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016659	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS063859.570994	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4453	SRR047042	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063859	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113053_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113022	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS049229.574524	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3412	SRR046777	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049229	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241891	241891	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105348_from_subject_516889361__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105319	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	19	0	WUGSC	HMP_production_phase_1
SRS054590.570811	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3865	SRR046698	19.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054590	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241882	241882	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106465_from_subject_338793263__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106437	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	19	4.9	WUGSC	HMP_production_phase_1
SRS045191.572712	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3043	SRR058092	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045191	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102348_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102314	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	29	0	JCVI	HMP_production_phase_1
SRS016769.573162	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_970	SRR041464	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016769	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032960_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032933	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	21	0	BI	HMP_production_phase_1
SRS016761.570689	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_967	SRR041365	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016761	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032952_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032929	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	BI	HMP_production_phase_1
SRS020372.575727	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1670	SRR042798	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020372	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095691_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700095658	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	32	4.2	BI	HMP_production_phase_1
SRS019231.572341	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1484	SRR044462	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019231	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241800	241800	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037702_from_subject_765034022__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037682	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.2	WUGSC	HMP_production_phase_1
SRS020653.572358	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1737	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096078_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096053	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	JCVI	HMP_production_phase_1
SRS047418.573173	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3250	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047418	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109425_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109393	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	22	4.8	JCVI	HMP_production_phase_1
SRS053713.571508	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3803	SRR058108	40.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053713	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241849	241849	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110277_from_subject_161473083__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110238	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	40	4.9	JCVI	HMP_production_phase_1
SRS050422.574087	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3526	SRR043613	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050422	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241825	241825	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038472_from_subject_763536994__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038445	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS053304.575442	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3768	SRR048915	32.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053304	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108272_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700108234	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	32	4.6	BCM	HMP_production_phase_1
SRS016948.575164	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1008	SRR042796	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033414_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033379	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS021678.571683	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1987	SRR058095	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021678	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097390_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097364	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	JCVI	HMP_production_phase_1
SRS052621.572851	TCAGAGCAGCTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3717	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110321_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110293	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	4.3	JCVI	HMP_production_phase_1
SRS042669.574497	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2812	SRR049607	19.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241758	241758	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103653_from_subject_765094712__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700103621	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	19	0	WUGSC	HMP_production_phase_1
SRS013652.575167	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_265	SRR041500	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013652	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016730_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016699	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	33	0	BI	HMP_production_phase_1
SRS044781.571887	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3004	SRR046465	38.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044781	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241878	241878	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105167_from_subject_612472597__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105146	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	38	4.3	WUGSC	HMP_production_phase_1
SRS021992.575806	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2064	SRR040638	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021992	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097732_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097699	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	4.1	BI	HMP_production_phase_1
SRS023581.573474	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2467	SRR041249	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023581	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241748	241748	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099858_from_subject_158802708__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099821	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS042205.574563	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2766	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042205	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257120	257120	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102354_from_subject_604812005__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700102317	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	JCVI	HMP_production_phase_1
SRS042602.573620	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2803	SRR048771	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042602	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109226_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109190	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	31	0	BCM	HMP_production_phase_1
SRS016491.573610	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_897	SRR042857	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016491	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241846	241846	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032187_from_subject_159429842__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700032186	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS015206.572797	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_542	SRR043790	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015206	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241675	241675	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023861_from_subject_763759525__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023823	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4	WUGSC	HMP_production_phase_1
SRS043966.572130	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2926	SRR047172	20.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043966	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241856	241856	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105114_from_subject_256789458__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105091	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	20	5.6	WUGSC	HMP_production_phase_1
SRS063292.575159	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4365	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063292	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110874_from_subject_809635352__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110832	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	26	4.7	JCVI	HMP_production_phase_1
SRS056824.576013	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4057	SRR048568	19.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056824	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241721	241721	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109679_from_subject_160319967__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109639	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	19	4.7	BCM	HMP_production_phase_1
SRS013714.573814	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_287	SRR041532	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013714	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241725	241725	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016792_from_subject_159268001__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016791	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS014424.571335	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_362	SRR045538	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014424	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023078_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023057	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	3.4	WUGSC	HMP_production_phase_1
SRS017957.572792	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1239	SRR041641	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017957	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035278_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035248	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS050710.570711	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3548	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050710	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257123	257123	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102163_from_subject_414519462__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700102127	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	36	3.9	JCVI	HMP_production_phase_1
SRS056841.575361	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4060	SRR048682	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056841	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109541_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109514	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	21	0	BCM	HMP_production_phase_1
SRS053925.573314	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3819	SRR045863	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038986_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038960	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	30	0	WUGSC	HMP_production_phase_1
SRS018457.573609	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1363	SRR042882	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018457	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035891_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS017002.572534	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1014	SRR041557	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017002	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033515_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033514	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS046986.571002	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3215	SRR046032	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046986	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038612_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038587	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS024240.575340	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2633	SRR041479	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024240	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101127_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101092	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS063675.575921	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4421	SRR046554	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113642_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700113612	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Left_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS023219.572466	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2380	SRR048367	29.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023219	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241700	241700	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099350_from_subject_158114885__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700099346	n	969	319	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	29	4.2	BCM	HMP_production_phase_1
SRS011541.571601	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_120	SRR049314	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011541	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016640_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016638	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS021569.576243	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1964	SRR048094	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021569	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241843	241843	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097281_from_subject_158216035__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097248	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	0	BCM	HMP_production_phase_1
SRS064439.571860	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4545	SRR046894	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064439	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241682	241682	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114458_from_subject_764042746__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114431	n	969	290	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	27	3.9	WUGSC	HMP_production_phase_1
SRS019787.575653	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1564	SRR043980	29.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019787	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241681	241681	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038263_from_subject_764669880__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038231	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	29	0	WUGSC	HMP_production_phase_1
SRS022631.572495	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2230	SRR041790	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022631	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098583_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700098553	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS024289.572560	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2643	SRR041936	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024289	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101267_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101236	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	3.7	BI	HMP_production_phase_1
SRS048973.572994	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3388	SRR046225	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048973	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038886_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700038862	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	WUGSC	HMP_production_phase_1
SRS063307.570653	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4370	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063307	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:268866	268866	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111596_from_subject_937495960__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111574	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	39	0	JCVI	HMP_production_phase_1
SRS020641.575934	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1735	SRR058093	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020641	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241776	241776	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096066_from_subject_160947100__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096047	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	JCVI	HMP_production_phase_1
SRS065346.571408	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4669	SRR046305	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065346	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114137_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114111	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	38	4.7	WUGSC	HMP_production_phase_1
SRS017733.575680	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1181	SRR043271	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034826_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700034788	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	30	4.1	BI	HMP_production_phase_1
SRS023047.572929	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_2331	SRR048110	24.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023047	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241789	241789	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099081_from_subject_158276726__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099059	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	4.1	BCM	HMP_production_phase_1
SRS024414.573901	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2677	SRR041107	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024414	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101560_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101528	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	5.1	BI	HMP_production_phase_1
SRS015576.571891	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_638	SRR043981	18.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015576	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241802	241802	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024231_from_subject_764285508__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024200	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	18	0	WUGSC	HMP_production_phase_1
SRS016862.573130	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_984	SRR041888	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016862	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033223_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS013195.574485	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_204	SRR040874	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013195	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015894_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015866	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	0	BI	HMP_production_phase_1
SRS022822.572831	TCAGTCGCTATATA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2281	SRR058086	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022822	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241816	241816	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098778_from_subject_295137534__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098747	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS020004.571502	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1588	SRR041037	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020004	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241847	241847	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095249_from_subject_160643649__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095220	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.3	BI	HMP_production_phase_1
SRS051384.573445	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3610	SRR049508	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051384	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241856	241856	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105122_from_subject_256789458__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105095	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	20	5.6	WUGSC	HMP_production_phase_1
SRS016488.572083	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_896	SRR043007	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032184_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032183	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS045807.570676	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3102	SRR048490	23.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045807	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107439_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700107396	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	23	4.7	BCM	HMP_production_phase_1
SRS045722.576171	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3094	SRR048286	22.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045722	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241796	241796	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102647_from_subject_159227541__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700102605	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	22	4.5	BCM	HMP_production_phase_1
SRS015917.572958	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_730	SRR044607	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015917	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024572_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024548	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	0	WUGSC	HMP_production_phase_1
SRS024265.576465	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2635	SRR041911	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024265	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241712	241712	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101243_from_subject_158944319__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101224	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	3.7	BI	HMP_production_phase_1
SRS053617.570609	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3797	SRR042872	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101323_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101297	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS023124.573426	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2353	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023124	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099255_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099134	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.3	JCVI	HMP_production_phase_1
SRS062784.572591	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4294	SRR046308	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062784	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114127_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114106	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	38	4.7	WUGSC	HMP_production_phase_1
SRS024365.574896	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2666	SRR042796	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024365	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101400_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101364	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS016775.573749	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_973	SRR041441	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016775	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032966_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	BI	HMP_production_phase_1
SRS017743.573018	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1186	SRR041313	30.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017743	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034836_from_subject_160582958__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034793	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	30	4.1	BI	HMP_production_phase_1
SRS020255.574514	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1640	SRR040770	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020255	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095508_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095478	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	0	BI	HMP_production_phase_1
SRS045910.576285	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3113	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241733	241733	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108304_from_subject_160825720__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108284	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS014572.575816	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_394	SRR045726	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014572	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241730	241730	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023226_from_subject_763638144__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700023188	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	3.8	WUGSC	HMP_production_phase_1
SRS055847.572863	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3966	SRR048686	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055847	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109533_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109510	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	21	0	BCM	HMP_production_phase_1
SRS011555.574199	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_127	SRR044866	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011555	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241837	241837	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016661_from_subject_159166850__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016659	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	WUGSC	HMP_production_phase_1
SRS064033.573525	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4490	SRR046895	28.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064033	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241850	241850	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114647_from_subject_763901136__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114612	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	28	4.3	WUGSC	HMP_production_phase_1
SRS045197.570482	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3044	SRR046395	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045197	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241758	241758	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103639_from_subject_765094712__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103614	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	19	0	WUGSC	HMP_production_phase_1
SRS017780.571576	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1191	SRR040795	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017780	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034873_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034846	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	0	BI	HMP_production_phase_1
SRS020390.571365	TCAGAATTAACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1679	SRR043061	32.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020390	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095709_from_subject_160704339__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095667	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	32	4.2	BI	HMP_production_phase_1
SRS024367.572458	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2667	SRR041022	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024367	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241814	241814	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101402_from_subject_159551223__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700101365	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS022267.571449	TCAGTATACACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2140	SRR058120	29.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022267	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241786	241786	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098036_from_subject_970836795__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097993	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	29	4.2	JCVI	HMP_production_phase_1
SRS063891.574229	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4459	SRR048801	38.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063891	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268878	268878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111252_from_subject_866653606__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111226	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	38	5	BCM	HMP_production_phase_1
SRS011659.572571	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_181	SRR047471	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011659	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033763_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033733	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.4	WUGSC	HMP_production_phase_1
SRS021304.570956	TCAGACTGTATATG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1894	SRR058095	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241735	241735	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096962_from_subject_161351702__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096943	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	0	JCVI	HMP_production_phase_1
SRS066144.572265	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4736	SRR058109	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS019842.575036	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1567	SRR047579	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019842	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241790	241790	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038318_from_subject_765661155__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	n	TCAG	UBERON:mucus	700038282	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.3	WUGSC	HMP_production_phase_1
SRS019570.572983	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1526	SRR043591	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019570	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038041_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038015	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	37	0	WUGSC	HMP_production_phase_1
SRS018698.575918	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1409	SRR046649	40.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018698	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241723	241723	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037165_from_subject_765195863__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037191	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	40	4.6	WUGSC	HMP_production_phase_1
SRS011410.570454	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_48	SRR047510	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011410	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241709	241709	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016012_from_subject_158964549__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS065120.575866	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4630	SRR046506	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065120	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257114	257114	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114515_from_subject_739574095__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114488	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	27	4.8	WUGSC	HMP_production_phase_1
SRS058416.575342	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4191	SRR047701	20.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058416	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241869	241869	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106978_from_subject_147406386__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106946	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	20	0	WUGSC	HMP_production_phase_1
SRS011419.574749	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_52	SRR045310	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011419	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016063_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016038	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	25	0	WUGSC	HMP_production_phase_1
SRS020901.571934	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1798	SRR042880	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020901	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241679	241679	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096412_from_subject_160765029__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096377	n	969	9	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	31	0	BI	HMP_production_phase_1
SRS056867.572643	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4062	SRR049599	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056867	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241872	241872	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105900_from_subject_668248235__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105880	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	WUGSC	HMP_production_phase_1
SRS052682.574873	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3722	SRR047199	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052682	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103605_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103573	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS049389.575958	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3427	SRR046214	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049389	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038420_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038395	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	39	0	WUGSC	HMP_production_phase_1
SRS063367.571464	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4376	SRR048786	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063367	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268876	268876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111200_from_subject_257905678__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700111167	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.9	BCM	HMP_production_phase_1
SRS023887.572707	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2542	SRR048217	29.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023887	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241755	241755	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100285_from_subject_158883629__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100245	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	4.9	BCM	HMP_production_phase_1
SRS022637.573017	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2233	SRR041863	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022637	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241820	241820	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098589_from_subject_158499257__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098556	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS024454.573057	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2686	SRR041114	38.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241794	241794	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101600_from_subject_159571453__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101581	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	38	0	BI	HMP_production_phase_1
SRS018021.573748	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1253	SRR040767	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018021	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035345_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035309	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	BI	HMP_production_phase_1
SRS015607.572783	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_644	SRR046140	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015607	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241784	241784	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024262_from_subject_764346198__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024238	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.4	WUGSC	HMP_production_phase_1
SRS058660.572782	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4212	SRR048721	23.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058660	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107431_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107392	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	4.7	BCM	HMP_production_phase_1
SRS049266.570476	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3415	SRR047202	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049266	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106372_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106344	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	29	0	WUGSC	HMP_production_phase_1
SRS065073.573202	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4625	SRR048708	35.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065073	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241804	241804	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110804_from_subject_158984779__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700110772	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	35	4.6	BCM	HMP_production_phase_1
SRS024165.572487	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2610	SRR042022	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024165	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100633_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100607	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS014809.576477	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_440	SRR045685	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014809	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023463_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023440	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	4.1	WUGSC	HMP_production_phase_1
SRS045849.570511	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3104	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045849	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257122	257122	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107244_from_subject_686765762__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107207	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	JCVI	HMP_production_phase_1
SRS018651.576175	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1408	SRR051582	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018651	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241692	241692	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037118_from_subject_765155402__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037088	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	18	0	WUGSC	HMP_production_phase_1
SRS051935.574329	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3656	SRR046302	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051935	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105703_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105675	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	31	5	WUGSC	HMP_production_phase_1
SRS011627.572976	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_165	SRR044854	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241795	241795	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033459_from_subject_159470302__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033457	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4.1	WUGSC	HMP_production_phase_1
SRS058494.572453	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4196	SRR048251	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058494	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102269_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700102246	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	BCM	HMP_production_phase_1
SRS050155.571440	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3492	SRR047645	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050155	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241873	241873	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038936_from_subject_355657046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038911	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS016376.572076	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_867	SRR041669	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016376	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241839	241839	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032040_from_subject_159632143__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS017521.574116	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1137	SRR043026	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241691	241691	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034254_from_subject_160502038__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700034232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.1	BI	HMP_production_phase_1
SRS015786.572236	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_695	SRR044210	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015786	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024441_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024410	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS043573.576452	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2889	SRR046493	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043573	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241769	241769	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105278_from_subject_764325968__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105260	n	969	216	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	0	WUGSC	HMP_production_phase_1
SRS064970.575909	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4611	SRR047083	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064970	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114737_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114711	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	0	WUGSC	HMP_production_phase_1
SRS018155.575365	TCAGAACCGACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1284	SRR040859	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018155	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035555_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700035525	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS011686.572513	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_194	SRR044909	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011686	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241764	241764	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033791_from_subject_159713063__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700033747	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	27	4.4	WUGSC	HMP_production_phase_1
SRS019578.571989	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1530	SRR043645	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019578	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038049_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038019	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS017296.573397	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1084	SRR042815	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017296	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033971_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033937	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS023867.574494	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2534	SRR048208	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023867	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100265_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100235	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	4.9	BCM	HMP_production_phase_1
SRS018037.571317	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1260	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018037	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035361_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035317	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.3	BI	HMP_production_phase_1
SRS011671.575536	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_187	SRR045352	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011671	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033775_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033739	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	4.4	WUGSC	HMP_production_phase_1
SRS022428.575580	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2176	SRR048191	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022428	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098303_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098274	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	5.8	BCM	HMP_production_phase_1
SRS019665.570799	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1537	SRR045794	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038136_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700038115	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS015368.573170	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_590	SRR044115	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015368	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024023_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023985	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	3.7	WUGSC	HMP_production_phase_1
SRS024244.576454	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2634	SRR041379	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024244	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241745	241745	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101131_from_subject_159308461__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700101094	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS046150.570726	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3142	SRR048646	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046150	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241711	241711	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108874_from_subject_160603188__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108847	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	0	BCM	HMP_production_phase_1
SRS023126.570710	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2354	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023126	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099257_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099135	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.3	JCVI	HMP_production_phase_1
SRS046281.576374	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3153	SRR047145	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046281	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105656_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105625	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	3.8	WUGSC	HMP_production_phase_1
SRS053714.574461	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3804	SRR047215	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053714	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241887	241887	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106908_from_subject_764811490__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106873	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	21	5.3	WUGSC	HMP_production_phase_1
SRS022331.570975	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2157	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022331	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241841	241841	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098171_from_subject_533247696__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098129	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	25	4.5	JCVI	HMP_production_phase_1
SRS017416.574700	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1111	SRR040663	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017416	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241703	241703	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034122_from_subject_160481808__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034092	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	0	BI	HMP_production_phase_1
SRS019566.574979	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1524	SRR043626	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019566	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038037_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038013	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	37	0	WUGSC	HMP_production_phase_1
SRS046149.572400	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3141	SRR044111	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046149	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241811	241811	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106026_from_subject_764184357__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106003	n	969	170	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	3.8	WUGSC	HMP_production_phase_1
SRS014315.572168	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_341	SRR045725	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014315	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021904_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021887	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	3.9	WUGSC	HMP_production_phase_1
SRS022743.574362	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2256	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022743	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098699_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098673	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	4.1	JCVI	HMP_production_phase_1
SRS019095.570320	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1473	SRR044738	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019095	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037566_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037542	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS016269.574333	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_832	SRR043982	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016269	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024932_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024909	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	29	0	WUGSC	HMP_production_phase_1
SRS053146.573838	TCAGCGTACTCAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3755	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053146	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109427_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109394	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	4.8	JCVI	HMP_production_phase_1
SRS047667.571535	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3280	SRR047582	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241853	241853	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038996_from_subject_370027359__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	30	0	WUGSC	HMP_production_phase_1
SRS049428.573332	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3430	SRR046286	33.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049428	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241808	241808	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103478_from_subject_763860675__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700103446	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	33	0	WUGSC	HMP_production_phase_1
SRS047723.572335	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3286	SRR058112	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047723	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241688	241688	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109800_from_subject_161331472__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109765	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	JCVI	HMP_production_phase_1
SRS017121.572223	TCAGTGGACCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1044	SRR041193	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017121	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033683_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033682	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS018037.572666	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1260	SRR042874	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018037	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035361_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700035317	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.3	BI	HMP_production_phase_1
SRS065240.572110	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4654	SRR047093	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065240	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114850_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114814	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	4.1	WUGSC	HMP_production_phase_1
SRS065499.571866	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4692	SRR047344	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065499	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:257121	257121	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113674_from_subject_250593475__sex_male_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700113652	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	WUGSC	HMP_production_phase_1
SRS066144.571776	TCAGAAGTGGTTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043080	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS020545.575788	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1712	SRR041711	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020545	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095868_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095840	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	BI	HMP_production_phase_1
SRS050987.570330	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3571	SRR049595	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050987	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241892	241892	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106320_from_subject_550534656__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	4.2	WUGSC	HMP_production_phase_1
SRS016426.576079	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_878	SRR041386	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016426	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032113_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032081	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS050208.573822	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3496	SRR049532	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050208	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241878	241878	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105195_from_subject_612472597__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105160	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	38	4.3	WUGSC	HMP_production_phase_1
SRS011287.574202	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_24	SRR045413	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015283_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700015281	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS011446.573060	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_69	SRR044890	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011446	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016097_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016055	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	20	4.2	WUGSC	HMP_production_phase_1
SRS017300.571356	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1086	SRR042980	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017300	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033975_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033939	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS052268.575713	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3690	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052268	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241744	241744	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108086_from_subject_161270782__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700108052	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS011535.575897	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_117	SRR044846	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011535	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016631_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016629	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	0	WUGSC	HMP_production_phase_1
SRS023320.573129	TCAGTAGCACACTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2400	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023320	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099482_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099451	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.3	JCVI	HMP_production_phase_1
SRS024308.576509	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2651	SRR041856	24.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024308	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241712	241712	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101286_from_subject_158944319__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700101282	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	24	3.7	BI	HMP_production_phase_1
SRS013782.574991	TCAGTGTCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_303	SRR048292	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013782	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016941_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016912	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	BCM	HMP_production_phase_1
SRS021213.572286	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1874	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021213	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096760_from_subject_161007791__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096719	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	24	5	JCVI	HMP_production_phase_1
SRS018341.576432	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1335	SRR042908	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018341	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035775_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035742	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS042415.573963	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2786	SRR046407	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042415	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241854	241854	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106930_from_subject_517810313__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700106412	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS011373.575725	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_40	SRR044979	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011373	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015662_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700015660	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS015253.574511	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_555	SRR045773	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015253	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241729	241729	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023908_from_subject_764143897__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700023875	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	26	4.4	WUGSC	HMP_production_phase_1
SRS017894.572520	TCAGTTCCGAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1221	SRR041438	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017894	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035192_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035165	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	33	0	BI	HMP_production_phase_1
SRS046640.571771	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3188	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046640	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109445_from_subject_370425937__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109403	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	22	4.8	JCVI	HMP_production_phase_1
SRS048140.575412	TCAGTATCTGTATA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_3324	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048140	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110446_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110423	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	29	0	JCVI	HMP_production_phase_1
SRS014357.575077	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_356	SRR046143	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023011_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021289	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS024655.571706	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2739	SRR041327	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101946_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101912	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS014927.573723	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_477	SRR043907	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014927	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023582_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023553	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS011450.576328	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_71	SRR044864	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011450	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016101_from_subject_159005010__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700016057	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	20	4.2	WUGSC	HMP_production_phase_1
SRS053478.572398	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3783	SRR045502	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053478	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038738_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700038701	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	25	3.7	WUGSC	HMP_production_phase_1
SRS014655.570952	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_413	SRR049334	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023309_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023288	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	37	0	WUGSC	HMP_production_phase_1
SRS045166.574158	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3038	SRR048535	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045166	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241797	241797	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109600_from_subject_160178356__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109572	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	24	0	BCM	HMP_production_phase_1
SRS017430.573431	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1118	SRR040661	30.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017430	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241703	241703	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034136_from_subject_160481808__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700034099	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	30	0	BI	HMP_production_phase_1
SRS019103.574954	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1477	SRR044718	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037574_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037546	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS017541.571596	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1143	SRR041681	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017541	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034274_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034242	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS015135.574611	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_518	SRR043889	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015135	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241850	241850	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023790_from_subject_763901136__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700023702	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	4.5	WUGSC	HMP_production_phase_1
SRS019661.572720	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1535	SRR045845	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038132_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700038113	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	WUGSC	HMP_production_phase_1
SRS049668.575088	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3454	SRR043608	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049668	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038474_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038446	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS017355.573217	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1094	SRR041221	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034061_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	BI	HMP_production_phase_1
SRS016895.571704	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_995	SRR041677	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016895	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241745	241745	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033256_from_subject_159308461__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033255	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS047998.571757	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3311	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047998	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241733	241733	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108340_from_subject_160825720__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700108302	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	JCVI	HMP_production_phase_1
SRS017092.575789	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1037	SRR041218	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017092	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033605_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033573	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	0	BI	HMP_production_phase_1
SRS019663.570318	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1536	SRR046195	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038134_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038114	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	0	WUGSC	HMP_production_phase_1
SRS047584.575253	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_3267	SRR040848	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047584	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102401_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102369	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	BI	HMP_production_phase_1
SRS019105.571751	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1478	SRR047448	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019105	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037576_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700037547	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS014287.575983	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_337	SRR043639	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241825	241825	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021876_from_subject_763536994__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700021677	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS049558.575147	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3438	SRR048596	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049558	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107802_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107771	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	0	BCM	HMP_production_phase_1
SRS015444.575916	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_604	SRR044686	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015444	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241743	241743	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024099_from_subject_764083206__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024082	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	35	0	WUGSC	HMP_production_phase_1
SRS022582.571362	TCAGTGTACGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2219	SRR058111	26.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022582	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098487_from_subject_809635352__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098447	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	5	JCVI	HMP_production_phase_1
SRS023641.575009	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2482	SRR040745	20.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023641	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241702	241702	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099944_from_subject_159005010__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099904	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	20	4.9	BI	HMP_production_phase_1
SRS014778.571995	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_435	SRR043793	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014778	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241824	241824	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023432_from_subject_763719065__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023396	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	25	4.2	WUGSC	HMP_production_phase_1
SRS048122.574383	TCAGAAGAACGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3323	SRR040870	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048122	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102403_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102370	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS051423.575006	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3612	SRR058096	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051423	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108517_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108485	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	32	0	JCVI	HMP_production_phase_1
SRS024712.571307	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2754	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024712	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102092_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102058	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	JCVI	HMP_production_phase_1
SRS021095.574957	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1841	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021095	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241694	241694	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096642_from_subject_160866180__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700096583	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	4.8	JCVI	HMP_production_phase_1
SRS064153.574719	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4506	SRR048793	27.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064153	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268876	268876	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111218_from_subject_257905678__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111176	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.9	BCM	HMP_production_phase_1
SRS023176.574817	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2365	SRR041953	33.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023176	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241767	241767	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099307_from_subject_158924089__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700099288	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	33	0	BI	HMP_production_phase_1
SRS016775.572407	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_973	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016775	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032966_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700032936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	BI	HMP_production_phase_1
SRS016547.570255	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_910	SRR040586	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016547	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032274_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032237	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4	BI	HMP_production_phase_1
SRS016841.576191	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_981	SRR041889	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016841	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241745	241745	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033202_from_subject_159308461__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033201	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS064383.572424	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4537	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064383	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111481_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111449	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.8	JCVI	HMP_production_phase_1
SRS014241.575768	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_324	SRR046159	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014241	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021830_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700021810	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS047225.572917	TCAGAACGGAACGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3236	SRR042808	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047225	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241838	241838	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107095_from_subject_159814214__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107058	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS055513.576272	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3933	SRR042017	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055513	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101329_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101300	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS011378.570489	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_43	SRR045367	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011378	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015671_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015669	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	WUGSC	HMP_production_phase_1
SRS017910.574812	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1229	SRR042795	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241799	241799	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035208_from_subject_160441347__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035173	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	BI	HMP_production_phase_1
SRS014669.571564	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_420	SRR046095	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014669	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023323_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023295	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	37	0	WUGSC	HMP_production_phase_1
SRS014297.574956	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_340	SRR046096	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014297	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241825	241825	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021886_from_subject_763536994__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700021682	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS017142.570290	TCAGTGGAACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1051	SRR041990	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017142	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033704_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033703	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS018864.571631	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1444	SRR046516	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018864	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241716	241716	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037331_from_subject_765256553__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037298	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	18	3.8	WUGSC	HMP_production_phase_1
SRS045934.576247	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3119	SRR048472	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045934	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107520_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107495	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	0	BCM	HMP_production_phase_1
SRS024594.570732	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2724	SRR040733	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024594	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101885_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101853	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS014277.572718	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_334	SRR043596	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014277	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021866_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021315	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	35	0	WUGSC	HMP_production_phase_1
SRS014570.575178	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_393	SRR045682	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014570	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241730	241730	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023224_from_subject_763638144__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700023187	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	3.8	WUGSC	HMP_production_phase_1
SRS049834.574597	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3461	SRR049350	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049834	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241886	241886	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038624_from_subject_404239096__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700038593	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	0	WUGSC	HMP_production_phase_1
SRS017038.575642	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1025	SRR043054	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017038	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033551_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033550	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS023877.576351	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2539	SRR048213	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023877	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100275_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100240	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	4.9	BCM	HMP_production_phase_1
SRS058122.571604	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4163	SRR049363	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058122	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241823	241823	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038526_from_subject_763476303__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038496	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	31	0	WUGSC	HMP_production_phase_1
SRS014275.575148	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_333	SRR045523	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014275	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021864_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700021314	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS043721.576120	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2906	SRR048468	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043721	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107528_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107499	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	BCM	HMP_production_phase_1
SRS051449.574281	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3616	SRR045884	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051449	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241889	241889	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038818_from_subject_765640925__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038798	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	39	5.3	WUGSC	HMP_production_phase_1
SRS015460.574534	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_608	SRR044739	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015460	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024115_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024090	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	35	0	WUGSC	HMP_production_phase_1
SRS016099.573124	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_782	SRR044455	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016099	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241701	241701	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024756_from_subject_764588959__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024734	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	4.5	WUGSC	HMP_production_phase_1
SRS048480.572475	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3346	SRR043741	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048480	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038564_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038539	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	32	0	WUGSC	HMP_production_phase_1
SRS024357.575421	TCAGTACGGATTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2662	SRR041110	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101392_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101360	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	26	0	BI	HMP_production_phase_1
SRS019099.571458	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1475	SRR044741	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019099	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037570_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037544	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS024412.574556	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2676	SRR041071	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024412	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101558_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101527	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	5.1	BI	HMP_production_phase_1
SRS016718.575577	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_958	SRR040964	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016718	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241836	241836	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032663_from_subject_160016515__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700032645	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	4.3	BI	HMP_production_phase_1
SRS023817.571571	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2526	SRR052699	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023817	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100211_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100178	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	JCVI	HMP_production_phase_1
SRS020378.573149	TCAGACCTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1673	SRR041627	32.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020378	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241726	241726	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095697_from_subject_160704339__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095661	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	32	4.2	BI	HMP_production_phase_1
SRS018741.572243	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1415	SRR049221	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018741	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037208_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037127	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	4.5	WUGSC	HMP_production_phase_1
SRS024177.572908	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2616	SRR041788	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100645_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100613	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS014919.573086	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_473	SRR045732	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014919	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023574_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023549	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS016054.575632	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_770	SRR044265	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016054	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241741	241741	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024709_from_subject_764508039__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024688	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	WUGSC	HMP_production_phase_1
SRS047094.572785	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3225	SRR045918	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047094	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038872_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	0	WUGSC	HMP_production_phase_1
SRS016207.572175	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_810	SRR044505	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016207	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241687	241687	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024870_from_subject_764649650__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024848	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.1	WUGSC	HMP_production_phase_1
SRS052931.572708	TCAGTCAGCGTCTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3736	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052931	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109429_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109395	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	22	4.8	JCVI	HMP_production_phase_1
SRS044813.576197	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3009	SRR047614	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044813	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038769_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	5.3	WUGSC	HMP_production_phase_1
SRS016008.570888	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_756	SRR047412	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016008	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024663_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024641	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	WUGSC	HMP_production_phase_1
SRS064735.575765	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4582	SRR058092	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064735	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241817	241817	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110864_from_subject_809635352__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110827	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	4.7	JCVI	HMP_production_phase_1
SRS063524.570449	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4403	SRR048814	24.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063524	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:268869	268869	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111767_from_subject_872848689__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.6	BCM	HMP_production_phase_1
SRS043066.576460	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2839	SRR049609	18.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043066	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241874	241874	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106087_from_subject_737052003__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700106062	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	18	4.5	WUGSC	HMP_production_phase_1
SRS020192.576545	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1622	SRR048144	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020192	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095445_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095418	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	32	0	BCM	HMP_production_phase_1
SRS014597.571112	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_397	SRR046068	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014597	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023251_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	38	4.1	WUGSC	HMP_production_phase_1
SRS015192.576562	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_535	SRR046574	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015192	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241675	241675	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023847_from_subject_763759525__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023816	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4	WUGSC	HMP_production_phase_1
SRS017139.573399	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1050	SRR042005	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017139	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033701_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700033700	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS065628.571993	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4720	SRR058084	30.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065628	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241753	241753	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110663_from_subject_368533040__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110644	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	30	0	JCVI	HMP_production_phase_1
SRS024287.571358	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2642	SRR041803	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024287	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101265_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700101235	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	3.7	BI	HMP_production_phase_1
SRS063438.571772	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4385	SRR047333	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063438	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114353_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114330	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	21	0	WUGSC	HMP_production_phase_1
SRS053700.572566	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3801	SRR048757	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053700	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110143_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700110105	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	4.3	BCM	HMP_production_phase_1
SRS024657.573792	TCAGACGAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2740	SRR043042	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101948_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101913	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS021934.573095	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2053	SRR048078	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021934	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097674_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097643	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	24	0	BCM	HMP_production_phase_1
SRS042441.576114	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2789	SRR048722	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042441	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108626_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108600	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	31	0	BCM	HMP_production_phase_1
SRS062445.576137	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4234	SRR048777	39.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062445	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268866	268866	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111634_from_subject_937495960__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	TRUE	n	TCAG	UBERON:mucus	700111593	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	39	4.8	BCM	HMP_production_phase_1
SRS021445.574028	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1930	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021445	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097153_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097125	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	32	0	JCVI	HMP_production_phase_1
SRS042989.575901	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2832	SRR045886	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042989	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241884	241884	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038404_from_subject_765701615__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038387	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS055211.573703	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3913	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055211	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101819_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101784	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	JCVI	HMP_production_phase_1
SRS020312.574911	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1655	SRR041160	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020312	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241829	241829	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095565_from_subject_160663879__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095535	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	BI	HMP_production_phase_1
SRS055432.574103	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3928	SRR048526	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055432	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107975_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107943	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	BCM	HMP_production_phase_1
SRS020553.572405	TCAGAAGGAACCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1716	SRR041672	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020553	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095876_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700095844	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	BI	HMP_production_phase_1
SRS017665.576427	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1162	SRR042023	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017665	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034680_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034634	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	19	0	BI	HMP_production_phase_1
SRS020255.575919	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1640	SRR040672	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020255	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095508_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095478	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	0	BI	HMP_production_phase_1
SRS015283.575276	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_562	SRR043938	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015283	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241787	241787	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023938_from_subject_763982056__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023920	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS066188.573540	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048706	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS014331.572166	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_345	SRR047643	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014331	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241844	241844	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021920_from_subject_763820215__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021895	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	3.9	WUGSC	HMP_production_phase_1
SRS015462.571524	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_609	SRR044717	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024117_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024091	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	35	0	WUGSC	HMP_production_phase_1
SRS021988.573812	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2062	SRR041472	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021988	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097728_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097697	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	4.1	BI	HMP_production_phase_1
SRS056529.572532	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_4032	SRR047670	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056529	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241761	241761	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105429_from_subject_763557224__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105406	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	34	4.2	WUGSC	HMP_production_phase_1
SRS023250.574855	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2383	SRR058092	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023250	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099408_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099385	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	JCVI	HMP_production_phase_1
SRS054917.572590	TCAGTCTCTCGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3885	SRR058112	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS054917	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241694	241694	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109374_from_subject_160866180__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700109334	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	25	4.6	JCVI	HMP_production_phase_1
SRS021918.572868	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_2046	SRR048077	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021918	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097658_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097635	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	24	0	BCM	HMP_production_phase_1
SRS019552.575016	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1518	SRR045505	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019552	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038023_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038006	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS056505.575284	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4026	SRR048477	23.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056505	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241831	241831	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107397_from_subject_159753524__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107375	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	4.7	BCM	HMP_production_phase_1
SRS011580.571946	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_141	SRR047509	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011580	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033038_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.7	WUGSC	HMP_production_phase_1
SRS016730.575459	TCAGCCGTTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_964	SRR040947	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016730	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241836	241836	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032675_from_subject_160016515__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700032651	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4.3	BI	HMP_production_phase_1
SRS021982.576289	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2059	SRR040589	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021982	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097722_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097694	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	4.1	BI	HMP_production_phase_1
SRS020018.571809	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1595	SRR040625	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020018	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095263_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095227	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	4.3	BI	HMP_production_phase_1
SRS055278.570283	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3916	SRR058090	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055278	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110032_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110000	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS018447.571549	TCAGTCCAACCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1358	SRR041754	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018447	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035881_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035852	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS044605.571558	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2982	SRR046529	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044605	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038570_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038542	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS052060.572022	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3666	SRR058084	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052060	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110464_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110432	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	JCVI	HMP_production_phase_1
SRS011596.571816	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_149	SRR045298	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011596	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033171_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033139	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.3	WUGSC	HMP_production_phase_1
SRS018457.575636	TCAGACCGTTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1363	SRR041753	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018457	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035891_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035857	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS019562.575161	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1523	SRR046097	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019562	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038033_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038011	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	37	0	WUGSC	HMP_production_phase_1
SRS011588.576568	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_145	SRR045308	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011588	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033161_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033134	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.3	WUGSC	HMP_production_phase_1
SRS049098.571850	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3398	SRR049395	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049098	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105846_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105829	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS023344.574858	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2412	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023344	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241835	241835	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099506_from_subject_206906765__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099463	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	4.3	JCVI	HMP_production_phase_1
SRS014319.572774	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_343	SRR047621	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014319	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021908_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700021889	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	3.9	WUGSC	HMP_production_phase_1
SRS020326.571901	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1662	SRR042895	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020326	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241829	241829	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095579_from_subject_160663879__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095542	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS023617.571158	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2470	SRR040772	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099920_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099892	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	20	4.9	BI	HMP_production_phase_1
SRS064910.575432	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4602	SRR049586	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241865	241865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114747_from_subject_764831721__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114716	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	0	WUGSC	HMP_production_phase_1
SRS018795.576557	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1431	SRR047647	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018795	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037262_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037241	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	WUGSC	HMP_production_phase_1
SRS017296.570647	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1084	SRR041902	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017296	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033971_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033937	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS043603.575241	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2895	SRR058113	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043603	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110331_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700110298	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	4.3	JCVI	HMP_production_phase_1
SRS044266.573043	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2951	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044266	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110452_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110426	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	JCVI	HMP_production_phase_1
SRS014651.571263	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_411	SRR043641	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014651	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023305_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023286	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	37	0	WUGSC	HMP_production_phase_1
SRS024226.570682	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2626	SRR041840	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024226	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101113_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101085	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS018735.574797	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1413	SRR044398	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018735	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241832	241832	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037202_from_subject_765013792__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037124	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	21	4.5	WUGSC	HMP_production_phase_1
SRS023005.575375	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2321	SRR048300	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023005	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099039_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099011	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	BCM	HMP_production_phase_1
SRS046986.573257	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3215	SRR045860	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046986	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038612_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038587	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS016283.575720	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_839	SRR044114	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016283	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024946_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024916	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	0	WUGSC	HMP_production_phase_1
SRS011582.571958	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_142	SRR044983	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011582	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033041_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033039	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	27	4.7	WUGSC	HMP_production_phase_1
SRS057075.572156	TCAGACATAGTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4077	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057075	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241694	241694	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109382_from_subject_160866180__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109338	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	25	4.6	JCVI	HMP_production_phase_1
SRS044434.575637	TCAGCGTAGATCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2965	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044434	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241849	241849	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110281_from_subject_161473083__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700110240	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	40	4.9	JCVI	HMP_production_phase_1
SRS016950.574149	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1009	SRR041475	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016950	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033416_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033380	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS057399.574587	TCAGAGCGTCAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4098	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057399	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241780	241780	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110038_from_subject_161412393__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110003	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS056777.576159	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4053	SRR048751	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056777	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108890_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108855	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	BCM	HMP_production_phase_1
SRS056777.576152	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4053	SRR048910	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056777	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108890_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108855	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	29	0	BCM	HMP_production_phase_1
SRS014422.572315	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_361	SRR043638	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023076_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023056	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	25	3.4	WUGSC	HMP_production_phase_1
SRS044948.573899	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3023	SRR048759	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044948	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110149_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700110108	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	24	4.3	BCM	HMP_production_phase_1
SRS044937.571092	TCAGTCACGACGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3019	SRR058112	26.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044937	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241776	241776	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109863_from_subject_160947100__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109825	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	JCVI	HMP_production_phase_1
SRS021117.575750	TCAGACTCTAGTCT	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1846	SRR058093	20.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021117	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241801	241801	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096664_from_subject_160744799__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096594	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	20	4.9	JCVI	HMP_production_phase_1
SRS046383.572330	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3165	SRR048638	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046383	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108564_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108536	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	30	3.9	BCM	HMP_production_phase_1
SRS047001.571855	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3217	SRR048672	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047001	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108248_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108222	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	32	4.6	BCM	HMP_production_phase_1
SRS019105.572122	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1478	SRR044656	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019105	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037576_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700037547	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS022677.575174	TCAGCGTGTCGCAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2239	SRR058111	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022677	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098629_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098603	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	4.6	JCVI	HMP_production_phase_1
SRS056629.574253	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4038	SRR048637	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108574_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700108541	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	30	3.9	BCM	HMP_production_phase_1
SRS064445.571941	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4546	SRR048421	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064445	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110782_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110761	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	35	4.6	BCM	HMP_production_phase_1
SRS013470.570398	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_237	SRR042019	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013470	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016401_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016384	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	29	0	BI	HMP_production_phase_1
SRS056606.571512	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_4036	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056606	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109835_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109811	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	26	0	JCVI	HMP_production_phase_1
SRS011518.571823	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_108	SRR044907	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011518	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016372_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016352	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	4.2	WUGSC	HMP_production_phase_1
SRS023017.575018	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2327	SRR048366	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023017	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241700	241700	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099051_from_subject_158114885__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099017	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	29	0	BCM	HMP_production_phase_1
SRS047658.575890	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3279	SRR057609	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047658	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241759	241759	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108828_from_subject_160987560__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108795	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	0	JCVI	HMP_production_phase_1
SRS045567.573443	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3086	SRR048605	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045567	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108206_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108174	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	21	0	BCM	HMP_production_phase_1
SRS016874.576157	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_988	SRR041728	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016874	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033235_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS051295.574351	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3603	SRR048516	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051295	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107587_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700107557	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	0	BCM	HMP_production_phase_1
SRS045483.574416	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3080	SRR047675	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045483	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105246_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105214	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	4	WUGSC	HMP_production_phase_1
SRS066188.575829	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048499	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS018811.575010	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1439	SRR046595	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018811	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241731	241731	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037278_from_subject_765135172__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037249	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS065466.573967	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4684	SRR049589	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065466	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257130	257130	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114246_from_subject_663835652__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114218	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.5	WUGSC	HMP_production_phase_1
SRS011462.573050	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_77	SRR044849	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011462	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016160_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016128	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	WUGSC	HMP_production_phase_1
SRS064708.576603	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4577	SRR046753	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064708	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113588_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113555	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	23	4.1	WUGSC	HMP_production_phase_1
SRS046938.570768	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3208	SRR048636	30.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046938	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108576_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108542	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	30	3.9	BCM	HMP_production_phase_1
SRS018995.571416	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1459	SRR044623	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018995	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037464_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700037443	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	23	0	WUGSC	HMP_production_phase_1
SRS023365.574376	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2413	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023365	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241697	241697	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099531_from_subject_246515023__sex_female_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700099512	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	0	JCVI	HMP_production_phase_1
SRS011657.572585	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_180	SRR044958	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011657	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033761_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033732	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	4.4	WUGSC	HMP_production_phase_1
SRS057051.573000	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4072	SRR058096	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057051	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108519_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108486	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	32	0	JCVI	HMP_production_phase_1
SRS047219.574413	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3235	SRR045542	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047219	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038456_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038437	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS024529.573645	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2706	SRR048168	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024529	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101675_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101647	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BCM	HMP_production_phase_1
SRS016026.570442	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_764	SRR044469	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016026	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241708	241708	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024681_from_subject_764447348__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024650	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS021865.572612	TCAGAGAGCGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2033	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021865	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097601_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097576	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	28	0	JCVI	HMP_production_phase_1
SRS053026.573880	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3742	SRR048603	21.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053026	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241715	241715	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108200_from_subject_160421117__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108171	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	21	0	BCM	HMP_production_phase_1
SRS053562.575718	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3790	SRR058112	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053562	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241735	241735	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109916_from_subject_161351702__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109880	n	969	194	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	0	JCVI	HMP_production_phase_1
SRS016464.570792	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_888	SRR041288	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032160_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032159	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS011479.573457	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_86	SRR045403	28.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011479	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241760	241760	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016178_from_subject_159146620__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016138	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	WUGSC	HMP_production_phase_1
SRS024007.573630	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2574	SRR042887	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024007	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241704	241704	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100468_from_subject_159369152__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100431	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	0	BI	HMP_production_phase_1
SRS057290.574282	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4091	SRR047684	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057290	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105757_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105732	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS056304.570865	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4006	SRR045802	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056304	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038884_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038861	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	WUGSC	HMP_production_phase_1
SRS064809.574352	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4591	SRR049516	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064809	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114625_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114601	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	4.3	WUGSC	HMP_production_phase_1
SRS019371.571673	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1508	SRR046672	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019371	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241771	241771	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037842_from_subject_765337473__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037809	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.5	WUGSC	HMP_production_phase_1
SRS055513.576480	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3933	SRR041153	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055513	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101329_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101300	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	25	0	BI	HMP_production_phase_1
SRS021577.574288	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1967	SRR048371	29.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021577	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241843	241843	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097289_from_subject_158216035__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097252	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	29	0	BCM	HMP_production_phase_1
SRS016549.573721	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_911	SRR041448	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016549	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241831	241831	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032276_from_subject_159753524__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032238	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	4	BI	HMP_production_phase_1
SRS046022.575542	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3127	SRR049432	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046022	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105812_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105782	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.6	WUGSC	HMP_production_phase_1
SRS062832.570543	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4302	SRR050062	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062832	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113586_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113554	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	23	4.1	WUGSC	HMP_production_phase_1
SRS015601.571241	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_641	SRR044467	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015601	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241784	241784	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024256_from_subject_764346198__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024235	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	23	4.4	WUGSC	HMP_production_phase_1
SRS011488.574833	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_91	SRR045106	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011488	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016325_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016304	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	34	0	WUGSC	HMP_production_phase_1
SRS024704.570235	TCAGAGACATATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2750	SRR052699	30.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024704	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241753	241753	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102084_from_subject_368533040__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700102054	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	30	0	JCVI	HMP_production_phase_1
SRS052454.576344	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3704	SRR047194	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052454	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257127	257127	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105666_from_subject_953045535__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105630	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	29	3.8	WUGSC	HMP_production_phase_1
SRS065266.573125	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4657	SRR046269	38.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065266	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241693	241693	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114159_from_subject_763840445__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114122	n	969	303	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	38	4.7	WUGSC	HMP_production_phase_1
SRS022693.574312	TCAGTGCGTACTCA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2246	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022693	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241689	241689	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098645_from_subject_432193348__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098611	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	4.6	JCVI	HMP_production_phase_1
SRS020991.572975	TCAGCAGTGAGACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1816	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020991	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096538_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096515	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	JCVI	HMP_production_phase_1
SRS022510.575660	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2200	SRR048384	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022510	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241810	241810	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098411_from_subject_158458797__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098374	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	30	4.5	BCM	HMP_production_phase_1
SRS065701.573794	TCAGTCTACAGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4731	SRR058092	23.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065701	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:268865	268865	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111491_from_subject_451588811__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700111454	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.8	JCVI	HMP_production_phase_1
SRS016944.571853	TCAGTTCTCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1006	SRR040956	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016944	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033410_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033377	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS024633.572915	TCAGTTGTTGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_2729	SRR041301	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024633	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101924_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101901	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	BI	HMP_production_phase_1
SRS016482.576398	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_894	SRR041261	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016482	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032178_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032177	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS021103.575705	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1842	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021103	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241694	241694	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096650_from_subject_160866180__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096587	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	25	4.8	JCVI	HMP_production_phase_1
SRS020141.576153	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1610	SRR048136	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020141	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241827	241827	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095394_from_subject_158398106__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700095364	n	969	208	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	31	0	BCM	HMP_production_phase_1
SRS066144.571717	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BI	y	BI	HMP_production_phase_4736	SRR043071	None	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BI	HMP_production_phase_1
SRS018579.574901	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1393	SRR044459	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018579	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037046_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037028	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	0	WUGSC	HMP_production_phase_1
SRS016074.571617	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_779	SRR044411	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016074	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024731_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024699	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS049164.574384	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3405	SRR049604	20.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049164	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241813	241813	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105612_from_subject_765074482__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700105580	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	20	0	WUGSC	HMP_production_phase_1
SRS016062.570753	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_773	SRR044253	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016062	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241741	241741	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024719_from_subject_764508039__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024693	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	21	0	WUGSC	HMP_production_phase_1
SRS024175.575986	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2615	SRR041054	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024175	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100643_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100612	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS024355.573576	TCAGAACCTTATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2661	SRR041014	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101390_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101359	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS043289.576614	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2857	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043289	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110267_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110233	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	40	4.9	JCVI	HMP_production_phase_1
SRS015454.574299	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_607	SRR044721	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024109_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024087	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS050616.572815	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3541	SRR046449	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050616	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241857	241857	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106563_from_subject_208027353__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106543	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	4.3	WUGSC	HMP_production_phase_1
SRS011482.575509	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_87	SRR045066	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011482	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016315_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	34	0	WUGSC	HMP_production_phase_1
SRS021187.572120	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1863	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021187	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241842	241842	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096734_from_subject_161007791__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096706	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	5	JCVI	HMP_production_phase_1
SRS021508.574045	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1948	SRR041511	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021508	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241722	241722	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097220_from_subject_158479027__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097189	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	28	0	BI	HMP_production_phase_1
SRS048393.571122	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3340	SRR046856	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048393	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106958_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106936	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	20	0	WUGSC	HMP_production_phase_1
SRS048973.572271	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3388	SRR051583	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048973	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038886_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700038862	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	WUGSC	HMP_production_phase_1
SRS021818.574233	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2025	SRR058111	40.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021818	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241849	241849	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097531_from_subject_161473083__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097495	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	40	0	JCVI	HMP_production_phase_1
SRS063516.572498	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4401	SRR047101	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063516	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114840_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114809	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	4.1	WUGSC	HMP_production_phase_1
SRS022123.573596	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2100	SRR041743	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022123	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097889_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097852	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.4	BI	HMP_production_phase_1
SRS018559.572688	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1391	SRR044432	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241851	241851	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037026_from_subject_764710340__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037008	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4	WUGSC	HMP_production_phase_1
SRS022516.574367	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2201	SRR048181	30.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022516	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241810	241810	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098417_from_subject_158458797__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700098377	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	30	4.5	BCM	HMP_production_phase_1
SRS057466.570488	TCAGTAGCGTGATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4106	SRR058090	29.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057466	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241786	241786	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109169_from_subject_970836795__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109127	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	29	4.1	JCVI	HMP_production_phase_1
SRS064833.570748	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4594	SRR048813	38.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064833	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268878	268878	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111282_from_subject_866653606__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700111241	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	38	5	BCM	HMP_production_phase_1
SRS044898.575605	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3016	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044898	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241670	241670	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109447_from_subject_370425937__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109404	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	22	4.8	JCVI	HMP_production_phase_1
SRS019560.575319	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1522	SRR043615	37.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019560	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241720	241720	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038031_from_subject_763597684__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700038010	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	37	0	WUGSC	HMP_production_phase_1
SRS022755.573996	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2261	SRR058114	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022755	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098711_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098679	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	4.1	JCVI	HMP_production_phase_1
SRS056854.575862	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4061	SRR048491	23.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056854	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107435_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700107394	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	23	4.7	BCM	HMP_production_phase_1
SRS023266.574467	TCAGTCGCTGATAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2390	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023266	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099424_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099393	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS015631.572511	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_654	SRR044260	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015631	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024286_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024250	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4.4	WUGSC	HMP_production_phase_1
SRS011596.575761	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_149	SRR044917	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011596	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033171_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033139	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	4.3	WUGSC	HMP_production_phase_1
SRS024659.575499	TCAGTCCGGAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2741	SRR041349	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101950_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101914	n	969	229	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS014883.576092	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_466	SRR046177	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014883	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023537_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023507	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	39	0	WUGSC	HMP_production_phase_1
SRS042619.573512	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_2806	SRR047567	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042619	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038432_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038401	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	39	0	WUGSC	HMP_production_phase_1
SRS044842.570819	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3013	SRR045928	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044842	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038422_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038396	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	39	0	WUGSC	HMP_production_phase_1
SRS019095.570709	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1473	SRR044711	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019095	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037566_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037542	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS016352.572417	TCAGAAGACGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_859	SRR040914	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016352	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032016_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032015	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS042387.574196	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2785	SRR046416	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042387	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:257131	257131	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103575_from_subject_863126187__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700103558	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	WUGSC	HMP_production_phase_1
SRS019679.572297	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1544	SRR043905	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019679	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038152_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038123	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS023188.575047	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2367	SRR041791	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023188	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241767	241767	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099319_from_subject_158924089__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099294	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	33	0	BI	HMP_production_phase_1
SRS023809.573775	TCAGAGTAGCGTGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2522	SRR058086	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023809	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100203_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700100174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	JCVI	HMP_production_phase_1
SRS065224.572776	TCAGATATACGCGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4652	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065224	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111061_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111034	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	JCVI	HMP_production_phase_1
SRS018765.570663	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1425	SRR044415	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018765	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241832	241832	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037232_from_subject_765013792__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037139	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	21	4.5	WUGSC	HMP_production_phase_1
SRS021259.575349	TCAGACATAGTAGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1882	SRR058109	34.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021259	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241669	241669	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096905_from_subject_161230322__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096874	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	34	5.3	JCVI	HMP_production_phase_1
SRS021215.573925	TCAGAGAGTACGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1875	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021215	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241842	241842	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096762_from_subject_161007791__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700096720	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	24	5	JCVI	HMP_production_phase_1
SRS044842.576555	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3013	SRR046213	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044842	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038422_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038396	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	39	0	WUGSC	HMP_production_phase_1
SRS013209.575306	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_211	SRR043004	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013209	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015908_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015873	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS021926.572528	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2049	SRR048073	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021926	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097666_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097639	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	0	BCM	HMP_production_phase_1
SRS015925.575946	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_734	SRR044595	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015925	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024580_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS017671.570264	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1165	SRR040689	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017671	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241775	241775	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034686_from_subject_160461578__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034637	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	19	0	BI	HMP_production_phase_1
SRS024128.574598	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2605	SRR043058	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024128	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100593_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700100557	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS022127.573447	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2102	SRR042845	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022127	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241803	241803	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097893_from_subject_158337416__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097854	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	4.4	BI	HMP_production_phase_1
SRS024482.575263	TCAGTTCGGACCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2696	SRR041075	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024482	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101628_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101595	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	38	0	BI	HMP_production_phase_1
SRS024343.571560	TCAGTGGTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2655	SRR041829	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024343	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101378_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101353	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	BI	HMP_production_phase_1
SRS017139.575029	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1050	SRR041115	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017139	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033701_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033700	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS062994.576335	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4324	SRR049564	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062994	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114854_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114816	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	4.1	WUGSC	HMP_production_phase_1
SRS024175.574808	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2615	SRR041719	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024175	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100643_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700100612	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	0	BI	HMP_production_phase_1
SRS045258.575468	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3052	SRR047581	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045258	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038767_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038744	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	5.3	WUGSC	HMP_production_phase_1
SRS058622.573649	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4208	SRR057609	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058622	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108074_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108046	n	969	152	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	28	0	JCVI	HMP_production_phase_1
SRS017951.575439	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1236	SRR041630	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017951	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241809	241809	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035272_from_subject_158357646__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035245	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	25	0	BI	HMP_production_phase_1
SRS015788.572137	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_696	SRR044275	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015788	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024443_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024411	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS024126.571039	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2604	SRR041470	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024126	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100591_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100556	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS019011.572642	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1465	SRR044594	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019011	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037480_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037451	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	23	0	WUGSC	HMP_production_phase_1
SRS022452.570321	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2186	SRR048206	27.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022452	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241719	241719	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098327_from_subject_158742018__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700098286	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	5.8	BCM	HMP_production_phase_1
SRS057473.571462	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_4107	SRR049633	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057473	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241884	241884	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038416_from_subject_765701615__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038393	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	39	0	WUGSC	HMP_production_phase_1
SRS064085.573679	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4500	SRR047000	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064085	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114262_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700114226	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	4.5	WUGSC	HMP_production_phase_1
SRS054464.570299	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3852	SRR058112	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110472_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110436	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	JCVI	HMP_production_phase_1
SRS057864.575286	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4145	SRR058108	27.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057864	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241780	241780	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110042_from_subject_161412393__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700110005	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	JCVI	HMP_production_phase_1
SRS011285.576261	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_23	SRR045419	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011285	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015280_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700015278	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	WUGSC	HMP_production_phase_1
SRS020441.575534	TCAGTCGGAACGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1691	SRR040883	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020441	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241680	241680	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095764_from_subject_160684109__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095731	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	0	BI	HMP_production_phase_1
SRS017717.574317	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1173	SRR040997	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017717	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034810_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034780	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	30	4.1	BI	HMP_production_phase_1
SRS042764.573528	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2818	SRR043000	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042764	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241749	241749	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101339_from_subject_159672603__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101305	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS024130.573915	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2606	SRR042792	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024130	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241724	241724	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100595_from_subject_159510762__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100558	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS020598.570522	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1725	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020598	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095989_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095963	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	JCVI	HMP_production_phase_1
SRS018733.576038	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1412	SRR047434	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018733	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241832	241832	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037200_from_subject_765013792__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037123	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	4.5	WUGSC	HMP_production_phase_1
SRS047772.575100	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3291	SRR046181	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241823	241823	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038522_from_subject_763476303__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038494	n	969	199	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	31	0	WUGSC	HMP_production_phase_1
SRS019345.574265	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1504	SRR046085	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019345	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241771	241771	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037816_from_subject_765337473__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037796	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.5	WUGSC	HMP_production_phase_1
SRS023734.573571	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_2503	SRR040976	27.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023734	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241773	241773	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100041_from_subject_158721788__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700100022	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	BI	HMP_production_phase_1
SRS021984.571528	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2060	SRR041173	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021984	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097724_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097695	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	4.1	BI	HMP_production_phase_1
SRS050081.571496	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3485	SRR048628	26.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050081	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108155_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108114	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	26	3.9	BCM	HMP_production_phase_1
SRS013185.573988	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_200	SRR040881	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013185	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015884_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015861	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	22	0	BI	HMP_production_phase_1
SRS017663.572181	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1161	SRR040778	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034678_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034633	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	19	0	BI	HMP_production_phase_1
SRS011539.573634	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_119	SRR047472	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011539	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016637_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016635	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS057060.576471	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4073	SRR058112	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057060	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257122	257122	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107236_from_subject_686765762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700107203	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	JCVI	HMP_production_phase_1
SRS064493.576561	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4552	SRR046748	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064493	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113634_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113608	n	969	373	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	3	37.09	n	Supragingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS045482.570708	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3079	SRR048625	26.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045482	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108147_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108110	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	3.9	BCM	HMP_production_phase_1
SRS016954.573937	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1010	SRR041333	23.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016954	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241705	241705	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033435_from_subject_159611913__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033559	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	0	BI	HMP_production_phase_1
SRS020198.573390	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_1625	SRR048379	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020198	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241762	241762	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095451_from_subject_158418336__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095421	n	969	212	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	0	BCM	HMP_production_phase_1
SRS023399.574065	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2426	SRR058092	38.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023399	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241697	241697	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099565_from_subject_246515023__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700099529	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	38	0	JCVI	HMP_production_phase_1
SRS011586.574634	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_144	SRR045344	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011586	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241783	241783	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033153_from_subject_159733294__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033130	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	4.3	WUGSC	HMP_production_phase_1
SRS043640.570707	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2897	SRR048413	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043640	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241796	241796	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102637_from_subject_159227541__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102600	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	4.5	BCM	HMP_production_phase_1
SRS016539.573599	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_906	SRR043273	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016539	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032266_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032233	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4	BI	HMP_production_phase_1
SRS024351.574521	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2659	SRR043236	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101386_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101357	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS018280.574355	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1318	SRR041298	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018280	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035687_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035650	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	3.9	BI	HMP_production_phase_1
SRS018347.573097	TCAGTTCCGGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1338	SRR043260	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018347	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241695	241695	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035781_from_subject_160380657__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035745	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS023206.573846	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2376	SRR041741	33.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099337_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700099303	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	33	0	BI	HMP_production_phase_1
SRS058527.570420	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4200	SRR049349	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058527	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038608_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038585	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	0	WUGSC	HMP_production_phase_1
SRS013837.576040	TCAGTCCGGTCCTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_315	SRR041876	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013837	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016997_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016996	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	38	0	BI	HMP_production_phase_1
SRS016458.571510	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_886	SRR041780	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016458	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241846	241846	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032154_from_subject_159429842__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032153	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS022426.574057	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2175	SRR048198	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	5.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022426	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241719	241719	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098301_from_subject_158742018__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098273	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	27	5.8	BCM	HMP_production_phase_1
SRS016930.570775	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_999	SRR040981	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016930	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033396_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033370	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	BI	HMP_production_phase_1
SRS014361.571011	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_357	SRR047641	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241736	241736	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023015_from_subject_763516763__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700021291	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	0	WUGSC	HMP_production_phase_1
SRS045191.576125	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3043	SRR052699	29.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045191	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257120	257120	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102348_from_subject_604812005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700102314	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	29	0	JCVI	HMP_production_phase_1
SRS043226.571543	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2852	SRR045511	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043226	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038710_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038687	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	25	3.7	WUGSC	HMP_production_phase_1
SRS063680.575127	TCAGTGATGACGCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_4423	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063680	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241742	241742	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111542_from_subject_336497421__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111514	n	969	126	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	0	JCVI	HMP_production_phase_1
SRS015972.575991	TCAGTTAAGATTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_747	SRR044122	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015972	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024627_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024599	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	0	WUGSC	HMP_production_phase_1
SRS022564.574582	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2210	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022564	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098469_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098438	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	5	JCVI	HMP_production_phase_1
SRS014444.575059	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_370	SRR045533	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014444	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023098_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700023067	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	25	3.4	WUGSC	HMP_production_phase_1
SRS011475.574636	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_84	SRR047519	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011475	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016174_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016135	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS055805.576127	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3960	SRR048495	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055805	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108636_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108605	n	969	268	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	31	0	BCM	HMP_production_phase_1
SRS043203.576314	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2850	SRR046285	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043203	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105699_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105673	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	31	5	WUGSC	HMP_production_phase_1
SRS013516.574586	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_248	SRR041892	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013516	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016496_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016469	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	BI	HMP_production_phase_1
SRS023001.574098	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2319	SRR048299	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023001	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099035_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099009	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	BCM	HMP_production_phase_1
SRS051356.575314	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3607	SRR049371	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051356	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103464_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700103439	n	969	280	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	33	0	WUGSC	HMP_production_phase_1
SRS011498.573958	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_97	SRR044894	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011498	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016337_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016310	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	34	0	WUGSC	HMP_production_phase_1
SRS011415.570700	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_50	SRR045312	34.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011415	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241673	241673	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016029_from_subject_159085930__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700016008	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	34	0	WUGSC	HMP_production_phase_1
SRS042498.572167	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2791	SRR045765	35.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042498	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241825	241825	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038478_from_subject_763536994__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038448	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	35	0	WUGSC	HMP_production_phase_1
SRS023087.575386	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2346	SRR048125	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023087	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241789	241789	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099121_from_subject_158276726__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099079	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	24	4.1	BCM	HMP_production_phase_1
SRS024351.572201	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2659	SRR041009	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024351	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101386_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101357	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	BI	HMP_production_phase_1
SRS043875.571854	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2919	SRR048507	31.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043875	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241690	241690	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108660_from_subject_159915365__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108617	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	31	4	BCM	HMP_production_phase_1
SRS014667.573539	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_419	SRR043599	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023321_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700023294	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS019111.571026	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1481	SRR044730	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019111	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037582_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024089	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS014593.576089	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_395	SRR045727	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014593	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023247_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023227	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	38	4.1	WUGSC	HMP_production_phase_1
SRS049206.575533	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3410	SRR048690	21.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049206	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241821	241821	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109561_from_subject_160845950__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700109524	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	21	0	BCM	HMP_production_phase_1
SRS057009.572991	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4070	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057009	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109352_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109323	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	4.6	JCVI	HMP_production_phase_1
SRS019367.570418	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1506	SRR045983	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019367	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241771	241771	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037838_from_subject_765337473__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037807	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	23	4.5	WUGSC	HMP_production_phase_1
SRS063068.571182	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_4333	SRR048796	38.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063068	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:268878	268878	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111244_from_subject_866653606__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700111222	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	38	5	BCM	HMP_production_phase_1
SRS017357.575507	TCAGACCTCCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1095	SRR041214	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017357	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241674	241674	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034063_from_subject_160340197__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034034	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	0	BI	HMP_production_phase_1
SRS020020.574315	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1596	SRR040594	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020020	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095265_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700095228	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	4.3	BI	HMP_production_phase_1
SRS018459.571563	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1364	SRR043281	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018459	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035893_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035858	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS015825.573553	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_705	SRR049225	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015825	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241763	241763	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024480_from_subject_763435843__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024454	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	21	0	WUGSC	HMP_production_phase_1
SRS018455.575778	TCAGCGGTTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1362	SRR043011	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018455	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035889_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035856	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	BI	HMP_production_phase_1
SRS051929.571886	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3655	SRR047136	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051929	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105598_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105573	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	20	0	WUGSC	HMP_production_phase_1
SRS024488.576339	TCAGTCGGAAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2699	SRR042916	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101634_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101598	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	38	0	BI	HMP_production_phase_1
SRS011378.572380	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_43	SRR045455	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011378	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015671_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700015669	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	WUGSC	HMP_production_phase_1
SRS014257.570829	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_328	SRR046201	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014257	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021846_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700021818	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	25	0	WUGSC	HMP_production_phase_1
SRS020891.572457	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1793	SRR041625	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020891	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096402_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700096372	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	31	0	BI	HMP_production_phase_1
SRS015526.574187	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_627	SRR047420	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015526	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241707	241707	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024181_from_subject_764245047__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024145	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.1	WUGSC	HMP_production_phase_1
SRS047410.570559	TCAGTTCCTGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3247	SRR046689	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047410	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241879	241879	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106538_from_subject_553359145__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106502	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	32	4.3	WUGSC	HMP_production_phase_1
SRS016617.575199	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_930	SRR041235	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016617	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032370_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032332	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	31	4.3	BI	HMP_production_phase_1
SRS017563.571949	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1153	SRR040602	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017563	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241691	241691	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034296_from_subject_160502038__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700034253	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	26	4.1	BI	HMP_production_phase_1
SRS019627.571611	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1534	SRR046642	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019627	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241807	241807	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038098_from_subject_765620695__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038066	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	4	WUGSC	HMP_production_phase_1
SRS066188.574395	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	Not_applicable	JCVI	y	JCVI	HMP_production_phase_4737	SRR058085	None	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	JCVI	HMP_production_phase_1
SRS049063.574246	TCAGTTGTTGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_3394	SRR041637	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049063	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102383_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102360	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	28	0	BI	HMP_production_phase_1
SRS015659.574820	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_660	SRR044456	26.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241845	241845	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024314_from_subject_764487809__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024294	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	WUGSC	HMP_production_phase_1
SRS063285.574907	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4363	SRR046827	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063285	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241730	241730	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114301_from_subject_763638144__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114274	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	24	4.5	WUGSC	HMP_production_phase_1
SRS017971.576149	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1244	SRR042815	25.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017971	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241809	241809	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035292_from_subject_158357646__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700035255	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	25	0	BI	HMP_production_phase_1
SRS053128.574849	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_3752	SRR046634	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053128	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241872	241872	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105922_from_subject_668248235__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105891	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS016337.573078	TCAGTTCAAGGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_855	SRR040983	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016337	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032001_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032000	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	0	BI	HMP_production_phase_1
SRS017657.574334	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1158	SRR041168	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017657	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034657_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034630	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	19	0	BI	HMP_production_phase_1
SRS019089.571344	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1471	SRR044668	35.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019089	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241743	241743	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037560_from_subject_764083206__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700037539	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	35	0	WUGSC	HMP_production_phase_1
SRS058210.572709	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4172	SRR048240	28.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS058210	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241760	241760	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102950_from_subject_159146620__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102918	n	969	285	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	BCM	HMP_production_phase_1
SRS011518.572645	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_108	SRR045287	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011518	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016372_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016352	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	20	4.2	WUGSC	HMP_production_phase_1
SRS044617.574931	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2984	SRR049603	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044617	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241875	241875	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106370_from_subject_289996019__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700106343	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	WUGSC	HMP_production_phase_1
SRS011281.572410	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_21	SRR045088	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011281	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015274_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015272	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	0	WUGSC	HMP_production_phase_1
SRS015013.570911	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_497	SRR044107	20.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015013	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241718	241718	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023668_from_subject_764062976__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023641	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	20	4.8	WUGSC	HMP_production_phase_1
SRS048819.570802	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3375	SRR045531	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048819	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241812	241812	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038740_from_subject_763698834__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700038702	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	3.7	WUGSC	HMP_production_phase_1
SRS051255.574747	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3600	SRR045540	25.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051255	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038734_from_subject_763698834__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700038699	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	25	3.7	WUGSC	HMP_production_phase_1
SRS024355.570534	TCAGAACCTTATC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2661	SRR041762	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024355	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241814	241814	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101390_from_subject_159551223__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101359	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS064078.573835	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4497	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064078	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111057_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111032	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	JCVI	HMP_production_phase_1
SRS023621.571814	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2472	SRR041959	20.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023621	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241702	241702	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099924_from_subject_159005010__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700099894	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	20	4.9	BI	HMP_production_phase_1
SRS019880.570984	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1570	SRR044460	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019880	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241772	241772	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038356_from_subject_764892411__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038339	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS016493.573033	TCAGATTAACGGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_898	SRR041169	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016493	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032189_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016987	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	0	BI	HMP_production_phase_1
SRS052849.576034	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3731	SRR058085	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052849	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110195_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700110164	n	969	131	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	38	4.5	JCVI	HMP_production_phase_1
SRS057878.573774	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4147	SRR048587	23.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057878	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241695	241695	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107928_from_subject_160380657__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700107891	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	23	0	BCM	HMP_production_phase_1
SRS062845.571503	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4304	SRR047163	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062845	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241879	241879	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114421_from_subject_553359145__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700106490	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	32	4.3	WUGSC	HMP_production_phase_1
SRS013407.575774	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_230	SRR041388	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013407	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241666	241666	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016235_from_subject_159328691__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700016234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS066144.575608	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4736	SRR048582	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066144	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	NA	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS064261.576558	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4518	SRR049567	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064261	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241858	241858	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114393_from_subject_764953101__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114374	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	32	0	WUGSC	HMP_production_phase_1
SRS053765.576566	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3808	SRR047689	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053765	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105751_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105729	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	WUGSC	HMP_production_phase_1
SRS024361.575488	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2664	SRR041778	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024361	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101396_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700101362	n	969	222	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS020269.572266	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1647	SRR040642	24.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020269	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241798	241798	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095522_from_subject_160400887__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095485	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	BI	HMP_production_phase_1
SRS016016.575528	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_760	SRR044214	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016016	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241708	241708	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024671_from_subject_764447348__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024645	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS019685.572621	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1547	SRR046224	25.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019685	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241791	241791	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038158_from_subject_763678604__sex_male_	UBERON:feces	n	y	ENVO:feces	V35	FALSE	y	TCAG	UBERON:feces	700038126	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	WUGSC	HMP_production_phase_1
SRS021009.570698	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_1824	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021009	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096556_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096524	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS014803.570813	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_438	SRR045684	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014803	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241793	241793	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023457_from_subject_763921366__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023437	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	27	4.1	WUGSC	HMP_production_phase_1
SRS044175.576366	TCAGATACGCACGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2942	SRR058085	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044175	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241694	241694	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109364_from_subject_160866180__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109329	n	969	189	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	4.6	JCVI	HMP_production_phase_1
SRS043722.575827	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2907	SRR046499	19.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043722	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241758	241758	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103647_from_subject_765094712__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700103618	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	19	0	WUGSC	HMP_production_phase_1
SRS011287.575677	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_24	SRR044887	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011287	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015283_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015281	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	0	WUGSC	HMP_production_phase_1
SRS047898.571621	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3301	SRR058108	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047898	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110343_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110304	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	28	4.3	JCVI	HMP_production_phase_1
SRS016422.575354	TCAGTCCGGTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_876	SRR041460	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016422	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032109_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032079	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	BI	HMP_production_phase_1
SRS055278.576532	TCAGTATCACTACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3916	SRR058084	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055278	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241780	241780	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110032_from_subject_161412393__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110000	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	27	0	JCVI	HMP_production_phase_1
SRS017428.573106	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1117	SRR040581	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017428	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241703	241703	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034134_from_subject_160481808__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034098	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	0	BI	HMP_production_phase_1
SRS014667.571297	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_419	SRR045534	37.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014667	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241720	241720	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023321_from_subject_763597684__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700023294	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	37	0	WUGSC	HMP_production_phase_1
SRS017245.571313	TCAGAATACGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1072	SRR041392	29.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017245	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241838	241838	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033851_from_subject_159814214__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033850	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	29	0	BI	HMP_production_phase_1
SRS042235.572023	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2768	SRR048543	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042235	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241797	241797	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109610_from_subject_160178356__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109577	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	0	BCM	HMP_production_phase_1
SRS011611.574330	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_157	SRR045077	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011611	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033187_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033147	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.3	WUGSC	HMP_production_phase_1
SRS014255.573776	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_327	SRR045801	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014255	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021844_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700021817	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	25	0	WUGSC	HMP_production_phase_1
SRS022299.571355	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2142	SRR058120	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022299	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241841	241841	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098139_from_subject_533247696__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098113	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	4.5	JCVI	HMP_production_phase_1
SRS014458.574671	TCAGAACAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_376	SRR046106	25.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014458	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241812	241812	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023112_from_subject_763698834__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700023074	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	25	3.4	WUGSC	HMP_production_phase_1
SRS024410.574076	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2675	SRR040632	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024410	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101556_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700101526	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	27	5.1	BI	HMP_production_phase_1
SRS064041.571234	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4494	SRR048816	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064041	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111781_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111752	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	24	4.6	BCM	HMP_production_phase_1
SRS018284.570859	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1320	SRR042964	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018284	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241785	241785	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035691_from_subject_160137896__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035652	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	3.9	BI	HMP_production_phase_1
SRS020592.575581	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_1723	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020592	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241740	241740	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095983_from_subject_160906640__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095960	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	JCVI	HMP_production_phase_1
SRS063514.571240	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4399	SRR047039	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063514	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241805	241805	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114357_from_subject_765560005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114332	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	21	0	WUGSC	HMP_production_phase_1
SRS016531.576070	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_902	SRR043297	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016531	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241831	241831	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032258_from_subject_159753524__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032229	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	23	4	BI	HMP_production_phase_1
SRS019882.574772	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1571	SRR044464	23.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019882	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241772	241772	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038358_from_subject_764892411__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700038340	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	23	0	WUGSC	HMP_production_phase_1
SRS015468.574953	TCAGATCTTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_612	SRR044674	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015468	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024123_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700024094	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	35	0	WUGSC	HMP_production_phase_1
SRS023262.571143	TCAGTCGACGAGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2388	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023262	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099420_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099391	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	0	JCVI	HMP_production_phase_1
SRS013788.573987	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_306	SRR048121	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013788	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241819	241819	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016948_from_subject_159389382__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016915	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BCM	HMP_production_phase_1
SRS049117.572552	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3399	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049117	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107856_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107826	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	27	0	JCVI	HMP_production_phase_1
SRS051852.572646	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3646	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051852	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241751	241751	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110329_from_subject_892969023__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110297	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	4.3	JCVI	HMP_production_phase_1
SRS017735.570282	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1182	SRR042907	30.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017735	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241710	241710	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034828_from_subject_160582958__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034789	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	30	4.1	BI	HMP_production_phase_1
SRS053074.571800	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3746	SRR048701	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053074	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109214_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700109184	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	31	0	BCM	HMP_production_phase_1
SRS024586.574331	TCAGAACCTTATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2720	SRR040723	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024586	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241833	241833	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101877_from_subject_159591683__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700101849	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BI	HMP_production_phase_1
SRS011598.571055	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_150	SRR045334	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011598	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033173_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033140	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.3	WUGSC	HMP_production_phase_1
SRS013512.571145	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_247	SRR041437	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013512	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016492_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016467	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	BI	HMP_production_phase_1
SRS015923.574341	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_733	SRR044633	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015923	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024578_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024551	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	23	0	WUGSC	HMP_production_phase_1
SRS057300.575769	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4093	SRR046627	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057300	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038771_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038746	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	5.3	WUGSC	HMP_production_phase_1
SRS011500.574657	TCAGTTCGTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_99	SRR045121	34.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011500	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241673	241673	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016341_from_subject_159085930__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016312	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	34	0	WUGSC	HMP_production_phase_1
SRS017521.571877	TCAGCCTTCCGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1137	SRR042796	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241691	241691	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034254_from_subject_160502038__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700034232	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	4.1	BI	HMP_production_phase_1
SRS023434.573961	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2430	SRR048166	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241766	241766	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099621_from_subject_158438567__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099596	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	0	BCM	HMP_production_phase_1
SRS023559.572469	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2456	SRR043245	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241748	241748	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099836_from_subject_158802708__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099810	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS051609.572227	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3625	SRR048590	24.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051609	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241798	241798	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107778_from_subject_160400887__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700107759	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	24	0	BCM	HMP_production_phase_1
SRS015724.576129	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_681	SRR044209	24.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015724	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241756	241756	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024379_from_subject_764467579__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024349	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	3.6	WUGSC	HMP_production_phase_1
SRS022546.571178	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2205	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022546	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241817	241817	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098451_from_subject_809635352__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700098429	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	5	JCVI	HMP_production_phase_1
SRS015599.573980	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_640	SRR047411	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241784	241784	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024254_from_subject_764346198__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700024234	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	4.4	WUGSC	HMP_production_phase_1
SRS053113.571603	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3750	SRR048736	19.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS053113	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109677_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109638	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	19	4.7	BCM	HMP_production_phase_1
SRS064983.574771	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4613	SRR047104	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064983	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257130	257130	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114256_from_subject_663835652__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114223	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	4.5	WUGSC	HMP_production_phase_1
SRS023770.573900	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2516	SRR040959	27.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023770	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241773	241773	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100077_from_subject_158721788__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700100040	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	BI	HMP_production_phase_1
SRS019759.573688	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1551	SRR044018	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019759	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038235_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038217	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	29	0	WUGSC	HMP_production_phase_1
SRS021441.576571	TCAGAGATACACAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1928	SRR058109	32.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021441	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241754	241754	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097149_from_subject_160967330__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700097123	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	32	0	JCVI	HMP_production_phase_1
SRS063908.571422	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4462	SRR049636	22.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063908	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257108	257108	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114880_from_subject_682102541__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114859	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	WUGSC	HMP_production_phase_1
SRS016606.576073	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_925	SRR041258	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016606	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032359_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700032327	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	31	4.3	BI	HMP_production_phase_1
SRS024112.574517	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2597	SRR041295	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024112	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100577_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100549	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	26	0	BI	HMP_production_phase_1
SRS014857.574438	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_455	SRR049815	39.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014857	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241830	241830	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023511_from_subject_764002286__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023494	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	39	0	WUGSC	HMP_production_phase_1
SRS020926.575158	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_1801	SRR058109	24.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020926	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241752	241752	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096437_from_subject_161068481__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700096418	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	0	JCVI	HMP_production_phase_1
SRS046488.571915	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_3170	SRR048525	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046488	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107957_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107934	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Saliva	25	0	BCM	HMP_production_phase_1
SRS014661.574108	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_416	SRR049408	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014661	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023315_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023291	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	37	0	WUGSC	HMP_production_phase_1
SRS011667.572261	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_185	SRR045100	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011667	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033771_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700033737	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	4.4	WUGSC	HMP_production_phase_1
SRS051468.571353	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3620	SRR048756	24.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051468	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110147_from_subject_160643649__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700110107	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	4.3	BCM	HMP_production_phase_1
SRS016103.574079	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_784	SRR046179	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016103	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241701	241701	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024760_from_subject_764588959__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700024736	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	21	4.5	WUGSC	HMP_production_phase_1
SRS052599.571144	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3714	SRR048878	19.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS052599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109675_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700109637	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	19	4.7	BCM	HMP_production_phase_1
SRS065071.574946	TCAGCTACGTCTGT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4624	SRR058114	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065071	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241817	241817	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110858_from_subject_809635352__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110824	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	4.7	JCVI	HMP_production_phase_1
SRS013193.573564	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_203	SRR040894	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013193	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015892_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015865	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	0	BI	HMP_production_phase_1
SRS053061.575205	TCAGTCCAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3745	SRR046765	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053061	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106954_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106934	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	20	0	WUGSC	HMP_production_phase_1
SRS017157.571444	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1056	SRR041109	26.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017157	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241814	241814	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033719_from_subject_159551223__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033718	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	26	0	BI	HMP_production_phase_1
SRS043034.571735	TCAGTTGGCCGGTC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2835	SRR041418	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043034	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107085_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107053	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	BI	HMP_production_phase_1
SRS056498.573585	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4025	SRR045803	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056498	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241852	241852	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038890_from_subject_861967750__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038864	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	21	0	WUGSC	HMP_production_phase_1
SRS046309.575043	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3155	SRR045885	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS046309	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241864	241864	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038783_from_subject_508703490__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038752	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	24	5.3	WUGSC	HMP_production_phase_1
SRS024128.570392	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2605	SRR042978	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024128	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100593_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700100557	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS015625.575679	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_651	SRR045759	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015625	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024280_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024247	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	23	4.4	WUGSC	HMP_production_phase_1
SRS044446.575403	TCAGCTACGCATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2967	SRR052699	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044446	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102555_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102526	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	4.6	JCVI	HMP_production_phase_1
SRS018427.573990	TCAGACCGGCGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1352	SRR041977	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018427	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241826	241826	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035861_from_subject_160218816__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700035842	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS016630.575910	TCAGAACCTTATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_936	SRR041505	23.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016630	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241713	241713	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032414_from_subject_160036745__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700032413	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	23	5	BI	HMP_production_phase_1
SRS022753.572480	TCAGCTACGCATCG	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2260	SRR058120	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022753	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098709_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098678	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	22	4.1	JCVI	HMP_production_phase_1
SRS044456.572620	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2969	SRR048884	30.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044456	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241710	241710	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108594_from_subject_160582958__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700108551	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	30	3.9	BCM	HMP_production_phase_1
SRS019763.570797	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_1553	SRR043985	29.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019763	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241681	241681	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038239_from_subject_764669880__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038219	n	969	87	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	29	0	WUGSC	HMP_production_phase_1
SRS020364.570850	TCAGTTCACGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1666	SRR041504	32.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020364	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095683_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700095654	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	32	4.2	BI	HMP_production_phase_1
SRS046522.572104	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3176	SRR047688	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046522	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105300_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105271	n	969	216	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	22	0	WUGSC	HMP_production_phase_1
SRS051086.572033	TCAGTCGACGCATA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3578	SRR058084	26.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051086	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241776	241776	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109827_from_subject_160947100__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700109807	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	0	JCVI	HMP_production_phase_1
SRS050362.575139	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3517	SRR043635	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050362	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241812	241812	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038708_from_subject_763698834__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038686	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	3.7	WUGSC	HMP_production_phase_1
SRS049947.576161	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3469	SRR046322	34.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049947	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241761	241761	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105449_from_subject_763557224__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105416	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	34	4.2	WUGSC	HMP_production_phase_1
SRS011163.573547	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4	SRR045380	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011163	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014976_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700014974	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	0	WUGSC	HMP_production_phase_1
SRS016127.572157	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_792	SRR044444	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016127	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241701	241701	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024784_from_subject_764588959__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700024748	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	4.5	WUGSC	HMP_production_phase_1
SRS023633.572861	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2478	SRR040761	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023633	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099936_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099900	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	20	4.9	BI	HMP_production_phase_1
SRS063816.574001	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4446	SRR049485	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063816	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241730	241730	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114299_from_subject_763638144__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114273	n	969	309	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	24	4.5	WUGSC	HMP_production_phase_1
SRS020549.575782	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1714	SRR041098	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020549	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241821	241821	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095872_from_subject_160845950__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700095842	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	21	0	BI	HMP_production_phase_1
SRS015683.574418	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_671	SRR044278	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015683	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024338_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024306	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	26	0	WUGSC	HMP_production_phase_1
SRS018266.571318	TCAGAACCTTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1311	SRR041284	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018266	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241785	241785	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035673_from_subject_160137896__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035643	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	3.9	BI	HMP_production_phase_1
SRS016485.575371	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_895	SRR042844	25.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016485	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241846	241846	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032181_from_subject_159429842__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700032180	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	BI	HMP_production_phase_1
SRS058192.570580	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4170	SRR048620	26.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058192	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108129_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108101	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	26	0	BCM	HMP_production_phase_1
SRS019902.572287	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1580	SRR044453	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019902	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241772	241772	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038378_from_subject_764892411__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038350	n	969	71	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	23	0	WUGSC	HMP_production_phase_1
SRS023383.572694	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2418	SRR058086	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023383	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241697	241697	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099549_from_subject_246515023__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099521	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	38	0	JCVI	HMP_production_phase_1
SRS020997.571044	TCAGACGCACACGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1818	SRR058095	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020997	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241806	241806	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096544_from_subject_161311242__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096518	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	27	0	JCVI	HMP_production_phase_1
SRS019399.576408	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1509	SRR045900	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019399	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241805	241805	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037870_from_subject_765560005__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037853	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS014605.570615	TCAGTGCGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_401	SRR045730	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014605	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241693	241693	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023259_from_subject_763840445__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023233	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	4.1	WUGSC	HMP_production_phase_1
SRS013822.575338	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_311	SRR041805	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013822	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016982_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016981	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	38	0	BI	HMP_production_phase_1
SRS021798.576190	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2016	SRR058095	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021798	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097511_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097485	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	40	0	JCVI	HMP_production_phase_1
SRS024484.575841	TCAGTTACGAATTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2697	SRR041131	38.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024484	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241794	241794	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101630_from_subject_159571453__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101596	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	38	0	BI	HMP_production_phase_1
SRS065634.575003	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4722	SRR048425	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065634	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110794_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110767	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	4.6	BCM	HMP_production_phase_1
SRS021877.570526	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2039	SRR058095	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021877	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241744	241744	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	34.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097613_from_subject_161270782__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700097582	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS022069.575698	TCAGTGAGATCTCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2088	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022069	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241738	241738	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097809_from_subject_161554003__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700097772	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	31	0	JCVI	HMP_production_phase_1
SRS054796.575614	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3878	SRR047137	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054796	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105600_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105574	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	20	0	WUGSC	HMP_production_phase_1
SRS051881.575743	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3650	SRR048670	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051881	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108258_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700108227	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	32	4.6	BCM	HMP_production_phase_1
SRS050385.573892	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3520	SRR048728	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050385	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107593_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700107560	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	22	0	BCM	HMP_production_phase_1
SRS051123.573345	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3583	SRR043764	32.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051123	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241727	241727	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038558_from_subject_763880905__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038536	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	32	0	WUGSC	HMP_production_phase_1
SRS011482.570713	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_87	SRR044841	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011482	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016315_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016299	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	34	0	WUGSC	HMP_production_phase_1
SRS021746.571641	TCAGTATATCGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2005	SRR058120	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021746	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241706	241706	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097459_from_subject_161493313__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700097426	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.1	JCVI	HMP_production_phase_1
SRS016557.576559	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_915	SRR040651	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241831	241831	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032284_from_subject_159753524__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032242	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	4	BI	HMP_production_phase_1
SRS023264.572103	TCAGTCTCGTGTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2389	SRR058092	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023264	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099422_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099392	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	27	0	JCVI	HMP_production_phase_1
SRS053664.572545	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3800	SRR048457	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053664	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102879_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102854	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	33	0	BCM	HMP_production_phase_1
SRS017280.571593	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1076	SRR041290	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017280	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033955_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033929	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS015860.572339	TCAGACGTTCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_714	SRR046175	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015860	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024515_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024495	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	39	0	WUGSC	HMP_production_phase_1
SRS045910.574904	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3113	SRR058084	25.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS045910	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241733	241733	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108304_from_subject_160825720__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108284	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	JCVI	HMP_production_phase_1
SRS022187.576136	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2117	SRR058111	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022187	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097956_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700097920	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.5	JCVI	HMP_production_phase_1
SRS062980.574072	TCAGTACACAGTCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4322	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS062980	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110732_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110707	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	0	JCVI	HMP_production_phase_1
SRS022000.573464	TCAGCCTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2068	SRR040622	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022000	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241747	241747	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097740_from_subject_158256496__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097703	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	4.1	BI	HMP_production_phase_1
SRS018858.574681	TCAGCCGGTCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1442	SRR049459	18.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018858	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241716	241716	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037325_from_subject_765256553__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037295	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	18	3.8	WUGSC	HMP_production_phase_1
SRS024228.572673	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2627	SRR041687	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024228	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101115_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101086	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	28	0	BI	HMP_production_phase_1
SRS020392.573113	TCAGTTCCGAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1680	SRR041576	32.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS020392	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241726	241726	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095711_from_subject_160704339__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700095668	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	32	4.2	BI	HMP_production_phase_1
SRS011490.570821	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_92	SRR045093	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011490	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016327_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016305	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	34	0	WUGSC	HMP_production_phase_1
SRS051265.571940	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3601	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS051265	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241867	241867	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101813_from_subject_514014184__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101781	n	969	2	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	21	0	JCVI	HMP_production_phase_1
SRS023310.575850	TCAGTGCTACTGAG	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	JCVI	y	JCVI	HMP_production_phase_2396	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023310	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099472_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099446	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.3	JCVI	HMP_production_phase_1
SRS011490.570922	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_92	SRR045408	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011490	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016327_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016305	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	34	0	WUGSC	HMP_production_phase_1
SRS043077.572974	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2840	SRR048275	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043077	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102621_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102592	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	4.5	BCM	HMP_production_phase_1
SRS014663.570263	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_417	SRR047538	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014663	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023317_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700023292	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	37	0	WUGSC	HMP_production_phase_1
SRS014827.573877	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_449	SRR049869	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014827	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241793	241793	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023481_from_subject_763921366__sex_female_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023449	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.1	WUGSC	HMP_production_phase_1
SRS014972.570880	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_490	SRR049836	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014972	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023627_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023600	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS044511.571507	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2972	SRR048666	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044511	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241847	241847	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110139_from_subject_160643649__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700110103	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	24	4.3	BCM	HMP_production_phase_1
SRS062985.572383	TCAGTGGTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4323	SRR049513	24.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062985	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241756	241756	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	TRUE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113154_from_subject_764467579__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	NA	n	TCAG	UBERON:nasal mucus	700113119	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	24	0	WUGSC	HMP_production_phase_1
SRS058297.574840	TCAGAAGCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4180	SRR048668	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS058297	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241847	241847	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110151_from_subject_160643649__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700110109	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Mid_vagina	24	4.3	BCM	HMP_production_phase_1
SRS066188.574369	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	Not_applicable	BCM	y	BCM	HMP_production_phase_4737	SRR048294	None	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	None	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	None	0.0	ENVO:human-associated habitat	SRS066188	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241817	241817	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	TRUE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110872_from_subject_809635352__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	NA	None	TCAG	UBERON:mucus	None	n	969	None	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	None	37.09	n	Vaginal_introitus	None	None	BCM	HMP_production_phase_1
SRS022368.575181	TCAGACGTATGACT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2162	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022368	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098234_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098208	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	35	0	JCVI	HMP_production_phase_1
SRS049620.573353	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3445	SRR047648	32.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS049620	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241727	241727	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038578_from_subject_763880905__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700038546	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	32	0	WUGSC	HMP_production_phase_1
SRS020618.571137	TCAGTCTGCAGTAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1733	SRR058093	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020618	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241740	241740	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096009_from_subject_160906640__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095973	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	25	0	JCVI	HMP_production_phase_1
SRS018700.571607	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1410	SRR045988	40.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018700	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241723	241723	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037167_from_subject_765195863__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037192	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	40	4.6	WUGSC	HMP_production_phase_1
SRS022008.570459	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2071	SRR040729	27.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022008	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241747	241747	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097748_from_subject_158256496__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700097707	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	27	4.1	BI	HMP_production_phase_1
SRS023510.570422	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2448	SRR048231	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023510	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099787_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099757	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	0	BCM	HMP_production_phase_1
SRS017904.574100	TCAGTTCCGTTCGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1226	SRR041490	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017904	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241799	241799	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035202_from_subject_160441347__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035170	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	33	0	BI	HMP_production_phase_1
SRS017221.571223	TCAGTTCGGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1064	SRR041391	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017221	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241838	241838	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033827_from_subject_159814214__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033826	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	29	0	BI	HMP_production_phase_1
SRS052440.572830	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3703	SRR048455	33.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052440	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102891_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700102860	n	969	289	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	33	0	BCM	HMP_production_phase_1
SRS054559.573290	TCAGTCTCCGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3861	SRR046400	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241813	241813	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105602_from_subject_765074482__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105575	n	969	195	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	20	0	WUGSC	HMP_production_phase_1
SRS055934.571557	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BCM	y	BCM	HMP_production_phase_3977	SRR048492	31.0	mimarks-survey	human	0	BCM	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055934	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241690	241690	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108618_from_subject_159915365__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700108596	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	31	4	BCM	HMP_production_phase_1
SRS018090.572010	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1268	SRR041307	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018090	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035414_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035380	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS021986.575198	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2061	SRR041070	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021986	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097726_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097696	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	27	4.1	BI	HMP_production_phase_1
SRS016437.570695	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_883	SRR040966	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016437	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241846	241846	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032133_from_subject_159429842__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700032132	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS011436.574172	TCAGCTTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_62	SRR044856	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011436	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016083_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016048	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	0	WUGSC	HMP_production_phase_1
SRS024418.571045	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2679	SRR040591	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024418	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101564_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101530	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	5.1	BI	HMP_production_phase_1
SRS063673.571060	TCAGTTGGAGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4420	SRR047060	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063673	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114844_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114811	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	24	4.1	WUGSC	HMP_production_phase_1
SRS017487.572781	TCAGACGACCGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1131	SRR042830	19.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017487	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241721	241721	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034220_from_subject_160319967__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034182	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	19	5.1	BI	HMP_production_phase_1
SRS024596.575619	TCAGAACCGCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2725	SRR040718	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024596	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241833	241833	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101887_from_subject_159591683__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101854	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	27	0	BI	HMP_production_phase_1
SRS048599.575667	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3354	SRR058096	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS048599	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109782_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109756	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	23	0	JCVI	HMP_production_phase_1
SRS044192.575470	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2944	SRR058090	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044192	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109431_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109396	n	969	139	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	4.8	JCVI	HMP_production_phase_1
SRS064820.573296	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4593	SRR046761	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064820	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241875	241875	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114181_from_subject_289996019__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700114163	n	969	105	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	29	0	WUGSC	HMP_production_phase_1
SRS022942.575441	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_2305	SRR048098	37.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022942	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241781	241781	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098972_from_subject_158236265__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098941	n	969	294	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	37	4.6	BCM	HMP_production_phase_1
SRS018202.570737	TCAGCGGAACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1294	SRR041028	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018202	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035609_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700035581	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	0	BI	HMP_production_phase_1
SRS047918.575549	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3304	SRR048529	25.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047918	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107961_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107936	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	25	0	BCM	HMP_production_phase_1
SRS047219.574604	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3235	SRR043643	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047219	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038456_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038437	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	35	0	WUGSC	HMP_production_phase_1
SRS017145.571879	TCAGAACTTGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1052	SRR041981	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017145	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241814	241814	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033707_from_subject_159551223__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033706	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	0	BI	HMP_production_phase_1
SRS011429.571133	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_57	SRR045090	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011429	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241709	241709	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016073_from_subject_158964549__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700016043	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	25	0	WUGSC	HMP_production_phase_1
SRS011611.573172	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_157	SRR045430	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011611	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241783	241783	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033187_from_subject_159733294__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033147	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	4.3	WUGSC	HMP_production_phase_1
SRS057759.574185	TCAGAGTCGAGCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4138	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057759	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102147_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102119	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	36	3.9	JCVI	HMP_production_phase_1
SRS024058.570354	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2586	SRR043040	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024058	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100520_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100486	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	27	4.7	BI	HMP_production_phase_1
SRS051979.575072	TCAGAGTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3660	SRR048902	24.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051979	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107810_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107775	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	24	0	BCM	HMP_production_phase_1
SRS053593.574779	TCAGTGAGACGAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3794	SRR058112	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053593	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241806	241806	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107870_from_subject_161311242__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700107833	n	969	175	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	JCVI	HMP_production_phase_1
SRS013205.572717	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_209	SRR042863	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013205	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015904_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700015871	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS055665.575312	TCAGACAAGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_3946	SRR047702	26.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055665	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241729	241729	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106837_from_subject_764143897__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106809	n	969	223	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	26	4.4	WUGSC	HMP_production_phase_1
SRS064960.573629	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4609	SRR046482	36.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064960	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241815	241815	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114043_from_subject_763395383__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700114013	n	969	352	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	36	0	WUGSC	HMP_production_phase_1
SRS019345.575395	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_1504	SRR045770	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019345	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241771	241771	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037816_from_subject_765337473__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037796	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	23	4.5	WUGSC	HMP_production_phase_1
SRS016162.576055	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_800	SRR044279	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016162	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241696	241696	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024819_from_subject_764366428__sex_female_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024794	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	27	3.9	WUGSC	HMP_production_phase_1
SRS024220.573101	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2623	SRR041694	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024220	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241745	241745	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101107_from_subject_159308461__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101082	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	28	0	BI	HMP_production_phase_1
SRS056161.574678	TCAGTCTCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3994	SRR048446	34.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS056161	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241673	241673	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109985_from_subject_159085930__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700109942	n	969	350	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Posterior_fornix	34	4.6	BCM	HMP_production_phase_1
SRS023085.573137	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2345	SRR048127	24.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023085	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241789	241789	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099119_from_subject_158276726__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099078	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Vaginal_introitus	24	4.1	BCM	HMP_production_phase_1
SRS047112.573461	TCAGCATATAGACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3226	SRR058108	28.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047112	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241751	241751	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110341_from_subject_892969023__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110303	n	969	112	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	4.3	JCVI	HMP_production_phase_1
SRS022047.575066	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2077	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022047	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097787_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097761	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	31	0	JCVI	HMP_production_phase_1
SRS044088.570603	TCAGTGTCTGCTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2937	SRR057609	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044088	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241780	241780	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110007_from_subject_161412393__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700109987	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS011290.570358	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_26	SRR045368	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011290	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015289_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015287	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS011598.573532	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_150	SRR044956	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011598	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033173_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033140	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	24	4.3	WUGSC	HMP_production_phase_1
SRS017098.570313	TCAGTCGGATTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1040	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017098	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241705	241705	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033611_from_subject_159611913__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033576	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS050772.572967	TCAGCTAGTGCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_3553	SRR058084	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050772	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241733	241733	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108328_from_subject_160825720__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700108296	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	25	0	JCVI	HMP_production_phase_1
SRS053096.576456	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_3749	SRR041949	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053096	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241749	241749	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101327_from_subject_159672603__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700101299	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS016585.571610	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_918	SRR042899	31.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016585	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241690	241690	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032338_from_subject_159915365__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	NA	n	TCAG	UBERON:feces	700032316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	31	4.3	BI	HMP_production_phase_1
SRS017288.573689	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1080	SRR041197	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017288	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033963_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033933	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS023132.575115	TCAGACGTCTCGCT	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2357	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023132	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099263_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099138	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	4.3	JCVI	HMP_production_phase_1
SRS042716.576252	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2816	SRR046638	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042716	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241727	241727	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038568_from_subject_763880905__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038541	n	969	156	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS022884.574755	TCAGCTAGCTCGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2294	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022884	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241698	241698	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098914_from_subject_650853796__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098879	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	4.6	JCVI	HMP_production_phase_1
SRS023242.573391	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2382	SRR058086	27.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023242	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241770	241770	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099400_from_subject_964271349__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099381	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	0	JCVI	HMP_production_phase_1
SRS055981.574519	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3981	SRR049481	24.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055981	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241890	241890	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105796_from_subject_375450439__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700105774	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	24	4.6	WUGSC	HMP_production_phase_1
SRS022508.572115	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2199	SRR048312	30.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022508	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241810	241810	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098409_from_subject_158458797__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098373	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	30	4.5	BCM	HMP_production_phase_1
SRS017855.571836	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1215	SRR042993	29.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017855	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034960_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034924	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	29	0	BI	HMP_production_phase_1
SRS047606.575487	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_3268	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047606	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257123	257123	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102153_from_subject_414519462__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102122	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	36	3.9	JCVI	HMP_production_phase_1
SRS052177.571155	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3678	SRR046705	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052177	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241880	241880	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105950_from_subject_658594300__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700105929	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	0	WUGSC	HMP_production_phase_1
SRS014929.575988	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_478	SRR043960	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014929	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241808	241808	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023584_from_subject_763860675__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700023554	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	33	0	WUGSC	HMP_production_phase_1
SRS017551.571123	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1148	SRR040620	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017551	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241691	241691	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034284_from_subject_160502038__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700034247	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	4.1	BI	HMP_production_phase_1
SRS050283.571916	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3508	SRR048556	25.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050283	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241826	241826	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108943_from_subject_160218816__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700108910	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	BCM	HMP_production_phase_1
SRS013464.571049	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_234	SRR041804	29.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013464	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241666	241666	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016395_from_subject_159328691__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016381	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	29	0	BI	HMP_production_phase_1
SRS016215.575763	TCAGACGCGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_814	SRR044438	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016215	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241687	241687	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024878_from_subject_764649650__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700024852	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	23	4.1	WUGSC	HMP_production_phase_1
SRS015807.574217	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_698	SRR044699	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015807	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241763	241763	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024462_from_subject_763435843__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024445	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS016883.574829	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_991	SRR041793	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016883	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033244_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033243	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS022129.572109	TCAGAGCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2103	SRR041751	22.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022129	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241803	241803	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097895_from_subject_158337416__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700097855	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	22	4.4	BI	HMP_production_phase_1
SRS011594.571381	TCAGACCGTAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_148	SRR047480	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011594	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033169_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033138	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	24	4.3	WUGSC	HMP_production_phase_1
SRS014237.571675	TCAGTATTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_322	SRR043921	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014237	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021826_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700021808	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS017786.572438	TCAGCGGACCGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1194	SRR040775	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017786	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241782	241782	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034879_from_subject_160542498__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700034849	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	BI	HMP_production_phase_1
SRS065507.575945	TCAGAGTCGACATG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4696	SRR058114	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065507	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268865	268865	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111473_from_subject_451588811__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111445	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	23	4.8	JCVI	HMP_production_phase_1
SRS062886.576447	TCAGTGACCGTC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_4307	SRR048838	39.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062886	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268877	268877	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111344_from_subject_763721271__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700111309	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	39	4.8	BCM	HMP_production_phase_1
SRS056733.573002	TCAGACTGTCTGTA	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4048	SRR057609	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS056733	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241688	241688	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109794_from_subject_161331472__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109762	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	0	JCVI	HMP_production_phase_1
SRS011485.571436	TCAGCGTCGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_89	SRR047521	34.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011485	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241673	241673	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016321_from_subject_159085930__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700016302	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	34	0	WUGSC	HMP_production_phase_1
SRS064035.575070	TCAGATACTGCGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4492	SRR058108	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064035	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110697_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700110661	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	30	0	JCVI	HMP_production_phase_1
SRS023709.573131	TCAGACGATGATCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2500	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human vagina metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023709	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241751	241751	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100016_from_subject_892969023__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700099975	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	28	4.1	JCVI	HMP_production_phase_1
SRS023141.575430	TCAGTCAGTCTCGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2360	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023141	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241757	241757	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099272_from_subject_441369442__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099283	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	JCVI	HMP_production_phase_1
SRS042958.573164	TCAGACGCGAGATA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2829	SRR052699	36.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042958	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257123	257123	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102165_from_subject_414519462__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700102128	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	36	3.9	JCVI	HMP_production_phase_1
SRS011589.575334	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_146	SRR045339	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011589	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241783	241783	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033164_from_subject_159733294__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033136	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.3	WUGSC	HMP_production_phase_1
SRS017798.575256	TCAGTTCCGGTTCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1200	SRR041076	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017798	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241782	241782	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034891_from_subject_160542498__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS023997.575274	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2569	SRR040933	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023997	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100458_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100426	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	22	0	BI	HMP_production_phase_1
SRS047957.570835	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3308	SRR047695	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS047957	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257131	257131	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103601_from_subject_863126187__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700103571	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	26	0	WUGSC	HMP_production_phase_1
SRS023579.572845	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2466	SRR042815	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023579	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099856_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700099820	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS015454.571639	TCAGTGACGAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_607	SRR044746	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015454	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024109_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024087	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	35	0	WUGSC	HMP_production_phase_1
SRS042703.572864	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_2815	SRR047222	21.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS042703	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241887	241887	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106914_from_subject_764811490__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700106876	n	969	171	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	21	5.3	WUGSC	HMP_production_phase_1
SRS015931.574854	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_737	SRR044583	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015931	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241778	241778	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024586_from_subject_764305738__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024555	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	23	0	WUGSC	HMP_production_phase_1
SRS055114.572540	TCAGAGTCAGTGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3901	SRR058098	38.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055114	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257133	257133	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102563_from_subject_937415040__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:mucus	700102530	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	38	4.6	JCVI	HMP_production_phase_1
SRS044038.572290	TCAGACTATATCTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2934	SRR052699	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044038	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257113	257113	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102690_from_subject_840279516__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102665	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	27	0	JCVI	HMP_production_phase_1
SRS013189.570565	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_201	SRR040986	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013189	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241704	241704	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015888_from_subject_159369152__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700015863	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	0	BI	HMP_production_phase_1
SRS015629.570245	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_653	SRR044220	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015629	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024284_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024249	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	23	4.4	WUGSC	HMP_production_phase_1
SRS016619.573469	TCAGTCGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_931	SRR042815	31.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016619	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032372_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700032333	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	31	4.3	BI	HMP_production_phase_1
SRS053775.573943	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3809	SRR046793	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053775	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241869	241869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106952_from_subject_147406386__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700106933	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	20	0	WUGSC	HMP_production_phase_1
SRS063968.575335	TCAGAGTGTGTACT	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_4477	SRR058090	35.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063968	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241768	241768	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110720_from_subject_492786515__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700110701	n	969	173	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	35	0	JCVI	HMP_production_phase_1
SRS018521.574279	TCAGCCGAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1378	SRR043220	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018521	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035985_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035947	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	4.1	BI	HMP_production_phase_1
SRS042274.571051	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2774	SRR051586	30.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS042274	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241853	241853	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038970_from_subject_370027359__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038952	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	30	0	WUGSC	HMP_production_phase_1
SRS044811.574535	TCAGTCTATCTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3008	SRR058085	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044811	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107222_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107196	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	28	0	JCVI	HMP_production_phase_1
SRS018795.576445	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1431	SRR045853	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018795	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241731	241731	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037262_from_subject_765135172__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700037241	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	WUGSC	HMP_production_phase_1
SRS015966.575347	TCAGTTCGTTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_744	SRR044096	22.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015966	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241769	241769	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024621_from_subject_764325968__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024596	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	22	0	WUGSC	HMP_production_phase_1
SRS017655.573116	TCAGAGGTTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1157	SRR041434	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017655	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034655_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034629	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	19	0	BI	HMP_production_phase_1
SRS017537.574550	TCAGAGTCCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1141	SRR041679	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017537	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034270_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700034240	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	26	0	BI	HMP_production_phase_1
SRS055253.571031	TCAGCGGTATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3915	SRR047148	30.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS055253	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241736	241736	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105870_from_subject_763516763__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700105841	n	969	259	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	30	0	WUGSC	HMP_production_phase_1
SRS020563.571709	TCAGTCGAACCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1721	SRR041103	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020563	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241821	241821	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095886_from_subject_160845950__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700095849	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	0	BI	HMP_production_phase_1
SRS020267.572055	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1646	SRR040640	24.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020267	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241798	241798	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095520_from_subject_160400887__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700095484	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	24	0	BI	HMP_production_phase_1
SRS052419.572956	TCAGAGTCTCTAGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3699	SRR057609	26.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052419	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241776	241776	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109847_from_subject_160947100__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109817	n	969	217	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	26	0	JCVI	HMP_production_phase_1
SRS018964.574879	TCAGACTAATTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1452	SRR046532	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018964	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241737	241737	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037433_from_subject_765276783__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037403	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	32	0	WUGSC	HMP_production_phase_1
SRS018102.573433	TCAGTTCTTGAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1274	SRR041072	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018102	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241671	241671	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035426_from_subject_160056975__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035386	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS011434.575433	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_60	SRR045428	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011434	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241709	241709	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016079_from_subject_158964549__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700016046	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS046977.574738	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3213	SRR045880	29.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046977	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241873	241873	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038942_from_subject_355657046__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038914	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	29	0	WUGSC	HMP_production_phase_1
SRS057737.575678	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4135	SRR048911	29.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057737	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241711	241711	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108892_from_subject_160603188__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108856	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	29	0	BCM	HMP_production_phase_1
SRS063457.570365	TCAGTAGCTACTGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4389	SRR058108	30.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063457	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241753	241753	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110691_from_subject_368533040__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700110658	n	969	89	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	30	0	JCVI	HMP_production_phase_1
SRS021384.573906	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_1914	SRR058109	25.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021384	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241774	241774	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097042_from_subject_161028021__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097010	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	25	4.6	JCVI	HMP_production_phase_1
SRS023013.573189	TCAGAAGGTGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2325	SRR048062	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023013	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241700	241700	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099047_from_subject_158114885__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700099015	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	29	0	BCM	HMP_production_phase_1
SRS063960.572930	TCAGAGTGACTAGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_4472	SRR058114	39.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063960	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268866	268866	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111618_from_subject_937495960__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700111585	n	969	4	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	39	4.8	JCVI	HMP_production_phase_1
SRS053920.572415	TCAGACCTGAAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BCM	y	BCM	HMP_production_phase_3818	SRR048467	27.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS053920	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241839	241839	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107526_from_subject_159632143__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107498	n	969	266	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	27	0	BCM	HMP_production_phase_1
SRS023671.575037	TCAGAGTCTAGTAG	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_2486	SRR058086	28.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023671	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241751	241751	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099978_from_subject_892969023__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700099956	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	4.1	JCVI	HMP_production_phase_1
SRS016990.572825	TCAGCCGTTCCTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1013	SRR041566	28.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016990	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241746	241746	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033503_from_subject_159490532__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700033502	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	28	0	BI	HMP_production_phase_1
SRS015131.570593	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_516	SRR045679	28.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015131	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241850	241850	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023786_from_subject_763901136__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023700	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	28	4.5	WUGSC	HMP_production_phase_1
SRS019013.574836	TCAGAGTTGGC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_1466	SRR044597	23.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019013	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241778	241778	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037484_from_subject_764305738__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700037453	n	969	77	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	23	0	WUGSC	HMP_production_phase_1
SRS023258.571633	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2386	SRR058092	27.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023258	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241770	241770	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099416_from_subject_964271349__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099389	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	27	0	JCVI	HMP_production_phase_1
SRS045119.572501	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3031	SRR047573	24.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045119	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241864	241864	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038785_from_subject_508703490__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	TRUE	n	TCAG	UBERON:sebum	700038753	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	24	5.3	WUGSC	HMP_production_phase_1
SRS015675.573249	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_667	SRR044250	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241845	241845	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024330_from_subject_764487809__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024302	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	26	0	WUGSC	HMP_production_phase_1
SRS020439.571746	TCAGAAGGAACCAAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1690	SRR040871	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020439	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241680	241680	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095762_from_subject_160684109__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700095730	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	24	0	BI	HMP_production_phase_1
SRS024118.571874	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2600	SRR041272	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024118	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100583_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100552	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	26	0	BI	HMP_production_phase_1
SRS021994.573633	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_2065	SRR041096	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS021994	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241747	241747	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097734_from_subject_158256496__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097700	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	27	4.1	BI	HMP_production_phase_1
SRS024001.575478	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2571	SRR040916	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024001	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100462_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100428	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	0	BI	HMP_production_phase_1
SRS018767.574335	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1426	SRR044394	21.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018767	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241832	241832	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037234_from_subject_765013792__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700037140	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	21	4.5	WUGSC	HMP_production_phase_1
SRS022763.576249	TCAGTGACGTGACA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2265	SRR058114	22.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022763	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241670	241670	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098719_from_subject_370425937__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098683	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	22	0	JCVI	HMP_production_phase_1
SRS013563.573535	TCAGAAGGCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_255	SRR048264	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013563	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016584_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	22	4.7	BCM	HMP_production_phase_1
SRS014544.576208	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_381	SRR049361	24.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS014544	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241730	241730	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023198_from_subject_763638144__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700023174	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	3.8	WUGSC	HMP_production_phase_1
SRS015805.570680	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_697	SRR044710	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015805	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241763	241763	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024460_from_subject_763435843__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024444	n	969	84	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	21	0	WUGSC	HMP_production_phase_1
SRS018763.570470	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1424	SRR044389	21.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018763	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241832	241832	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037230_from_subject_765013792__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700037138	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	4.5	WUGSC	HMP_production_phase_1
SRS017796.575812	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1199	SRR040746	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017796	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241782	241782	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034889_from_subject_160542498__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034854	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS062889.570467	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4308	SRR048847	39.0	mimarks-survey	human	0	BCM	9606	n	human vagina metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062889	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:268877	268877	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111358_from_subject_763721271__sex_female_	UBERON:vagina	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:mucus	700111316	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	39	4.8	BCM	HMP_production_phase_1
SRS051232.575617	TCAGCAAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3597	SRR048511	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051232	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107579_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700107553	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	22	0	BCM	HMP_production_phase_1
SRS062747.571296	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4289	SRR048423	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS062747	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110788_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110764	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	4.6	BCM	HMP_production_phase_1
SRS055630.576478	TCAGTCTTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3941	SRR046684	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS055630	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241879	241879	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106512_from_subject_553359145__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700106489	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	32	4.3	WUGSC	HMP_production_phase_1
SRS023324.575222	TCAGTGTACTACAT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2402	SRR058086	23.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023324	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241835	241835	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099486_from_subject_206906765__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099453	n	969	6	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	4.3	JCVI	HMP_production_phase_1
SRS047859.570659	TCAGACTCAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_3297	SRR046045	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS047859	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241864	241864	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038773_from_subject_508703490__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700038747	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	24	5.3	WUGSC	HMP_production_phase_1
SRS064922.572131	TCAGTGTCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4606	SRR049427	21.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS064922	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257117	257117	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114584_from_subject_875002022__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114552	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	WUGSC	HMP_production_phase_1
SRS018958.572900	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1449	SRR046526	32.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018958	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241737	241737	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037427_from_subject_765276783__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700037400	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	32	0	WUGSC	HMP_production_phase_1
SRS023118.574128	TCAGTACACGATGT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2350	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023118	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099249_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700099131	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	24	4.3	JCVI	HMP_production_phase_1
SRS018167.573404	TCAGAACGCCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1290	SRR043235	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018167	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241828	241828	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035567_from_subject_160158126__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700035531	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS043043.575543	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2836	SRR048519	22.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043043	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241765	241765	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107595_from_subject_160097436__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700107561	n	969	243	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	22	0	BCM	HMP_production_phase_1
SRS021936.574731	TCAGAGACAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2054	SRR048303	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021936	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241739	241739	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097676_from_subject_158155345__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097644	n	969	254	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	24	0	BCM	HMP_production_phase_1
SRS015450.573348	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_605	SRR044758	35.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015450	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241743	241743	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024105_from_subject_764083206__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700024085	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	35	0	WUGSC	HMP_production_phase_1
SRS022109.574810	TCAGTGAAGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2093	SRR041624	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022109	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241803	241803	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097875_from_subject_158337416__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097845	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	22	4.4	BI	HMP_production_phase_1
SRS020829.573858	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_1778	SRR058093	21.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020829	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241677	241677	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700096303_from_subject_160886410__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700096276	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	21	0	JCVI	HMP_production_phase_1
SRS063554.573856	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4407	SRR049488	23.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063554	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241784	241784	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113596_from_subject_764346198__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113559	n	969	308	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	23	4.1	WUGSC	HMP_production_phase_1
SRS046154.572165	TCAGATTACGGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3143	SRR040849	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046154	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102454_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102424	n	969	201	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS049599.574136	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3442	SRR045518	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS049599	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241812	241812	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038726_from_subject_763698834__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038695	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	25	3.7	WUGSC	HMP_production_phase_1
SRS018525.572531	TCAGTTATTCCTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1380	SRR042865	21.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018525	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241667	241667	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035989_from_subject_160259276__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700035949	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	21	4.1	BI	HMP_production_phase_1
SRS019673.571386	TCAGTCCGCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1541	SRR045878	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019673	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241791	241791	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038146_from_subject_763678604__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	NA	y	TCAG	UBERON:saliva	700038120	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	25	0	WUGSC	HMP_production_phase_1
SRS015858.571023	TCAGACACGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_713	SRR046504	39.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015858	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241830	241830	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024513_from_subject_764002286__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024494	n	969	35	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	39	0	WUGSC	HMP_production_phase_1
SRS013559.576546	TCAGTTGACAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_253	SRR048261	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013559	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016580_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016550	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Buccal_mucosa	22	4.7	BCM	HMP_production_phase_1
SRS057251.575701	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4084	SRR048764	32.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057251	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241726	241726	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108262_from_subject_160704339__sex_female_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700108229	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	32	4.6	BCM	HMP_production_phase_1
SRS023128.575885	TCAGAGAGTCACGA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2355	SRR058089	24.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023128	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241757	241757	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099259_from_subject_441369442__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700099136	n	969	14	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	24	4.3	JCVI	HMP_production_phase_1
SRS019675.574470	TCAGAATGGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1542	SRR043963	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019675	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038148_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700038121	n	969	157	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS017086.570817	TCAGTCGAAGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1034	SRR041323	23.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017086	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241705	241705	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033599_from_subject_159611913__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700033570	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	23	0	BI	HMP_production_phase_1
SRS057450.571067	TCAGTTATCGGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_4103	SRR043618	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS057450	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241825	241825	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038470_from_subject_763536994__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038444	n	969	191	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS011663.574477	TCAGAACGAGGC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	WUGSC	y	WUGSC	HMP_production_phase_183	SRR044985	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011663	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033767_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033735	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	27	4.4	WUGSC	HMP_production_phase_1
SRS011294.575578	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_29	SRR049323	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011294	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241748	241748	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015298_from_subject_158802708__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700015296	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	0	WUGSC	HMP_production_phase_1
SRS065061.573992	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BCM	y	BCM	HMP_production_phase_4622	SRR048819	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065061	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:268869	268869	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111775_from_subject_872848689__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111749	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	24	4.6	BCM	HMP_production_phase_1
SRS018147.575493	TCAGACGAATTAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1280	SRR043020	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018147	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241828	241828	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035547_from_subject_160158126__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035520	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	26	0	BI	HMP_production_phase_1
SRS019705.573458	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1548	SRR049409	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019705	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241779	241779	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038179_from_subject_765539774__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700038159	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	25	3.8	WUGSC	HMP_production_phase_1
SRS022045.571339	TCAGTCGCTACGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2076	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022045	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097785_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097760	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Tongue_dorsum	31	0	JCVI	HMP_production_phase_1
SRS063615.570791	TCAGTGGTGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4413	SRR048842	39.0	mimarks-survey	human	0	BCM	9606	n	human nose metagenome	0	3.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063615	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:268877	268877	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	33.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111354_from_subject_763721271__sex_female_	UBERON:nostril	n	y	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700111314	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	39	4.8	BCM	HMP_production_phase_1
SRS024116.571245	TCAGACGAAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2599	SRR041237	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024116	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100581_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700100551	n	969	203	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	BI	HMP_production_phase_1
SRS064595.572787	TCAGCTACATCACG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_4560	SRR058114	28.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064595	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257122	257122	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	29.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700111071_from_subject_686765762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700111039	n	969	54	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	28	0	JCVI	HMP_production_phase_1
SRS017659.570271	TCAGAAGAAGAC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1159	SRR041134	19.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017659	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241775	241775	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	NA	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034659_from_subject_160461578__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034631	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	19	0	BI	HMP_production_phase_1
SRS044018.570796	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2930	SRR048724	31.0	mimarks-survey	human	0	BCM	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS044018	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241690	241690	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108652_from_subject_159915365__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700108613	n	969	261	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	31	4	BCM	HMP_production_phase_1
SRS063727.576430	TCAGCACGC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_4428	SRR048870	35.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063727	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241804	241804	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110784_from_subject_158984779__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110762	n	969	364	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	35	4.6	BCM	HMP_production_phase_1
SRS022372.573780	TCAGTGTCGTAGCA	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	JCVI	y	JCVI	HMP_production_phase_2164	SRR058089	35.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022372	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241768	241768	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098238_from_subject_492786515__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098210	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	35	0	JCVI	HMP_production_phase_1
SRS019580.573840	TCAGTCACAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_1531	SRR045500	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019580	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038051_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700038020	n	969	161	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	37	0	WUGSC	HMP_production_phase_1
SRS014239.571320	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_323	SRR043883	25.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014239	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241791	241791	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700021828_from_subject_763678604__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700021809	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	25	0	WUGSC	HMP_production_phase_1
SRS011159.576385	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_2	SRR045072	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011159	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014968_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014965	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	38	0	WUGSC	HMP_production_phase_1
SRS054576.574211	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_3863	SRR046042	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054576	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241886	241886	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038596_from_subject_404239096__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700038579	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	25	0	WUGSC	HMP_production_phase_1
SRS018212.575746	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1299	SRR041980	22.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018212	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241765	241765	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035619_from_subject_160097436__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:mucus	700035586	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	22	0	BI	HMP_production_phase_1
SRS013664.572303	TCAGACCGGAAGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_271	SRR041547	33.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013664	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241672	241672	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016742_from_subject_159288231__sex_male_	UBERON:oral cavity	n	y	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700016705	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	33	0	BI	HMP_production_phase_1
SRS011175.571936	TCAGATACCAC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_10	SRR045292	38.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011175	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241686	241686	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700014994_from_subject_158822939__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700014992	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	38	0	WUGSC	HMP_production_phase_1
SRS018023.570445	TCAGAACCGACCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1254	SRR040709	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018023	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241734	241734	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035347_from_subject_160239046__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035310	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS018519.571982	TCAGTTAATGGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1377	SRR042854	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018519	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241667	241667	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035983_from_subject_160259276__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700035946	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	21	4.1	BI	HMP_production_phase_1
SRS015346.572318	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_581	SRR044121	23.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	3.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015346	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241811	241811	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024001_from_subject_764184357__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700023974	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	23	3.7	WUGSC	HMP_production_phase_1
SRS023143.575454	TCAGTATGATACTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2361	SRR058111	24.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023143	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241757	241757	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099274_from_subject_441369442__sex_female_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700099284	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	24	0	JCVI	HMP_production_phase_1
SRS016020.571798	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_762	SRR044473	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016020	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241708	241708	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024675_from_subject_764447348__sex_male_	UBERON:skin	n	None	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700024647	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	0	WUGSC	HMP_production_phase_1
SRS045212.574626	TCAGACCTTGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3047	SRR047143	25.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045212	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241844	241844	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105254_from_subject_763820215__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700105218	n	969	273	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	25	4	WUGSC	HMP_production_phase_1
SRS043201.574783	TCAGTTCGCGAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2849	SRR048700	31.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS043201	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241679	241679	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109216_from_subject_160765029__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109185	n	969	182	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	31	0	BCM	HMP_production_phase_1
SRS019842.574918	TCAGCCGGCCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1567	SRR047651	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS019842	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241790	241790	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700038318_from_subject_765661155__sex_female_	UBERON:vagina	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700038282	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	4.3	WUGSC	HMP_production_phase_1
SRS018041.572549	TCAGAACTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1262	SRR042815	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	3.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018041	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241836	241836	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035365_from_subject_160016515__sex_female_	UBERON:skin	n	y	ENVO:sebum	V35	NA	y	TCAG	UBERON:sebum	700035319	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	23	4.3	BI	HMP_production_phase_1
SRS015017.570397	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_499	SRR046081	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015017	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023672_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700023643	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	20	4.8	WUGSC	HMP_production_phase_1
SRS022323.571537	TCAGCGTCAGCACG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2153	SRR058111	25.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022323	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241841	241841	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098163_from_subject_533247696__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098125	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	25	4.5	JCVI	HMP_production_phase_1
SRS015017.573435	TCAGAACACAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_499	SRR045766	20.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015017	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241718	241718	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023672_from_subject_764062976__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023643	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	20	4.8	WUGSC	HMP_production_phase_1
SRS063522.574124	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4402	SRR047034	26.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.6	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063522	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:257130	257130	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114230_from_subject_663835652__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700114210	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	26	4.5	WUGSC	HMP_production_phase_1
SRS050257.572040	TCAGTCTATACGCT	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3504	SRR058112	32.0	mimarks-survey	human	0	JCVI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS050257	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241754	241754	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700108529_from_subject_160967330__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	y	TCAG	UBERON:nasal mucus	700108491	n	969	196	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	32	0	JCVI	HMP_production_phase_1
SRS065357.572338	TCAGCCACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4671	SRR049563	24.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS065357	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241890	241890	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114842_from_subject_375450439__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700114810	n	969	92	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	24	4.1	WUGSC	HMP_production_phase_1
SRS017300.570861	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1086	SRR042977	26.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017300	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241724	241724	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033975_from_subject_159510762__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033939	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	26	0	BI	HMP_production_phase_1
SRS022627.575851	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_2228	SRR041424	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022627	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241820	241820	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098579_from_subject_158499257__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098551	n	969	238	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Attached_Keratinized_gingiva	25	0	BI	HMP_production_phase_1
SRS023871.570950	TCAGAACCGTGTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_2536	SRR048211	29.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.2	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023871	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241755	241755	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	28.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100269_from_subject_158883629__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100237	n	969	271	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	29	4.9	BCM	HMP_production_phase_1
SRS017719.572148	TCAGTAACCGGATC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1174	SRR040972	30.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017719	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241710	241710	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034812_from_subject_160582958__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034781	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	30	4.1	BI	HMP_production_phase_1
SRS054512.573551	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3857	SRR048880	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054512	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107800_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700107770	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	24	0	BCM	HMP_production_phase_1
SRS024165.575624	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2610	SRR041157	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024165	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241676	241676	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100633_from_subject_159207311__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100607	n	969	231	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS022053.570608	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2080	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022053	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241738	241738	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097793_from_subject_161554003__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700097764	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	31	0	JCVI	HMP_production_phase_1
SRS063961.575790	TCAGCGACTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_4473	SRR046985	22.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS063961	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241865	241865	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114749_from_subject_764831721__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700114717	n	969	248	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	22	0	WUGSC	HMP_production_phase_1
SRS024005.572126	TCAGTTCATAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2573	SRR041417	22.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024005	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241704	241704	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100466_from_subject_159369152__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700100430	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	22	0	BI	HMP_production_phase_1
SRS017044.573288	TCAGACGGTCCGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1027	SRR042812	28.0	mimarks-survey	human	0	BI	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017044	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241746	241746	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033557_from_subject_159490532__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700033556	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Anterior_nares	28	0	BI	HMP_production_phase_1
SRS017274.573248	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1074	SRR041291	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017274	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241724	241724	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033949_from_subject_159510762__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033926	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS024285.571233	TCAGCCAGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2641	SRR042001	24.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024285	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241712	241712	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101263_from_subject_158944319__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101234	n	969	278	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	24	3.7	BI	HMP_production_phase_1
SRS019103.575962	TCAGACTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_1477	SRR049227	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS019103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700037574_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700037546	n	969	106	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	35	0	WUGSC	HMP_production_phase_1
SRS021516.572690	TCAGTGCCGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1952	SRR042875	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS021516	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241722	241722	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097228_from_subject_158479027__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700097193	n	969	205	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS011375.570456	TCAGAGGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_41	SRR049321	33.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011375	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241767	241767	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	32.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015665_from_subject_158924089__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015663	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	33	0	WUGSC	HMP_production_phase_1
SRS022065.575213	TCAGCGTGAGTGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2086	SRR058120	31.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS022065	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241738	241738	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097805_from_subject_161554003__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700097770	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	31	0	JCVI	HMP_production_phase_1
SRS018453.570514	TCAGTTCCGTCCAC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1361	SRR041900	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018453	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035887_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	NA	n	TCAG	UBERON:saliva	700035855	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	25	0	BI	HMP_production_phase_1
SRS013557.574445	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_252	SRR048262	22.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS013557	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241796	241796	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016578_from_subject_159227541__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700016549	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	22	4.7	BCM	HMP_production_phase_1
SRS024238.573754	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2632	SRR042012	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024238	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241745	241745	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101125_from_subject_159308461__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700101091	n	969	224	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Retroauricular_crease	28	0	BI	HMP_production_phase_1
SRS022761.571696	TCAGCTGTACGTAG	CCGTCAATTCMTTTRAGT	v35	curette	JCVI	y	JCVI	HMP_production_phase_2264	SRR058089	22.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022761	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241670	241670	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098717_from_subject_370425937__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700098682	n	969	1	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	22	4.1	JCVI	HMP_production_phase_1
SRS017369.572298	TCAGTTGTTCGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1101	SRR042937	23.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017369	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241674	241674	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034075_from_subject_160340197__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700034040	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	23	0	BI	HMP_production_phase_1
SRS016948.572925	TCAGAACTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1008	SRR042996	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS016948	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241792	241792	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033414_from_subject_159450072__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700033379	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS018290.575826	TCAGTCCGGTCCTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1323	SRR041286	26.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	3.7	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018290	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241785	241785	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035697_from_subject_160137896__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700035655	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Mid_vagina	26	3.9	BI	HMP_production_phase_1
SRS022189.575376	TCAGCTAGAGTGTG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2118	SRR058111	27.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022189	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241683	241683	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	NA	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700097958_from_subject_638754422__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700097921	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	27	4.5	JCVI	HMP_production_phase_1
SRS020559.571758	TCAGTTAACCGAATC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1719	SRR042796	21.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS020559	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241821	241821	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	NA	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700095882_from_subject_160845950__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700095847	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	21	0	BI	HMP_production_phase_1
SRS011580.573956	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_141	SRR044945	27.0	mimarks-survey	human	0	WUGSC	9606	n	human vagina metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vagina	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011580	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241834	241834	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vagina	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033038_from_subject_159247771__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700033036	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Vaginal_introitus	27	4.7	WUGSC	HMP_production_phase_1
SRS015472.573611	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_614	SRR047454	35.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS015472	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241743	241743	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	NA	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024127_from_subject_764083206__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024096	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Subgingival_plaque	35	0	WUGSC	HMP_production_phase_1
SRS016604.572186	TCAGTTGTGTTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_924	SRR041228	31.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016604	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241690	241690	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	21.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032357_from_subject_159915365__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700032326	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	31	4.3	BI	HMP_production_phase_1
SRS023633.576505	TCAGTATCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2478	SRR040595	20.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS023633	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241702	241702	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700099936_from_subject_159005010__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700099900	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Left_Retroauricular_crease	20	4.9	BI	HMP_production_phase_1
SRS050719.575069	TCAGAACCAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3549	SRR046326	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS050719	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105693_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105670	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	31	5	WUGSC	HMP_production_phase_1
SRS017935.573883	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1232	SRR041871	25.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017935	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241809	241809	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	25.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035256_from_subject_158357646__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035237	n	969	154	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Stool	25	0	BI	HMP_production_phase_1
SRS022697.576204	TCAGCTAGTATGCG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2248	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022697	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241689	241689	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098649_from_subject_432193348__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098613	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	26	4.6	JCVI	HMP_production_phase_1
SRS052103.573887	TCAGAACGGAGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_3671	SRR040928	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS052103	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241792	241792	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102991_from_subject_159450072__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700102969	n	969	245	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	28	0	BI	HMP_production_phase_1
SRS017529.574423	TCAGTCGAGGAAC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	BI	y	BI	HMP_production_phase_1138	SRR041043	26.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS017529	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241691	241691	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	NA	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700034262_from_subject_160502038__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700034236	n	969	5	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	0	BI	HMP_production_phase_1
SRS017017.574566	TCAGAGGTCCTTC	CCGTCAATTCMTTTRAGT	v35	Attached_Keratinized_gingiva_FIX	BI	y	BI	HMP_production_phase_1018	SRR041574	28.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017017	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241746	241746	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingival epithelium	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033530_from_subject_159490532__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700033529	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Attached_Keratinized_gingiva	28	0	BI	HMP_production_phase_1
SRS044569.575080	TCAGTCACCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2976	SRR047134	27.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044569	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241708	241708	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105769_from_subject_764447348__sex_male_	UBERON:nostril	n	None	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700105738	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	27	0	WUGSC	HMP_production_phase_1
SRS017038.575191	TCAGCGGTCCAAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1025	SRR042896	28.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS017038	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241746	241746	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033551_from_subject_159490532__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033550	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	28	0	BI	HMP_production_phase_1
SRS018370.571565	TCAGCGGACGGTTC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1340	SRR041369	24.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018370	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241797	241797	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035804_from_subject_160178356__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035785	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	24	0	BI	HMP_production_phase_1
SRS023748.575486	TCAGACTTGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2506	SRR040897	27.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS023748	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241773	241773	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700100055_from_subject_158721788__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700100029	n	969	275	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Hard_palate	27	0	BI	HMP_production_phase_1
SRS024422.575966	TCAGAAGGCAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2681	SRR040590	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS024422	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241764	241764	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101568_from_subject_159713063__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700101532	n	969	219	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Right_Antecubital_fossa	27	5.1	BI	HMP_production_phase_1
SRS014653.570582	TCAGTCGCGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_412	SRR045513	37.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014653	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241720	241720	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023307_from_subject_763597684__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700023287	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	37	0	WUGSC	HMP_production_phase_1
SRS011477.573536	TCAGCCGTTCAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_85	SRR044844	28.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS011477	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241760	241760	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700016176_from_subject_159146620__sex_male_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700016137	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	28	0	WUGSC	HMP_production_phase_1
SRS046134.572735	TCAGAGACCTC	CCGTCAATTCMTTTRAGT	v35	swab	BCM	y	BCM	HMP_production_phase_3138	SRR048598	24.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:tongue	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS046134	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241798	241798	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:mucosa of tongue	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700107790_from_subject_160400887__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700107765	n	969	210	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Tongue_dorsum	24	0	BCM	HMP_production_phase_1
SRS065615.572510	TCAGTATTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4717	SRR046992	32.0	mimarks-survey	human	0	WUGSC	9606	n	human nose metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:nostril	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS065615	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Airways	969:241858	241858	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:nostril	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114417_from_subject_764953101__sex_male_	UBERON:nostril	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:nasal mucus	700114386	n	969	226	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Anterior_nares	32	0	WUGSC	HMP_production_phase_1
SRS016693.575144	TCAGAATAACCGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_953	SRR041524	23.0	mimarks-survey	human	0	BI	9606	n	human vagina metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:vaginal fornix	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS016693	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Urogenital_tract	969:241713	241713	646099	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:vaginal fornix	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700032477_from_subject_160036745__sex_female_	UBERON:vagina	n	n	ENVO:mucus	V35	FALSE	n	TCAG	UBERON:mucus	700032476	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Posterior_fornix	23	5	BI	HMP_production_phase_1
SRS048008.572082	TCAGTACGAGTACA	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	JCVI	y	JCVI	HMP_production_phase_3312	SRR052699	21.0	mimarks-survey	human	0	JCVI	9606	n	human gut metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS048008	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241867	241867	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101793_from_subject_514014184__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700101771	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	21	4.2	JCVI	HMP_production_phase_1
SRS018441.574722	TCAGTCGGTCCGGC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_1355	SRR041172	25.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018441	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241826	241826	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:hard palate	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035875_from_subject_160218816__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035849	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Hard_palate	25	0	BI	HMP_production_phase_1
SRS011405.573854	TCAGCGCAAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	WUGSC	y	WUGSC	HMP_production_phase_45	SRR044948	27.0	mimarks-survey	human	0	WUGSC	9606	n	human gut metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011405	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241834	241834	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015981_from_subject_159247771__sex_female_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700015979	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	27	4.7	WUGSC	HMP_production_phase_1
SRS063770.570704	TCAGAAGAGTTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4436	SRR049428	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS063770	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:257114	257114	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	TRUE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700114513_from_subject_739574095__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	NA	n	TCAG	UBERON:sebum	700114487	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Antecubital_fossa	27	4.8	WUGSC	HMP_production_phase_1
SRS064811.570944	TCAGTCCAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4592	SRR047084	21.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS064811	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241876	241876	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	None	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700113049_from_subject_764750800__sex_male_	UBERON:oral cavity	n	None	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700113020	n	969	241	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	21	0	WUGSC	HMP_production_phase_1
SRS051870.571481	TCAGCTCACGCGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3648	SRR058085	29.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS051870	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:257120	257120	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110454_from_subject_604812005__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110427	n	969	82	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	29	0	JCVI	HMP_production_phase_1
SRS018513.572822	TCAGACCGACCGGC	CCGTCAATTCMTTTRAGT	v35	curette	BI	y	BI	HMP_production_phase_1374	SRR040771	21.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS018513	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241667	241667	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035977_from_subject_160259276__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700035943	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	21	4.1	BI	HMP_production_phase_1
SRS045153.571812	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3036	SRR046836	19.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.9	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045153	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241855	241855	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103321_from_subject_682449369__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700103286	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Throat	19	4.7	WUGSC	HMP_production_phase_1
SRS013264.576297	TCAGAACGCGGAC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_226	SRR042953	27.0	mimarks-survey	human	0	BI	9606	n	human skin metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:fossa	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS013264	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241833	241833	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:fossa	FALSE	years	y	31.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700015971_from_subject_159591683__sex_male_	UBERON:skin	n	y	ENVO:sebum	V35	FALSE	y	TCAG	UBERON:sebum	700015970	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Antecubital_fossa	27	0	BI	HMP_production_phase_1
SRS043378.570462	TCAGACGGCTC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_2869	SRR047723	31.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS043378	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241860	241860	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700103263_from_subject_465578759__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700105983	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	31	4.4	WUGSC	HMP_production_phase_1
SRS014915.571302	TCAGTAGGAATC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_471	SRR046091	33.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS014915	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241808	241808	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023570_from_subject_763860675__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023547	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Palatine_Tonsils	33	0	WUGSC	HMP_production_phase_1
SRS045667.572931	TCAGATTCGTAC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_3091	SRR048565	19.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045667	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241721	241721	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	20.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700109667_from_subject_160319967__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700109633	n	969	236	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Supragingival_plaque	19	4.7	BCM	HMP_production_phase_1
SRS024474.571387	TCAGTTCAACGGTC	CCGTCAATTCMTTTRAGT	v35	swab	BI	y	BI	HMP_production_phase_2692	SRR041016	38.0	mimarks-survey	human	0	BI	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS024474	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241794	241794	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	NA	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700101620_from_subject_159571453__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700101591	n	969	233	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	38	0	BI	HMP_production_phase_1
SRS044630.570409	TCAGAACCTGGC	CCGTCAATTCMTTTRAGT	v35	curette	BCM	y	BCM	HMP_production_phase_2985	SRR048252	23.0	mimarks-survey	human	0	BCM	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS044630	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241837	241837	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700102287_from_subject_159166850__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700102255	n	969	252	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Subgingival_plaque	23	0	BCM	HMP_production_phase_1
SRS011669.570746	TCAGTAATCTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_186	SRR044962	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011669	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241764	241764	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	30.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033773_from_subject_159713063__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	y	TCAG	UBERON:saliva	700033738	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	4.4	WUGSC	HMP_production_phase_1
SRS054954.575406	TCAGCGTGAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_3889	SRR047150	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS054954	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241685	241685	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oropharynx	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700106679_from_subject_764224817__sex_male_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:mucus	700106655	n	969	174	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Throat	26	0	WUGSC	HMP_production_phase_1
SRS045945.574923	TCAGCGACTACGAG	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_3120	SRR058090	40.0	mimarks-survey	human	0	JCVI	9606	n	human oral metagenome	0	4.4	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:oropharynx	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS045945	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241849	241849	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:palatine tonsil	FALSE	years	y	27.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700110263_from_subject_161473083__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700110231	n	969	187	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Palatine_Tonsils	40	4.9	JCVI	HMP_production_phase_1
SRS018133.570446	TCAGAGGTTCCGAC	CCGTCAATTCMTTTRAGT	v35	stool_specimen_collection_kit	BI	y	BI	HMP_production_phase_1277	SRR040925	26.0	mimarks-survey	human	0	BI	9606	n	human gut metagenome	0	0	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:feces	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	0	0.0	ENVO:human-associated habitat	SRS018133	male	Titanium	GAZ:United States of America	HMP_production_phase_1	Gastrointestinal_tract	969:241828	241828	408170	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:feces	FALSE	years	y	24.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700035533_from_subject_160158126__sex_male_	UBERON:feces	n	n	ENVO:feces	V35	FALSE	n	TCAG	UBERON:feces	700035514	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Stool	26	0	BI	HMP_production_phase_1
SRS015227.570701	TCAGCGGTCTTC	CCGTCAATTCMTTTRAGT	v35	Falcon_tube	WUGSC	y	WUGSC	HMP_production_phase_543	SRR044003	26.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.3	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015227	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241729	241729	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:oral cavity	FALSE	years	y	22.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700023882_from_subject_764143897__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700023862	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Saliva	26	4.4	WUGSC	HMP_production_phase_1
SRS011573.570478	TCAGACGAGAAC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_136	SRR044919	27.0	mimarks-survey	human	0	WUGSC	9606	n	human skin metagenome	0	4.1	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS011573	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241834	241834	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700033023_from_subject_159247771__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700033021	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Left_Retroauricular_crease	27	4.7	WUGSC	HMP_production_phase_1
SRS022699.573235	TCAGATCGCTAGTA	CCGTCAATTCMTTTRAGT	v35	swab	JCVI	y	JCVI	HMP_production_phase_2249	SRR058089	26.0	mimarks-survey	human	0	JCVI	9606	n	human skin metagenome	0	3.8	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:skin	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS022699	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Skin	969:241689	241689	539655	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:skin	FALSE	years	y	26.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700098651_from_subject_432193348__sex_female_	UBERON:skin	n	n	ENVO:sebum	V35	FALSE	n	TCAG	UBERON:sebum	700098614	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Right_Retroauricular_crease	26	4.6	JCVI	HMP_production_phase_1
SRS015407.573973	TCAGTTGAACTC	CCGTCAATTCMTTTRAGT	v35	curette	WUGSC	y	WUGSC	HMP_production_phase_598	SRR045738	27.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	3.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS015407	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241682	241682	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:gingiva	FALSE	years	y	19.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700024062_from_subject_764042746__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700024033	n	969	0	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	1	37.09	n	Supragingival_plaque	27	3.6	WUGSC	HMP_production_phase_1
SRS057259.575056	TCAGTTCGAGC	CCGTCAATTCMTTTRAGT	v35	swab	WUGSC	y	WUGSC	HMP_production_phase_4086	SRR046267	31.0	mimarks-survey	human	0	WUGSC	9606	n	human oral metagenome	0	4.5	-95.71	This HMP production phase represents pyrosequencing of 16S rRNA genes amplified from multiple body sites across hundreds of human subjects. There are two time points represented for a subset of these subjects. Using default protocol v4.2., data for the 16S window spanning V3-V5 was generated for all samples, with a second 16S window spanning V1-V3 generated for a majority of the samples. 16S rRNA sequencing is being used to characterize the complexity of microbial communities at individual body sites, and to determine whether there is a core microbiome at each site. Several body sites will be studied, including the gastrointestinal and female urogenital tracts, oral cavity, nasal and pharyngeal tract, and skin.	UBERON:mouth	pyrosequencing	HMP_v35	256.05	2010	Negative	2008-2010	1	0.0	ENVO:human-associated habitat	SRS057259	female	Titanium	GAZ:United States of America	HMP_production_phase_1	Oral	969:241717	241717	447426	0	None	ENVO:human-associated habitat	HMP_production_phase_1	UBERON:buccal mucosa	FALSE	years	y	23.0	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	HMP_Human_metagenome_sample_700105695_from_subject_763456073__sex_female_	UBERON:oral cavity	n	n	ENVO:saliva	V35	FALSE	n	TCAG	UBERON:saliva	700105671	n	969	323	n	None	HMP_v35	FWD:CCATCTCATCCCTGCGTGTCTCCGA;REV:CCGTCAATTCMTTTRAGT	http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf	2	37.09	n	Buccal_mucosa	31	5	WUGSC	HMP_production_phase_1